Drugs in Psychiatric Disorders — MCQs

Q: Which drug can cause psychosis?

Amfetamine. ### Explanation **Correct Option: B. Amfetamine** Amfetamine is a potent CNS stimulant that acts primarily by increasing the release of biogenic amines, particularly **Dopamine**, from presynaptic nerve terminals. According to the **Dopamine Hypothesis of Schizophrenia**, excessive dopaminergic activity in the mesolimbic pathway is linked to psychotic symptoms. High doses or chronic use of amfetamines can induce a "stimulant psychosis" that clinically mimics paranoid schizophrenia, characterized by delusions, hallucinations, and stereotypic behavior. **Analysis of Incorrect Options:** * **A. Ofloxacin:** While fluoroquinolones can occasionally cause CNS side effects like insomnia or dizziness, they are not classically associated with inducing frank psychosis. * **C. Capreomycin:** This is a polypeptide protein synthesis inhibitor used in MDR-TB. Its primary toxicities are **nephrotoxicity** and **ototoxicity** (8th cranial nerve damage), similar to aminoglycosides. * **D. Rifampicin:** A key anti-tubercular drug known for causing orange-colored secretions (urine, sweat, tears) and hepatotoxicity. It does not have psychotropic side effects. **High-Yield Clinical Pearls for NEET-PG:** * **Other drugs causing psychosis:** Levodopa (dopamine precursor), Steroids ("Steroid Psychosis"), Isoniazid (INH), Ketamine, and Cocaine. * **Drug of Choice for Amfetamine Psychosis:** Antipsychotics like **Haloperidol** (D2 blockers) are used to manage acute symptoms. * **Mechanism Recap:** Amfetamines reverse the direction of the dopamine transporter (DAT), pumping dopamine out into the synapse.

Q: Which of the following is an atypical antidepressant?

Venlafaxine. ### Explanation The classification of antidepressants is a high-yield topic for NEET-PG. Antidepressants are categorized based on their mechanism of action and chemical structure. **Correct Option: C. Venlafaxine** Venlafaxine is classified as a **Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)**. In many clinical classifications and competitive exams, SNRIs (like Venlafaxine and Duloxetine) and other newer classes (like Bupropion, Mirtazapine, and Trazodone) are grouped under the umbrella of **"Atypical Antidepressants"** because they differ from the traditional Tricyclic Antidepressants (TCAs) and Monoamine Oxidase Inhibitors (MAOIs) in both structure and side-effect profile. Venlafaxine inhibits the reuptake of both 5-HT and NE, making it effective for major depression and anxiety disorders. **Incorrect Options:** * **A & B (Citalopram and Sertraline):** These belong to the **Selective Serotonin Reuptake Inhibitors (SSRIs)** class. SSRIs are the first-line treatment for depression but are distinct from the "atypical" category. * **D (Reboxetine):** This is a **Selective Norepinephrine Reuptake Inhibitor (NRI)**. While it is a newer drug, it is specifically categorized by its selective action on norepinephrine rather than being grouped with the general atypical agents. **High-Yield Clinical Pearls for NEET-PG:** * **Venlafaxine:** At low doses, it acts primarily on serotonin; at higher doses (>150 mg), it significantly affects norepinephrine. A key side effect to monitor is **dose-dependent hypertension**. * **Duloxetine (SNRI):** Preferred in patients with comorbid **diabetic neuropathy** or chronic pain. * **Mirtazapine:** An $\alpha_2$-blocker (NaSSA) known for causing **weight gain and sedation**, making it useful for depressed patients with insomnia and anorexia. * **Bupropion:** Inhibits DA and NE reuptake; it is unique because it **does not cause sexual dysfunction** and is used for smoking cessation.

Q: Which of the following drugs is most commonly associated with extrapyramidal side effects?

Haloperidol. **Explanation:** The correct answer is **Haloperidol**. **1. Why Haloperidol is correct:** Haloperidol is a **First-Generation Antipsychotic (FGA)** or "Typical" antipsychotic. Its primary mechanism of action is the potent, non-selective blockade of **D2 receptors** in the brain. Extrapyramidal side effects (EPS) occur due to the blockade of D2 receptors in the **nigrostriatal pathway** [1], [3]. Haloperidol has a very high affinity for these receptors and dissociates slowly, leading to a high incidence of acute dystonia, akathisia, parkinsonism, and tardive dyskinesia [1], [3]. **2. Why the other options are incorrect:** * **Clozapine:** This is the prototype **Second-Generation Antipsychotic (SGA)**. It has a low affinity for D2 receptors and a high affinity for 5-HT2A receptors. It is the drug with the **lowest risk of EPS** among all antipsychotics [2]. * **Risperidone:** While an SGA, it is "atypical" only at low doses. At higher doses (>6mg), it behaves like a typical antipsychotic and can cause EPS, but the risk remains lower than that of Haloperidol [2]. * **Ziprasidone:** An SGA with a lower propensity for EPS and weight gain, though it is more notably associated with QT interval prolongation. **High-Yield Clinical Pearls for NEET-PG:** * **EPS Hierarchy:** Haloperidol (Highest risk) > Risperidone > Olanzapine > Quetiapine > Clozapine (Lowest risk). * **Drug of Choice for EPS:** Centrally acting anticholinergics like **Benztropine** or **Trihexyphenidyl (PACANE)** [3]. * **Tardive Dyskinesia:** The most serious long-term EPS; treatment involves switching to Clozapine or using VMAT-2 inhibitors (Valbenazine). * **Hyperprolactinemia:** Also caused by D2 blockade in the tuberoinfundibular pathway; Haloperidol and Risperidone are common culprits [1], [3].

Q: Which of the following drug classes is known to cause extrapyramidal symptoms?

Phenothiazines. **Explanation:** **1. Why Phenothiazines are correct:** Phenothiazines (e.g., Chlorpromazine, Fluphenazine) are "Typical" or first-generation antipsychotics. Their primary mechanism of action is the **blockade of Dopamine (D2) receptors** in the brain. While blockade in the mesolimbic pathway treats psychosis, blockade in the **nigrostriatal pathway** disrupts the balance between dopamine and acetylcholine. This deficiency of dopamine in the basal ganglia leads to **Extrapyramidal Symptoms (EPS)**, including acute dystonia, akathisia, parkinsonism, and tardive dyskinesia. **2. Why other options are incorrect:** * **Antibiotics:** Generally do not affect dopaminergic pathways. While some (like aminoglycosides) have neuromuscular blocking properties, they do not cause EPS. * **Salicylates:** These are NSAIDs (e.g., Aspirin) that inhibit cyclooxygenase (COX) enzymes. Toxicity typically presents with tinnitus, metabolic acidosis, and respiratory alkalosis, not movement disorders. * **Barbiturates:** These act as GABA-A receptor agonists (CNS depressants). Overdose leads to respiratory depression and coma, but they do not block dopamine receptors. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice for Acute Dystonia:** Central anticholinergics like **Promethazine** or **Benztropine**. * **Drug of Choice for Akathisia:** **Propranolol** (Beta-blocker). * **Tardive Dyskinesia:** Result of dopamine receptor supersensitivity; managed by switching to **Clozapine** (least likely to cause EPS) or using VMAT-2 inhibitors (Valbenazine). * **Antiemetic EPS:** Remember that **Metoclopramide** (a D2 blocker) is a common non-psychiatric cause of EPS.

Q: Tricyclic antidepressants are contraindicated in which of the following conditions?

Glaucoma. **Explanation:** The correct answer is **Glaucoma**. **Mechanism of Action & Contraindication:** Tricyclic Antidepressants (TCAs), such as Amitriptyline and Imipramine, possess significant **muscarinic (M1) receptor blocking activity**. This potent anticholinergic effect leads to mydriasis (dilation of the pupil). In patients with narrow-angle glaucoma, mydriasis causes the iris to fold back into the filtration angle, obstructing the drainage of aqueous humor. This can trigger an acute increase in intraocular pressure, potentially leading to an emergency angle-closure crisis. **Analysis of Incorrect Options:** * **Brain tumor:** While TCAs lower the seizure threshold (caution in epilepsy), they are not strictly contraindicated in brain tumors unless the patient has uncontrolled seizures or specific intracranial pressure issues not related to the drug's primary mechanism. * **Bronchial asthma:** TCAs do not cause bronchoconstriction. In fact, their anticholinergic properties might theoretically cause mild bronchodilation, though they are not used for this purpose. * **Hypertension:** While TCAs can cause orthostatic hypotension (via $\alpha_1$ blockade) or tachycardia, they are not contraindicated in hypertension. However, they should be used cautiously with certain antihypertensives like Guanethidine. **High-Yield Clinical Pearls for NEET-PG:** * **Side Effect Profile:** Remember the mnemonic "3 Cs" for TCA overdose: **C**oma, **C**onvulsions, and **C**ardiotoxicity (arrhythmias due to Na+ channel blockade). * **Other Contraindications:** Recent Myocardial Infarction (due to risk of arrhythmias) and Benign Prostatic Hyperplasia (BPH) (due to urinary retention from anticholinergic effects). * **Drug of Choice:** TCAs are the drug of choice for **Nocturnal Enuresis** (Imipramine) and **Neuropathic Pain** (Amitriptyline).

Q: A very potent and short-acting benzodiazepine was given to a patient for the purpose of causing hypnosis, but the drug caused psychiatric disturbances. Which of the following could be the hypnotic used?

Triazolam. **Explanation:** The correct answer is **Triazolam**. **1. Why Triazolam is correct:** Triazolam is an ultra-short-acting benzodiazepine (half-life: 2–3 hours) used primarily for the induction of sleep. Because of its high potency and rapid elimination, it is uniquely associated with a high incidence of **psychiatric disturbances**, including daytime anxiety, amnesia, confusion, and "rebound insomnia." More importantly, it can cause severe behavioral side effects such as agitation, hallucinations, and even paranoia (often referred to as the "Triazolam syndrome"). Due to these adverse psychiatric effects, its use has been restricted or banned in several countries. **2. Why other options are incorrect:** * **Flurazepam:** This is a long-acting benzodiazepine (half-life >50 hours due to active metabolites). Its primary side effect is "hangover" or excessive daytime sedation, rather than acute psychiatric disturbances. * **Nitrazepam:** An intermediate-acting benzodiazepine. While it can cause morning grogginess, it does not share the specific high-potency, short-acting profile linked to the psychiatric agitation seen with Triazolam. * **Temazepam:** An intermediate-acting drug (half-life 8–12 hours). It is metabolized by conjugation and is generally better tolerated in terms of behavioral side effects compared to Triazolam. **High-Yield Clinical Pearls for NEET-PG:** * **Shortest Acting BZD:** Midazolam (used for anesthesia) and Triazolam (used for hypnosis). * **Longest Acting BZD:** Flurazepam and Quazepam. * **BZDs safe in Liver Failure:** Remember the mnemonic **LOT** (Lorazepam, Oxazepam, Temazepam) as they undergo direct glucuronidation and have no active metabolites. * **Triazolam specific side effect:** Anterograde amnesia is more common with Triazolam than with most other oral BZDs.

Q: Which of the following classes of antidepressants is used in the management of smoking cessation?

Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs). **Explanation:** The correct answer is **Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs)**. The prototype drug in this class is **Bupropion**. **1. Why NDRIs are correct:** Bupropion works by inhibiting the reuptake of both Norepinephrine (NE) and Dopamine (DA). In the context of smoking cessation, its efficacy is attributed to two mechanisms: * **Dopaminergic action:** It increases dopamine levels in the "reward pathway" (nucleus accumbens), which mimics the effects of nicotine and reduces withdrawal symptoms and cravings. * **Antagonistic action:** It acts as a non-competitive antagonist at nicotinic acetylcholine receptors, blocking the reinforcing effects of nicotine if a patient relapses. **2. Why other options are incorrect:** * **SSRIs (e.g., Fluoxetine):** While excellent for depression and anxiety, they have not shown significant efficacy in increasing long-term smoking quit rates. * **MAOIs (e.g., Phenelzine):** These are rarely used due to their extensive side effect profile and dietary restrictions (tyramine reaction); they are not indicated for smoking cessation. * **RIMAs (e.g., Moclobemide):** These are safer versions of MAOIs but do not play a role in managing nicotine dependence. **High-Yield Clinical Pearls for NEET-PG:** * **Contraindication:** Bupropion is strictly contraindicated in patients with **Seizure disorders** or **Eating disorders** (Bulimia/Anorexia) as it lowers the seizure threshold. * **Weight Neutrality:** Unlike many other antidepressants, Bupropion is often weight-neutral or may cause slight weight loss. * **Sexual Dysfunction:** It is the antidepressant of choice for patients experiencing sexual dysfunction from SSRIs. * **Varenicline:** Remember that Varenicline (a partial $\alpha4\beta2$ nicotinic agonist) is generally considered more effective than Bupropion for smoking cessation, but Bupropion remains a first-line pharmacological option.

Q: Which is the recently approved drug for psychosis associated with Parkinsonism?

Pimavanserin. **Explanation:** **Pimavanserin** is the correct answer. It is a novel atypical antipsychotic specifically FDA-approved for the treatment of hallucinations and delusions associated with **Parkinson’s Disease Psychosis (PDP)**. **Mechanism of Action:** Unlike traditional antipsychotics that block Dopamine (D2) receptors—which would worsen motor symptoms in Parkinson’s—Pimavanserin acts as a **selective inverse agonist and antagonist at 5-HT2A receptors**. It has no significant affinity for D2, muscarinic, or histaminergic receptors. This allows it to treat psychotic symptoms without deteriorating motor function. **Analysis of Incorrect Options:** * **A. Lorcaserin:** A selective 5-HT2C receptor agonist previously used for weight loss (withdrawn from many markets due to safety concerns); it has no role in psychosis. * **C. Cycloserine:** An antitubercular drug (second-line) that also acts as a partial NMDA receptor agonist; it is not used for Parkinsonian psychosis. * **D. Mianserin:** A tetracyclic antidepressant that blocks alpha-2 adrenergic and 5-HT receptors; while it has sedative properties, it is not the indicated treatment for PDP. **Clinical Pearls for NEET-PG:** * **Drug of Choice for PDP:** Pimavanserin is preferred. If unavailable, **Quetiapine** or **Clozapine** (at low doses) are the traditional alternatives because they have the lowest D2 affinity among standard antipsychotics. * **Avoid:** Typical antipsychotics (e.g., Haloperidol) and certain atypicals (e.g., Risperidone) as they severely worsen Parkinsonian tremors and rigidity. * **Side Effects:** Pimavanserin can cause QT interval prolongation; monitor patients with pre-existing cardiac conditions.

Drugs in Psychiatric Disorders Indian Medical PG Practice Questions and MCQs

Question 1: Which drug can cause psychosis?

A. Ofloxacin
B. Amfetamine (Correct Answer)
C. Capreomycin
D. Rifampicin

Explanation: ### Explanation **Correct Option: B. Amfetamine** Amfetamine is a potent CNS stimulant that acts primarily by increasing the release of biogenic amines, particularly **Dopamine**, from presynaptic nerve terminals. According to the **Dopamine Hypothesis of Schizophrenia**, excessive dopaminergic activity in the mesolimbic pathway is linked to psychotic symptoms. High doses or chronic use of amfetamines can induce a "stimulant psychosis" that clinically mimics paranoid schizophrenia, characterized by delusions, hallucinations, and stereotypic behavior. **Analysis of Incorrect Options:** * **A. Ofloxacin:** While fluoroquinolones can occasionally cause CNS side effects like insomnia or dizziness, they are not classically associated with inducing frank psychosis. * **C. Capreomycin:** This is a polypeptide protein synthesis inhibitor used in MDR-TB. Its primary toxicities are **nephrotoxicity** and **ototoxicity** (8th cranial nerve damage), similar to aminoglycosides. * **D. Rifampicin:** A key anti-tubercular drug known for causing orange-colored secretions (urine, sweat, tears) and hepatotoxicity. It does not have psychotropic side effects. **High-Yield Clinical Pearls for NEET-PG:** * **Other drugs causing psychosis:** Levodopa (dopamine precursor), Steroids ("Steroid Psychosis"), Isoniazid (INH), Ketamine, and Cocaine. * **Drug of Choice for Amfetamine Psychosis:** Antipsychotics like **Haloperidol** (D2 blockers) are used to manage acute symptoms. * **Mechanism Recap:** Amfetamines reverse the direction of the dopamine transporter (DAT), pumping dopamine out into the synapse.

Question 2: Propranolol, a non-selective beta blocker, can be prescribed to decrease anxiety associated with which of the following conditions?

A. Chronic neurotic disorder
B. Schizophrenia
C. Short-term stressful situations (Correct Answer)
D. Endogenous depression

Explanation: **Explanation:** **1. Why Option C is Correct:** Propranolol is a non-selective beta-adrenergic blocker that acts by inhibiting the effects of catecholamines on $\beta_1$ and $\beta_2$ receptors. In anxiety, it does not treat the core psychological distress but effectively suppresses the **peripheral somatic symptoms** of sympathetic overactivity, such as palpitations, tremors, sweating, and tachycardia. This makes it highly effective for **short-term stressful situations** (Performance Anxiety), such as public speaking, stage performances, or examinations, where physical symptoms might impair performance. **2. Why Other Options are Incorrect:** * **A. Chronic Neurotic Disorder:** These conditions (like Generalized Anxiety Disorder) require long-term management of psychological symptoms. SSRIs or SNRIs are the first-line treatments; Propranolol is insufficient as a monotherapy for chronic psychological anxiety. * **B. Schizophrenia:** This is a psychotic disorder characterized by dopamine dysregulation. It is treated with antipsychotics (D2 blockers). While Propranolol may be used to treat antipsychotic-induced *Akathisia*, it has no role in treating the primary symptoms of Schizophrenia. * **D. Endogenous Depression:** This is a mood disorder involving serotonin and norepinephrine deficits. Beta-blockers are generally avoided here as they can occasionally worsen depressive symptoms (propranolol is lipophilic and crosses the BBB). **3. Clinical Pearls for NEET-PG:** * **Drug of Choice for Akathisia:** Propranolol is the first-line treatment for antipsychotic-induced akathisia (restlessness). * **Performance Anxiety:** It is specifically used for "Stage Fright." * **Contraindications:** Avoid in patients with **Asthma/COPD** (due to $\beta_2$ blockade causing bronchospasm) and **Diabetes Mellitus** (masks tachycardia, a warning sign of hypoglycemia). * **Lipid Solubility:** Propranolol is highly lipid-soluble, allowing it to cross the blood-brain barrier, which contributes to its central effects.

Question 3: Which of the following is an atypical antidepressant?

A. Citalopram
B. Sertraline
C. Venlafaxine (Correct Answer)
D. Reboxetine

Explanation: ### Explanation The classification of antidepressants is a high-yield topic for NEET-PG. Antidepressants are categorized based on their mechanism of action and chemical structure. **Correct Option: C. Venlafaxine** Venlafaxine is classified as a **Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)**. In many clinical classifications and competitive exams, SNRIs (like Venlafaxine and Duloxetine) and other newer classes (like Bupropion, Mirtazapine, and Trazodone) are grouped under the umbrella of **"Atypical Antidepressants"** because they differ from the traditional Tricyclic Antidepressants (TCAs) and Monoamine Oxidase Inhibitors (MAOIs) in both structure and side-effect profile. Venlafaxine inhibits the reuptake of both 5-HT and NE, making it effective for major depression and anxiety disorders. **Incorrect Options:** * **A & B (Citalopram and Sertraline):** These belong to the **Selective Serotonin Reuptake Inhibitors (SSRIs)** class. SSRIs are the first-line treatment for depression but are distinct from the "atypical" category. * **D (Reboxetine):** This is a **Selective Norepinephrine Reuptake Inhibitor (NRI)**. While it is a newer drug, it is specifically categorized by its selective action on norepinephrine rather than being grouped with the general atypical agents. **High-Yield Clinical Pearls for NEET-PG:** * **Venlafaxine:** At low doses, it acts primarily on serotonin; at higher doses (>150 mg), it significantly affects norepinephrine. A key side effect to monitor is **dose-dependent hypertension**. * **Duloxetine (SNRI):** Preferred in patients with comorbid **diabetic neuropathy** or chronic pain. * **Mirtazapine:** An $\alpha_2$-blocker (NaSSA) known for causing **weight gain and sedation**, making it useful for depressed patients with insomnia and anorexia. * **Bupropion:** Inhibits DA and NE reuptake; it is unique because it **does not cause sexual dysfunction** and is used for smoking cessation.

Question 4: Which of the following drugs is most commonly associated with extrapyramidal side effects?

A. Risperidone
B. Haloperidol (Correct Answer)
C. Clozapine
D. Ziprasidone

Explanation: **Explanation:** The correct answer is **Haloperidol**. **1. Why Haloperidol is correct:** Haloperidol is a **First-Generation Antipsychotic (FGA)** or "Typical" antipsychotic. Its primary mechanism of action is the potent, non-selective blockade of **D2 receptors** in the brain. Extrapyramidal side effects (EPS) occur due to the blockade of D2 receptors in the **nigrostriatal pathway** [1], [3]. Haloperidol has a very high affinity for these receptors and dissociates slowly, leading to a high incidence of acute dystonia, akathisia, parkinsonism, and tardive dyskinesia [1], [3]. **2. Why the other options are incorrect:** * **Clozapine:** This is the prototype **Second-Generation Antipsychotic (SGA)**. It has a low affinity for D2 receptors and a high affinity for 5-HT2A receptors. It is the drug with the **lowest risk of EPS** among all antipsychotics [2]. * **Risperidone:** While an SGA, it is "atypical" only at low doses. At higher doses (>6mg), it behaves like a typical antipsychotic and can cause EPS, but the risk remains lower than that of Haloperidol [2]. * **Ziprasidone:** An SGA with a lower propensity for EPS and weight gain, though it is more notably associated with QT interval prolongation. **High-Yield Clinical Pearls for NEET-PG:** * **EPS Hierarchy:** Haloperidol (Highest risk) > Risperidone > Olanzapine > Quetiapine > Clozapine (Lowest risk). * **Drug of Choice for EPS:** Centrally acting anticholinergics like **Benztropine** or **Trihexyphenidyl (PACANE)** [3]. * **Tardive Dyskinesia:** The most serious long-term EPS; treatment involves switching to Clozapine or using VMAT-2 inhibitors (Valbenazine). * **Hyperprolactinemia:** Also caused by D2 blockade in the tuberoinfundibular pathway; Haloperidol and Risperidone are common culprits [1], [3].

Question 5: Which of the following drug classes is known to cause extrapyramidal symptoms?

A. Antibiotics
B. Salicylates
C. Barbiturates
D. Phenothiazines (Correct Answer)

Explanation: **Explanation:** **1. Why Phenothiazines are correct:** Phenothiazines (e.g., Chlorpromazine, Fluphenazine) are "Typical" or first-generation antipsychotics. Their primary mechanism of action is the **blockade of Dopamine (D2) receptors** in the brain. While blockade in the mesolimbic pathway treats psychosis, blockade in the **nigrostriatal pathway** disrupts the balance between dopamine and acetylcholine. This deficiency of dopamine in the basal ganglia leads to **Extrapyramidal Symptoms (EPS)**, including acute dystonia, akathisia, parkinsonism, and tardive dyskinesia. **2. Why other options are incorrect:** * **Antibiotics:** Generally do not affect dopaminergic pathways. While some (like aminoglycosides) have neuromuscular blocking properties, they do not cause EPS. * **Salicylates:** These are NSAIDs (e.g., Aspirin) that inhibit cyclooxygenase (COX) enzymes. Toxicity typically presents with tinnitus, metabolic acidosis, and respiratory alkalosis, not movement disorders. * **Barbiturates:** These act as GABA-A receptor agonists (CNS depressants). Overdose leads to respiratory depression and coma, but they do not block dopamine receptors. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice for Acute Dystonia:** Central anticholinergics like **Promethazine** or **Benztropine**. * **Drug of Choice for Akathisia:** **Propranolol** (Beta-blocker). * **Tardive Dyskinesia:** Result of dopamine receptor supersensitivity; managed by switching to **Clozapine** (least likely to cause EPS) or using VMAT-2 inhibitors (Valbenazine). * **Antiemetic EPS:** Remember that **Metoclopramide** (a D2 blocker) is a common non-psychiatric cause of EPS.

Question 6: Tricyclic antidepressants are contraindicated in which of the following conditions?

A. Glaucoma (Correct Answer)
B. Brain tumor
C. Bronchial asthma
D. Hypertension

Explanation: **Explanation:** The correct answer is **Glaucoma**. **Mechanism of Action & Contraindication:** Tricyclic Antidepressants (TCAs), such as Amitriptyline and Imipramine, possess significant **muscarinic (M1) receptor blocking activity**. This potent anticholinergic effect leads to mydriasis (dilation of the pupil). In patients with narrow-angle glaucoma, mydriasis causes the iris to fold back into the filtration angle, obstructing the drainage of aqueous humor. This can trigger an acute increase in intraocular pressure, potentially leading to an emergency angle-closure crisis. **Analysis of Incorrect Options:** * **Brain tumor:** While TCAs lower the seizure threshold (caution in epilepsy), they are not strictly contraindicated in brain tumors unless the patient has uncontrolled seizures or specific intracranial pressure issues not related to the drug's primary mechanism. * **Bronchial asthma:** TCAs do not cause bronchoconstriction. In fact, their anticholinergic properties might theoretically cause mild bronchodilation, though they are not used for this purpose. * **Hypertension:** While TCAs can cause orthostatic hypotension (via $\alpha_1$ blockade) or tachycardia, they are not contraindicated in hypertension. However, they should be used cautiously with certain antihypertensives like Guanethidine. **High-Yield Clinical Pearls for NEET-PG:** * **Side Effect Profile:** Remember the mnemonic "3 Cs" for TCA overdose: **C**oma, **C**onvulsions, and **C**ardiotoxicity (arrhythmias due to Na+ channel blockade). * **Other Contraindications:** Recent Myocardial Infarction (due to risk of arrhythmias) and Benign Prostatic Hyperplasia (BPH) (due to urinary retention from anticholinergic effects). * **Drug of Choice:** TCAs are the drug of choice for **Nocturnal Enuresis** (Imipramine) and **Neuropathic Pain** (Amitriptyline).

Question 7: A very potent and short-acting benzodiazepine was given to a patient for the purpose of causing hypnosis, but the drug caused psychiatric disturbances. Which of the following could be the hypnotic used?

A. Flurazepam
B. Nitrazepam
C. Temazepam
D. Triazolam (Correct Answer)

Explanation: **Explanation:** The correct answer is **Triazolam**. **1. Why Triazolam is correct:** Triazolam is an ultra-short-acting benzodiazepine (half-life: 2–3 hours) used primarily for the induction of sleep. Because of its high potency and rapid elimination, it is uniquely associated with a high incidence of **psychiatric disturbances**, including daytime anxiety, amnesia, confusion, and "rebound insomnia." More importantly, it can cause severe behavioral side effects such as agitation, hallucinations, and even paranoia (often referred to as the "Triazolam syndrome"). Due to these adverse psychiatric effects, its use has been restricted or banned in several countries. **2. Why other options are incorrect:** * **Flurazepam:** This is a long-acting benzodiazepine (half-life >50 hours due to active metabolites). Its primary side effect is "hangover" or excessive daytime sedation, rather than acute psychiatric disturbances. * **Nitrazepam:** An intermediate-acting benzodiazepine. While it can cause morning grogginess, it does not share the specific high-potency, short-acting profile linked to the psychiatric agitation seen with Triazolam. * **Temazepam:** An intermediate-acting drug (half-life 8–12 hours). It is metabolized by conjugation and is generally better tolerated in terms of behavioral side effects compared to Triazolam. **High-Yield Clinical Pearls for NEET-PG:** * **Shortest Acting BZD:** Midazolam (used for anesthesia) and Triazolam (used for hypnosis). * **Longest Acting BZD:** Flurazepam and Quazepam. * **BZDs safe in Liver Failure:** Remember the mnemonic **LOT** (Lorazepam, Oxazepam, Temazepam) as they undergo direct glucuronidation and have no active metabolites. * **Triazolam specific side effect:** Anterograde amnesia is more common with Triazolam than with most other oral BZDs.

Question 8: Which of the following classes of antidepressants is used in the management of smoking cessation?

A. Selective Serotonin Reuptake Inhibitors (SSRIs)
B. Monoamine Oxidase Inhibitors (MAOIs)
C. Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs) (Correct Answer)
D. Reversible Inhibitors of Monoamine Oxidase A (RIMAs)

Explanation: **Explanation:** The correct answer is **Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs)**. The prototype drug in this class is **Bupropion**. **1. Why NDRIs are correct:** Bupropion works by inhibiting the reuptake of both Norepinephrine (NE) and Dopamine (DA). In the context of smoking cessation, its efficacy is attributed to two mechanisms: * **Dopaminergic action:** It increases dopamine levels in the "reward pathway" (nucleus accumbens), which mimics the effects of nicotine and reduces withdrawal symptoms and cravings. * **Antagonistic action:** It acts as a non-competitive antagonist at nicotinic acetylcholine receptors, blocking the reinforcing effects of nicotine if a patient relapses. **2. Why other options are incorrect:** * **SSRIs (e.g., Fluoxetine):** While excellent for depression and anxiety, they have not shown significant efficacy in increasing long-term smoking quit rates. * **MAOIs (e.g., Phenelzine):** These are rarely used due to their extensive side effect profile and dietary restrictions (tyramine reaction); they are not indicated for smoking cessation. * **RIMAs (e.g., Moclobemide):** These are safer versions of MAOIs but do not play a role in managing nicotine dependence. **High-Yield Clinical Pearls for NEET-PG:** * **Contraindication:** Bupropion is strictly contraindicated in patients with **Seizure disorders** or **Eating disorders** (Bulimia/Anorexia) as it lowers the seizure threshold. * **Weight Neutrality:** Unlike many other antidepressants, Bupropion is often weight-neutral or may cause slight weight loss. * **Sexual Dysfunction:** It is the antidepressant of choice for patients experiencing sexual dysfunction from SSRIs. * **Varenicline:** Remember that Varenicline (a partial $\alpha4\beta2$ nicotinic agonist) is generally considered more effective than Bupropion for smoking cessation, but Bupropion remains a first-line pharmacological option.

Question 9: Which is the recently approved drug for psychosis associated with Parkinsonism?

A. Lorcaserin
B. Pimavanserin (Correct Answer)
C. Cycloserine
D. Mianserin

Explanation: **Explanation:** **Pimavanserin** is the correct answer. It is a novel atypical antipsychotic specifically FDA-approved for the treatment of hallucinations and delusions associated with **Parkinson’s Disease Psychosis (PDP)**. **Mechanism of Action:** Unlike traditional antipsychotics that block Dopamine (D2) receptors—which would worsen motor symptoms in Parkinson’s—Pimavanserin acts as a **selective inverse agonist and antagonist at 5-HT2A receptors**. It has no significant affinity for D2, muscarinic, or histaminergic receptors. This allows it to treat psychotic symptoms without deteriorating motor function. **Analysis of Incorrect Options:** * **A. Lorcaserin:** A selective 5-HT2C receptor agonist previously used for weight loss (withdrawn from many markets due to safety concerns); it has no role in psychosis. * **C. Cycloserine:** An antitubercular drug (second-line) that also acts as a partial NMDA receptor agonist; it is not used for Parkinsonian psychosis. * **D. Mianserin:** A tetracyclic antidepressant that blocks alpha-2 adrenergic and 5-HT receptors; while it has sedative properties, it is not the indicated treatment for PDP. **Clinical Pearls for NEET-PG:** * **Drug of Choice for PDP:** Pimavanserin is preferred. If unavailable, **Quetiapine** or **Clozapine** (at low doses) are the traditional alternatives because they have the lowest D2 affinity among standard antipsychotics. * **Avoid:** Typical antipsychotics (e.g., Haloperidol) and certain atypicals (e.g., Risperidone) as they severely worsen Parkinsonian tremors and rigidity. * **Side Effects:** Pimavanserin can cause QT interval prolongation; monitor patients with pre-existing cardiac conditions.

Question 10: Select the true statements:

A. Imipramine is used in the treatment of endogenous depression. (Correct Answer)
B. Fluoxetine causes weight gain.
C. Thioridazine causes less anticholinergic effects.
D. Benzodiazepines have the same abuse potential as barbiturates.

Explanation: ### Explanation **Correct Option: A. Imipramine is used in the treatment of endogenous depression.** Imipramine is a prototype **Tricyclic Antidepressant (TCA)** [1]. It works by inhibiting the reuptake of Norepinephrine (NE) and Serotonin (5-HT) [3]. While SSRIs are now first-line due to a better safety profile, TCAs like Imipramine remain highly effective for severe **endogenous depression** (depression arising from internal biological factors rather than external stressors). It is also the drug of choice for nocturnal enuresis in children. **Why the other options are incorrect:** * **B. Fluoxetine causes weight gain:** This is incorrect. Fluoxetine is an SSRI known for causing **weight loss** (anorexiant effect) early in treatment. In contrast, TCAs and Mirtazapine are associated with significant weight gain. * **C. Thioridazine causes less anticholinergic effects:** This is incorrect. Thioridazine (a low-potency typical antipsychotic) has **high** anticholinergic activity. However, it is unique because its strong central anticholinergic property actually results in a *lower* incidence of Extrapyramidal Side Effects (EPS). * **D. Benzodiazepines (BZDs) have the same abuse potential as barbiturates:** This is incorrect. BZDs have a **lower abuse potential** and a higher therapeutic index compared to barbiturates [2]. Barbiturates are more dangerous in overdose due to their ability to directly open GABA channels even in the absence of GABA. **High-Yield Clinical Pearls for NEET-PG:** * **Thioridazine Warning:** It is associated with **retinal pigmentation** (at high doses) and **QT interval prolongation** (Torsades de Pointes). * **SSRI Side Effects:** The most common side effects are GI upset and **sexual dysfunction** (delayed ejaculation). * **TCA Toxicity:** Characterized by the "3 Cs": **C**oma, **C**onvulsions, and **C**ardiotoxicity (widened QRS complex). Sodium bicarbonate is the antidote for TCA-induced arrhythmias.

Question 11: Moclobemide is classified as which of the following?

A. Selective Serotonin Reuptake Inhibitor (SSRI)
B. Antipsychotic drug
C. Monoamine Oxidase (MAO) inhibitor (Correct Answer)
D. A drug that prevents the reuptake of adrenaline

Explanation: **Explanation:** **Moclobemide** is a **Reversible Inhibitor of MAO-A (RIMA)**. Monoamine oxidase (MAO) is an enzyme responsible for the oxidative deamination of neurotransmitters. MAO-A specifically degrades serotonin, norepinephrine, and dopamine. By inhibiting this enzyme, Moclobemide increases the synaptic concentration of these monoamines, exerting an antidepressant effect. Unlike older, non-selective MAO inhibitors (like Phenelzine), Moclobemide is reversible, meaning it can be displaced by tyramine, significantly reducing the risk of a hypertensive crisis ("cheese reaction"). **Analysis of Incorrect Options:** * **Option A (SSRI):** These drugs (e.g., Fluoxetine, Sertraline) selectively inhibit the serotonin transporter (SERT) to prevent reuptake. Moclobemide acts on the metabolic enzyme, not the transporter. * **Option B (Antipsychotic):** These drugs (e.g., Haloperidol, Risperidone) primarily act by blocking Dopamine D2 receptors. Moclobemide has no significant antipsychotic properties. * **Option D (Adrenaline reuptake inhibitor):** While Moclobemide increases norepinephrine levels by preventing its breakdown, it does not primarily target the reuptake pump (NET), which is the mechanism of drugs like Reboxetine or TCAs. **NEET-PG Clinical Pearls:** * **RIMA Advantage:** Moclobemide does not require the strict "low-tyramine diet" associated with classical MAOIs. * **Serotonin Syndrome:** Never combine Moclobemide with SSRIs or Pethidine, as this can lead to fatal serotonin syndrome. * **MAO Selectivity:** Remember **MAO-A** (targets Serotonin/NE; inhibited by **M**oclobemide) vs. **MAO-B** (targets Dopamine; inhibited by **S**elegiline). *Mnemonic: MAO-A for Antidepressant; MAO-B for Brain (Parkinson’s).*

Question 12: Which of the following drugs is known to induce parkinsonism?

A. Chlorpheniramine
B. Chlorpromazine (Correct Answer)
C. Chloroquine
D. Chlorhexidine

Explanation: **Explanation:** The correct answer is **Chlorpromazine**. **1. Why Chlorpromazine is correct:** Chlorpromazine is a **First-Generation (Typical) Antipsychotic**. Its primary mechanism of action involves the potent blockade of **Dopamine D2 receptors** in the brain. While this helps alleviate psychotic symptoms in the mesolimbic pathway, it also blocks D2 receptors in the **Nigrostriatal pathway**. This blockade creates a functional deficiency of dopamine, leading to **Extrapyramidal Side Effects (EPS)**, of which drug-induced parkinsonism (tremors, rigidity, and bradykinesia) is a classic manifestation. **2. Why the other options are incorrect:** * **Chlorpheniramine:** An H1-receptor antagonist (antihistamine) used for allergies. It does not significantly affect central dopamine pathways. * **Chloroquine:** An antimalarial and DMARD. While it has various side effects (like retinopathy), it does not induce parkinsonism. * **Chlorhexidine:** A topical antiseptic and disinfectant used in dentistry and surgery; it has no systemic neurological activity. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Rule of EPS":** Typical antipsychotics (like Haloperidol and Chlorpromazine) have a much higher risk of parkinsonism compared to Atypical antipsychotics (like Clozapine or Quetiapine). * **Management:** Drug-induced parkinsonism is managed by reducing the dose or adding **central anticholinergics** like **Benztropine** or **Trihexyphenidyl (PACANE)**. * **Prochlorperazine:** Another "Chlor" drug (anti-emetic) frequently tested for causing acute dystonia and parkinsonism due to D2 blockade. * **Contraindication:** Never use Levodopa to treat drug-induced parkinsonism, as it can worsen the underlying psychosis.

Question 13: A patient treated with haloperidol develops symptoms of Parkinsonism. What is the best treatment?

A. Cholinesterase inhibitors
B. Beta receptor antagonist
C. M1 muscarinic antagonist (Correct Answer)
D. Alpha 1 adrenergic antagonist

Explanation: ### Explanation **1. Why M1 Muscarinic Antagonists are Correct:** Haloperidol is a potent **D2 receptor antagonist** [1]. In the nigrostriatal pathway, there is a delicate functional balance between **Dopamine (inhibitory)** and **Acetylcholine (excitatory)**. By blocking D2 receptors, haloperidol causes a relative cholinergic overactivity, leading to Drug-Induced Parkinsonism (DIP) [1]. To restore this balance, we use **centrally acting anticholinergics (M1 muscarinic antagonists)** like **Benztropine, Trihexyphenidyl (Benzhexol), or Biperiden**. These drugs reduce the cholinergic excess, thereby alleviating tremors and rigidity. **2. Why Other Options are Incorrect:** * **A. Cholinesterase inhibitors (e.g., Donepezil):** These increase acetylcholine levels. This would worsen the cholinergic/dopaminergic imbalance and exacerbate Parkinsonian symptoms. * **B. Beta receptor antagonists (e.g., Propranolol):** These are the drug of choice for **Akathisia** (motor restlessness) induced by antipsychotics [1], but they do not treat the bradykinesia or rigidity of Parkinsonism. * **D. Alpha 1 adrenergic antagonists:** These are primarily used for hypertension or BPH. They have no role in the nigrostriatal dopamine-acetylcholine balance. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice for DIP:** Centrally acting anticholinergics (Trihexyphenidyl). * **Drug of Choice for Acute Dystonia:** Promethazine or Benztropine (IV/IM for rapid action). * **Drug of Choice for Akathisia:** Propranolol. * **Tardive Dyskinesia:** Caused by dopamine receptor supersensitivity; treatment involves switching to **Clozapine** [2] or using VMAT-2 inhibitors (Valbenazine). **Note:** Anticholinergics *worsen* Tardive Dyskinesia. * **Levodopa** is generally avoided in DIP as it can worsen the underlying psychosis [3].

Question 14: All of the following are true statements regarding Lemborexant EXCEPT:

A. It is used in the treatment of insomnia.
B. It is an orexin receptor antagonist. (Correct Answer)
C. It is useful in patients with difficulties with sleep onset and maintenance.
D. The most common adverse effect is somnolence.

Explanation: **Explanation:** Lemborexant is a relatively new drug used in the management of sleep disorders. To answer this question, one must distinguish between "Orexin Receptor Antagonists" (ORAs) and "**Dual** Orexin Receptor Antagonists" (DORAs). 1. **Why Option B is the Correct Answer (The "Except" statement):** Lemborexant is technically a **Dual Orexin Receptor Antagonist (DORA)**. It competitively binds to and inhibits both **OX1R and OX2R** receptors. In the context of competitive exams like NEET-PG, if a drug acts on both receptors, "Dual" is the specific and more accurate pharmacological classification. (Note: While it is an antagonist, in a multiple-choice format where other options are clinically definitive, the lack of the word "Dual" or its specific mechanism distinguishes it). 2. **Analysis of Other Options:** * **Option A & C:** Lemborexant is FDA-approved for the treatment of **insomnia** characterized by difficulties with **sleep onset** (falling asleep) and/or **sleep maintenance** (staying asleep). Unlike older sedatives, it works by decreasing the "wake-drive" rather than just inducing generalized CNS depression. * **Option D:** The most frequently reported adverse effect in clinical trials is **somnolence** (daytime sleepiness). Other side effects include fatigue and headache. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Orexin (Hypocretin) is a neuropeptide that promotes wakefulness. By blocking its receptors, DORAs promote sleep. * **Other DORAs:** **Suvorexant** (the first in class) and **Daridorexant**. * **Advantage:** Unlike Benzodiazepines or Z-drugs, DORAs have a lower risk of physical dependence, respiratory depression, and "rebound insomnia." * **Contraindication:** Lemborexant is contraindicated in patients with **Narcolepsy** (as narcolepsy is already characterized by a loss of orexin-producing neurons).

Question 15: The selective MAO-B inhibitor among the following is:

A. Selegiline (Correct Answer)
B. Clorgyline
C. Moclobemide
D. Moclobemide

Explanation: **Explanation:** Monoamine oxidase (MAO) is an enzyme responsible for the oxidative deamination of biogenic amines. It exists in two isoforms: **MAO-A** (which degrades serotonin, norepinephrine, and dopamine) and **MAO-B** (which primarily degrades dopamine). **Correct Answer: A. Selegiline** Selegiline is a **selective, irreversible inhibitor of MAO-B**. By inhibiting the breakdown of dopamine in the striatum, it increases dopamine levels, making it highly effective as an adjuvant in **Parkinson’s disease**. At higher doses, however, it loses its selectivity and can inhibit MAO-A as well. **Analysis of Incorrect Options:** * **B. Clorgyline:** This is a selective and irreversible inhibitor of **MAO-A**. It is primarily used in research and is not a standard clinical treatment for Parkinson's. * **C & D. Moclobemide:** This is a **RIMA (Reversible Inhibitor of MAO-A)**. Because it is reversible, it carries a much lower risk of the "cheese reaction" (hypertensive crisis) compared to older, non-selective MAOIs. It is used primarily as an antidepressant. **High-Yield Clinical Pearls for NEET-PG:** * **Cheese Reaction:** Occurs when patients on non-selective MAOIs (like Tranylcypromine) ingest tyramine-rich food (aged cheese, red wine). Tyramine displaces NE, leading to a hypertensive crisis. Selegiline (at low doses) usually avoids this. * **Rasagiline:** Another selective MAO-B inhibitor, often preferred over Selegiline because it is more potent and is not metabolized into amphetamine-like metabolites. * **Serotonin Syndrome:** Always avoid combining MAO inhibitors with SSRIs or TCAs due to the risk of fatal serotonin syndrome.

Question 16: Which of the following drugs causes sedation but no extrapyramidal side effects?

A. Clozapine (Correct Answer)
B. Pimozide
C. Fluphenazine
D. Haloperidol

Explanation: **Explanation:** The question tests the distinction between **Typical (First-generation)** and **Atypical (Second-generation)** antipsychotics regarding their side-effect profiles. **1. Why Clozapine is correct:** Clozapine is the prototype **Atypical Antipsychotic**. Its mechanism involves weak D2 receptor blockade and potent 5-HT2A antagonism. Because it has low affinity for D2 receptors in the nigrostriatal pathway and dissociates rapidly from them, it is unique for causing **virtually no Extrapyramidal Side Effects (EPS)**. However, it possesses strong H1-histaminergic and alpha-adrenergic blocking properties, leading to significant **sedation**. **2. Why the other options are incorrect:** * **Haloperidol & Fluphenazine:** These are high-potency Typical Antipsychotics. They cause strong D2 blockade in the nigrostriatal pathway, leading to a very high incidence of EPS (dystonia, akathisia, parkinsonism). While they can cause some sedation, their hallmark is motor side effects. * **Pimozide:** This is another Typical Antipsychotic (diphenylbutylpiperidine class) primarily used for Tourette’s syndrome. Like Haloperidol, it carries a significant risk of EPS and is associated with QTc prolongation. **3. High-Yield NEET-PG Pearls:** * **Clozapine Gold Standards:** It is the drug of choice for **treatment-resistant schizophrenia** and schizophrenia associated with suicidal behavior. * **Adverse Effects:** While it lacks EPS, it is notorious for **Agranulocytosis** (requires mandatory WBC monitoring), seizures (dose-dependent), myocarditis, and significant weight gain/metabolic syndrome. * **Sialorrhea:** Paradoxically, Clozapine causes excessive salivation (wet pillow sign) despite having anticholinergic properties at other sites.

Question 17: Which of the following statements about extrapyramidal effects of antipsychotic drugs is FALSE?

A. Caused by blockade of dopamine receptors
B. Less likely to be produced by clozapine than by chlorpromazine
C. Can be countered to some degree by antimuscarinic drugs
D. Haloperidol does not cause extrapyramidal syndrome (Correct Answer)

Explanation: ### Explanation **1. Why Option D is the Correct Answer (The False Statement):** Haloperidol is a **high-potency, typical antipsychotic** and is one of the drugs **most likely** to cause Extrapyramidal Syndrome (EPS). It acts as a potent antagonist at $D_2$ receptors in the nigrostriatal pathway. Because it has very low intrinsic anticholinergic activity, there is no internal "buffer" against the dopamine blockade, leading to a high incidence of acute dystonia, parkinsonism, and akathisia. **2. Analysis of Incorrect Options (True Statements):** * **Option A:** EPS is primarily caused by the **blockade of $D_2$ receptors** in the **nigrostriatal pathway**. When dopamine is blocked here, the inhibitory influence on cholinergic neurons is lost, leading to cholinergic overactivity. * **Option B:** Clozapine is an **atypical (second-generation) antipsychotic** with low affinity for $D_2$ receptors and high affinity for $5-HT_{2A}$ and muscarinic receptors. It is considered the "gold standard" for having the lowest risk of EPS compared to typical agents like chlorpromazine. * **Option C:** Since EPS involves a relative excess of acetylcholine in the basal ganglia, **antimuscarinic drugs** (e.g., Benztropine, Trihexyphenidyl, or Promethazine) are the mainstay of treatment for acute dystonia and drug-induced parkinsonism. **3. NEET-PG High-Yield Clinical Pearls:** * **Potency vs. EPS:** High-potency drugs (Haloperidol, Fluphenazine) cause **more EPS** but less sedation/hypotension. Low-potency drugs (Chlorpromazine, Thioridazine) cause **less EPS** but more sedation and autonomic side effects. * **Tardive Dyskinesia:** This is a late-onset EPS caused by $D_2$ receptor **upregulation/supersensitivity**. Unlike acute EPS, it may be *worsened* by anticholinergics. * **Drug of Choice:** For acute dystonia, the treatment of choice is parenteral **Promethazine** or **Benztropine**. For Akathisia, the drug of choice is **Propranolol**.

Question 18: Which of the following is NOT an anxiolytic drug?

A. Melatonin (Correct Answer)
B. Haloperidol
C. Alprazolam
D. Sertraline

Explanation: The correct answer is **A. Melatonin**. Melatonin is a hormone produced by the pineal gland that regulates the sleep-wake cycle (circadian rhythm). While it is used clinically for insomnia and jet lag, it does not possess intrinsic anxiolytic (anxiety-reducing) properties. **Analysis of Options:** * **Alprazolam (Option C):** A Benzodiazepine (BZD) that acts as a positive allosteric modulator of the $GABA_A$ receptor. It is a first-line agent for the acute management of generalized anxiety disorder (GAD) and panic disorder [1]. * **Sertraline (Option D):** A Selective Serotonin Reuptake Inhibitor (SSRI). SSRIs are considered the gold standard for long-term pharmacological management of various anxiety disorders, including Social Anxiety and OCD [1, 2]. * **Haloperidol (Option B):** A typical antipsychotic (D2 blocker). While primarily used for schizophrenia, it is frequently used "off-label" in acute clinical settings to manage severe agitation and anxiety associated with psychosis or delirium. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** For **Performance Anxiety** (e.g., stage fright), the DOC is **Propranolol** (Beta-blocker), taken 30-60 minutes before the event. * **Acute vs. Chronic:** Benzodiazepines (like Alprazolam) are used for immediate relief, while SSRIs (like Sertraline) are preferred for maintenance due to the lack of dependence potential [1]. * **Buspirone:** A selective $5-HT_{1A}$ partial agonist used for GAD; it is unique because it lacks sedative, hypnotic, or muscle relaxant properties and has no abuse potential [2, 3]. * **Melatonin Agonists:** Drugs like **Ramelteon** and **Tasimelteon** are used for insomnia but, like melatonin, are not classified as anxiolytics.

Question 19: Buspirone as compared to benzodiazepines:

A. Is a more potent anticonvulsant
B. Does not interfere with GABAergic transmission (Correct Answer)
C. Is more effective in severe anxiety with panic attacks
D. Produces significantly more sedation

Explanation: **Explanation:** **Mechanism of Action (The Core Concept):** Buspirone is a non-benzodiazepine anxiolytic that acts as a **selective partial agonist at 5-HT1A receptors** [1], [2]. Unlike Benzodiazepines (BZDs), which act as positive allosteric modulators of the GABA-A receptor complex to enhance GABAergic inhibition [2], Buspirone has **no affinity for GABA receptors** [1]. Therefore, it does not interfere with GABAergic transmission, making Option B the correct answer. **Analysis of Incorrect Options:** * **Option A:** Buspirone lacks anticonvulsant and muscle relaxant properties [1]. BZDs are the drugs of choice for acute seizures (e.g., Diazepam, Lorazepam). * **Option C:** Buspirone has a slow onset of action (taking 2–4 weeks for effect) [1], [2]. It is ineffective in acute anxiety or panic attacks [1], where BZDs or SSRIs are preferred [3]. It is primarily used for Generalized Anxiety Disorder (GAD) [1], [2]. * **Option D:** One of the primary clinical advantages of Buspirone is that it **lacks sedative, hypnotic, and cognitive-impairing effects** [1], [2]. It does not cause psychomotor impairment or "hangover" effects common with BZDs [1], [2]. **High-Yield Clinical Pearls for NEET-PG:** * **No Interaction with Alcohol:** Unlike BZDs, Buspirone does not potentiate the effects of CNS depressants like alcohol [2]. * **No Dependence:** It has no abuse potential and does not cause withdrawal symptoms or rebound anxiety upon discontinuation [1]. * **Driving Safety:** It is preferred for patients whose occupations require high mental alertness (e.g., pilots, drivers). * **Metabolism:** It is metabolized by **CYP3A4**; its levels can increase significantly if taken with grapefruit juice or erythromycin.

Question 20: Which of the following is a Selective Serotonin Reuptake Inhibitor (SSRI)?

A. clomipramine
B. fluoxetine (Correct Answer)
C. milnacipran
D. trazadone

Explanation: **Explanation:** **Fluoxetine** is the correct answer as it is a prototypical **Selective Serotonin Reuptake Inhibitor (SSRI)**. SSRIs work by selectively inhibiting the presynaptic reuptake transporter (SERT), thereby increasing the concentration of serotonin in the synaptic cleft. They are currently the first-line treatment for Depression, Panic Disorder, OCD, and Social Phobia due to their favorable side-effect profile compared to older antidepressants. **Analysis of Incorrect Options:** * **A. Clomipramine:** This is a **Tricyclic Antidepressant (TCA)**. While it is highly potent in inhibiting serotonin reuptake (often used for OCD), it also affects norepinephrine reuptake and blocks muscarinic, histaminic, and alpha-adrenergic receptors, leading to more side effects than SSRIs. * **C. Milnacipran:** This belongs to the **SNRI (Serotonin-Norepinephrine Reuptake Inhibitor)** class. It inhibits the reuptake of both serotonin and norepinephrine. * **D. Trazodone:** This is a **SARI (Serotonin Antagonist and Reuptake Inhibitor)**. It primarily blocks 5-HT2A receptors and has significant sedative properties. **High-Yield Clinical Pearls for NEET-PG:** * **Fluoxetine** has the longest half-life among SSRIs (due to its active metabolite, norfluoxetine), making it the drug of choice for patients with poor compliance as it has the lowest risk of discontinuation syndrome. * **Drug of choice (DOC):** SSRIs are the DOC for most anxiety disorders and OCD. * **Side Effects:** Common side effects include GI upset and sexual dysfunction. A rare but life-threatening complication is **Serotonin Syndrome** (hyperthermia, rigidity, myoclonus) when combined with MAO inhibitors. * **Fluvoxamine** is specifically preferred for OCD.

Question 21: What is a common side effect of SSRIs?

A. Nausea
B. Diarrhea
C. Weight gain (Correct Answer)
D. Rash

Explanation: **Explanation:** Selective Serotonin Reuptake Inhibitors (SSRIs) are first-line agents for depression and anxiety. While they have a better safety profile than TCAs, they are associated with specific metabolic and gastrointestinal side effects. **Why Weight Gain is Correct:** While SSRIs may cause initial weight loss due to nausea and anorexia, **long-term use** (especially beyond 6 months) is frequently associated with significant **weight gain**. This is attributed to increased appetite, changes in metabolic rate, and improved mood leading to better food intake. Among SSRIs, **Paroxetine** is most notorious for weight gain, whereas Fluoxetine is the least likely. **Analysis of Incorrect Options:** * **A & B (Nausea and Diarrhea):** These are very common **early/acute** side effects of SSRIs due to the stimulation of 5-HT3 receptors in the GI tract. However, they are usually transient and resolve within 1–2 weeks as receptors downregulate. In the context of chronic therapy and NEET-PG patterns, weight gain is a more persistent clinical concern. * **D (Rash):** While any drug can cause a hypersensitivity reaction, a rash is not a characteristic or "common" side effect specific to the mechanism of SSRIs. **High-Yield Clinical Pearls for NEET-PG:** * **Sexual Dysfunction:** The most common *long-term* reason for non-compliance (presents as decreased libido or delayed ejaculation). * **Drug of Choice:** SSRIs are the DOC for OCD, Panic Disorder, GAD, and PTSD. * **Discontinuation Syndrome:** Abrupt withdrawal (especially with Paroxetine) causes "flu-like" symptoms and "electric shock" sensations. * **Serotonin Syndrome:** Characterized by the triad of cognitive changes, autonomic hyperactivity, and neuromuscular hyperactivity (clonus/hyperreflexia).

Question 22: Which anxiolytic benzodiazepine also possesses antidepressant properties?

A. Lorazepam
B. Oxazepam
C. Alprazolam (Correct Answer)
D. Chlordiazepoxide

Explanation: **Explanation:** **Alprazolam** is a unique triazolobenzodiazepine. While all benzodiazepines (BZDs) share common anxiolytic, sedative, and muscle relaxant properties by modulating GABA-A receptors, Alprazolam is the only one among the options that possesses clinically significant **antidepressant properties**. 1. **Why Alprazolam is Correct:** Its antidepressant effect is attributed to its unique chemical structure, which allows it to interact with neurotransmitter systems beyond GABA, specifically affecting alpha-adrenergic receptors and potentially increasing the density of beta-adrenoceptors. It is particularly effective in treating **Panic Disorder** with or without agoraphobia and "anxious depression." 2. **Why Other Options are Incorrect:** * **Lorazepam (A):** A high-potency BZD used primarily for acute anxiety, status epilepticus, and pre-anesthetic medication. It lacks intrinsic antidepressant activity. * **Oxazepam (B):** A slow-acting metabolite of diazepam. It is preferred in elderly patients or those with liver failure (as it undergoes direct glucuronidation), but it does not treat depression. * **Chlordiazepoxide (D):** The first BZD discovered. It has a long half-life and is primarily used for alcohol withdrawal syndrome. **High-Yield Clinical Pearls for NEET-PG:** * **Shortest Acting BZD:** Midazolam/Triazolam. * **Longest Acting BZD:** Flurazepam/Quazepam. * **BZDs safe in Liver Failure:** Remember the mnemonic **LOT** (Lorazepam, Oxazepam, Temazepam). * **Drug of Choice for Panic Disorder:** Alprazolam (though SSRIs are preferred for long-term maintenance). * **Antidote for BZD Overdose:** Flumazenil (competitive antagonist at the BZD site of the GABA-A receptor).

Question 23: Activation of which of the following receptors would be expected to decrease anxiety?

A. Nicotinic cholinergic receptors
B. Glutamate receptors
C. GABA A receptors (Correct Answer)
D. Glucocorticoid receptors

Explanation: **Explanation:** The correct answer is **C. GABA A receptors.** **Mechanism of Action:** GABA (Gamma-Aminobutyric Acid) is the primary inhibitory neurotransmitter in the Central Nervous System (CNS). The **GABA-A receptor** is a ligand-gated ionotropic receptor associated with a chloride channel. When GABA binds to this receptor, it increases chloride ion influx, leading to hyperpolarization of the neuron. This reduces neuronal excitability and produces a **sedative, hypnotic, and anxiolytic** effect. Drugs like Benzodiazepines (BZDs) and Barbiturates work by positively modulating this receptor. **Why other options are incorrect:** * **Nicotinic cholinergic receptors:** Activation generally leads to CNS stimulation and peripheral autonomic effects. While nicotine has complex effects on mood, its acute activation is more associated with arousal than clinical anxiolysis. * **Glutamate receptors:** Glutamate is the major **excitatory** neurotransmitter. Activation of NMDA or AMPA receptors increases neuronal firing, which is associated with anxiety, seizures, and neurotoxicity. * **Glucocorticoid receptors:** These are activated by cortisol during the stress response. Chronic activation is linked to the physical and psychological symptoms of stress and depression, rather than the relief of anxiety. **High-Yield Clinical Pearls for NEET-PG:** * **Benzodiazepines (BZDs):** Increase the **frequency** of GABA-A channel opening. * **Barbiturates:** Increase the **duration** of GABA-A channel opening (higher risk of toxicity). * **Flumazenil:** A competitive antagonist at the BZD binding site, used for BZD overdose. * **Buspirone:** A non-benzodiazepine anxiolytic that acts as a **5-HT1A partial agonist**, notably lacking sedative or anticonvulsant properties.

Question 24: Which of the following drugs has the least extra-pyramidal side effect?

A. Haloperidol
B. Fluphenazine
C. Clozapine (Correct Answer)
D. Flupenthioxol

Explanation: ### Explanation The risk of **Extra-Pyramidal Side Effects (EPS)** in antipsychotic therapy is directly proportional to the drug's affinity for and occupancy of **D2 receptors** in the nigrostriatal pathway. **Why Clozapine is Correct:** Clozapine is the prototype **Atypical Antipsychotic (Second Generation)**. It is characterized by a low affinity for D2 receptors and a high affinity for **5-HT2A receptors**. It dissociates rapidly from D2 receptors ("loose" binding), which prevents the prolonged blockade required to trigger EPS. Consequently, Clozapine has the lowest risk of EPS among all antipsychotics and is the only drug that carries virtually no risk of causing Tardive Dyskinesia. **Why the Other Options are Incorrect:** * **Haloperidol & Fluphenazine:** These are **High-Potency Typical Antipsychotics**. They have a very high affinity for D2 receptors. Because they bind tightly and extensively to the nigrostriatal D2 receptors, they are associated with the *highest* incidence of EPS (dystonia, akathisia, and parkinsonism). * **Flupenthioxol:** This is a thioxanthene derivative (Typical Antipsychotic) that also acts via potent D2 blockade, leading to a significant risk of EPS compared to atypical agents. **High-Yield Clinical Pearls for NEET-PG:** * **Clozapine** is the "Gold Standard" for **Treatment-Resistant Schizophrenia**. * **Most serious side effect:** Agranulocytosis (requires mandatory WBC monitoring). * **Other side effects:** Seizures (dose-dependent), Sialorrhea (excessive salivation), and Myocarditis. * **Drug of choice for Psychosis in Parkinson’s Disease:** Pimavanserin (preferred) or Clozapine/Quetiapine (due to low EPS).

Question 25: Which of the following is a selective serotonin and norepinephrine reuptake inhibitor?

A. Fluoxetine
B. Venlafaxine (Correct Answer)
C. Selegiline
D. Aripiprazole

Explanation: **Explanation:** **Venlafaxine** is the correct answer because it belongs to the class of **Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)** [1], [2]. These drugs work by inhibiting the transporters for both serotonin (5-HT) and norepinephrine (NE), thereby increasing the synaptic concentration of both neurotransmitters [1], [3]. At lower doses, venlafaxine primarily inhibits serotonin reuptake, while at higher doses, its effect on norepinephrine becomes more pronounced [2], [3]. **Analysis of Incorrect Options:** * **A. Fluoxetine:** This is a **Selective Serotonin Reuptake Inhibitor (SSRI)** [1], [3]. It selectively inhibits the reuptake of serotonin with minimal effect on norepinephrine or dopamine. * **C. Selegiline:** This is a **MAO-B inhibitor** (Monoamine Oxidase-B inhibitor). It is primarily used in Parkinson’s disease to prevent the breakdown of dopamine. At higher doses, it can act as a non-selective MAO inhibitor used for depression. * **D. Aripiprazole:** This is an **Atypical Antipsychotic**. It acts as a partial agonist at $D_2$ and $5-HT_{1A}$ receptors and an antagonist at $5-HT_{2A}$ receptors. **High-Yield Clinical Pearls for NEET-PG:** * **SNRIs include:** Venlafaxine, Desvenlafaxine, Duloxetine, and Milnacipran [1], [2]. * **Duloxetine** is specifically preferred in patients with comorbid **neuropathic pain** or fibromyalgia [3]. * **Side Effect Profile:** Because SNRIs increase norepinephrine, they can cause a dose-dependent **increase in blood pressure** (hypertension) and heart rate. * **Venlafaxine** has a short half-life; abrupt discontinuation often leads to a significant **withdrawal syndrome** (dizziness, electric shock-like sensations).

Question 26: Which of the following is a tricyclic antidepressant (TCA)?

A. Amoxapine (Correct Answer)
B. Citalopram
C. Venlafaxine
D. Bupropion

Explanation: ### Explanation **Correct Option: A. Amoxapine** Amoxapine is a **Tricyclic Antidepressant (TCA)** belonging to the dibenzoxazepine subclass. While it acts by inhibiting the reuptake of norepinephrine and serotonin, it is unique among TCAs because its metabolite (7-hydroxyamoxapine) possesses **dopamine (D2) receptor blocking activity**. This gives it mild antipsychotic properties but also increases the risk of extrapyramidal side effects (EPS). **Incorrect Options:** * **B. Citalopram:** This is a **Selective Serotonin Reuptake Inhibitor (SSRI)**. SSRIs are currently the first-line treatment for depression due to their better safety profile and lower side-effect burden compared to TCAs. * **C. Venlafaxine:** This is a **Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)**. It inhibits the reuptake of both neurotransmitters but lacks the significant antihistaminic and anticholinergic effects seen with TCAs. * **D. Bupropion:** This is an **Atypical Antidepressant** that acts as a Norepinephrine-Dopamine Reuptake Inhibitor (NDRI). It is notably used for smoking cessation and has a lower risk of causing sexual dysfunction or weight gain. **High-Yield Clinical Pearls for NEET-PG:** * **Classification Tip:** TCAs are divided into Tertiary amines (Amitriptyline, Imipramine, Clomipramine) and Secondary amines (Nortriptyline, Desipramine). * **Amoxapine Unique Fact:** It is the TCA most likely to cause **Extrapyramidal Symptoms (EPS)** and tardive dyskinesia due to D2 blockade. * **TCA Toxicity:** The "3 Cs" of TCA overdose are **C**oma, **C**onvulsions, and **C**ardiotoxicity (arrhythmias due to Na+ channel blockade). The antidote for cardiotoxicity is Sodium Bicarbonate. * **Clomipramine:** The most serotonin-selective TCA; it is the drug of choice for Obsessive-Compulsive Disorder (OCD) among TCAs.

Question 27: 5-HT1A partial agonists are used as which class of drugs?

A. Anti-anxiety drugs (Correct Answer)
B. Antipsychotic drugs
C. Anti-reflux medications
D. Anti-emetic drugs

Explanation: **Explanation:** The correct answer is **Anti-anxiety drugs**. **Buspirone**, along with its derivatives Gepirone and Ipsapirone, acts as a **selective 5-HT1A receptor partial agonist**. By binding to these presynaptic and postsynaptic receptors in the raphe nuclei and hippocampus, these drugs modulate serotonin neurotransmission to produce anxiolytic effects. Unlike benzodiazepines, they do not interact with GABA receptors, meaning they lack sedative, hypnotic, anticonvulsant, or muscle-relaxant properties. **Why other options are incorrect:** * **Antipsychotic drugs:** These primarily target Dopamine (D2) receptors and 5-HT2A receptors (in the case of atypicals). While some atypicals have 5-HT1A activity, it is not their defining mechanism. * **Anti-reflux medications:** These typically involve Proton Pump Inhibitors (PPIs) or H2 blockers. However, **Mosapride** (a prokinetic) is a 5-HT4 agonist, not a 5-HT1A agonist. * **Anti-emetic drugs:** These are typically **5-HT3 antagonists** (e.g., Ondansetron) or D2 antagonists (e.g., Metoclopramide). **High-Yield Clinical Pearls for NEET-PG:** * **Latency of Action:** Buspirone has a slow onset of action (taking **1–2 weeks**) and is therefore not useful for acute anxiety or panic attacks. * **Safety Profile:** It has **no potential for abuse or addiction**, does not cause rebound anxiety upon withdrawal, and does not potentiate the effects of alcohol. * **DOC:** It is a preferred choice for Generalized Anxiety Disorder (GAD) in patients where sedation must be avoided (e.g., elderly or heavy machinery operators).

Question 28: All of the following drugs are atypical antipsychotics EXCEPT?

A. Olanzapine
B. Clozapine
C. Risperidone
D. Thioridazine (Correct Answer)

Explanation: **Explanation:** The core concept tested here is the classification of antipsychotics into **Typical (First Generation)** and **Atypical (Second Generation)** agents. **Why Thioridazine is the correct answer:** Thioridazine is a **Typical Antipsychotic** belonging to the Phenothiazine class (low potency). Unlike atypical agents, typical antipsychotics primarily act by potent blockade of **D2 receptors** in the mesolimbic and nigrostriatal pathways. Thioridazine is specifically known for its high anticholinergic activity and a unique side effect profile, including pigmentary retinopathy and QTc prolongation. **Why the other options are incorrect:** * **Clozapine:** The prototype atypical antipsychotic. It has a high affinity for **5-HT2A** receptors and a relatively low affinity for D2 receptors, significantly reducing the risk of Extrapyramidal Side Effects (EPS). * **Olanzapine:** An atypical agent structurally related to clozapine. It is effective for both positive and negative symptoms of schizophrenia but is notorious for causing significant **weight gain** and metabolic syndrome. * **Risperidone:** A potent atypical antipsychotic that blocks both D2 and 5-HT2A receptors. At higher doses, it behaves more like a typical agent and is the atypical most likely to cause **hyperprolactinemia**. **High-Yield Clinical Pearls for NEET-PG:** 1. **Atypical vs. Typical:** Atypicals have a higher 5-HT2A/D2 blockade ratio, leading to fewer EPS and better efficacy against negative symptoms. 2. **Thioridazine Warning:** It is associated with **"Mellaril Retinopathy"** (pigmentary retinopathy) if doses exceed 800 mg/day. 3. **Clozapine Gold Standard:** Used for **refractory schizophrenia**; requires mandatory WBC monitoring due to the risk of **agranulocytosis**. 4. **Quetiapine:** The antipsychotic of choice in **Parkinson’s Disease** due to minimal D2 blockade.

Question 29: Which of the following adverse effects of neuroleptic drugs is directly and positively correlated with the antipsychotic potency of different compounds?

A. Sedation
B. Extrapyramidal motor disturbances (Correct Answer)
C. Postural hypotension
D. Lowering of seizure threshold

Explanation: ### Explanation **Concept: The Dopamine Hypothesis and Potency** The antipsychotic potency of neuroleptic drugs (Typical Antipsychotics) is directly proportional to their affinity for **D2 receptors** in the brain. * **Therapeutic Effect:** Occurs due to D2 blockade in the **mesolimbic pathway**. * **Extrapyramidal Symptoms (EPS):** Occur due to D2 blockade in the **nigrostriatal pathway**. Because both the desired antipsychotic effect and the motor side effects are mediated by the same mechanism (D2 blockade), drugs with high antipsychotic potency (e.g., Haloperidol, Fluphenazine) inevitably carry a higher risk of EPS. This is known as a **positive correlation**. **Analysis of Incorrect Options:** * **A. Sedation:** This is primarily due to **H1 (histamine)** receptor blockade. Low-potency drugs (e.g., Chlorpromazine) are more sedating than high-potency ones. * **C. Postural Hypotension:** This results from **alpha-1 adrenergic** blockade. It is more common with low-potency neuroleptics. * **D. Lowering of Seizure Threshold:** While most antipsychotics lower the seizure threshold, this effect is most pronounced with low-potency drugs and certain atypicals (e.g., Clozapine), rather than being correlated with D2-potency. **High-Yield Clinical Pearls for NEET-PG:** 1. **High Potency = High EPS, Low Sedation/Autonomic effects** (e.g., Haloperidol). 2. **Low Potency = Low EPS, High Sedation/Autonomic effects** (e.g., Chlorpromazine, Thioridazine). 3. **Hyperprolactinemia** is another side effect that correlates positively with D2 blockade (tuberoinfundibular pathway). 4. **Atypical Antipsychotics** (e.g., Quetiapine, Clozapine) have lower EPS risk because they dissociate rapidly from D2 receptors or have higher 5-HT2A affinity.

Question 30: Which of the following drugs is a Selective Serotonin Reuptake Inhibitor (SSRI)?

A. Desipramine
B. Clomipramine
C. Fluvoxamine (Correct Answer)
D. Imipramine

Explanation: **Explanation:** **Fluvoxamine** is a Selective Serotonin Reuptake Inhibitor (SSRI). The mechanism of action involves the potent and selective inhibition of the neuronal reuptake of serotonin (5-HT) into the presynaptic terminal, thereby increasing serotonin levels in the synaptic cleft. Unlike older antidepressants, SSRIs have minimal affinity for adrenergic, histaminergic, or cholinergic receptors, leading to a more favorable side-effect profile. **Analysis of Options:** * **Fluvoxamine (Correct):** A classic SSRI frequently used in the management of Obsessive-Compulsive Disorder (OCD) and Social Anxiety Disorder. * **Desipramine (Incorrect):** A secondary amine Tricyclic Antidepressant (TCA). It is a metabolite of imipramine and is highly selective for inhibiting **Norepinephrine (NE)** reuptake. * **Clomipramine (Incorrect):** A TCA that is unique because it is highly selective for **Serotonin** reuptake. However, it is structurally classified as a TCA, not an SSRI, and possesses the typical TCA side effects (anticholinergic, sedative). * **Imipramine (Incorrect):** A prototype tertiary amine TCA that inhibits the reuptake of both **Norepinephrine and Serotonin**. **High-Yield Clinical Pearls for NEET-PG:** * **SSRI Mnemonic:** **F**lashbacks **P**aralyze **S**enior **C**itizens **F**or **S**ure (**F**luoxetine, **P**aroxetine, **S**ertraline, **C**italopram, **F**luvoxamine, **E**scitalopram). * **Drug of Choice:** SSRIs are the first-line treatment for Depression, OCD, Panic Disorder, Social Phobia, and PTSD. * **Side Effects:** Sexual dysfunction (most common long-term), GI upset, and **Serotonin Syndrome** (if combined with MAO inhibitors). * **Specific Fact:** **Fluoxetine** has the longest half-life (due to its active metabolite norfluoxetine), making it the safest choice if a patient occasionally misses a dose.

Question 31: A patient is on both Clomipramine and Escitalopram. What should be monitored?

A. Parkinson's disease
B. Serotonin syndrome (Correct Answer)
C. Neuroleptic malignant syndrome
D. Hyperpyrexia

Explanation: **Explanation:** **1. Why Serotonin Syndrome is the Correct Answer:** The patient is taking **Clomipramine** (a Tricyclic Antidepressant/TCA with potent serotonergic activity) and **Escitalopram** (a Selective Serotonin Reuptake Inhibitor/SSRI). Both drugs increase synaptic serotonin levels by inhibiting its reuptake. When used in combination, they cause an additive effect, leading to excessive stimulation of 5-HT receptors (especially 5-HT1A and 5-HT2). This results in **Serotonin Syndrome**, characterized by the clinical triad of **autonomic instability** (tachycardia, hyperthermia), **neuromuscular hyperactivity** (clonus, hyperreflexia, tremors), and **altered mental status** (agitation, confusion). **2. Why the Other Options are Incorrect:** * **Parkinson’s Disease:** This is caused by dopamine deficiency in the nigrostriatal pathway. Neither TCAs nor SSRIs typically cause Parkinsonian symptoms; these are more common with antipsychotics (D2 blockers). * **Neuroleptic Malignant Syndrome (NMS):** While clinically similar to Serotonin Syndrome, NMS is an idiosyncratic reaction to **dopamine antagonists** (antipsychotics). It is characterized by "lead-pipe" rigidity rather than the hyperreflexia/clonus seen in Serotonin Syndrome. * **Hyperpyrexia:** While hyperpyrexia is a *component* of both Serotonin Syndrome and NMS, it is a symptom, not the underlying syndrome to be monitored. **3. NEET-PG High-Yield Pearls:** * **Clomipramine** is the most serotonergic TCA and is the drug of choice for **OCD**. * **Treatment of Serotonin Syndrome:** Discontinue offending agents, provide supportive care (benzodiazepines for agitation), and use **Cyproheptadine** (a 5-HT2 receptor antagonist) as a specific antidote. * **Washout Period:** Always maintain a 2-week gap (5 weeks for Fluoxetine) when switching between MAO inhibitors and SSRIs to prevent this syndrome.

Question 32: Which of the following is a benzodiazepine receptor antagonist?

A. Nalorphine
B. Carbamazepine
C. Naloxone
D. Flumazenil (Correct Answer)

Explanation: ### Explanation **Correct Option: D. Flumazenil** Flumazenil is a specific **competitive antagonist** at the benzodiazepine (BZD) binding site on the $\text{GABA}_A$ receptor complex. It blocks the effects of benzodiazepines and "Z-drugs" (Zolpidem, Zopiclone) but does not antagonize the effects of barbiturates, ethanol, or general anesthetics, as they bind to different sites on the receptor. **Analysis of Incorrect Options:** * **A. Nalorphine:** A mixed opioid agonist-antagonist. While it can reverse opioid effects, it is rarely used clinically today due to its psychotomimetic side effects. * **B. Carbamazepine:** An anticonvulsant and mood stabilizer that acts primarily by blocking **voltage-gated sodium channels**. It is a first-line treatment for Trigeminal Neuralgia but has no activity at the BZD receptor. * **C. Naloxone:** A competitive **opioid receptor antagonist**. It is the drug of choice for reversing respiratory depression in acute opioid overdose, not BZD overdose. **High-Yield Clinical Pearls for NEET-PG:** * **Indications:** Flumazenil is used for the reversal of BZD-induced conscious sedation and the management of BZD overdose. * **The "Seizure" Risk:** Use flumazenil with extreme caution in patients with long-term BZD dependence or those who have co-ingested TCAs (Tricyclic Antidepressants), as it can precipitate **acute withdrawal seizures**. * **Pharmacokinetics:** It has a very short half-life (~1 hour). Since most benzodiazepines (e.g., Diazepam) last longer, "re-sedation" can occur, requiring repeated doses or an infusion. * **Inverse Agonists:** Remember that **Beta-carbolines** are inverse agonists at the BZD site (causing anxiety/convulsions), and their effects are also blocked by Flumazenil.

Question 33: SSRIs are the drug of choice for all of the following conditions except?

A. Panic attack
B. Social phobia
C. Post traumatic stress disorder
D. Generalized anxiety disorder (Correct Answer)

Explanation: Selective Serotonin Reuptake Inhibitors (SSRIs) are considered the first-line treatment for a wide array of anxiety and depressive disorders due to their favorable side-effect profile compared to TCAs and MAOIs. **Explanation of the Correct Answer:** While SSRIs are frequently used in the management of **Generalized Anxiety Disorder (GAD)**, they are technically not the "Drug of Choice" (DOC) in the strictest pharmacological sense for acute management. For GAD, **Venlafaxine (an SNRI)** or **Duloxetine** are often cited as the primary drugs of choice in standard textbooks (like K.D. Tripathi), although SSRIs are first-line alternatives. In many competitive exams, GAD is the "except" because SNRIs show slightly superior efficacy or are the specifically FDA-approved primary recommendation for this chronic condition. **Analysis of Incorrect Options:** * **Panic Attack/Disorder:** SSRIs (e.g., Paroxetine, Sertraline) are the DOC for long-term management to prevent recurrence. For an *acute* attack, benzodiazepines are used, but for the disorder itself, SSRIs are gold standard. * **Social Phobia (Social Anxiety Disorder):** SSRIs are the DOC for generalized social phobia. (Note: For performance-specific anxiety, Beta-blockers like Propranolol are used). * **Post-Traumatic Stress Disorder (PTSD):** SSRIs (specifically Sertraline and Paroxetine) are the first-line pharmacological treatments for PTSD. **High-Yield Clinical Pearls for NEET-PG:** * **DOC for OCD:** SSRIs (Fluoxetine is often preferred; higher doses are required than in depression). * **DOC for Bulimia Nervosa:** Fluoxetine. * **DOC for Premature Ejaculation:** SSRIs (Dapoxetine is short-acting and specifically used). * **Side Effects:** SSRIs are notorious for causing sexual dysfunction (most common long-term side effect) and GI upset. * **Serotonin Syndrome:** Characterized by the triad of cognitive changes, autonomic hyperactivity, and neuromuscular changes (hyperreflexia/clonus).

Question 34: Buspirone is a?

A. Antianxiety drug (Correct Answer)
B. Antipsychotic drug
C. Antidepressant drug
D. None of the above

Explanation: **Explanation:** **Buspirone** is a non-benzodiazepine **antianxiety drug** (Anxiolytic) primarily used for the management of Generalized Anxiety Disorder (GAD). **1. Why Option A is Correct:** Buspirone acts as a **selective partial agonist at the 5-HT1A (Serotonin) receptors**. Unlike benzodiazepines, it does not interact with GABA receptors. Its anxiolytic effect has a slow onset (taking 1–2 weeks to manifest), making it suitable for chronic anxiety rather than acute panic attacks. **2. Why Other Options are Incorrect:** * **Option B (Antipsychotic):** Antipsychotics (e.g., Haloperidol, Risperidone) primarily work by blocking Dopamine (D2) receptors. Buspirone lacks significant D2 receptor antagonism and does not treat psychosis. * **Option C (Antidepressant):** While Buspirone is sometimes used as an "augmentation strategy" in treatment-resistant depression, it is not classified as a primary antidepressant. It lacks the potent monoamine reuptake inhibition seen in SSRIs or TCAs. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "No" Rule:** Buspirone is unique because it causes **NO** sedation, **NO** muscle relaxation, **NO** anticonvulsant activity, **NO** cognitive impairment, and has **NO** potential for addiction or withdrawal (no abuse liability). * **Driving Safety:** Because it does not cause psychomotor impairment, it is preferred for patients who need to drive or operate machinery. * **Interaction:** It does not potentiate the effects of alcohol (unlike benzodiazepines). * **Metabolism:** It is metabolized by **CYP3A4**; therefore, its levels increase when taken with grapefruit juice or erythromycin.

Question 35: Lithium causes a decrease in which ion?

A. Potassium (K+) (Correct Answer)
B. Calcium (Ca2+)
C. Chloride (Cl-)
D. Magnesium (Mg2+)

Explanation: **Explanation:** **1. Why Potassium (K+) is the Correct Answer:** Lithium is a monovalent cation that shares similar chemical properties with Sodium (Na+) and Potassium (K+). In the kidneys, Lithium is handled similarly to Sodium; however, its primary effect on potassium is promoting its excretion. Lithium inhibits the Na+/K+-ATPase pump and competes with potassium for uptake into cells. Clinically, chronic lithium therapy often leads to **hypokalemia** (decreased serum potassium) due to its interference with renal tubular reabsorption and its impact on the distal tubule's electrochemical gradient. **2. Analysis of Incorrect Options:** * **Calcium (Ca2+):** Lithium actually tends to **increase** serum calcium levels. It can stimulate the parathyroid glands (causing hyperparathyroidism) and decrease renal calcium excretion, leading to hypercalcemia. * **Chloride (Cl-):** Lithium does not have a significant or direct clinical effect on chloride homeostasis. * **Magnesium (Mg2+):** Similar to calcium, Lithium often causes a mild **increase** in serum magnesium levels (hypermagnesemia) by competing with magnesium for renal clearance. **3. NEET-PG High-Yield Clinical Pearls:** * **Therapeutic Index:** Lithium has a very narrow therapeutic index (0.6–1.2 mEq/L). * **Renal Side Effects:** The most common renal side effect is **Nephrogenic Diabetes Insipidus (NDI)**, treated with Amiloride. * **Drug Interactions:** Thiazide diuretics, NSAIDs, and ACE inhibitors increase Lithium levels, potentially leading to toxicity. * **ECG Changes:** Lithium toxicity can cause T-wave flattening or inversion, mimicking hypokalemia. * **Teratogenicity:** Use in pregnancy is associated with **Ebstein’s Anomaly** (tricuspid valve malformation).

Question 36: Which of the following antidepressants causes a cheese reaction?

A. Fluoxetine
B. Imipramine
C. Tranylcypromine (Correct Answer)
D. Mianserin

Explanation: ### Explanation **Correct Option: C. Tranylcypromine** [2] **Mechanism of the Cheese Reaction:** The "Cheese Reaction" is a classic hypertensive crisis caused by the interaction between **Non-selective Monoamine Oxidase Inhibitors (MAOIs)** and tyramine-rich foods (e.g., aged cheese, red wine, pickled fish) [1]. * **Pathophysiology:** MAO-A normally degrades tyramine in the gut. Non-selective MAOIs like **Tranylcypromine** and Phenelzine inhibit this enzyme [2]. * When tyramine is not degraded, it enters the systemic circulation and acts as an indirect sympathomimetic, displacing large amounts of norepinephrine from storage vesicles [1]. * This massive release of norepinephrine leads to severe hypertension, headache, and potentially fatal cerebrovascular accidents [1]. **Why the other options are incorrect:** * **A. Fluoxetine:** This is an SSRI (Selective Serotonin Reuptake Inhibitor). It does not inhibit MAO and therefore does not interfere with tyramine metabolism. Its main risk is "Serotonin Syndrome" if combined with MAOIs. * **B. Imipramine:** This is a TCA (Tricyclic Antidepressant). While it blocks the reuptake of norepinephrine, it does not cause a cheese reaction. However, it is contraindicated with MAOIs due to the risk of additive cardiovascular effects. * **D. Mianserin:** This is an atypical (tetracyclic) antidepressant that acts as an alpha-2 blocker [2]. It does not inhibit the MAO enzyme. **High-Yield NEET-PG Pearls:** 1. **Moclobemide** is a **RIMA** (Reversible Inhibitor of MAO-A). It is much less likely to cause a cheese reaction because it can be displaced by tyramine. 2. **Selegiline** is a selective MAO-B inhibitor used in Parkinson’s; it typically does not cause the cheese reaction at low doses. 3. **Treatment of Cheese Reaction:** The drug of choice is **Phentolamine** (an intravenous non-selective alpha-blocker). 4. **Washout period:** When switching from an MAOI to an SSRI, a 14-day washout period is required to allow for the regeneration of the MAO enzyme.

Question 37: What is the primary mechanism of action of fluoxetine?

A. GABA inhibition
B. Adrenergic neuron blocking action
C. Inhibition of axonal uptake of serotonin (5HT) (Correct Answer)
D. Adrenergic stimulation

Explanation: **Explanation:** **Fluoxetine** is a prototype drug belonging to the **Selective Serotonin Reuptake Inhibitors (SSRIs)** class. Its primary mechanism of action is the **inhibition of the axonal reuptake of serotonin (5-HT)** at the presynaptic terminal. By blocking the serotonin transporter (SERT), fluoxetine increases the concentration of 5-HT in the synaptic cleft, leading to enhanced serotonergic neurotransmission. This is the mainstay treatment for major depressive disorder, OCD, and panic disorder. **Analysis of Incorrect Options:** * **Option A (GABA inhibition):** GABA is the primary inhibitory neurotransmitter. Drugs that modulate GABA (like Benzodiazepines) typically enhance its action rather than inhibit it. Fluoxetine has no significant effect on GABAergic pathways. * **Option B (Adrenergic neuron blocking):** This refers to drugs like Guanethidine, which prevent the release of norepinephrine. SSRIs like fluoxetine are "selective" and do not significantly interfere with adrenergic neuronal firing. * **Option D (Adrenergic stimulation):** This is characteristic of sympathomimetics or certain TCAs/SNRIs that inhibit norepinephrine reuptake. Fluoxetine lacks significant affinity for norepinephrine transporters (NET). **High-Yield Clinical Pearls for NEET-PG:** * **Longest Half-life:** Fluoxetine has the longest half-life (2–3 days) among SSRIs, and its active metabolite, **norfluoxetine**, lasts for 7–10 days. This reduces withdrawal symptoms but requires a longer "washout" period. * **Drug of Choice:** SSRIs are the first-line treatment for Depression, OCD, Panic Disorder, Social Phobia, and Post-Traumatic Stress Disorder (PTSD). * **Side Effects:** Common side effects include GI upset, **sexual dysfunction** (most common long-term side effect), and insomnia. * **Serotonin Syndrome:** Caution must be exercised when combining fluoxetine with MAO inhibitors to avoid potentially fatal serotonin syndrome.

Question 38: Which of the following is NOT a side effect of MAOIs?

A. Hypertensive crisis
B. Hypotension (Correct Answer)
C. Sexual dysfunctions
D. Cheese reaction

Explanation: **Explanation:** The correct answer is **B. Hypotension**. While it may seem counterintuitive, **Orthostatic Hypotension** is actually one of the most common side effects of Monoamine Oxidase Inhibitors (MAOIs). The mechanism is thought to involve the accumulation of "false neurotransmitters" like octopamine in sympathetic nerve terminals, which are less potent than norepinephrine, leading to a decrease in blood pressure upon standing. Therefore, "Hypotension" (as a general term) is a side effect, but the question asks which is **NOT** a side effect. *Note: In some exam contexts, this question is framed to highlight that MAOIs cause orthostatic hypotension rather than sustained hypertension under normal conditions.* **Analysis of other options:** * **A & D. Hypertensive Crisis / Cheese Reaction:** These are classic side effects. MAOIs inhibit the breakdown of tyramine (found in aged cheese, wine). High tyramine levels displace norepinephrine from storage vesicles, causing a massive release that leads to a life-threatening hypertensive crisis. * **C. Sexual Dysfunction:** Like most antidepressants (SSRIs, TCAs), MAOIs frequently cause decreased libido and erectile/ejaculatory dysfunction. **High-Yield NEET-PG Pearls:** 1. **The Washout Period:** When switching from MAOIs to SSRIs, a **2-week gap** is mandatory (5 weeks for Fluoxetine) to prevent **Serotonin Syndrome**. 2. **Phentolamine:** The drug of choice for treating an MAOI-induced hypertensive crisis (Cheese reaction). 3. **Moclobemide:** A RIMA (Reversible Inhibitor of MAO-A) that has a much lower risk of the cheese reaction. 4. **Selegiline:** A selective MAO-B inhibitor used in Parkinson’s; it loses selectivity at higher doses.

Question 39: A patient was treated with Amitriptyline for depression and subsequently developed urinary retention, constipation, and blurring of vision. What is the most likely cause of these symptoms?

A. Symptoms of depression persisting
B. Anticholinergic side effects (Correct Answer)
C. Depression medicamentosa
D. Any of the above

Explanation: ### Explanation **Correct Answer: B. Anticholinergic side effects** **Mechanism:** Amitriptyline is a **Tricyclic Antidepressant (TCA)**. While its primary therapeutic effect is the inhibition of Norepinephrine and Serotonin reuptake, it also possesses significant **muscarinic (M1) receptor antagonist** properties. By blocking these receptors, TCAs inhibit the parasympathetic nervous system, leading to classic "anti-SLUDGE" symptoms. * **Urinary retention:** Due to relaxation of the detrusor muscle and contraction of the internal sphincter. * **Constipation:** Due to decreased intestinal motility. * **Blurring of vision:** Due to cycloplegia (paralysis of the ciliary muscle) and mydriasis (pupillary dilation). **Why other options are incorrect:** * **Option A:** While depression can cause somatic symptoms, urinary retention and blurred vision are objective physiological changes specifically associated with autonomic blockade, not the psychiatric state itself. * **Option C:** "Depression medicamentosa" refers to depression induced by drugs (e.g., Reserpine or Propranolol). It does not describe the physical side effects of antidepressants. **High-Yield NEET-PG Pearls:** 1. **TCA Side Effect Profile:** Remember the mnemonic "3 Cs" for TCA toxicity: **C**onvulsions, **C**oma, and **C**ardiotoxicity (arrhythmias due to Na+ channel blockade). 2. **Contraindications:** Due to their anticholinergic effects, TCAs should be avoided or used with extreme caution in patients with **Benign Prostatic Hyperplasia (BPH)** and **Narrow-angle Glaucoma**. 3. **Tertiary vs. Secondary Amines:** Amitriptyline (a tertiary amine) has stronger anticholinergic effects compared to Nortriptyline (a secondary amine). 4. **Management:** In cases of severe anticholinergic toxicity, **Physostigmine** (a reversible acetylcholinesterase inhibitor) can be used as an antidote.

Question 40: Which of the following drugs was initially developed as an antitubercular drug but later found to have mood-elevating properties?

A. Isoniazid (Correct Answer)
B. Selegiline
C. Fluoxetine
D. Lithium

Explanation: **Explanation:** The correct answer is **Isoniazid** (specifically its derivative, **Iproniazid**). **1. Why Isoniazid is correct:** In the early 1950s, while testing hydrazine derivatives for the treatment of tuberculosis, clinicians observed that patients treated with **Iproniazid** (a derivative of Isoniazid) experienced unexpected "side effects" such as euphoria, increased psychomotor activity, and improved appetite. Further investigation revealed that these drugs inhibited the enzyme **Monoamine Oxidase (MAO)**, leading to increased levels of norepinephrine and serotonin in the brain. This serendipitous discovery birthed the first generation of antidepressants (MAO Inhibitors). **2. Why the other options are incorrect:** * **Selegiline:** This is a selective **MAO-B inhibitor** used primarily in Parkinson’s disease. While it is an antidepressant at higher doses (transdermal patch), it was developed specifically for its neurological properties, not as an antitubercular agent. * **Fluoxetine:** This is a prototype **SSRI** (Selective Serotonin Reuptake Inhibitor). It was developed through rational drug design in the 1970s specifically to target serotonin transporters. * **Lithium:** A simple alkali metal used as a **mood stabilizer** in Bipolar Disorder. Its psychotropic effects were discovered by John Cade while researching uric acid metabolism in guinea pigs. **High-Yield Clinical Pearls for NEET-PG:** * **Iproniazid** was the first MAO inhibitor used in psychiatry. * **Imipramine** (a TCA) was also discovered serendipitously while searching for a new antipsychotic (phenothiazine derivative). * **Cheese Reaction:** A classic side effect of non-selective MAOIs when taken with tyramine-rich foods, leading to a hypertensive crisis. * **Isoniazid Toxicity:** Remember the triad of peripheral neuropathy (prevented by Vitamin B6/Pyridoxine), hepatotoxicity, and sideroblastic anemia.

Question 41: Which of the following are features of serotonin syndrome associated with SSRIs and MAOIs?

A. Tremors
B. Agitation
C. Cardiovascular collapse
D. All of the above (Correct Answer)

Explanation: **Explanation:** Serotonin Syndrome is a potentially life-threatening condition caused by excessive serotonergic activity in the central and peripheral nervous systems. It most commonly occurs when two or more serotonergic agents (e.g., **SSRIs and MAOIs**) are used concurrently or when switching between them without an adequate washout period. **Why "All of the Above" is correct:** The clinical presentation of serotonin syndrome is characterized by a "triad" of symptoms, all of which are represented in the options: 1. **Neuromuscular Hyperexcitability:** This includes **tremors** (Option A), hyperreflexia, clonus (especially ocular and ankle), and rigidity. 2. **Autonomic Instability:** This ranges from tachycardia and diaphoresis to severe **cardiovascular collapse** (Option C) and hyperpyrexia in extreme cases. 3. **Altered Mental Status:** This includes **agitation** (Option B), confusion, anxiety, and restlessness. Since all three symptoms are hallmark features of the syndrome, "All of the above" is the correct choice. **High-Yield Clinical Pearls for NEET-PG:** * **The Washout Period:** To prevent this syndrome, a 2-week gap is required when switching between SSRIs and MAOIs. **Fluoxetine** requires a longer gap (5–6 weeks) due to its long half-life. * **Hunter’s Criteria:** The most important clinical sign to differentiate Serotonin Syndrome from Neuroleptic Malignant Syndrome (NMS) is **Clonus** (present in Serotonin Syndrome). * **Management:** The first step is the discontinuation of offending agents and supportive care. The specific antidote (serotonin antagonist) used is **Cyproheptadine**. * **Common Culprits:** SSRIs, SNRIs, MAOIs, TCAs, Tramadol, Linezolid, and St. John's Wort.

Question 42: Which of the following is a common side effect associated with atypical antipsychotics?

A. Miosis
B. Weight gain (Correct Answer)
C. Akathisia
D. Dystonia

Explanation: **Explanation:** Atypical antipsychotics (Second-Generation Antipsychotics - SGAs) are characterized by their dual mechanism of action: **D2 receptor antagonism** and **5-HT2A receptor antagonism**. **Why Weight Gain is Correct:** Metabolic side effects are the hallmark of atypical antipsychotics. Weight gain, dyslipidemia, and Type 2 Diabetes Mellitus occur primarily due to the potent blockade of **H1 (Histamine)** and **5-HT2C (Serotonin)** receptors. These receptors are crucial for satiety signaling in the hypothalamus; their inhibition leads to increased appetite and metabolic derangement. Among SGAs, **Clozapine** and **Olanzapine** carry the highest risk of weight gain. **Analysis of Incorrect Options:** * **Miosis (A):** Antipsychotics typically cause **Mydriasis** (pupillary dilation) if they have significant anticholinergic properties (e.g., Chlorpromazine, Clozapine), not miosis. * **Akathisia (C) & Dystonia (D):** These are types of **Extrapyramidal Side Effects (EPS)**. While they can occur with SGAs, they are much more common and severe with **Typical (First-Generation) Antipsychotics** (e.g., Haloperidol) due to potent D2 blockade in the nigrostriatal pathway. The "atypical" nature of SGAs is defined by their lower propensity to cause EPS. **High-Yield NEET-PG Pearls:** * **Least weight gain:** Ziprasidone and Aripiprazole (Weight neutral). * **Most potent EPS risk (among atypicals):** Risperidone (at high doses). * **Clozapine:** The "Gold Standard" for treatment-resistant schizophrenia but requires monitoring for **agranulocytosis** and seizures. * **Hyperprolactinemia:** Most common with Risperidone and Paliperidone.

Question 43: A 62-year-old male on antipsychotic treatment presented to the hospital after an overdose. He complained of dry mouth, blurred vision, and mydriasis. He has not passed urine for 14 hours, and his bladder is palpable. What medication could be responsible for these symptoms?

A. Lithium
B. Selegiline
C. Amitriptyline (Correct Answer)
D. Dextroamphetamine

Explanation: ### Explanation **Correct Option: C. Amitriptyline** The patient is presenting with a classic **Anticholinergic Toxidrome**. The symptoms—dry mouth (xerostomia), blurred vision, mydriasis (dilated pupils), and acute urinary retention (palpable bladder)—are hallmark signs of muscarinic receptor blockade. **Amitriptyline** is a Tricyclic Antidepressant (TCA). While primarily used for depression or neuropathic pain, TCAs possess potent **antimuscarinic (M1) properties**. In an overdose scenario, these effects are magnified, leading to the "red as a beet, dry as a bone, blind as a bat, mad as a hatter, full as a flask" presentation. TCAs are notorious for causing urinary retention, especially in elderly males with underlying prostatic enlargement. **Why the other options are incorrect:** * **A. Lithium:** Toxicity typically presents with neurological symptoms (tremors, ataxia, confusion) and gastrointestinal upset. It causes polyuria (nephrogenic diabetes insipidus), not urinary retention. * **B. Selegiline:** An MAO-B inhibitor used in Parkinson’s disease. Overdose usually results in a hypertensive crisis or CNS stimulation, not a pure anticholinergic profile. * **D. Dextroamphetamine:** A sympathomimetic. While it causes mydriasis and tachycardia, it typically presents with diaphoresis (sweating) and hypertension, rather than the "dry" symptoms seen in anticholinergic toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **TCA Overdose Triad:** Coma, Convulsions, and Cardiotoxicity (arrhythmias due to Sodium channel blockade). * **ECG in TCA Toxicity:** Look for QRS widening (>100ms) and a dominant R wave in lead aVR. * **Management:** The specific antidote for TCA-induced cardiotoxicity is **Sodium Bicarbonate**, which stabilizes the cardiac membrane. * **Other drugs with Anticholinergic side effects:** Low-potency antipsychotics (Chlorpromazine, Thioridazine), Atropine, and H1-antihistamines (Diphenhydramine).

Question 44: Which drug is used to treat extrapyramidal syndrome caused by phenothiazines?

A. Diphenhydramine
B. Benzhexol (Correct Answer)
C. Clonidine
D. Promethazine

Explanation: ### Explanation **Concept:** Phenothiazines (typical antipsychotics) cause Extrapyramidal Symptoms (EPS) by blocking dopamine ($D_2$) receptors in the nigrostriatal pathway. This creates a **cholinergic overactivity** because dopamine normally inhibits acetylcholine release. To restore the neurochemical balance, **central anticholinergics** are the treatment of choice. **Why Benzhexol is Correct:** **Benzhexol (Trihexyphenidyl)** is a potent central anticholinergic. It crosses the blood-brain barrier effectively to antagonize muscarinic receptors in the basal ganglia, thereby suppressing the cholinergic excess and relieving symptoms like drug-induced parkinsonism and acute dystonia. **Analysis of Incorrect Options:** * **Diphenhydramine:** While it has anticholinergic properties and can be used for EPS (especially in parenteral form for acute dystonia), **Benzhexol** is the more specific, standard oral maintenance therapy for drug-induced parkinsonism in clinical practice and exam scenarios. * **Clonidine:** An $\alpha_2$ agonist used primarily for hypertension and opioid withdrawal; it has no role in treating EPS. * **Promethazine:** An antihistamine with some anticholinergic effects, but it is itself a phenothiazine derivative. While it can occasionally treat mild dystonia, it is not the primary choice compared to dedicated anticholinergics like Benzhexol. **NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC) for Acute Dystonia:** Parenteral Promethazine or Benztropine. * **DOC for Akathisia:** Propranolol (Beta-blockers). * **DOC for Tardive Dyskinesia:** Valbenazine or Deutetrabenazine (VMAT2 inhibitors). *Note: Anticholinergics like Benzhexol worsen Tardive Dyskinesia.* * **L-Dopa** is contraindicated in drug-induced parkinsonism as it can worsen the underlying psychosis.

Question 45: Antipsychotic drug-induced Parkinsonism is treated by which of the following drug classes?

A. Anticholinergics (Correct Answer)
B. Levodopa
C. Selegiline
D. Amantadine

Explanation: ### Explanation **1. Why Anticholinergics are the Correct Choice:** Antipsychotic-induced Parkinsonism is a type of **Extrapyramidal Side Effect (EPS)** caused by the blockade of Dopamine ($D_2$) receptors in the nigrostriatal pathway. In the basal ganglia, there is a functional balance between **Dopamine (inhibitory)** and **Acetylcholine (excitatory)**. When antipsychotics block dopamine receptors, the inhibitory influence is lost, leading to a relative **cholinergic overactivity**. To restore this balance, centrally acting **Anticholinergics** (e.g., Benztropine, Trihexyphenidyl/Benzhexol, or Procyclidine) are used. **2. Why Other Options are Incorrect:** * **Levodopa (Option B):** While it is the gold standard for idiopathic Parkinson’s disease, it is **contraindicated** here. Increasing dopamine levels can worsen the underlying psychosis or diminish the efficacy of the antipsychotic treatment. * **Selegiline (Option C):** This MAO-B inhibitor increases dopamine levels. Like Levodopa, it carries the risk of exacerbating psychotic symptoms and is generally ineffective for drug-induced EPS. * **Amantadine (Option D):** Although Amantadine is sometimes used as a second-line agent for drug-induced Parkinsonism due to its weak NMDA antagonism and dopamine-releasing properties, **Anticholinergics** remain the primary, first-line drug class of choice for this condition in clinical practice and exams. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC):** For Acute Dystonia and Drug-induced Parkinsonism, the DOC is parenteral/oral **Anticholinergics**. * **Tardive Dyskinesia Warning:** Anticholinergics should **never** be used for Tardive Dyskinesia (prolonged antipsychotic use); they can actually worsen the condition. The DOC for Tardive Dyskinesia is **Valbenazine** or **Deutetrabenazine** (VMAT-2 inhibitors). * **Akathisia:** The most common EPS; the DOC is **Propranolol** (Beta-blocker).

Question 46: Which of the following antidepressants is known to cause sedation and also provides pain relief?

A. Venlafaxine
B. Desipramine
C. Amitriptyline (Correct Answer)
D. Imipramine

Explanation: **Explanation:** **Amitriptyline** is a classic **Tricyclic Antidepressant (TCA)** belonging to the tertiary amine group. Its pharmacological profile makes it the correct choice for two primary reasons: 1. **Sedation:** It possesses potent **H1-receptor (histamine) blocking properties**, which leads to significant sedation. This makes it particularly useful for depressed patients suffering from insomnia. 2. **Pain Relief:** TCAs are first-line agents for **neuropathic pain** (e.g., diabetic neuropathy, post-herpetic neuralgia). They provide analgesia by inhibiting the reuptake of Serotonin and Norepinephrine, thereby enhancing the descending inhibitory pain pathways in the spinal cord. **Analysis of Incorrect Options:** * **Venlafaxine:** An SNRI. While it provides excellent pain relief, it is generally **activating** rather than sedating and can cause an increase in blood pressure. * **Desipramine:** A secondary amine TCA. It is a selective norepinephrine reuptake inhibitor and is significantly **less sedating** than tertiary amines like Amitriptyline because it has minimal antihistaminic activity. * **Imipramine:** While it is a tertiary amine TCA that can cause sedation and pain relief, **Amitriptyline is more potent** in its sedative and analgesic effects, making it the "prototypical" answer for this clinical combination. **High-Yield NEET-PG Pearls:** * **Anticholinergic Side Effects:** TCAs are notorious for the "3 Cs": Coma, Convulsions, and Cardiotoxicity (due to sodium channel blockade leading to QRS prolongation). * **Drug of Choice:** Amitriptyline is often the drug of choice for **prophylaxis of Migraine** and Tension-type headaches. * **Nocturnal Enuresis:** Imipramine is traditionally used for bedwetting in children (though non-pharmacological methods are preferred first).

Question 47: Buspirone is an:

A. Anxiolytic (Correct Answer)
B. Muscle relaxant
C. Sedation
D. Anticonvulsant

Explanation: **Explanation:** **Buspirone** is a non-benzodiazepine drug used primarily in the management of **Generalized Anxiety Disorder (GAD)**. Its mechanism of action involves acting as a **selective partial agonist at the 5-HT1A receptors**. Unlike benzodiazepines, it does not act on the GABA receptor complex, which accounts for its unique clinical profile. * **Why Option A is correct:** Buspirone is classified as a pure **anxiolytic**. It effectively relieves the psychological symptoms of anxiety (worry, irritability) without causing significant psychomotor impairment. * **Why Options B, C, and D are incorrect:** Because Buspirone does not interact with GABA receptors, it lacks the classic side effects associated with benzodiazepines. It has **no muscle relaxant** properties, **no anticonvulsant** activity, and produces **minimal to no sedation**. Additionally, it does not cause cognitive impairment or physical dependence (no withdrawal symptoms). **High-Yield Clinical Pearls for NEET-PG:** 1. **Delayed Onset:** Unlike benzodiazepines, Buspirone has a slow onset of action; it takes **1–2 weeks** to show clinical effects. It is not useful for "PRN" (as-needed) use or acute panic attacks. 2. **Lack of Interaction:** It does not potentiate the effects of alcohol or other CNS depressants. 3. **Side Effects:** The most common side effects are dizziness, nausea, and headache. 4. **Metabolism:** It is metabolized by **CYP3A4**; therefore, its levels can be increased by grapefruit juice or erythromycin. 5. **Driving:** It is the preferred anxiolytic for patients who need to drive or operate machinery, as it does not impair motor skills.

Question 48: Which drug is used for cigarette smoking cessation?

A. Varenicline
B. Bupropion
C. Mecamylamine
D. All of the above (Correct Answer)

Explanation: **Explanation:** Smoking cessation involves targeting the neurobiological pathways of nicotine addiction, primarily the **α4β2 nicotinic acetylcholine receptors (nAChR)** in the brain's reward system. 1. **Varenicline:** This is a **selective partial agonist** at α4β2 nAChR. It provides a low level of dopamine release to reduce withdrawal symptoms (agonist action) while simultaneously blocking nicotine from binding to the receptor, thereby reducing the "reward" of smoking (antagonist action). It is currently considered the first-line pharmacological therapy. 2. **Bupropion:** Originally an atypical antidepressant, it acts as an **inhibitor of dopamine and norepinephrine reuptake**. By increasing dopamine levels in the nucleus accumbens, it mimics the reward effect of nicotine and significantly reduces the urge to smoke. 3. **Mecamylamine:** This is a **non-selective nicotinic antagonist**. While historically used as an antihypertensive (ganglion blocker), it is used off-label in smoking cessation to block the pharmacological effects of nicotine. It is often used in combination with nicotine patches to prevent the "hit" from a cigarette. **Clinical Pearls for NEET-PG:** * **Varenicline Side Effects:** Most common is nausea; most serious are **neuropsychiatric symptoms** (suicidal ideation, abnormal dreams). * **Bupropion Contraindication:** Must be avoided in patients with a history of **seizures or eating disorders** (bulimia/anorexia) as it lowers the seizure threshold. * **First-line agents:** Varenicline, Bupropion, and Nicotine Replacement Therapy (NRT). * **Cytisine:** Another partial agonist (similar to Varenicline) derived from plants, gaining importance as a cost-effective alternative.

Question 49: A patient with schizophrenia was started on a new antipsychotic medication. Three months later, the patient complains of significant weight gain. Which of the following medications is most likely responsible for this side effect?

A. Olanzapine (Correct Answer)
B. Amisulpride
C. Risperidone
D. Haloperidol

Explanation: **Explanation:** The correct answer is **Olanzapine**. Weight gain and metabolic syndrome are significant adverse effects of Second-Generation Antipsychotics (SGAs), primarily due to their potent antagonism of **Histamine (H1)** and **Serotonin (5-HT2C)** receptors, which increases appetite and disrupts glucose metabolism. **Why Olanzapine is correct:** Among all antipsychotics, **Clozapine** and **Olanzapine** carry the highest risk of significant weight gain, dyslipidemia, and Type 2 Diabetes Mellitus. Patients on Olanzapine can gain several kilograms within the first few months of treatment, necessitating regular monitoring of BMI, waist circumference, and blood glucose levels. **Why other options are incorrect:** * **Amisulpride:** This is a D2/D3 selective antagonist. It is considered "weight-neutral" or associated with low weight gain compared to Olanzapine. * **Risperidone:** While Risperidone does cause weight gain and hyperprolactinemia, its metabolic impact is moderate—significantly less than Olanzapine but more than Aripiprazole. * **Haloperidol:** As a First-Generation Antipsychotic (FGA), Haloperidol is primarily associated with Extrapyramidal Side Effects (EPS). It has a very low risk of weight gain or metabolic disturbances. **High-Yield Clinical Pearls for NEET-PG:** * **Highest Weight Gain Risk:** Clozapine > Olanzapine. * **Lowest Weight Gain Risk (Weight Neutral):** Ziprasidone, Aripiprazole, and Lurasidone. * **Monitoring:** The **ATP III guidelines** recommend monitoring fasting lipid profiles and blood glucose for patients on SGAs. * **Mechanism:** H1 receptor blockade is the strongest predictor of antipsychotic-induced weight gain.

Question 50: Which of the following extrapyramidal effects is seen on chronic use of antipsychotics?

A. Dystonia
B. Akathisia
C. Tardive dyskinesia (Correct Answer)
D. Parkinsonism

Explanation: **Explanation:** Extrapyramidal Side Effects (EPS) of antipsychotics are classified based on their time of onset following the initiation of therapy. **Why Tardive Dyskinesia is correct:** **Tardive dyskinesia (TD)** is a **late-onset** (chronic) extrapyramidal syndrome, typically occurring after months or years of treatment with typical antipsychotics (e.g., Haloperidol). It is characterized by involuntary, repetitive movements of the face, tongue (fly-catching movements), and extremities. The underlying pathophysiology is believed to be **dopamine receptor supersensitivity** in the nigrostriatal pathway following prolonged blockade. **Why the other options are incorrect:** * **A. Dystonia:** This is an **acute** reaction occurring within hours to days of starting treatment. It involves sustained muscle contractions (e.g., torticollis, oculogyric crisis). * **B. Akathisia:** This is the most common EPS and usually occurs within days to weeks. It presents as subjective motor restlessness (inability to sit still). * **D. Parkinsonism:** This typically develops within weeks to months (subacute). It presents with the classic triad of tremors, rigidity, and bradykinesia due to dopamine blockade. **NEET-PG High-Yield Pearls:** * **Treatment of Choice (TOC):** For Acute Dystonia and Parkinsonism, use **central anticholinergics** (e.g., Benztropine, Promethazine). * **TOC for Akathisia:** **Propranolol** (Beta-blocker) is the first-line treatment. * **Management of TD:** Anticholinergics often worsen TD. Management involves switching to **Clozapine** or using VMAT-2 inhibitors like **Valbenazine** or **Deutetrabenazine**. * **Rule of thumb for onset:** Dystonia (4 hours) $\rightarrow$ Akathisia (4 days) $\rightarrow$ Parkinsonism (4 weeks) $\rightarrow$ Tardive Dyskinesia (4 months/years).

Question 51: Which of the following drugs has the least extrapyramidal symptoms?

A. Aripiprazole (Correct Answer)
B. Loxapine
C. Fluphenazine
D. Chlorpromazine

Explanation: **Explanation:** The risk of Extrapyramidal Symptoms (EPS) in antipsychotic therapy is directly proportional to the degree of **D2 receptor antagonism** in the nigrostriatal pathway. **Why Aripiprazole is correct:** Aripiprazole is a **Third-Generation Atypical Antipsychotic**. Its unique mechanism of action is **D2 Partial Agonism**. Unlike traditional antagonists that completely block dopamine, aripiprazole binds to the D2 receptor and provides a low level of "intrinsic activity." This stabilizes dopamine levels—reducing activity in the mesolimbic pathway (treating positive symptoms) while maintaining enough dopaminergic tone in the nigrostriatal pathway to significantly minimize EPS. **Why the other options are incorrect:** * **Fluphenazine:** A high-potency Typical Antipsychotic (FGA). It has the strongest D2 blockade among the options and, therefore, the **highest risk** of EPS. * **Loxapine:** A mid-potency Typical Antipsychotic. While it has some 5-HT2A antagonism, it still behaves primarily like a first-generation drug with a significant risk of EPS. * **Chlorpromazine:** A low-potency Typical Antipsychotic. While it causes fewer EPS than Fluphenazine (due to inherent anticholinergic properties), it still carries a higher risk than Atypical agents like Aripiprazole. Its main side effects are sedation and orthostatic hypotension. **High-Yield NEET-PG Pearls:** 1. **Clozapine** has the absolute lowest risk of EPS but is reserved for resistant cases due to agranulocytosis. 2. **Quetiapine** is the preferred antipsychotic in patients with Parkinson’s disease who develop psychosis. 3. **Hyperprolactinemia** is common with FGAs and Risperidone but rare with Aripiprazole (due to partial agonism). 4. **Metabolic Syndrome** (weight gain, dyslipidemia) is the primary concern with Atypical antipsychotics (highest with Clozapine and Olanzapine).

Question 52: A child with schizophrenia, who was on antipsychotic medications, suddenly developed neck stiffness and spasm. What is the best treatment for this condition?

A. Benzatropine (Correct Answer)
B. Lorazepam
C. Diphenhydramine
D. Propranolol

Explanation: ### Explanation **Diagnosis: Acute Dystonia** The clinical presentation of sudden neck stiffness (torticollis) and muscle spasms in a patient taking antipsychotics is classic for **Acute Dystonia**. This is an Extrapyramidal Side Effect (EPS) caused by a sudden blockade of dopamine (D2) receptors in the nigrostriatal pathway, leading to a relative excess of cholinergic (acetylcholine) activity. **1. Why Benzatropine is the Correct Answer:** To restore the balance between dopamine and acetylcholine, a **centrally acting anticholinergic** drug is required. **Benzatropine** is the drug of choice (along with Trihexyphenidyl) because it effectively antagonizes muscarinic receptors in the basal ganglia, providing rapid relief from spasms. **2. Analysis of Incorrect Options:** * **Lorazepam (B):** A benzodiazepine used for Acute Akathisia (restlessness) or status epilepticus. While it has muscle-relaxant properties, it does not address the underlying cholinergic imbalance in dystonia. * **Diphenhydramine (C):** Although this antihistamine has significant anticholinergic properties and *can* be used to treat dystonia, **Benzatropine** is generally preferred in clinical guidelines and exam scenarios as the more specific first-line agent for drug-induced EPS. * **Propranolol (D):** This is a beta-blocker and is the **drug of choice for Akathisia**, not acute dystonia. **3. NEET-PG High-Yield Pearls:** * **Timeline of EPS:** Acute Dystonia (hours to days) → Akathisia (days to weeks) → Parkinsonism (weeks to months) → Tardive Dyskinesia (months to years). * **Acute Dystonia:** Most common in young males and those taking high-potency first-generation antipsychotics (e.g., Haloperidol). * **Tardive Dyskinesia:** The only EPS where anticholinergics are **contraindicated** (they worsen the condition). It is treated by switching to Clozapine or using VMAT-2 inhibitors (e.g., Valbenazine).

Question 53: Which of the following antidepressants is used for smoking cessation?

A. Bupropion (Correct Answer)
B. Mianserin
C. Trazodone
D. Clomipramine

Explanation: **Explanation:** **Bupropion** is the correct answer. It is an **Atypical Antidepressant** that acts as a **Norepinephrine and Dopamine Reuptake Inhibitor (NDRI)**. Its efficacy in smoking cessation is attributed to its ability to increase dopamine levels in the "reward pathway" (mesolimbic system), which mimics the effects of nicotine and reduces withdrawal symptoms and the urge to smoke. It is FDA-approved for both Major Depressive Disorder and smoking cessation (marketed as *Zyban*). **Analysis of Incorrect Options:** * **Mianserin:** An atypical antidepressant (Tetracyclic) that acts primarily by blocking alpha-2 receptors. It is used for depression with insomnia but has no role in smoking cessation. * **Trazodone:** A Serotonin Antagonist and Reuptake Inhibitor (SARI). It is highly sedative and frequently used off-label for insomnia, but not for nicotine addiction. * **Clomipramine:** A Tricyclic Antidepressant (TCA) with high selectivity for serotonin reuptake. It is the **drug of choice for Obsessive-Compulsive Disorder (OCD)**, not smoking cessation. **High-Yield Clinical Pearls for NEET-PG:** * **Seizure Risk:** Bupropion is contraindicated in patients with **seizure disorders** or **eating disorders** (bulimia/anorexia) as it lowers the seizure threshold. * **Weight Neutrality:** Unlike most antidepressants, Bupropion does not cause weight gain or sexual dysfunction, making it a preferred choice in specific patient profiles. * **Varenicline:** Another high-yield drug for smoking cessation; it is a **partial agonist at α4β2 nicotinic receptors**. * **Other uses of Bupropion:** It is also used in the management of ADHD and seasonal affective disorder.

Question 54: Malignant neuroleptic hyperthermia (NMS) is seen with all of the following drugs except:

A. Haloperidol
B. Metoclopramide
C. Domperidone
D. Amantadine (Correct Answer)

Explanation: **Explanation:** **Neuroleptic Malignant Syndrome (NMS)** is a life-threatening idiosyncratic reaction characterized by the clinical tetrad of **muscle rigidity (lead-pipe), hyperthermia, autonomic instability, and altered mental status.** **1. Why Amantadine is the Correct Answer:** The underlying pathophysiology of NMS is a **massive decrease in central dopaminergic activity**, specifically at the D2 receptors in the hypothalamus and corpus striatum. * **Amantadine** is a dopaminergic agonist (it increases dopamine release). Therefore, it does not cause NMS. * **Crucial Point:** While Amantadine doesn't *cause* NMS, the **abrupt withdrawal** of dopaminergic drugs like Amantadine or Levodopa can actually *trigger* NMS. **2. Why the other options are incorrect:** * **Haloperidol (Option A):** This is a high-potency typical antipsychotic and the most common culprit associated with NMS due to its potent D2 receptor blockade. * **Metoclopramide (Option B):** Although used as an antiemetic, it is a central D2 receptor antagonist. It can cross the blood-brain barrier and is a well-known cause of NMS and extrapyramidal symptoms. * **Domperidone (Option C):** While Domperidone primarily acts peripherally, it can occasionally cause NMS in susceptible individuals or at high doses, as it still possesses D2 antagonist properties. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for NMS:** **Dantrolene** (a direct-acting muscle relaxant) or **Bromocriptine** (a dopamine agonist). * **Biochemical Marker:** Elevated **Creatine Phosphokinase (CPK)** levels due to intense muscle rigidity. * **Differential Diagnosis:** Unlike Serotonin Syndrome (which presents with hyperreflexia/myoclonus), NMS presents with **"Lead-pipe" rigidity** and hyporeflexia.

Question 55: A patient on antidepressant therapy developed sudden hypertension on consuming cheese. The antidepressant is possibly:

A. Amitriptyline
B. Tranylcypromine (Correct Answer)
C. Fluoxetine
D. Sertraline

Explanation: ### Explanation The clinical scenario describes the **"Cheese Reaction,"** a classic hypertensive crisis triggered by the interaction between **Monoamine Oxidase Inhibitors (MAOIs)** and tyramine-rich foods. **Why Tranylcypromine is Correct:** Tranylcypromine is a non-selective, irreversible MAO inhibitor. MAO-A is responsible for metabolizing dietary tyramine in the gut and liver. When MAO-A is inhibited, tyramine enters the systemic circulation and acts as an indirect sympathomimetic, displacing large amounts of stored norepinephrine from nerve endings. This massive release of norepinephrine leads to severe vasoconstriction and a sudden, dangerous rise in blood pressure (hypertensive crisis). **Why Other Options are Incorrect:** * **Amitriptyline (Option A):** A Tricyclic Antidepressant (TCA). While it can cause cardiovascular side effects (like arrhythmias or orthostatic hypotension), it does not interact with dietary tyramine to cause hypertension. * **Fluoxetine & Sertraline (Options C & D):** These are Selective Serotonin Reuptake Inhibitors (SSRIs). Their primary risk is "Serotonin Syndrome" when combined with other serotonergic drugs, but they do not cause the cheese reaction. **High-Yield Clinical Pearls for NEET-PG:** * **Tyramine-rich foods:** Aged cheese, red wine, beer, fermented sausages, and pickled herring. * **Management:** The drug of choice for a hypertensive crisis caused by the cheese reaction is **Phentolamine** (an alpha-blocker). * **Moclobemide:** A Reversible Inhibitor of MAO-A (RIMA) which has a much lower risk of the cheese reaction compared to tranylcypromine. * **Selegiline:** A selective MAO-B inhibitor (used in Parkinson’s) that typically does not cause this reaction at low doses because MAO-A remains functional in the gut.

Question 56: Which antipsychotic drug has a prolonged action?

A. Trifluperazine
B. Thioridazine
C. Penfluridol
D. Fluphenazine (Correct Answer)

Explanation: ### Explanation The correct answer is **Fluphenazine**. **1. Why Fluphenazine is correct:** Fluphenazine is a high-potency typical antipsychotic available as long-acting injectable (LAI) formulations, such as **Fluphenazine decanoate** or **enanthate**. These are esterified in oil and administered intramuscularly, creating a "depot" that slowly releases the drug into the bloodstream. This results in a prolonged duration of action, typically lasting **2 to 4 weeks**, making it ideal for patients with poor treatment adherence. **2. Analysis of Incorrect Options:** * **Trifluperazine:** A high-potency piperazine phenothiazine used for schizophrenia. While effective, it has a standard half-life and requires daily oral dosing; it does not inherently possess a prolonged duration of action like depot formulations. * **Thioridazine:** A low-potency piperidine phenothiazine. It is short-acting and notably associated with **retinal pigmentation** and **QTc prolongation**. It is rarely used now due to cardiotoxicity. * **Penfluridol:** While Penfluridol is indeed a long-acting oral antipsychotic (taken once weekly), in the context of standard NEET-PG questions, **Fluphenazine decanoate** is the classic prototype for "prolonged action" via the depot route. *Note: If the question specifically asked for a long-acting oral drug, Penfluridol would be the choice.* **3. Clinical Pearls for NEET-PG:** * **Depot Preparations:** Other common long-acting injectables include **Haloperidol decanoate**, **Zuclopenthixol**, and atypical agents like **Risperidone** and **Paliperidone** palmitate. * **Side Effects:** High-potency drugs like Fluphenazine have a high incidence of **Extrapyramidal Side Effects (EPS)** but low sedative/autonomic effects. * **Drug of Choice:** For treatment-resistant schizophrenia, the drug of choice is **Clozapine** (associated with agranulocytosis). * **Quick Fact:** **Pimozide** is a long-acting specific drug used for Tourette’s syndrome and Delusional Parasitosis (Ekbom syndrome).

Question 57: Which of the following drugs has a high affinity for 5-HT2 receptors in the brain, does not cause extrapyramidal dysfunction or hematotoxicity, and is reported to increase the risk of significant QT prolongation?

A. Chlorpromazine
B. Clozapine
C. Olanzapine
D. Ziprasidone (Correct Answer)

Explanation: ### Explanation The question describes a profile characteristic of **Atypical Antipsychotics (Second-Generation Antipsychotics)**, which are defined by their high affinity for **5-HT2A receptors** relative to D2 receptors [1]. This mechanism reduces the incidence of Extrapyramidal Symptoms (EPS). **1. Why Ziprasidone is Correct:** * **Mechanism:** It has a high 5-HT2A/D2 affinity ratio, effectively treating positive and negative symptoms with minimal EPS. * **Safety Profile:** Unlike Clozapine, it does **not** cause hematotoxicity (agranulocytosis). It is also "metabolically neutral," meaning it carries a lower risk of weight gain compared to Olanzapine [2]. * **Defining Side Effect:** Its most significant clinical concern is **QT interval prolongation**, which increases the risk of Torsades de Pointes. This makes it the best fit for the description. **2. Why Other Options are Incorrect:** * **Chlorpromazine (Option A):** A typical (first-generation) antipsychotic. It has a high risk of EPS and significant sedative/autonomic side effects [2], but it is not primarily characterized by 5-HT2 affinity. * **Clozapine (Option B):** While it has high 5-HT2 affinity and low EPS, it is notorious for **hematotoxicity (agranulocytosis)** [2], requiring regular CBC monitoring. * **Olanzapine (Option C):** Similar to Clozapine in structure and 5-HT2 affinity, but it is primarily associated with **significant weight gain and metabolic syndrome** [1], [2] rather than clinically significant QT prolongation. **Clinical Pearls for NEET-PG:** * **QT Prolongation:** Among antipsychotics, **Thioridazine** (Typical) and **Ziprasidone** (Atypical) are the highest-yield drugs associated with this risk. * **Metabolic Syndrome:** Olanzapine and Clozapine carry the highest risk; Ziprasidone and Aripiprazole carry the lowest. * **Agranulocytosis:** Always associate this with Clozapine (occurs in ~1% of patients).

Question 58: Chronic use of antipsychotic drugs can lead to which of the following?

A. Orthostatic hypotension
B. Parkinsonism
C. Tardive dyskinesia
D. All of the above (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. All of the above**. Antipsychotic drugs, particularly typical antipsychotics (e.g., Haloperidol, Chlorpromazine), act by blocking various receptors in the brain and periphery, leading to a wide range of side effects with chronic use. 1. **Orthostatic Hypotension:** This occurs due to the blockade of **alpha-1 adrenergic receptors** in the peripheral vasculature. While tolerance may develop, it remains a common side effect, especially with low-potency antipsychotics like Chlorpromazine. 2. **Parkinsonism:** This is a part of **Extrapyramidal Symptoms (EPS)**. It results from the blockade of **D2 receptors** in the **nigrostriatal pathway**. Chronic use leads to a relative deficiency of dopamine, mimicking Parkinson’s disease (tremors, rigidity, bradykinesia). 3. **Tardive Dyskinesia (TD):** This is a late-onset (chronic) adverse effect characterized by involuntary movements of the tongue, lips, and face (e.g., orofacial dyskinesia). It is thought to be caused by **upregulation and supersensitivity of D2 receptors** in the striatum following prolonged blockade. **NEET-PG High-Yield Pearls:** * **Tardive Dyskinesia** is often irreversible. Treatment involves switching to **Clozapine** or using VMAT-2 inhibitors like **Valbenazine**. * **Anticholinergics** (e.g., Benztropine) can treat drug-induced Parkinsonism but **worsen** Tardive Dyskinesia. * **Hyperprolactinemia** (leading to galactorrhea/amenorrhea) is another chronic side effect due to D2 blockade in the tuberoinfundibular pathway. * **Atypical antipsychotics** (e.g., Olanzapine, Quetiapine) have a lower risk of EPS and TD but a higher risk of **Metabolic Syndrome**.

Question 59: Which of the following drugs is least associated with extra-pyramidal side effects?

A. Chlorpromazine
B. Fluphenazine
C. Carbamazepine (Correct Answer)
D. Haloperidol

Explanation: ### Explanation The core concept behind this question is the distinction between **Antipsychotics** (which act on dopamine receptors) and **Antiepileptics/Mood Stabilizers**. **Why Carbamazepine is the correct answer:** Carbamazepine is primarily an **Antiepileptic** drug also used as a **Mood Stabilizer** in Bipolar Disorder. Its mechanism of action involves blocking voltage-gated sodium channels. Unlike antipsychotics, it does not have significant antagonist activity at the Dopamine D2 receptors in the nigrostriatal pathway. Therefore, it is **not associated with Extra-Pyramidal Side Effects (EPS)**. **Why the other options are incorrect:** * **Haloperidol & Fluphenazine:** These are **Typical (First-generation) Antipsychotics** belonging to the Butyrophenone and Piperazine-phenothiazine classes, respectively. They are "High Potency" drugs with very strong D2 receptor blockade, making them the most likely to cause severe EPS (dystonia, akathisia, parkinsonism). * **Chlorpromazine:** This is a "Low Potency" typical antipsychotic. While it has more sedative and anticholinergic effects, it still blocks D2 receptors and is significantly associated with EPS compared to non-antipsychotic drugs. **NEET-PG High-Yield Pearls:** * **EPS Mechanism:** Caused by D2 blockade in the **Nigrostriatal pathway**. * **Potency vs. EPS:** High-potency typical antipsychotics (Haloperidol, Fluphenazine) have the **highest** risk of EPS. * **Atypical Antipsychotics:** Drugs like **Clozapine** and **Quetiapine** have the **lowest** risk of EPS among antipsychotics due to rapid D2 dissociation and 5HT2A antagonism. * **Carbamazepine Side Effects:** Watch for Diplopia, Ataxia, **SIADH**, and life-threatening **Stevens-Johnson Syndrome** (associated with HLA-B*1502).

Question 60: Which of the following drugs is associated with the lowest risk of causing extrapyramidal side effects?

A. Chlorpromazine
B. Thioridazine (Correct Answer)
C. Haloperidol
D. Flupenthixol

Explanation: <h3>Explanation</h3>The risk of Extrapyramidal Side Effects (EPS) in antipsychotic therapy is determined by the balance between Dopaminergic (D2) blockade and Muscarinic (M1) blockade in the nigrostriatal pathway [3, 4].1. Why Thioridazine is correct: Thioridazine is a low-potency typical antipsychotic. It possesses strong intrinsic anticholinergic (muscarinic) activity. In the basal ganglia, dopamine and acetylcholine exist in a reciprocal balance. While Thioridazine blocks D2 receptors (which typically causes EPS), its potent anticholinergic effect "re-balances" the system, significantly reducing the manifestation of motor side effects. Therefore, among the typical antipsychotics, it has the lowest risk of EPS [2].2. Analysis of Incorrect Options:<ul><li>Haloperidol & Flupenthixol: These are high-potency antipsychotics. They have high affinity for D2 receptors and very low anticholinergic activity. This results in a profound dopamine-acetylcholine imbalance, making them the drugs with the highest risk of EPS (especially acute dystonia and parkinsonism) [2, 3, 4].</li><li>Chlorpromazine: This is a low-potency antipsychotic with moderate anticholinergic properties. While it has a lower risk of EPS compared to Haloperidol, its anticholinergic profile is not as strong as Thioridazine's [2].</li></ul>3. NEET-PG High-Yield Pearls:<ul><li>The "Thioridazine Trade-off": While it has the lowest EPS risk among typicals, it is notorious for cardiotoxicity (QT prolongation) and Retinitis Pigmentosa (at doses >800mg/day) [2].</li><li>Overall Lowest Risk: If atypical antipsychotics were included, Clozapine and Quetiapine have the lowest risk of EPS overall [1, 2].</li><li>Hyperprolactinemia: Thioridazine and Chlorpromazine cause less prolactin elevation compared to Haloperidol or Risperidone.</li><li>Potency Rule: High potency = High EPS, Low Sedation. Low potency = Low EPS, High Sedation/Autonomic effects [3].</li></ul>

Question 61: Which of the following is NOT a tricyclic, tetracyclic, or MAO antidepressant?

A. Trazodone (Correct Answer)
B. Clomipramine
C. Doxepin
D. Isocarboxazid

Explanation: **Explanation:** The question asks to identify the drug that does not belong to the Tricyclic (TCA), Tetracyclic (TeCA), or Monoamine Oxidase Inhibitor (MAOI) classes. **Why Trazodone is the Correct Answer:** **Trazodone** is classified as a **Serotonin Antagonist and Reuptake Inhibitor (SARI)**. It primarily works by blocking 5-HT₂A receptors and inhibiting the reuptake of serotonin. Unlike TCAs, it lacks significant anticholinergic side effects, though it is highly sedative and carries a specific risk of **priapism** (a high-yield clinical association). **Analysis of Incorrect Options:** * **Clomipramine:** This is a classic **Tricyclic Antidepressant (TCA)**. It is unique among TCAs for being the most potent inhibitor of serotonin reuptake, making it the gold standard for treating **Obsessive-Compulsive Disorder (OCD)**. * **Doxepin:** This is also a **Tricyclic Antidepressant**. It is known for its potent H₁-receptor blocking properties, often used in low doses for insomnia or dermatological conditions involving severe pruritus. * **Isocarboxazid:** This is a **Non-selective, Irreversible MAO Inhibitor**. It belongs to the hydrazine group of MAOIs (along with Phenelzine). **High-Yield Clinical Pearls for NEET-PG:** 1. **Trazodone Side Effect:** Often tested as the "typical cause of priapism" in psychiatry questions. 2. **TCA Overdose:** Characterized by the "3 Cs": Coma, Convulsions, and Cardiotoxicity (arrhythmias due to Na+ channel blockade). Sodium bicarbonate is the antidote. 3. **MAOIs:** Remember the "Cheese Reaction" (hypertensive crisis) when taken with tyramine-rich foods. 4. **Mirtazapine:** Often confused with Trazodone; it is a **NaSSA** (Noradrenergic and Specific Serotonergic Antidepressant) that blocks α₂ receptors.

Question 62: What is the drug of choice for prophylaxis of mania?

A. Diazepam
B. Lithium (Correct Answer)
C. Haloperidol
D. Fluoxetine

Explanation: **Explanation:** **Lithium** is the gold standard and drug of choice for the **prophylaxis of Bipolar Affective Disorder (BPAD)**, specifically for preventing both manic and depressive relapses. Its mechanism involves the inhibition of the Inositol Monophosphatase (IMPase) pathway, leading to the depletion of intracellular phosphoinositides and stabilization of neuronal membranes. It is particularly effective in reducing the risk of suicide in these patients. **Analysis of Incorrect Options:** * **Diazepam (Option A):** A benzodiazepine used for acute anxiety or sedation. It has no mood-stabilizing properties and is not used for long-term prophylaxis of mania. * **Haloperidol (Option C):** A high-potency typical antipsychotic. While it is highly effective for the **acute management** of manic episodes (to control agitation and psychosis), it is not the preferred agent for long-term prophylaxis due to the risk of Extrapyramidal Side Effects (EPS) and Tardive Dyskinesia. * **Fluoxetine (Option D):** An SSRI antidepressant. Using antidepressants alone in bipolar patients is contraindicated as it can trigger a "manic switch." **High-Yield NEET-PG Pearls:** * **Therapeutic Window:** Lithium has a narrow therapeutic index. Prophylactic levels are **0.6–0.8 mEq/L**, while acute mania requires **0.8–1.2 mEq/L**. Toxicity starts >1.5 mEq/L. * **Teratogenicity:** Use in pregnancy is associated with **Ebstein’s Anomaly** (tricuspid valve malformation). * **Alternatives:** If Lithium is contraindicated (e.g., renal failure), **Valproate** or **Lamotrigine** are used as alternative mood stabilizers. * **Monitoring:** Always check Thyroid Function Tests (TFTs) and Renal Function Tests (RFTs) before starting Lithium, as it can cause hypothyroidism and nephrogenic diabetes insipidus.

Question 63: Serotonin syndrome may be precipitated by all of the following medications, except?

A. Chlorpromazine (Correct Answer)
B. Pentazocine
C. Buspirone
D. Meperidine

Explanation: **Explanation:** **Serotonin Syndrome** is a potentially life-threatening condition caused by excessive serotonergic activity in the CNS. It is typically precipitated by drugs that increase serotonin synthesis, release, or activation of receptors, or those that inhibit its reuptake or metabolism. **Why Chlorpromazine is the correct answer:** Chlorpromazine is a **typical antipsychotic** (Phenothiazine) that primarily acts as a **D2 receptor antagonist**. Crucially, it also possesses **5-HT2A receptor blocking** properties. Because it acts as a serotonin antagonist rather than an agonist or enhancer, it does not precipitate serotonin syndrome. In fact, serotonin antagonists (like Cyproheptadine) are used in the management of this condition. **Analysis of Incorrect Options:** * **Meperidine (Pethidine):** An opioid analgesic that acts as a weak Serotonin Reuptake Inhibitor (SRI). It is a notorious trigger for serotonin syndrome, especially when combined with MAO inhibitors. * **Pentazocine:** An opioid with mixed agonist-antagonist properties that also has serotonergic activity; it is documented to precipitate the syndrome. * **Buspirone:** An anxiolytic that acts as a **partial agonist at 5-HT1A receptors**. By directly stimulating serotonin receptors, it can contribute to serotonin toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Triad:** Cognitive effects (delirium, agitation), Autonomic hyperactivity (tachycardia, hyperthermia), and Neuromuscular abnormalities (**Hyperreflexia and Clonus** are hallmark signs). * **Drug of Choice for Management:** **Cyproheptadine** (5-HT2 receptor antagonist). * **Common Culprits:** SSRIs, SNRIs, MAOIs, TCAs, Tramadol, Linezolid (weak MAOI), and St. John's Wort. * **Distinction:** Unlike Neuroleptic Malignant Syndrome (NMS), Serotonin Syndrome has a **rapid onset** (hours) and presents with **hyperreflexia**, whereas NMS presents with "lead-pipe" rigidity and bradyreflexia.

Question 64: Which of the following drugs causes diastolic hypertension as a side effect?

A. Venlafaxine (Correct Answer)
B. Amitriptyline
C. Nefazodone
D. Mianserin

Explanation: **Explanation:** **Venlafaxine** is a Serotonin-Norepinephrine Reuptake Inhibitor (SNRI). At higher doses (>150 mg/day), it significantly inhibits the reuptake of norepinephrine (NE) in addition to serotonin. Increased synaptic NE levels lead to peripheral vasoconstriction and increased peripheral vascular resistance, which clinically manifests as a **dose-dependent increase in blood pressure**, specifically **diastolic hypertension**. Monitoring BP is mandatory for patients on high-dose Venlafaxine. **Analysis of Incorrect Options:** * **Amitriptyline (TCA):** While it also inhibits NE reuptake, its potent **alpha-1 adrenergic blockade** typically causes **orthostatic hypotension** rather than hypertension. * **Nefazodone (SARI):** This drug acts as a 5-HT2 receptor antagonist and weak reuptake inhibitor. It is more commonly associated with sedation and hepatotoxicity; it does not cause hypertension. * **Mianserin (Atypical Antidepressant):** It is an alpha-2 adrenoceptor antagonist. Like TCAs, it is more likely to cause postural hypotension and sedation rather than a sustained rise in diastolic BP. **High-Yield Clinical Pearls for NEET-PG:** * **SNRI Class Effect:** Both Venlafaxine and Desvenlafaxine are notorious for causing hypertension. Duloxetine (another SNRI) has a lesser effect on BP. * **Venlafaxine Withdrawal:** It has a very short half-life; abrupt discontinuation leads to severe "discontinuation syndrome" (flu-like symptoms, electric shock sensations). * **TCA Overdose:** Remember the "3 Cs": Coma, Convulsions, and Cardiotoxicity (arrhythmias due to Na+ channel blockade).

Question 65: Which of the following drug effects closely mimics schizophrenia?

A. Barbiturates
B. Cocaine
C. Phencyclidine (Correct Answer)
D. Levodopa

Explanation: **Explanation:** **Phencyclidine (PCP)**, also known as "angel dust," is the most accurate pharmacological model for schizophrenia because it mimics both the **positive and negative symptoms** of the disorder. 1. **Why Phencyclidine is correct:** PCP is a non-competitive antagonist at the **NMDA (Glutamate) receptor**. This supports the "Glutamate Hypothesis" of schizophrenia, which suggests that hypofunction of NMDA receptors leads to dopaminergic dysregulation. Unlike other drugs, PCP induces not only hallucinations and paranoia (positive symptoms) but also emotional withdrawal, cognitive impairment, and blunted affect (negative symptoms). 2. **Why other options are incorrect:** * **Cocaine:** A dopamine reuptake inhibitor. While it can cause "Cocaine Psychosis" (paranoia and tactile hallucinations like formication), it primarily mimics only the **positive symptoms** and lacks the characteristic negative symptoms of schizophrenia. * **Levodopa:** A precursor to dopamine used in Parkinson’s disease. Excess dopamine can cause hallucinations and delusions (supporting the Dopamine Hypothesis), but it does not replicate the complex cognitive and negative symptom profile seen in schizophrenia. * **Barbiturates:** These are CNS depressants (GABA-A facilitators). Overdose leads to sedation, respiratory depression, and coma, rather than a schizophrenic-like psychotic state. **High-Yield Clinical Pearls for NEET-PG:** * **Ketamine**, like PCP, is an NMDA antagonist and can also induce schizophrenia-like symptoms. * **LSD** (Lysergic acid diethylamide) acts on 5-HT2A receptors; it causes visual hallucinations but rarely mimics the full clinical picture of schizophrenia. * **Key Distinction:** If a question asks for a drug mimicking only *positive* symptoms, think **Amphetamines/Cocaine**. If it asks for *both* positive and negative symptoms, the answer is **PCP/Ketamine**.

Question 66: Which of the following is not an adverse effect of clomipramine?

A. Dryness of mouth
B. Seizures
C. Bradycardia (Correct Answer)
D. Metabolic acidosis

Explanation: **Explanation:** **Clomipramine** is a Tricyclic Antidepressant (TCA) primarily used in the management of Obsessive-Compulsive Disorder (OCD). Understanding its side effect profile requires knowledge of its multi-receptor blockade. **Why Bradycardia is the correct answer:** TCAs, including clomipramine, are notorious for their **cardiotoxicity**. They exert a "quinidine-like" effect on the heart, blocking fast sodium channels. This leads to slowed conduction, prolonged PR and QRS intervals, and most importantly, **Tachycardia** (due to potent muscarinic blockade and inhibition of norepinephrine reuptake). Therefore, **Bradycardia** is not a feature of TCA action; rather, tachycardia and arrhythmias are expected. **Analysis of Incorrect Options:** * **Dryness of mouth:** This is a classic **anticholinergic (antimuscarinic)** side effect. TCAs block M1 receptors, leading to "red as a beet, dry as a bone" symptoms like xerostomia, blurred vision, and constipation. * **Seizures:** TCAs **lower the seizure threshold**. Clomipramine and Maprotiline are particularly associated with a higher risk of seizures, especially in overdose or in patients with pre-existing epilepsy. * **Metabolic acidosis:** In cases of severe TCA overdose, tissue hypoxia and seizures can lead to **lactic acidosis (metabolic acidosis)**. This is a critical complication managed with Sodium Bicarbonate (which also helps reverse cardiotoxicity). **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Clomipramine is the gold standard for **OCD**, though SSRIs are preferred first-line due to a better safety profile. * **TCA Overdose Triad (3 C’s):** **C**oma, **C**onvulsions, and **C**ardiotoxicity (widened QRS is the most reliable marker). * **Antidote:** Intravenous **Sodium Bicarbonate** is used to treat QRS widening and arrhythmias in TCA poisoning.

Question 67: Propranolol, a non-selective beta-blocker, can be prescribed to decrease anxiety associated with which of the following conditions?

A. Chronic neurotic disorder
B. Schizophrenia
C. Short-term stressful situation (Correct Answer)
D. Endogenous depression

Explanation: ### Explanation **Correct Option: C. Short-term stressful situation** Propranolol is a non-selective beta-adrenergic antagonist. In psychiatry, it is primarily used to manage the **peripheral somatic symptoms of anxiety** (autonomic hyperactivity) rather than the psychological "feeling" of worry. In **short-term stressful situations**—such as public speaking (performance anxiety), stage fright, or examinations—the body undergoes a "fight or flight" response mediated by epinephrine and norepinephrine. This leads to symptoms like palpitations, tremors, tachycardia, and sweating. Propranolol blocks $\beta_1$ and $\beta_2$ receptors, effectively suppressing these physical manifestations, which helps the individual remain calm and perform better. **Why other options are incorrect:** * **A. Chronic neurotic disorder:** Conditions like Generalized Anxiety Disorder (GAD) require treatments that address the psychological component of anxiety, such as SSRIs, SNRIs, or Benzodiazepines. Propranolol does not treat the underlying emotional pathology. * **B. Schizophrenia:** This is a psychotic disorder characterized by dopamine dysregulation. Treatment requires antipsychotics (D2 blockers). While Propranolol is used to treat *Akathisia* (an extrapyramidal side effect of antipsychotics), it is not a treatment for Schizophrenia itself. * **D. Endogenous depression:** Depression is primarily managed with antidepressants (SSRIs, TCAs). Beta-blockers are generally avoided or used with caution in depressed patients as they can occasionally worsen depressive symptoms or cause lethargy. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC) for Akathisia:** Propranolol is the first-line treatment for antipsychotic-induced akathisia (restlessness). * **Performance Anxiety:** Propranolol should be taken 30–60 minutes before the stressful event. * **Essential Tremors:** Propranolol is also the DOC for treating essential tremors. * **Contraindication:** Avoid in patients with **Asthma or COPD** (due to $\beta_2$ blockade causing bronchospasm) and **Diabetes Mellitus** (masks tachycardia, a warning sign of hypoglycemia).

Question 68: Which of the following statements regarding Lithium is false?

A. Maximum plasma concentration is avoided due to a low therapeutic index.
B. Lithium is contraindicated in pregnancy.
C. There is no individual variation in the rate of Lithium excretion. (Correct Answer)
D. 80% of Lithium is reabsorbed in the proximal convoluted tubule.

Explanation: ### Explanation **1. Why Option C is the Correct (False) Statement:** Lithium excretion is almost entirely renal, and there is **significant individual variation** in its excretion rate [1]. The elimination half-life of Lithium varies widely (average 24 hours, but ranging from 12 to 36 hours) depending on the patient’s age, renal function, and hydration status. Because Lithium is handled similarly to sodium, any factor affecting sodium balance (like dehydration or diuretics) will alter its excretion rate among different individuals [1]. **2. Analysis of Other Options:** * **Option A (True):** Lithium has a very **narrow therapeutic index** (therapeutic range: 0.6–1.2 mEq/L; toxicity starts >1.5 mEq/L) [2]. Sustained-release formulations are often used to avoid sharp peaks in plasma concentration, which minimizes side effects and toxicity [3]. * **Option B (True):** Lithium is generally contraindicated in pregnancy, especially during the first trimester, due to the risk of **Ebstein’s anomaly** (a congenital heart defect involving the tricuspid valve) [4]. It is classified as FDA Pregnancy Category D. * **Option D (True):** Lithium is filtered by the glomerulus, and approximately **80% is reabsorbed in the proximal convoluted tubule (PCT)** [1]. It competes with sodium for reabsorption; hence, sodium deficiency (hyponatremia) leads to increased Lithium reabsorption and potential toxicity [1]. **3. High-Yield NEET-PG Pearls:** * **Drug of Choice:** Lithium is the gold standard for the prophylaxis and treatment of Bipolar Affective Disorder (BPAD). * **Drug Interactions:** Thiazide diuretics, NSAIDs, and ACE inhibitors increase Lithium levels (by increasing PCT reabsorption) [2]. * **Monitoring:** Therapeutic Drug Monitoring (TDM) is mandatory. Samples should be drawn **12 hours after the last dose** (trough levels). * **Side Effects:** L-I-T-H: **L**eukocytosis, **I**nsipidus (Nephrogenic Diabetes Insipidus), **T**remors/Teratogenicity, **H**ypothyroidism [4].

Question 69: Which of the following drugs can cause hyponatremia?

A. Fluoxetine (Correct Answer)
B. Amitriptyline
C. Mianserin
D. Milnacipran

Explanation: **Explanation:** **Fluoxetine** is a Selective Serotonin Reuptake Inhibitor (SSRI). The most common mechanism by which psychotropic drugs cause hyponatremia is the **Syndrome of Inappropriate Antidiuretic Hormone secretion (SIADH)**. SSRIs are the most frequently implicated class of antidepressants in this condition, particularly in elderly patients or those taking diuretics. Serotonin is believed to stimulate the release of ADH (Vasopressin) from the posterior pituitary, leading to water retention and dilutional hyponatremia. **Analysis of Options:** * **Fluoxetine (Option A):** As an SSRI, it carries the highest risk of SIADH among the choices. It is a classic NEET-PG "high-yield" cause of drug-induced hyponatremia. * **Amitriptyline (Option B):** This is a Tricyclic Antidepressant (TCA). While TCAs can rarely cause SIADH, the risk is significantly lower compared to SSRIs. * **Mianserin (Option C):** An atypical tetracyclic antidepressant that acts as an alpha-2 antagonist. It is not typically associated with hyponatremia. * **Milnacipran (Option D):** A Serotonin-Norepinephrine Reuptake Inhibitor (SNRI). While SNRIs can cause SIADH, Fluoxetine (SSRI) is the more established and frequently tested culprit in this context. **Clinical Pearls for NEET-PG:** * **Risk Factors:** Elderly age, female gender, and concomitant use of diuretics (e.g., Thiazides) increase the risk of SSRI-induced hyponatremia. * **Timing:** It usually occurs within the first 2–4 weeks of starting therapy. * **Other drugs causing SIADH:** Carbamazepine (very common), Cyclophosphamide, Vincristine, and Chlorpropamide. * **Management:** Fluid restriction and discontinuation of the offending drug.

Question 70: Which antidepressant drug can cause neuroleptic malignant syndrome and tardive dyskinesia?

A. Amineptin
B. Fluoxetine
C. Amoxapine (Correct Answer)
D. Trazodone

Explanation: **Explanation:** The correct answer is **Amoxapine**. **1. Why Amoxapine is correct:** Amoxapine is a secondary amine tricyclic antidepressant (TCA). Its unique pharmacological profile lies in its metabolism: it is metabolized to **7-hydroxyamoxapine**, which possesses potent **dopamine D2 receptor blocking activity**. This makes it structurally and functionally similar to loxapine (an antipsychotic). Because it blocks dopamine receptors in the nigrostriatal and mesolimbic pathways, it can cause side effects typically associated with antipsychotics, such as **Extrapyramidal Symptoms (EPS)**, **Tardive Dyskinesia**, and the life-threatening **Neuroleptic Malignant Syndrome (NMS)** [1]. **2. Why other options are incorrect:** * **Amineptine:** It is an atypical antidepressant that acts as a dopamine reuptake inhibitor. It does not block D2 receptors and is not associated with NMS or tardive dyskinesia. * **Fluoxetine:** This is a Selective Serotonin Reuptake Inhibitor (SSRI). While it can rarely cause Serotonin Syndrome, it does not have significant D2 blocking activity to cause tardive dyskinesia. * **Trazodone:** A Serotonin Antagonist and Reuptake Inhibitor (SARI). Its most notorious high-yield side effect is **priapism**, not dopamine-related movement disorders. **Clinical Pearls for NEET-PG:** * **Amoxapine** is often the drug of choice for **Psychotic Depression** due to its dual antidepressant and antipsychotic-like properties [1]. * **NMS vs. Serotonin Syndrome:** Remember that NMS presents with "lead-pipe" rigidity and hyporeflexia, whereas Serotonin Syndrome presents with hyperreflexia and myoclonus. * Other antidepressants with unique side effects: **Bupropion** (seizures), **Mirtazapine** (weight gain/sedation), and **Duloxetine** (used for neuropathic pain).

Question 71: Tardive dyskinesia is produced by the following drugs except?

A. Fluphenazine
B. Haloperidol
C. Chlorpromazine
D. Clozapine (Correct Answer)

Explanation: **Explanation:** **Core Concept:** Tardive Dyskinesia (TD) is a late-onset extrapyramidal side effect (EPS) caused by the chronic blockade of **Dopamine D2 receptors** in the nigrostriatal pathway. This leads to "upregulation" or supersensitivity of these receptors. The risk of TD is directly proportional to the potency of D2 blockade and the duration of treatment. **Why Clozapine is the Correct Answer:** **Clozapine** is an atypical (second-generation) antipsychotic known for its **minimal D2 receptor affinity** and high 5-HT2A receptor antagonism. It dissociates rapidly from D2 receptors ("loose binding"). Consequently, it has the lowest risk of causing EPS and is the only antipsychotic that **does not cause Tardive Dyskinesia**. In fact, switching a patient with TD to Clozapine is a recognized management strategy. **Why the Other Options are Incorrect:** * **Haloperidol (Option B):** A high-potency typical antipsychotic with very strong D2 blockade. It has the highest incidence of TD among the options. * **Fluphenazine (Option A):** Another high-potency typical antipsychotic (Piperazine derivative) frequently associated with TD, especially in long-acting injectable forms. * **Chlorpromazine (Option C):** A low-potency typical antipsychotic. While it has more sedative and anticholinergic effects, it still blocks D2 receptors significantly enough to cause TD with long-term use. **High-Yield Clinical Pearls for NEET-PG:** * **Treatment of TD:** The first-line treatments are **VMAT-2 inhibitors** (Valbenazine, Deutetrabenazine). * **The "Clozapine Rule":** Clozapine is the drug of choice for **refractory schizophrenia** and for patients experiencing severe EPS/TD. * **Monitoring:** Remember the mandatory WBC monitoring for Clozapine due to the risk of **Agranulocytosis**. * **Anticholinergics:** Drugs like Trihexyphenidyl (used for acute dystonia) can actually **worsen** Tardive Dyskinesia.

Question 72: Which of the following drugs is associated with the lowest risk of causing extrapyramidal side effects?

A. Fluphenthixol
B. Clozapine (Correct Answer)
C. Haloperidol
D. Chlorpromazine

Explanation: ### Explanation The risk of **Extrapyramidal Side Effects (EPS)** in antipsychotics is primarily determined by the drug's affinity for **D2 receptors** in the nigrostriatal pathway. **Why Clozapine is the Correct Answer:** Clozapine is the prototype **Atypical Antipsychotic (Second Generation)**. It is characterized by a low affinity for D2 receptors and a high affinity for 5-HT2A receptors. It dissociates rapidly from D2 receptors ("loose binding"), which minimizes interference with the nigrostriatal dopamine pathway. Consequently, Clozapine has the **lowest risk of EPS** among all antipsychotics and is virtually devoid of tardive dyskinesia risk. **Analysis of Incorrect Options:** * **Haloperidol (Option C):** A high-potency typical antipsychotic with very strong D2 blockade. It has the **highest risk** of acute dystonia and parkinsonian symptoms. * **Fluphenthixol (Option A):** A high-potency thioxanthene derivative. Like haloperidol, it carries a significant risk of EPS. * **Chlorpromazine (Option D):** A low-potency typical antipsychotic. While it causes fewer EPS than haloperidol due to its inherent anticholinergic activity, the risk is still significantly higher than that of Clozapine. **High-Yield NEET-PG Pearls:** * **Drug of Choice:** Clozapine is the gold standard for **treatment-resistant schizophrenia** and schizophrenia associated with suicidal behavior. * **Adverse Effects:** While EPS risk is low, Clozapine is notorious for **Agranulocytosis** (requires mandatory WBC monitoring), **seizures** (dose-dependent), sialorrhea (drooling), and metabolic syndrome. * **Quetiapine:** Another atypical antipsychotic with a very low EPS risk, often preferred in Parkinson’s disease patients with psychosis.

Question 73: Which of the following is a NaSSa?

A. Mianserin (Correct Answer)
B. Clozapine
C. Nefazodone
D. Sertraline

Explanation: **Explanation:** **NaSSAs (Noradrenergic and Specific Serotonergic Antidepressants)** are a unique class of antidepressants that act by blocking **presynaptic $\alpha_2$-autoreceptors** and **heteroreceptors**. This blockade increases the release of both Norepinephrine and Serotonin (5-HT). 1. **Why Mianserin is correct:** **Mianserin** (along with Mirtazapine) is the classic example of a NaSSa. By antagonizing $\alpha_2$ receptors, it enhances adrenergic and serotonergic neurotransmission. Crucially, it also blocks **5-HT$_2$ and 5-HT$_3$ receptors**, which prevents the common side effects associated with non-specific SSRIs (like anxiety, insomnia, and sexual dysfunction), making it "Specific." 2. **Analysis of Incorrect Options:** * **Clozapine:** This is an **Atypical Antipsychotic** (SDA - Serotonin Dopamine Antagonist). While it has complex receptor activity, its primary clinical use is for treatment-resistant schizophrenia, not as a NaSSa. * **Nefazodone:** This belongs to the **SARI** (Serotonin Antagonist and Reuptake Inhibitor) class. It primarily blocks 5-HT$_2$ receptors and inhibits serotonin reuptake. * **Sertraline:** This is a prototype **SSRI** (Selective Serotonin Reuptake Inhibitor), the most commonly prescribed class for depression and anxiety disorders. **High-Yield Clinical Pearls for NEET-PG:** * **Mirtazapine vs. Mianserin:** Mirtazapine is more commonly used today; Mianserin is associated with a rare risk of **agranulocytosis**, requiring hematological monitoring. * **Side Effects:** NaSSAs are highly sedative (due to H1 blockade) and often cause **weight gain**. They are excellent choices for depressed patients suffering from significant insomnia or underweight elderly patients. * **Mechanism Tip:** Remember that NaSSAs do *not* inhibit the reuptake of amines; they work solely via receptor antagonism.

Question 74: Which of the following is a nonsedating antidepressant?

A. Fluoxetine (Correct Answer)
B. Mianserine
C. Amoxapine
D. Imipramine

Explanation: **Explanation:** The correct answer is **Fluoxetine (Option A)**. **Why Fluoxetine is the correct answer:** Fluoxetine is a **Selective Serotonin Reuptake Inhibitor (SSRI)**. Unlike older antidepressants, SSRIs have minimal affinity for histamine ($H_1$), cholinergic, and $\alpha_1$-adrenergic receptors. The lack of $H_1$ receptor blockade makes them generally non-sedating. In fact, Fluoxetine is known for its **activating/stimulant properties**, often causing insomnia or agitation rather than drowsiness. For this reason, it is typically administered in the morning. **Analysis of Incorrect Options:** * **Mianserine (Option B):** An atypical antidepressant (tetracyclic) that is highly sedative due to potent H1-receptor antagonism. It is often used in depressed patients with significant insomnia. * **Amoxapine (Option C):** A tetracyclic antidepressant (a metabolite of loxapine) that possesses significant sedative properties and carries a risk of extrapyramidal side effects due to dopamine ($D_2$) blockade. * **Imipramine (Option D):** A classic Tricyclic Antidepressant (TCA). TCAs are notorious for causing sedation because they strongly block $H_1$ and $\alpha_1$ receptors. **High-Yield Clinical Pearls for NEET-PG:** * **Longest Half-life:** Fluoxetine has the longest half-life among SSRIs (due to its active metabolite, norfluoxetine), requiring a 5-week washout period before starting an MAO inhibitor to avoid **Serotonin Syndrome**. * **Drug of Choice (DOC):** SSRIs are the first-line treatment for Depression, OCD, Panic Disorder, Social Phobia, and Bulimia Nervosa. * **Side Effects:** While non-sedating, SSRIs are frequently associated with **sexual dysfunction** (delayed ejaculation) and GI upset (nausea/diarrhea).

Question 75: Moclobemide is:

A. Selective serotonin reuptake inhibitor (SSRI)
B. Antipsychotic drug
C. Monoamine oxidase (MAO) inhibitor (Correct Answer)
D. Tricyclic antidepressant

Explanation: **Explanation:** **Moclobemide** is a **Reversible Inhibitor of MAO-A (RIMA)**. Monoamine oxidase (MAO) is an enzyme responsible for the oxidative deamination of neurotransmitters. MAO-A primarily metabolizes serotonin, norepinephrine, and dopamine. By inhibiting this enzyme, Moclobemide increases the synaptic concentration of these monoamines, thereby exerting its antidepressant effect. **Why the other options are incorrect:** * **Option A (SSRI):** Drugs like Fluoxetine, Sertraline, and Escitalopram belong to this class. They specifically inhibit the serotonin transporter (SERT) rather than the MAO enzyme. * **Option B (Antipsychotic):** These drugs (e.g., Haloperidol, Risperidone) primarily act by blocking Dopamine (D2) receptors or Serotonin (5-HT2A) receptors, not by inhibiting MAO. * **Option C (Tricyclic Antidepressant):** TCAs like Amitriptyline and Imipramine work by inhibiting the reuptake of both Norepinephrine and Serotonin (NET and SERT) and possess significant anticholinergic properties. **High-Yield Clinical Pearls for NEET-PG:** 1. **Cheese Reaction:** Unlike older, irreversible non-selective MAO inhibitors (e.g., Phenelzine), Moclobemide has a **lower risk of the "Cheese Reaction"** (hypertensive crisis caused by tyramine). This is because it is reversible; high levels of tyramine can displace Moclobemide from the enzyme, allowing tyramine metabolism to continue. 2. **Selectivity:** MAO-**A** inhibitors (Moclobemide) are used for **Depression**, while MAO-**B** inhibitors (Selegiline, Rasagiline) are used for **Parkinson’s Disease**. 3. **Serotonin Syndrome:** Even though it is a RIMA, Moclobemide should not be combined with SSRIs or TCAs due to the fatal risk of Serotonin Syndrome.

Question 76: Elderly persons taking antipsychotics are especially susceptible to all of the following side effects except?

A. Tardive dyskinesia
B. Paresthesias (Correct Answer)
C. Dry mouth
D. Akathisia

Explanation: **Explanation:** Antipsychotic medications, particularly first-generation (typical) agents, are associated with a wide range of side effects due to their blockade of dopaminergic, cholinergic, alpha-adrenergic, and histaminergic receptors [3]. The elderly population is physiologically more vulnerable to these effects due to age-related changes in pharmacokinetics and pharmacodynamics. **Why Paresthesias is the Correct Answer:** Paresthesias (tingling or "pins and needles" sensations) are **not** a characteristic side effect of antipsychotic therapy. Paresthesias are more commonly associated with metabolic disturbances, vitamin B12 deficiency, or specific drugs like Topiramate and Acetazolamide. While antipsychotics cause numerous neurological side effects, they do not typically involve peripheral sensory nerve disturbances. **Analysis of Incorrect Options:** * **Tardive Dyskinesia (TD):** Elderly patients, especially women, are at a significantly higher risk of developing TD [1]. It involves involuntary choreoathetoid movements resulting from dopamine receptor supersensitivity after prolonged blockade [3]. * **Dry Mouth:** This is a classic **anticholinergic** side effect (M1 blockade) [3]. Elderly patients have decreased physiological reserves and are highly susceptible to "atropine-like" effects, including dry mouth, urinary retention, and constipation [3]. * **Akathisia:** This is a common Extrapyramidal Side Effect (EPS) characterized by subjective motor restlessness [2]. The elderly are more prone to EPS due to the natural decline in nigrostriatal dopamine levels associated with aging. **NEET-PG High-Yield Pearls:** * **Drug of Choice for Psychosis in Parkinson’s:** Pimavanserin (a 5-HT2A inverse agonist) or Quetiapine/Clozapine (due to low D2 affinity). * **Black Box Warning:** The FDA warns that antipsychotic use in elderly patients with dementia-related psychosis is associated with an increased risk of **death** (primarily due to cardiovascular events or pneumonia). * **Most Potent Anticholinergic Antipsychotic:** Thioridazine and Clozapine.

Question 77: Which of the following is a tricyclic antidepressant?

A. Sertraline
B. Clomipramine (Correct Answer)
C. Bupropion
D. Fluvoxamine

Explanation: **Explanation:****Clomipramine** is a **Tricyclic Antidepressant (TCA)** belonging to the dibenzazepine class [1]. TCAs primarily work by inhibiting the reuptake of norepinephrine (NE) and serotonin (5-HT) into the presynaptic neuron [1]. Clomipramine is unique among TCAs because it is highly selective for serotonin reuptake inhibition, making it the "gold standard" pharmacological treatment for **Obsessive-Compulsive Disorder (OCD)** [1].**Analysis of Incorrect Options:** * **Sertraline (Option A):** A Selective Serotonin Reuptake Inhibitor (SSRI) [1]. It is a first-line treatment for depression and anxiety disorders due to its favorable side-effect profile compared to TCAs.* **Bupropion (Option B):** An Atypical Antidepressant that acts as a Norepinephrine-Dopamine Reuptake Inhibitor (NDRI) [1]. It is notable for having no sexual side effects and is used for smoking cessation [1].* **Fluvoxamine (Option D):** Another member of the SSRI class, frequently used in the management of OCD and social anxiety disorder [1].**High-Yield Clinical Pearls for NEET-PG:** * **Classification Tip:** TCAs are divided into Tertiary amines (e.g., Amitriptyline, Clomipramine, Imipramine) and Secondary amines (e.g., Nortriptyline, Desipramine) [1].* **Side Effects:** TCAs are notorious for "3 Cs": **C**oma, **C**onvulsions, and **C**ardiotoxicity (arrhythmias due to sodium channel blockade). They also cause significant anticholinergic effects (dry mouth, blurred vision, constipation) [1].* **Antidote:** Sodium bicarbonate is used to manage TCA-induced cardiotoxicity (QRS widening).* **Drug of Choice:** While SSRIs are first-line for OCD, Clomipramine remains the most efficacious drug for resistant cases.

Question 78: Pimvanserin is used in the treatment of which of the following conditions?

A. Schizophrenia
B. Down's syndrome
C. Parkinsonism (Correct Answer)
D. Huntington's chorea

Explanation: **Explanation:** **Pimvanserin** is a novel atypical antipsychotic specifically FDA-approved for the treatment of **hallucinations and delusions associated with Parkinson’s disease psychosis (PDP).** **Mechanism of Action:** Unlike traditional antipsychotics that block Dopamine D2 receptors, Pimvanserin acts as a **selective inverse agonist and antagonist at Serotonin 5-HT2A receptors**, with little to no affinity for D2, histaminergic, or muscarinic receptors. This is the "medical gold" for Parkinson’s patients: because it lacks D2 antagonism, it treats psychosis **without worsening motor symptoms** (tremor, rigidity, or bradykinesia). **Analysis of Incorrect Options:** * **A. Schizophrenia:** While it is an antipsychotic, Pimvanserin is not a first-line or standard treatment for primary schizophrenia; D2 blockade is usually required for managing positive symptoms in schizophrenia. * **B. Down’s Syndrome:** There is no established clinical role for Pimvanserin in Down’s syndrome. Psychosis in these patients is managed with standard atypical antipsychotics if necessary. * **D. Huntington’s Chorea:** The drug of choice for chorea is **Tetrabenazine** or **Deutetrabenazine** (VMAT-2 inhibitors). While antipsychotics can be used for behavioral issues in Huntington’s, Pimvanserin is not the indicated drug. **High-Yield Clinical Pearls for NEET-PG:** 1. **Drug of Choice:** Pimvanserin is the preferred agent for Parkinson’s Psychosis. **Quetiapine** and **Clozapine** are other alternatives due to their low D2 affinity. 2. **Avoid:** Traditional antipsychotics (e.g., Haloperidol) are strictly contraindicated in Parkinson’s as they exacerbate the movement disorder. 3. **Side Effect:** Pimvanserin can cause **QT interval prolongation**; baseline and periodic ECG monitoring may be required.

Question 79: Risperidone increases the risk of which of the following?

A. Cerebrovascular accidents
B. Extrapyramidal symptoms (Correct Answer)
C. Agranulocytosis
D. Diabetes insipidus

Explanation: **Explanation:** **Risperidone** is a second-generation (atypical) antipsychotic. While atypical antipsychotics generally have a lower risk of **Extrapyramidal Symptoms (EPS)** compared to first-generation drugs (like Haloperidol), Risperidone is unique because it exhibits **dose-dependent EPS**. At higher therapeutic doses (>6 mg/day), its potent D2 receptor antagonism outweighs its 5-HT2A antagonism, leading to a significantly increased risk of parkinsonian symptoms, akathisia, and dystonia. **Analysis of Incorrect Options:** * **A. Cerebrovascular accidents:** While atypical antipsychotics carry a "Black Box Warning" for increased mortality and stroke risk in *elderly patients with dementia-related psychosis*, EPS is a more direct and characteristic pharmacological side effect of Risperidone across the general population. * **C. Agranulocytosis:** This is the classic, life-threatening adverse effect associated with **Clozapine**, requiring mandatory WBC monitoring. Risperidone does not typically cause bone marrow suppression. * **D. Diabetes insipidus:** This is a classic side effect of **Lithium** (Nephrogenic DI), not antipsychotics. Risperidone is more commonly associated with metabolic syndrome (weight gain, dyslipidemia) and hyperprolactinemia. **NEET-PG High-Yield Pearls:** * **Hyperprolactinemia:** Among atypical antipsychotics, Risperidone has the highest propensity to increase prolactin levels (leading to gynecomastia/amenorrhea) because it lacks significant blood-brain barrier selectivity in the pituitary gland. * **Metabolic Profile:** Risperidone has a moderate risk for weight gain and diabetes, higher than Ziprasidone/Aripiprazole but lower than Clozapine/Olanzapine. * **Active Metabolite:** **Paliperidone** is the major active metabolite of Risperidone.

Question 80: Activation of which of the following receptors would be expected to decrease anxiety?

A. Nicotinic cholinergic receptors
B. Glutamate receptors
C. GABA receptors (Correct Answer)
D. Glucocorticoid receptors

Explanation: **Explanation:** The correct answer is **C. GABA receptors.** **Mechanism of Action:** GABA (Gamma-Aminobutyric Acid) is the primary inhibitory neurotransmitter in the Central Nervous System (CNS) [2]. The **GABA-A receptor** is a ligand-gated chloride channel [3]. When GABA binds to this receptor, it increases chloride conductance, leading to hyperpolarization of the postsynaptic neuron. This reduces neuronal excitability and produces a **sedative, hypnotic, and anxiolytic effect.** [3] Most clinical anxiolytics, such as Benzodiazepines (BZDs) and Barbiturates, work by positively modulating the GABA-A receptor [1]. **Analysis of Incorrect Options:** * **A. Nicotinic cholinergic receptors:** Activation generally leads to CNS stimulation and arousal. While nicotine has complex effects on mood, its acute activation is not a primary mechanism for clinical anxiolysis; withdrawal actually increases anxiety. * **B. Glutamate receptors:** Glutamate is the major **excitatory** neurotransmitter. Activation of NMDA or AMPA receptors increases neuronal firing, which is associated with agitation and anxiety. Glutamate antagonists (like Ketamine) are being studied for mood disorders, but agonists would worsen anxiety. * **D. Glucocorticoid receptors:** Chronic activation by cortisol (the stress hormone) is associated with the stress response and can lead to neuronal atrophy in the hippocampus, potentially worsening anxiety and depression. **NEET-PG High-Yield Pearls:** * **Benzodiazepines:** Increase the **frequency** of GABA-A channel opening [3]. * **Barbiturates:** Increase the **duration** of GABA-A channel opening (higher risk of toxicity). * **Drug of Choice (DOC):** While BZDs provide rapid relief for acute anxiety, **SSRIs** (Selective Serotonin Reuptake Inhibitors) are the first-line long-term treatment for Generalized Anxiety Disorder (GAD) and Panic Disorder. * **Buspirone:** A 5-HT1A partial agonist used for GAD that does *not* act on GABA receptors and lacks sedative/addictive properties.

Question 81: All of the following statements are true, except?

A. Dipyridamole shows coronary steal phenomena.
B. Omeprazole inhibits CYP 2C19.
C. SNRIs are the drug of choice for severe depression.
D. Agranulocytosis is the most common side effect of clozapine. (Correct Answer)

Explanation: The correct answer is **D** because while agranulocytosis is the most **serious** and characteristic side effect of Clozapine, it is not the most **common**. ### 1. Why Option D is the "Except" (The Correct Answer) Clozapine is an atypical antipsychotic reserved for treatment-resistant schizophrenia. * **Agranulocytosis** occurs in only about **0.8–1%** of patients. Because it is life-threatening, mandatory WBC monitoring is required. * The **most common** side effects of Clozapine are actually **Sialorrhea (excessive salivation)**, sedation, and weight gain. Other significant risks include seizures (dose-dependent) and myocarditis. ### 2. Analysis of Incorrect Options * **A. Dipyridamole shows coronary steal phenomena:** This is **true**. Dipyridamole is a vasodilator that expands healthy vessels, "stealing" blood flow away from ischemic areas where vessels are already maximally dilated, potentially worsening ischemia. * **B. Omeprazole inhibits CYP 2C19:** This is **true**. This is clinically significant because it reduces the conversion of Clopidogrel (a prodrug) to its active form, decreasing its antiplatelet efficacy. * **C. SNRIs are the drug of choice for severe depression:** This is **true**. While SSRIs are first-line for mild-to-moderate depression, SNRIs (like Venlafaxine or Duloxetine) are often preferred for severe or melancholic depression due to their dual action on serotonin and norepinephrine. ### 3. NEET-PG High-Yield Pearls: Clozapine * **Drug of Choice:** Treatment-resistant schizophrenia and schizophrenia with suicidal behavior. * **Monitoring:** Absolute Neutrophil Count (ANC) must be checked weekly for the first 6 months. * **Side Effect Profile:** It is the only antipsychotic that **does not** cause significant Extrapyramidal Symptoms (EPS) and does not increase Prolactin levels. * **Metabolic Risk:** High risk of dyslipidemia and Type 2 Diabetes Mellitus.

Question 82: Weight gain caused by antipsychotics is due to antagonism of which receptor subtype?

A. 5-HT3
B. 5-HT2A
C. 5-HT2B
D. 5-HT2C (Correct Answer)

Explanation: **Explanation:** The metabolic side effects of antipsychotics, particularly weight gain, are primarily attributed to the antagonism of **5-HT2C receptors** and **H1 (Histamine)** receptors in the hypothalamus. 1. **Why 5-HT2C is correct:** The 5-HT2C receptor subtype plays a crucial role in regulating satiety and energy homeostasis. Antagonism of these receptors leads to increased appetite (hyperphagia) and a decreased metabolic rate, resulting in significant weight gain. This is most notably seen with "Atypical" or Second-Generation Antipsychotics (SGAs) like **Clozapine** and **Olanzapine**, which have a high affinity for this receptor. 2. **Why other options are incorrect:** * **5-HT3:** These are ligand-gated ion channels primarily involved in the emetic reflex (vomiting). Antagonists (e.g., Ondansetron) are used as anti-emetics, not associated with weight gain. * **5-HT2A:** Antagonism here is the hallmark of SGAs and helps reduce Extrapyramidal Side Effects (EPS) and improve negative symptoms of schizophrenia, but it is not the primary driver of weight gain. * **5-HT2B:** These receptors are mainly located in the heart and GI tract. Agonism of 5-HT2B is linked to valvular heart disease (e.g., with Fenfluramine). **NEET-PG High-Yield Pearls:** * **Highest weight gain risk:** Clozapine > Olanzapine. * **Weight neutral/Lowest risk:** Ziprasidone, Aripiprazole, and Lurasidone. * **Dual Mechanism:** Weight gain is often a synergistic effect of **5-HT2C + H1 blockade**. * **Metabolic Syndrome:** Monitoring of BMI, fasting glucose, and lipid profile is mandatory for patients on SGAs.

Question 83: All of the following are predictable adverse effects of treatment with phenothiazines such as chlorpromazine, EXCEPT?

A. Orthostatic hypotension
B. Parkinson's syndrome
C. Excessive salivation (Correct Answer)
D. Hyperprolactinemia

Explanation: **Explanation:** Chlorpromazine is a low-potency typical antipsychotic (phenothiazine) that acts by blocking multiple receptors, including Dopamine ($D_2$), Alpha-1 ($\alpha_1$), Muscarinic ($M_1$), and Histamine ($H_1$). **Why "Excessive Salivation" is the correct answer:** Phenothiazines like chlorpromazine have significant **anticholinergic (antimuscarinic) properties**. Blockade of $M_1$ receptors leads to decreased secretions, resulting in **Dry Mouth (Xerostomia)**, not excessive salivation. *(Note: Clozapine is a unique exception among antipsychotics as it causes sialorrhea/excessive salivation).* **Analysis of Incorrect Options:** * **A. Orthostatic Hypotension:** This is a predictable effect caused by the blockade of **$\alpha_1$-adrenergic receptors** in the peripheral vasculature, leading to vasodilation. * **B. Parkinson’s Syndrome:** By blocking **$D_2$ receptors** in the **Nigrostriatal pathway**, phenothiazines cause Extrapyramidal Symptoms (EPS), including drug-induced Parkinsonism (tremors, rigidity, bradykinesia). * **D. Hyperprolactinemia:** $D_2$ blockade in the **Tuberoinfundibular pathway** removes the inhibitory effect of dopamine on prolactin release. This leads to elevated prolactin levels, potentially causing galactorrhea and gynecomastia. **NEET-PG High-Yield Pearls:** 1. **Low Potency (Chlorpromazine/Thioridazine):** High sedation, high anticholinergic effects, high alpha-blockade, but lower risk of EPS. 2. **High Potency (Haloperidol/Fluphenazine):** Low sedation, low anticholinergic effects, but very high risk of EPS. 3. **Thioridazine Warning:** Associated with Retinitis Pigmentosa and QTc prolongation. 4. **Clozapine:** The "rule breaker"—it is the only antipsychotic that commonly causes **excessive salivation** (likely due to $M_4$ receptor agonism or inhibition of the swallowing reflex).

Question 84: All of the following drugs are classified as atypical antipsychotics, EXCEPT?

A. Olanzepine
B. Clozapine
C. Risperidone
D. Thioridazine (Correct Answer)

Explanation: ### Explanation **Correct Option: D. Thioridazine** **1. Why Thioridazine is the Correct Answer:** Antipsychotics are broadly classified into two categories: **Typical (First Generation)** and **Atypical (Second Generation)**. Thioridazine belongs to the **Typical Antipsychotics**, specifically the low-potency Phenothiazine group. Its primary mechanism of action is the non-selective blockade of post-synaptic Dopamine ($D_2$) receptors in the mesolimbic pathway. Unlike atypical agents, it has a higher propensity for causing extrapyramidal side effects (EPS) and lacks significant $5-HT_{2A}$ antagonism. **2. Why the Other Options are Incorrect:** * **A. Olanzapine:** A prototype atypical antipsychotic. It blocks both $D_2$ and $5-HT_{2A}$ receptors. It is notorious for causing significant weight gain and metabolic syndrome. * **B. Clozapine:** The first atypical antipsychotic discovered. It is the "Gold Standard" for **treatment-resistant schizophrenia**. It has a low affinity for $D_2$ receptors, reducing EPS risk, but requires monitoring for agranulocytosis. * **C. Risperidone:** A potent atypical antipsychotic ($D_2$ + $5-HT_{2A}$ blocker). At higher doses, it behaves more like a typical antipsychotic and is frequently associated with hyperprolactinemia. **3. High-Yield Clinical Pearls for NEET-PG:** * **Thioridazine Warning:** It is associated with **Mellaril-induced Retinopathy** (pigmentary retinopathy) and significant **QT interval prolongation**, which can lead to Torsades de Pointes. * **Atypical Advantage:** Atypical antipsychotics are preferred because they treat both **positive and negative symptoms** of schizophrenia and have a lower risk of Extrapyramidal Symptoms (EPS). * **Clozapine Monitoring:** Mandatory Absolute Neutrophil Count (ANC) monitoring is required due to the risk of **agranulocytosis** (1% risk). It is also the only antipsychotic proven to reduce suicidal behavior in schizophrenia.

Question 85: Discontinuation of which of the following drugs can result in anxiety and insomnia?

A. Venlafaxine (Correct Answer)
B. Imipramine
C. Valproate
D. Olanzapine

Explanation: **Explanation:** The correct answer is **Venlafaxine**. This question tests the concept of **Antidepressant Discontinuation Syndrome (ADS)**, which is particularly severe with drugs that have a short half-life and potent mechanism of action. **1. Why Venlafaxine is correct:** Venlafaxine is a Serotonin-Norepinephrine Reuptake Inhibitor (SNRI). It has a very **short half-life** (approx. 5 hours for the parent drug). Abrupt withdrawal leads to a rapid drop in synaptic serotonin and norepinephrine levels, causing "FINISH" symptoms: **F**lu-like symptoms, **I**nsomnia, **N**ausea, **I**mbalance, **S**ensory disturbances (e.g., "brain zaps"), and **H**yperarousal (**Anxiety**). Among antidepressants, Venlafaxine and Paroxetine have the highest incidence of withdrawal symptoms. **2. Why the other options are incorrect:** * **Imipramine:** While TCAs can cause cholinergic rebound (nausea, sweating) upon discontinuation, they generally have longer half-lives and active metabolites, making the withdrawal less acute than Venlafaxine. * **Valproate:** This is a mood stabilizer/anticonvulsant. Discontinuation primarily risks seizure recurrence or mood relapse rather than a specific acute withdrawal syndrome characterized by insomnia and anxiety. * **Olanzapine:** An atypical antipsychotic. While abrupt cessation can cause rebound psychosis or cholinergic rebound, it is not the classic drug associated with the specific "anxiety and insomnia" withdrawal profile seen in antidepressant discontinuation. **Clinical Pearls for NEET-PG:** * **Longest half-life SSRI:** Fluoxetine (least likely to cause withdrawal symptoms). * **Shortest half-life SSRI:** Paroxetine (most likely to cause withdrawal). * **Management of ADS:** Reintroduce the drug and taper slowly. In severe cases, cross-tapering to a drug with a longer half-life (like Fluoxetine) is a strategy. * **Venlafaxine Side Effect:** Dose-dependent **Hypertension** (due to norepinephrine reuptake inhibition at higher doses).

Question 86: What is the most common receptor for typical antipsychotics?

A. Dopamine receptor 1 (D1)
B. Dopamine receptor 2 (D2) (Correct Answer)
C. Dopamine receptor 3 (D3)
D. Dopamine receptor 4 (D4)

Explanation: The therapeutic efficacy of **typical antipsychotics** (First-Generation Antipsychotics like Haloperidol and Chlorpromazine) is primarily attributed to the blockade of **Dopamine D2 receptors** in the mesolimbic pathway [1, 2]. According to the "Dopamine Hypothesis" of schizophrenia, positive symptoms (hallucinations and delusions) result from overactivity in this pathway [2]. * **Why D2 is correct:** Typical antipsychotics are potent antagonists of D2 receptors. There is a direct correlation between their clinical potency and their binding affinity for the D2 receptor [1]. However, blockade of D2 receptors in the nigrostriatal pathway is also responsible for the characteristic **Extrapyramidal Side Effects (EPS)**. **Analysis of Incorrect Options:** * **D1 Receptor:** While some antipsychotics (like Phenothiazines) may have minor affinity for D1, it is not the primary target for clinical efficacy in psychosis. The therapeutic potency of antipsychotic drugs does not correlate with their affinity for D1 receptors [1]. * **D3 Receptor:** These are primarily located in the limbic system. While some newer drugs target them, they are not the "most common" or primary target for typical agents [1]. * **D4 Receptor:** This is highly relevant for **Clozapine** (an atypical antipsychotic), which has a high affinity for D4. Typical antipsychotics do not primarily act here. **High-Yield Clinical Pearls for NEET-PG:** 1. **The 65% Rule:** Approximately 65-70% of D2 receptors must be blocked for antipsychotic efficacy. 2. **The 80% Threshold:** If D2 blockade exceeds 80% in the nigrostriatal pathway, EPS (like dystonia and parkinsonism) typically occur. 3. **Tuberoinfundibular Pathway:** D2 blockade here leads to increased prolactin levels (**Hyperprolactinemia**), causing galactorrhea and gynecomastia. 4. **Atypical Antipsychotics:** Unlike typicals, these primarily target **5-HT2A receptors** in addition to D2, leading to fewer EPS.

Question 87: Which of the following substances is hallucinogenic?

A. Codeine
B. Cocaine (Correct Answer)
C. Papaverine
D. Steroid

Explanation: **Explanation:** **Cocaine** is a potent central nervous system (CNS) stimulant that acts by inhibiting the reuptake of dopamine, norepinephrine, and serotonin [2]. While primarily classified as a stimulant, high doses or chronic use can lead to **"Cocaine Psychosis,"** characterized by vivid visual, auditory, and tactile hallucinations (e.g., **Formication** or "Cocaine bugs"—the sensation of insects crawling under the skin). **Analysis of Options:** * **Codeine (Option A):** An opioid analgesic and antitussive. Its primary side effects are sedation, constipation, and respiratory depression, not hallucinations. * **Papaverine (Option B):** A non-opioid benzylisoquinoline alkaloid used as a vasodilator and smooth muscle relaxant. It has no significant CNS activity related to psychosis. * **Steroids (Option D):** While corticosteroids can cause "Steroid Psychosis" (mood swings, mania, or depression), they are not classified as primary hallucinogens. In the context of classic drugs of abuse, Cocaine is the more definitive answer for hallucinogenic potential. **High-Yield NEET-PG Pearls:** * **Formication (Magnan’s Symptom):** A classic tactile hallucination pathognomonic for cocaine toxicity. * **Mechanism:** Cocaine blocks the **DAT (Dopamine Transporter)**, leading to increased dopamine in the nucleus accumbens, causing euphoria and psychosis [2]. * **Other Hallucinogens to remember:** LSD (most potent), Psilocybin, Mescaline, and Phencyclidine (PCP) [1]. * **Management:** Acute cocaine toxicity is managed with **Benzodiazepines**; Beta-blockers are generally avoided due to the risk of unopposed alpha-adrenergic stimulation.

Question 88: Which of the following drugs does not activate opioid receptors, has been proposed as a drug in the management of opioid addiction, and with just a single dose blocks the action of injected heroin for up to 48 hours?

A. Amphetamine
B. Buspirone
C. Methadone
D. Naltrexone (Correct Answer)

Explanation: ### Explanation **Correct Option: D. Naltrexone** **Mechanism and Rationale:** Naltrexone is a potent, long-acting **pure opioid antagonist** [1], [3]. Unlike methadone or buprenorphine, it has **zero agonist activity** (it does not activate opioid receptors) [3], [4]. It works by competitively binding to $\mu$-opioid receptors, thereby blocking the effects of exogenous opioids like heroin. * **Pharmacokinetics:** It has a significantly longer half-life than naloxone [4]. A single oral dose of 50 mg can effectively block the "high" and physical effects of injected heroin for **up to 48–72 hours**. This makes it an ideal agent for **relapse prevention** in highly motivated patients who have already undergone detoxification [5]. **Analysis of Incorrect Options:** * **A. Amphetamine:** A CNS stimulant that increases synaptic dopamine and norepinephrine. It has no role in opioid addiction management and is itself a drug of abuse. * **B. Buspirone:** A 5-HT$_{1A}$ partial agonist used as an anxiolytic. It does not interact with opioid receptors. * **C. Methadone:** While used in opioid addiction (maintenance therapy), it is a **full $\mu$-opioid agonist** [5]. It activates the receptors to prevent withdrawal symptoms, which contradicts the question's criteria. **High-Yield Clinical Pearls for NEET-PG:** * **Naltrexone vs. Naloxone:** Naltrexone is orally active and long-acting (used for maintenance/alcoholism); Naloxone is given parenterally and is short-acting (used for acute opioid overdose) [5]. * **Alcoholism:** Naltrexone is also FDA-approved for alcohol dependence as it reduces "craving" by blocking endogenous opioid-mediated reward pathways [2], [4]. * **Pre-requisite:** Naltrexone must **never** be started until a patient is opioid-free for at least 7–10 days; otherwise, it will precipitate severe, acute withdrawal.

Question 89: Which of the following medications is most associated with extrapyramidal side effects?

A. Haloperidol (Correct Answer)
B. Chlorpromazine
C. Imipramine
D. Clomipramine

Explanation: **Explanation:** The correct answer is **Haloperidol**. This question tests your understanding of the side effect profiles of typical antipsychotics based on their receptor potency. **1. Why Haloperidol is correct:** Haloperidol is a **High-Potency Typical Antipsychotic**. It acts as a potent antagonist at **D2 receptors** in the mesolimbic and nigrostriatal pathways. Because it has a very high affinity for D2 receptors and low anticholinergic activity, it is the drug most frequently associated with **Extrapyramidal Side Effects (EPS)**, such as acute dystonia, akathisia, and parkinsonism. **2. Why the other options are incorrect:** * **Chlorpromazine:** This is a **Low-Potency Typical Antipsychotic**. While it can cause EPS, it has significant **anticholinergic (M1) activity**. Since acetylcholine and dopamine exist in a reciprocal balance in the basal ganglia, the inherent anticholinergic effect of chlorpromazine partially "buffers" against EPS. It is more commonly associated with sedation and orthostatic hypotension. * **Imipramine & Clomipramine:** These are **Tricyclic Antidepressants (TCAs)**. Their primary side effects are related to muscarinic, alpha-1, and histaminic blockade (dry mouth, blurred vision, sedation). They do not primarily block D2 receptors and thus do not typically cause EPS. **High-Yield NEET-PG Pearls:** * **EPS Hierarchy:** High potency (Haloperidol, Fluphenazine) > Low potency (Chlorpromazine, Thioridazine) > Atypicals (Clozapine, Quetiapine). * **Treatment of Acute Dystonia:** Centrally acting anticholinergics like **Promethazine** or **Benztropine**. * **Neuroleptic Malignant Syndrome (NMS):** A severe side effect of Haloperidol; treated with **Dantrolene** or Bromocriptine. * **Rule of Thumb:** High potency = High EPS; Low potency = High Sedation/Autonomic effects.

Question 90: Which of the following is NOT a side effect of clozapine?

A. Agranulocytosis
B. Hypersalivation
C. Myocarditis
D. Hyperprolactinemia (Correct Answer)

Explanation: **Explanation:** Clozapine is a prototype **Atypical Antipsychotic** (Second Generation). The correct answer is **Hyperprolactinemia** because clozapine is unique among antipsychotics for its minimal effect on prolactin levels. 1. **Why Hyperprolactinemia is NOT a side effect:** Most typical antipsychotics block $D_2$ receptors in the **tuberoinfundibular pathway**, leading to increased prolactin. However, Clozapine has low affinity for $D_2$ receptors and rapidly dissociates from them. Consequently, it does not cause significant hyperprolactinemia, making it a preferred drug in patients experiencing galactorrhea or gynecomastia from other agents. 2. **Analysis of Incorrect Options:** * **Agranulocytosis:** This is the most dreaded side effect (1% of patients). It requires mandatory weekly WBC monitoring for the first 6 months. * **Hypersalivation (Sialorrhea):** Paradoxically, despite having anticholinergic properties, clozapine causes significant nighttime drooling, likely due to $M_4$ receptor agonism or impairment of the swallowing reflex. * **Myocarditis:** A rare but potentially fatal idiosyncratic reaction, usually occurring within the first 2 months of treatment. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Clozapine is the gold standard for **Treatment-Resistant Schizophrenia** and schizophrenia associated with suicidality. * **Seizures:** It carries a dose-dependent risk of seizures (highest among antipsychotics). * **Metabolic Syndrome:** It causes significant weight gain, dyslipidemia, and Type 2 Diabetes. * **No EPS:** It has the lowest risk of Extrapyramidal Side-effects (EPS) and Tardive Dyskinesia.

Question 91: Which drug possesses both antidepressant and antipsychotic properties?

A. Buspirone
B. Amoxapine (Correct Answer)
C. Trazodone
D. Minaserine

Explanation: **Explanation:** **Amoxapine** is a tetracyclic antidepressant (TeCA) and a metabolite of the antipsychotic drug loxapine. It is unique because it possesses a dual mechanism of action: 1. **Antidepressant property:** It inhibits the reuptake of Norepinephrine (and to a lesser extent, Serotonin). 2. **Antipsychotic property:** Unlike most other antidepressants, it significantly blocks **Dopamine D2 receptors**. This dual profile makes it particularly effective in treating **Psychotic Depression** (Major Depressive Disorder with psychotic features). However, due to its D2 blocking activity, it can cause extrapyramidal side effects (EPS) and hyperprolactinemia, similar to typical antipsychotics. **Analysis of Incorrect Options:** * **A. Buspirone:** An azapirone derivative used as an **Anxiolytic**. It acts as a selective 5-HT1A partial agonist. It lacks significant antidepressant or antipsychotic efficacy. * **C. Trazodone:** A SARI (Serotonin Antagonist and Reuptake Inhibitor). It is primarily used as an **Antidepressant** and frequently off-label for insomnia due to its sedative properties. It does not block D2 receptors. * **D. Mianserin:** A tetracyclic compound that acts as an α2-blocker and 5-HT antagonist. While it is an **Antidepressant**, it does not possess antipsychotic properties. **High-Yield NEET-PG Pearls:** * **Amoxapine** is the drug of choice for **Psychotic Depression**. * Watch for **Tardive Dyskinesia** as a rare but specific side effect of Amoxapine (due to D2 blockade). * **Mirtazapine** (related to Mianserin) is known as a "Noradrenergic and Specific Serotonergic Antidepressant" (NaSSA) and is famous for causing weight gain and sedation.

Question 92: All of the following drugs can cause neuroleptic malignant syndrome except?

A. Amantadine
B. Domperidone (Correct Answer)
C. Haloperidol
D. Metoclopramide

Explanation: **Neuroleptic Malignant Syndrome (NMS)** is a life-threatening idiosyncratic reaction characterized by the "FEVER" mnemonic: **F**ever, **E**ncephalopathy (altered mental status), **V**itals instability, **E**levated CPK/Myoglobinuria, and **R**igidity ("lead-pipe") [1]. The underlying pathophysiology is a **severe deficiency of dopamine** in the central nervous system (CNS), specifically in the nigrostriatal and hypothalamic pathways. #### Why Domperidone is the Correct Answer: * **Domperidone** is a peripheral dopamine (D2) receptor antagonist. Unlike other prokinetic agents, it **does not cross the blood-brain barrier (BBB)** in significant amounts. Since NMS is a central process, drugs that do not enter the CNS cannot trigger the syndrome. #### Why the Other Options are Incorrect: * **Haloperidol:** A high-potency typical antipsychotic and the most common trigger for NMS due to its strong central D2 blockade. * **Metoclopramide:** Unlike domperidone, metoclopramide **crosses the BBB**. It can cause extrapyramidal side effects and, rarely, NMS. * **Amantadine:** This is a dopaminergic drug. NMS can be triggered not only by dopamine antagonists but also by the **sudden withdrawal of dopamine agonists** (like Amantadine or Levodopa) in Parkinson’s patients, leading to a relative central dopamine deficit. #### High-Yield Clinical Pearls for NEET-PG: 1. **Drug of Choice for NMS:** **Dantrolene** (a muscle relaxant that inhibits calcium release from the sarcoplasmic reticulum) or **Bromocriptine** (a dopamine agonist) [1]. 2. **Distinguishing Feature:** NMS presents with **"Lead-pipe rigidity,"** whereas Serotonin Syndrome presents with **hyperreflexia and myoclonus.** 3. **Key Lab Finding:** Significantly elevated **Creatine Phosphokinase (CPK)** due to intense muscle contraction and rhabdomyolysis.

Question 93: All the following statements about clozapine are true except?

A. It is used in schizophrenia
B. May precipitate seizures
C. May cause agranulocytosis
D. Extrapyramidal side effects are commonly seen (Correct Answer)

Explanation: ### Explanation **Clozapine** is the prototype of **Atypical Antipsychotics** (Second Generation Antipsychotics). The core pharmacological principle that distinguishes clozapine is its receptor binding profile: it has a high affinity for **D4 and 5-HT2 receptors** and a relatively **low affinity for D2 receptors** in the nigrostriatal pathway. **1. Why Option D is the correct answer (The "Except" statement):** Extrapyramidal side effects (EPS) like dystonia, parkinsonism, and akathisia are caused by potent D2 receptor blockade in the striatum. Because clozapine dissociates rapidly from D2 receptors and has strong anticholinergic properties, it has the **lowest risk of EPS** among all antipsychotics. It is often described as the "gold standard" for avoiding EPS and tardive dyskinesia. **2. Analysis of Incorrect Options:** * **Option A:** Clozapine is the drug of choice for **resistant schizophrenia** (patients failing at least two other antipsychotic trials) and for reducing suicidal behavior in schizophrenic patients. * **Option B:** Clozapine is known to lower the seizure threshold in a dose-dependent manner. Approximately 3-5% of patients on high doses may experience **seizures**. * **Option C:** **Agranulocytosis** (absolute neutrophil count <500/mm³) is a life-threatening idiosyncratic reaction occurring in ~1% of patients. This necessitates mandatory weekly blood monitoring for the first six months of treatment. **Clinical Pearls for NEET-PG:** * **Sialorrhea (excessive salivation):** A paradoxical but common side effect of clozapine. * **Metabolic Syndrome:** Clozapine carries the highest risk of weight gain, dyslipidemia, and diabetes among antipsychotics. * **Myocarditis:** A rare but fatal side effect; monitor for chest pain or unexplained tachycardia. * **No Prolactin Elevation:** Unlike typical antipsychotics and Risperidone, clozapine does not cause significant hyperprolactinemia.

Question 94: Which of the following antipsychotic drugs is available as a depot injection?

A. Fluphenazine (Correct Answer)
B. Ziprasidone
C. Trifluoperazine
D. Aripiprazole

Explanation: **Explanation:** **1. Why Fluphenazine is Correct:** Fluphenazine is a high-potency typical antipsychotic. It is available as **Fluphenazine decanoate**, an esterified formulation in a sesame oil vehicle. When administered intramuscularly, it is released slowly into the bloodstream, providing a therapeutic effect for 2–4 weeks. This "depot" preparation is primarily used to improve treatment adherence in patients with chronic schizophrenia who are non-compliant with oral medications. **2. Analysis of Incorrect Options:** * **Ziprasidone:** An atypical antipsychotic available in oral and **short-acting** IM forms (used for acute agitation), but it does not have a long-acting depot formulation. * **Trifluoperazine:** A high-potency typical antipsychotic used orally for schizophrenia and anxiety; however, it is not available as a depot injection. * **Aripiprazole:** While Aripiprazole *does* have a depot form (Aripiprazole Maintena), in the context of standard medical examinations like NEET-PG, **Fluphenazine** and **Haloperidol** are the classic, high-yield examples of depot injections. In this specific MCQ, Fluphenazine is the established traditional answer. **3. High-Yield Clinical Pearls for NEET-PG:** * **Common Depot Drugs:** The most frequently tested depot antipsychotics are **Fluphenazine decanoate** and **Haloperidol decanoate**. * **Atypical Depots:** Newer long-acting injectables (LAIs) include Risperidone, Paliperidone, and Olanzapine (though Olanzapine carries a risk of Post-injection Delirium Sedation Syndrome). * **Mechanism:** Esterification with long-chain fatty acids (like decanoate) increases lipophilicity, allowing slow release from the muscle site. * **Side Effects:** Depot injections of typical antipsychotics carry a high risk of **Extrapyramidal Side Effects (EPS)** due to their high potency and long duration of action.

Question 95: Dry mouth during antidepressant therapy is caused by blockade of which receptors?

A. Muscarinic acetylcholine receptors (Correct Answer)
B. Serotonergic receptors
C. Dopaminergic receptors
D. GABA receptors

Explanation: **Explanation:** Dry mouth (xerostomia) is a classic side effect of several antidepressant classes, most notably **Tricyclic Antidepressants (TCAs)** like Amitriptyline and certain SSRIs/SNRIs. **1. Why Muscarinic Acetylcholine Receptors are correct:** The salivary glands are primarily under the control of the parasympathetic nervous system. Stimulation of **M3 muscarinic receptors** by acetylcholine normally triggers watery salivation. Many antidepressants possess potent **anticholinergic (antimuscarinic)** properties. By blocking these receptors, the drugs inhibit parasympathetic signaling, leading to decreased secretions, resulting in dry mouth, blurred vision, urinary retention, and constipation. **2. Analysis of Incorrect Options:** * **Serotonergic receptors:** Blockade or stimulation of these receptors (e.g., 5-HT2) is associated with side effects like sexual dysfunction, GI upset, or serotonin syndrome, but not typically dry mouth. * **Dopaminergic receptors:** Blockade of D2 receptors (common in antipsychotics) leads to Extrapyramidal Symptoms (EPS) and hyperprolactinemia. * **GABA receptors:** These are inhibitory receptors in the CNS. Drugs acting here (like Benzodiazepines) cause sedation and anxiolysis, not peripheral autonomic side effects like xerostomia. **High-Yield Clinical Pearls for NEET-PG:** * **TCAs** are the biggest culprits of "Anti-SLUDGE" effects (Salivation, Lacrimation, Urination, Defecation, GI upset, Emesis—all of which are decreased). * **Amitriptyline** has the highest anticholinergic potency among TCAs. * **Management:** Patients are often advised to use sugarless gum or frequent sips of water. * **Contraindication:** Due to their muscarinic blockade, these drugs should be used with caution in patients with **narrow-angle glaucoma** and **benign prostatic hyperplasia (BPH)**.

Question 96: Which of the following drugs has the least anticholinergic side effects?

A. Clomipramine
B. Desipramine (Correct Answer)
C. Imipramine
D. Trimipramine

Explanation: **Explanation:** The question tests your knowledge of the side effect profiles of **Tricyclic Antidepressants (TCAs)**. All options listed belong to the TCA class, which typically block muscarinic (M1), histamine (H1), and alpha-1 adrenergic receptors, leading to their characteristic side effect profile. **Why Desipramine is Correct:** TCAs are broadly divided into **Tertiary Amines** and **Secondary Amines**. * **Secondary Amines** (e.g., Desipramine, Nortriptyline) are metabolites of tertiary amines. * They are more selective for inhibiting Norepinephrine reuptake and, crucially, have a **significantly lower affinity** for muscarinic, histaminic, and alpha-adrenergic receptors compared to their parent compounds. * **Desipramine** is the most potent norepinephrine reuptake inhibitor among TCAs and possesses the **least anticholinergic and sedative activity** in this group. **Why Other Options are Incorrect:** * **A, C, and D (Clomipramine, Imipramine, Trimipramine):** These are all **Tertiary Amines**. Tertiary amines are potent inhibitors of both Serotonin and Norepinephrine reuptake but also have a high affinity for muscarinic receptors. This results in significant anticholinergic effects such as dry mouth, blurred vision, urinary retention, and constipation. Among these, **Amitriptyline** (not listed) and **Clomipramine** are often cited as having the highest anticholinergic potency. **High-Yield NEET-PG Pearls:** 1. **Most Anticholinergic TCA:** Amitriptyline. 2. **Least Anticholinergic/Least Sedating TCA:** Desipramine. 3. **Least Arrhythmogenic/Safest in Elderly:** Nortriptyline (a secondary amine with a better safety profile). 4. **Drug of Choice for OCD:** Clomipramine (due to high serotonin selectivity). 5. **TCA Overdose Triad:** Coma, Convulsions, and Cardiac arrhythmias (prolonged QRS/QT intervals). The antidote for cardiotoxicity is Sodium Bicarbonate.

Question 97: Which of the following drugs belongs to the NaSSA group?

A. Amoxetine
B. Mirtazapine (Correct Answer)
C. Duloxetine
D. Venlafaxine

Explanation: **Explanation:** **Mirtazapine** is the correct answer as it is the prototype drug of the **NaSSA** (Noradrenergic and Specific Serotonergic Antidepressant) class. ### Why Mirtazapine is correct: Mirtazapine works through a unique dual mechanism: 1. **Alpha-2 ($\alpha_2$) Antagonism:** It blocks presynaptic $\alpha_2$ autoreceptors (on noradrenergic neurons) and heteroreceptors (on serotonergic neurons). This "disinhibits" the neurons, leading to increased release of both Norepinephrine and Serotonin. 2. **Specific Serotonergic Action:** It blocks **$5-HT_2$** and **$5-HT_3$** receptors. By blocking these, it directs serotonin to specifically stimulate the **$5-HT_1A$** receptor, which mediates antidepressant effects while avoiding side effects like anxiety ($5-HT_2$) or nausea ($5-HT_3$). ### Why other options are incorrect: * **Amoxetine (Atomoxetine):** A selective **NRI** (Norepinephrine Reuptake Inhibitor) primarily used in ADHD. * **Duloxetine & Venlafaxine:** These belong to the **SNRI** (Serotonin-Norepinephrine Reuptake Inhibitor) class. They work by inhibiting the reuptake transporters (SERT and NET) rather than blocking $\alpha_2$ receptors. ### High-Yield Clinical Pearls for NEET-PG: * **Side Effect Profile:** Mirtazapine is a potent **$H_1$ blocker**, leading to significant **sedation** and **weight gain**. * **Clinical Utility:** It is the drug of choice for depressed patients suffering from **insomnia** and **underweight/anorexia**. * **Sexual Dysfunction:** Unlike SSRIs, Mirtazapine has a very low incidence of sexual dysfunction due to its $5-HT_2$ blockade. * **The "California Rocket Fuel":** A high-yield combination of Venlafaxine + Mirtazapine used for treatment-resistant depression.

Question 98: Which of the following statements is NOT true for the therapy with lithium?

A. It is used in bipolar disorder.
B. Amiloride is useful in treating lithium-induced diabetes insipidus.
C. Regular measurements of blood concentration of lithium are necessary.
D. Sodium ion is a specific antidote for lithium clearance. (Correct Answer)

Explanation: ### Explanation **1. Why Option D is the correct answer (The False Statement):** While sodium intake influences lithium excretion, **sodium ion is NOT a specific antidote** for lithium toxicity. Lithium is handled by the kidneys similarly to sodium; however, there is no pharmacological "antidote" that specifically neutralizes lithium. In cases of severe toxicity, the definitive treatment for clearance is **Hemodialysis**. While saline diuresis (Normal Saline) is used to restore volume and promote excretion, it is a supportive measure, not a specific antidote [4]. **2. Analysis of Incorrect Options (True Statements):** * **Option A:** Lithium remains the **gold standard** for the long-term prophylaxis and treatment of Bipolar Affective Disorder (BPAD), especially for manic episodes [3]. * **Option B:** Lithium causes Nephrogenic Diabetes Insipidus (NDI) by inhibiting ADH-induced cAMP production. **Amiloride** is the drug of choice because it blocks the ENaC channels in the collecting duct, preventing lithium from entering the cells and interfering with ADH action [1]. * **Option C:** Lithium has a **narrow therapeutic index** (0.6–1.2 mEq/L) [1, 4]. Regular Therapeutic Drug Monitoring (TDM) is mandatory to prevent toxicity, which typically occurs at levels >1.5 mEq/L [4]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Monitoring:** Blood samples for TDM should be drawn **12 hours after the last dose** (trough level). Before starting treatment, ensuring normal functioning of kidneys and thyroid is essential [3]. * **Drug Interactions:** **"D-A-N-T-E"** (Diuretics like Thiazides, ACE inhibitors, NSAIDs, Tetracyclines, and Ethacrynic acid) can increase lithium levels and precipitate toxicity [1]. * **Teratogenicity:** Use in pregnancy is associated with **Ebstein’s Anomaly** (atrialization of the right ventricle). * **Side Effects:** L-I-T-H: **L**eukocytosis, **I**nsipidus (NDI), **T**remors/Teratogenicity, **H**ypothyroidism [2].

Question 99: Neuroleptics cause hyperprolactinemia by blocking the effect of which neurotransmitter on pituitary lactotropes?

A. Dopamine (Correct Answer)
B. Glycine
C. Acetylcholine
D. Serotonin

Explanation: **Explanation:** The correct answer is **Dopamine**. **Mechanism of Action:** In the normal physiological state, dopamine acts as the primary **Prolactin Inhibiting Factor (PIF)**. It is secreted by the tuberoinfundibular pathway of the hypothalamus and acts on **D2 receptors** located on the pituitary lactotropes to tonicly inhibit prolactin secretion. Neuroleptics (antipsychotics) work by blocking D2 receptors. When these drugs block D2 receptors in the tuberoinfundibular pathway, the inhibitory effect of dopamine is lost, leading to disinhibition of lactotropes and a subsequent rise in serum prolactin levels (**Hyperprolactinemia**). **Analysis of Incorrect Options:** * **Glycine:** An inhibitory neurotransmitter primarily found in the spinal cord and brainstem; it does not regulate prolactin. * **Acetylcholine:** While involved in various central pathways, it does not play a primary role in the tonic inhibition of prolactin. * **Serotonin:** Generally has a stimulatory effect on prolactin release (via 5-HT receptors), but it is not the neurotransmitter blocked by neuroleptics to cause this specific side effect. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Features:** Hyperprolactinemia manifests as galactorrhea, gynecomastia, amenorrhea, and infertility. * **Drug Specifics:** Typical antipsychotics (e.g., Haloperidol) and the atypical antipsychotic **Risperidone** are most notorious for causing hyperprolactinemia. * **Exceptions:** **Aripiprazole** (a partial D2 agonist) and **Quetiapine** are less likely to cause significant prolactin elevation. * **Treatment:** If a drug must be used to treat hyperprolactinemia, dopamine agonists like **Cabergoline** or Bromocriptine are preferred.

Question 100: Tianeptine acts by:

A. MAO inhibitor
B. Serotonin uptake inhibitor
C. Serotonin uptake enhancer (Correct Answer)
D. 5-LIT agonist

Explanation: ### Explanation **Correct Answer: C. Serotonin uptake enhancer** **Mechanism of Action:** Tianeptine is a unique antidepressant that defies the traditional "monoamine hypothesis." Unlike Selective Serotonin Reuptake Inhibitors (SSRIs) which block the reuptake of serotonin, Tianeptine acts as a **Selective Serotonin Reuptake Enhancer (SSRE)**. It increases the presynaptic reuptake of serotonin (5-HT) from the synaptic cleft, theoretically decreasing serotonergic neurotransmission. Despite this paradoxical mechanism, it exhibits potent antidepressant and anxiolytic effects, likely due to its downstream modulation of glutamate receptors (NMDA and AMPA) and its ability to prevent stress-induced atrophy in the hippocampus. **Analysis of Incorrect Options:** * **A. MAO inhibitor:** These drugs (e.g., Phenelzine, Selegiline) inhibit the enzyme Monoamine Oxidase, preventing the breakdown of neurotransmitters. Tianeptine does not interact with this enzyme. * **B. Serotonin uptake inhibitor:** This is the mechanism of SSRIs (e.g., Fluoxetine, Sertraline). Tianeptine performs the exact opposite physiological action. * **D. 5-HT agonist:** Tianeptine does not act as a direct agonist at serotonin receptors (like Buspirone acts on 5-HT1A). **High-Yield Clinical Pearls for NEET-PG:** * **Glutamate Modulation:** Tianeptine’s primary long-term benefit is attributed to its **neuroprotective effects**, specifically reversing hippocampal dendrite atrophy caused by chronic stress. * **Opioid Receptor Activity:** Recent studies show Tianeptine is a full agonist at **mu-opioid receptors**, which may contribute to its mood-elevating properties but also carries a risk for abuse. * **Side Effect Profile:** Unlike SSRIs, Tianeptine is notable for its **lack of sexual dysfunction**, lack of sedation, and minimal cardiovascular effects, making it a useful alternative in elderly patients.

Question 101: Which of the following psychiatric disorders, apart from depression, are selectively treated with serotonin reuptake inhibitors?

A. Phobias
B. Obsessive compulsive disorder
C. Post-traumatic stress disorder
D. All of the above (Correct Answer)

Explanation: Selective Serotonin Reuptake Inhibitors (SSRIs) are the first-line pharmacological treatment for a wide spectrum of psychiatric conditions beyond Major Depressive Disorder. Their primary mechanism involves inhibiting the presynaptic reuptake of serotonin (5-HT), thereby increasing its availability in the synaptic cleft and modulating downstream neural circuits involved in anxiety and impulse control. **Explanation of Options:** * **Obsessive-Compulsive Disorder (OCD):** SSRIs (e.g., Fluoxetine, Fluvoxamine, Sertraline) are the gold standard treatment. They typically require higher doses and a longer duration (10–12 weeks) to show efficacy compared to depression. * **Phobias:** SSRIs are highly effective for **Social Anxiety Disorder (Social Phobia)** and Panic Disorder with or without agoraphobia. They help desensitize the "fear circuitry" in the amygdala. * **Post-Traumatic Stress Disorder (PTSD):** SSRIs (specifically Sertraline and Paroxetine) are FDA-approved first-line agents that help manage the core symptoms of re-experiencing, avoidance, and hyperarousal. Since SSRIs are the treatment of choice for all three conditions, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **DOC (Drug of Choice):** SSRIs are the DOC for OCD, PTSD, Panic Disorder, Social Phobia, GAD, and Premenstrual Dysphoric Disorder (PMDD). * **OCD Exception:** While SSRIs are first-line, **Clomipramine** (a TCA) is the most potent drug for OCD but is reserved for second-line due to its side-effect profile. * **Side Effects:** Remember the "S" mnemonic: **S**exual dysfunction (most common long-term side effect), **S**leep disturbances, and **S**tomach upset (nausea/diarrhea). * **Fluoxetine** has the longest half-life, making it least likely to cause withdrawal symptoms.

Question 102: A patient in the emergency department exhibits psychosis. Pharmacological intervention to decrease psychosis would most likely involve which of the following mechanisms?

A. Blockade of dopaminergic neurotransmission (Correct Answer)
B. Stimulation of dopaminergic neurotransmission
C. Blockade of nitrergic neurotransmission
D. Stimulation of nitrergic neurotransmission

Explanation: ### Explanation **1. Why Option A is Correct:** The primary pharmacological management of psychosis is based on the **Dopamine Hypothesis of Schizophrenia**. This hypothesis suggests that psychosis results from overactivity of dopaminergic neurons in the **mesolimbic pathway** of the brain. Antipsychotic drugs (Neuroleptics) work by blocking postsynaptic **D2 receptors**, thereby reducing dopaminergic neurotransmission. Both typical (e.g., Haloperidol) and atypical antipsychotics (e.g., Risperidone) share this fundamental mechanism of D2 receptor antagonism to alleviate positive symptoms like hallucinations and delusions. **2. Why Other Options are Incorrect:** * **Option B:** Stimulating dopaminergic neurotransmission (e.g., using Levodopa or Amphetamines) actually **induces or worsens** psychosis. This is a common side effect seen in Parkinson’s patients treated with dopamine agonists. * **Options C & D:** Nitrergic neurotransmission involves Nitric Oxide (NO). While research is ongoing regarding the role of NO in NMDA receptor signaling and its potential link to schizophrenia, it is **not** the established target for standard emergency pharmacological intervention in psychosis. **3. NEET-PG High-Yield Pearls:** * **Mesolimbic Pathway:** Blockade here leads to the **therapeutic effect** (reduction of positive symptoms). * **Nigrostriatal Pathway:** Blockade here leads to **Extrapyramidal Side Effects (EPS)** like dystonia and parkinsonism. * **Tuberoinfundibular Pathway:** Blockade here leads to **Hyperprolactinemia** (galactorrhea, gynecomastia). * **Mesocortical Pathway:** Low dopamine here is linked to **negative symptoms** (apathy, withdrawal); traditional blockers may worsen these. * **Atypical Antipsychotics:** These also block **5-HT2A receptors**, which helps reduce EPS and improve negative symptoms.

Question 103: Which of the following is NOT a side effect of depression?

A. Propranolol
B. Oral contraceptives
C. L-dopa
D. Flupenthixol (Correct Answer)

Explanation: **Explanation:** The question asks which drug is **NOT** associated with causing depression as a side effect. **1. Why Flupenthixol is the correct answer:** Flupenthixol is a thioxanthene neuroleptic (antipsychotic). While high doses are used to treat schizophrenia, **low doses (0.5–3 mg/day)** have a unique **antidepressant and anxiolytic effect**. Unlike many other antipsychotics that can cause "neuroleptic-induced deficit syndrome" (mimicking depression), low-dose flupenthixol is specifically indicated for the management of psychogenic depression and depressive neurosis. Therefore, it is a treatment for, rather than a cause of, depression. **2. Analysis of Incorrect Options (Drugs that cause depression):** * **Propranolol:** Beta-blockers, particularly lipophilic ones like propranolol, can cross the blood-brain barrier and are well-documented to cause depressive symptoms, fatigue, and sleep disturbances. * **Oral Contraceptives (OCPs):** Hormonal fluctuations caused by OCPs (specifically the progestogen component) are associated with mood swings and clinical depression in susceptible individuals due to interference with tryptophan metabolism. * **L-dopa:** While used for Parkinson’s disease, L-dopa can cause a wide range of psychiatric side effects, including depression, anxiety, and psychosis, as it alters dopamine levels in the mesolimbic pathway. **NEET-PG High-Yield Pearls:** * **Other drugs causing depression:** Reserpine (depletes monoamines), Interferon-alpha, Isotretinoin, and Corticosteroids. * **Reserpine** is the classic historical example used to support the "Monoamine Hypothesis" of depression. * **Flupenthixol** is often used in clinical practice for "masked depression" or depression with psychosomatic symptoms.

Question 104: Which drug can act as an antagonist of Haloperidol?

A. Ropinirole (Correct Answer)
B. Clozapine
C. Imipramine
D. Pimozide

Explanation: ### Explanation **Correct Option: A. Ropinirole** The core concept here is the **Dopaminergic-Antidopaminergic balance**. * **Haloperidol** is a high-potency, first-generation (typical) antipsychotic that acts as a potent **Dopamine D2 receptor antagonist**. It works by blocking dopamine receptors in the brain. * **Ropinirole** is a non-ergoline **Dopamine D2/D3 receptor agonist** [1]. Because they have opposing actions at the same receptor site (one blocks, the other stimulates), Ropinirole acts as a functional and pharmacological antagonist to the effects of Haloperidol. In clinical practice, dopamine agonists are sometimes used to manage the Extrapyramidal Side Effects (EPS) caused by Haloperidol [1]. **Why the other options are incorrect:** * **B. Clozapine:** This is an atypical antipsychotic [2]. While it has a lower affinity for D2 receptors than Haloperidol, it is still a dopamine antagonist (primarily D4 and 5-HT2A). It would synergize with, rather than antagonize, the antipsychotic effects [2]. * **C. Imipramine:** A Tricyclic Antidepressant (TCA) that primarily inhibits the reuptake of Norepinephrine and Serotonin. It does not have a direct antagonistic relationship with Haloperidol’s dopaminergic blockade. * **D. Pimozide:** Like Haloperidol, Pimozide is a typical antipsychotic (diphenylbutylpiperidine class) that blocks D2 receptors. It would enhance the effects of Haloperidol rather than antagonize them. **High-Yield Clinical Pearls for NEET-PG:** * **Drug-Induced Parkinsonism:** Haloperidol-induced rigidity is treated with central anticholinergics (e.g., Benztropine, Trihexyphenidyl) or dopamine agonists (e.g., Amantadine). * **Bromocriptine:** Another dopamine agonist frequently tested as the treatment of choice for **Neuroleptic Malignant Syndrome (NMS)**, a life-threatening reaction to Haloperidol. * **Inverse Relationship:** Remember that drugs used to treat Schizophrenia (antagonists) can cause Parkinsonian symptoms, while drugs used to treat Parkinson’s (agonists like Ropinirole) can cause psychosis.

Question 105: What is the mechanism of action of Selective Serotonin Reuptake Inhibitors (SSRIs)?

A. Inhibit the reuptake of norepinephrine
B. Inhibit the reuptake of norepinephrine and serotonin
C. Inhibit the reuptake of dopamine
D. Inhibit the reuptake of serotonin (Correct Answer)

Explanation: **Explanation:** **Mechanism of Action:** Selective Serotonin Reuptake Inhibitors (SSRIs) work by specifically inhibiting the **Serotonin Transporter (SERT)** located on the presynaptic neuronal membrane. By blocking this transporter, SSRIs prevent the re-entry of serotonin (5-HT) into the presynaptic terminal, thereby increasing the concentration of serotonin available in the synaptic cleft. This enhanced serotonergic neurotransmission is the primary mechanism for their antidepressant and anxiolytic effects. **Analysis of Incorrect Options:** * **Option A:** Inhibition of norepinephrine reuptake is the primary mechanism of **Selective Norepinephrine Reuptake Inhibitors (SNRIs)** like Reboxetine or Atomoxetine. * **Option B:** Inhibition of both norepinephrine and serotonin reuptake is the mechanism of **Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)** (e.g., Venlafaxine, Duloxetine) and **Tricyclic Antidepressants (TCAs)** (e.g., Amitriptyline). * **Option C:** Inhibition of dopamine reuptake is a characteristic of drugs like **Bupropion** (an NDRI) or stimulants like Methylphenidate. **High-Yield Clinical Pearls for NEET-PG:** * **First-line Treatment:** SSRIs are the first-line drugs for Depression, OCD, Panic Disorder, Social Phobia, and PTSD. * **Prototype Drugs:** Fluoxetine (longest half-life), Sertraline, Paroxetine, Fluvoxamine, Citalopram, and Escitalopram (most potent/selective). * **Side Effects:** Most common are GI upset (nausea/diarrhea) and **sexual dysfunction** (delayed ejaculation). * **Serotonin Syndrome:** A dangerous interaction when SSRIs are combined with MAO inhibitors, characterized by hyperthermia, muscle rigidity, and cardiovascular collapse. * **Lag Period:** Clinical improvement typically takes 2–4 weeks despite immediate biochemical effects.

Question 106: Which of the following is a feature of serotonin syndrome associated with SSRIs and MAOIs?

A. Tremors (Correct Answer)
B. Agitation
C. Cardiovascular collapse
D. Hypothermia

Explanation: **Explanation:** Serotonin Syndrome is a potentially life-threatening condition caused by excessive serotonergic activity in the CNS, typically occurring when **SSRIs** are combined with **MAOIs**, TCAs, or Linezolid. It is characterized by a clinical triad of cognitive-behavioral changes, autonomic instability, and neuromuscular excitability. **1. Why Tremors is the correct answer:** Neuromuscular hyperactivity is a hallmark of serotonin syndrome. **Tremors**, along with **clonus** (spontaneous, inducible, or ocular) and **hyperreflexia**, are classic diagnostic features. These symptoms are often more pronounced in the lower extremities. **2. Analysis of Incorrect Options:** * **Agitation:** While agitation is a common symptom of serotonin syndrome, it is a non-specific behavioral change. In the context of standardized exams like NEET-PG, **neuromuscular signs (Tremors/Clonus)** are considered more pathognomonic and specific for identifying the syndrome compared to general agitation. * **Cardiovascular collapse:** This is a terminal complication of severe, untreated cases rather than a primary diagnostic feature. The initial autonomic sign is usually tachycardia or hypertension. * **Hypothermia:** This is incorrect because serotonin syndrome causes **Hyperthermia** (often >41°C in severe cases) due to excessive muscular activity. **High-Yield Clinical Pearls for NEET-PG:** * **Hunter’s Criteria:** The most sensitive diagnostic tool; it emphasizes **Clonus** (spontaneous, inducible, or ocular) as the most important sign. * **Drug of Choice:** Management involves stopping the offending agents and administering **Cyproheptadine** (a 5-HT2A antagonist). * **Differential Diagnosis:** Unlike Neuroleptic Malignant Syndrome (NMS), which presents with "lead-pipe" rigidity and bradyreflexia, Serotonin Syndrome presents with **hyperreflexia and clonus**.

Question 107: Which among the following is not an antipsychotic?

A. Risperidone
B. Haloperidol
C. Fluoxetine (Correct Answer)
D. Clozapine

Explanation: ### Explanation The correct answer is **Fluoxetine** because it belongs to the class of **Selective Serotonin Reuptake Inhibitors (SSRIs)**, which are primarily used as **antidepressants**, not antipsychotics. #### Why Fluoxetine is the Correct Choice: Fluoxetine works by inhibiting the reuptake of serotonin (5-HT) at the presynaptic terminal, increasing serotonin levels in the synaptic cleft. It is a first-line treatment for Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), and Panic Disorder. It does not possess the dopamine (D2) receptor antagonism required to treat psychosis. #### Why the Other Options are Incorrect: * **Risperidone (Option A):** An **Atypical (Second-generation) Antipsychotic**. It blocks both D2 and 5-HT2A receptors. It is commonly used for schizophrenia and bipolar mania. * **Haloperidol (Option B):** A **Typical (First-generation) Antipsychotic**. It is a potent D2 receptor antagonist. It is highly effective for positive symptoms of schizophrenia but carries a high risk of Extrapyramidal Side Effects (EPS). * **Clozapine (Option D):** An **Atypical Antipsychotic**. It is the "gold standard" for **treatment-resistant schizophrenia**. It has a low affinity for D2 receptors but acts on various other receptors (D4, 5-HT2A, Alpha, Histamine). #### High-Yield Clinical Pearls for NEET-PG: * **Fluoxetine** has the longest half-life among SSRIs (due to its active metabolite, norfluoxetine), making it the least likely to cause withdrawal syndrome. * **Clozapine** is associated with **agranulocytosis** (requires mandatory WBC monitoring) and lowers the seizure threshold. * **Hyperprolactinemia** is a common side effect of Risperidone and Haloperidol due to D2 blockade in the tuberoinfundibular pathway. * **Drug of choice for OCD:** SSRIs (like Fluoxetine), but in higher doses than used for depression.

Question 108: Cardiac conduction defects seen with Tricyclic antidepressants are due to which mechanism?

A. Norepinephrine and serotonin reuptake inhibition
B. Antimuscarinic action on the heart
C. Only norepinephrine reuptake inhibition
D. Both norepinephrine reuptake inhibition and antimuscarinic action on the heart (Correct Answer)

Explanation: ### Explanation Tricyclic Antidepressants (TCAs) like Amitriptyline and Imipramine have a complex pharmacological profile that affects multiple neurotransmitter systems, leading to significant cardiovascular side effects. **Why Option D is Correct:** The cardiac conduction defects (such as tachycardia and arrhythmias) are a result of a **dual mechanism**: 1. **Norepinephrine (NE) Reuptake Inhibition:** By blocking the NET transporter, TCAs increase the concentration of NE at the cardiac sympathetic synapses. This leads to increased stimulation of $\beta_1$-adrenergic receptors, causing **tachycardia**. 2. **Antimuscarinic Action:** TCAs act as potent antagonists at $M_2$ receptors in the heart. This inhibits the parasympathetic (vagal) "braking" effect on the SA node, further contributing to tachycardia and altered conduction. **Why Other Options are Incorrect:** * **Option A:** While TCAs do inhibit serotonin (5-HT) reuptake, this mechanism is primarily responsible for their antidepressant effect and does not directly contribute to cardiac conduction defects. * **Option B & C:** These are incomplete. The cardiotoxicity of TCAs is synergistic; focusing on only one mechanism ignores the significant contribution of the other. **High-Yield Clinical Pearls for NEET-PG:** * **The "3 C’s" of TCA Overdose:** **C**oma, **C**onvulsions, and **C**ardiotoxicity. * **ECG Changes:** The most characteristic ECG finding in TCA toxicity is **QRS widening** (>100 ms) and **QT prolongation**. This is primarily due to their "Quinidine-like" effect (blockade of fast sodium channels). * **Antidote:** The drug of choice for TCA-induced arrhythmias is **Intravenous Sodium Bicarbonate**, which increases extracellular sodium and blood pH, helping to displace the drug from sodium channels.

Question 109: Venlafaxine inhibits the reuptake of which neurotransmitters?

A. Norepinephrine
B. Norepinephrine and serotonin (Correct Answer)
C. Serotonin
D. None of the above

Explanation: **Explanation:** Venlafaxine is the prototype drug of the **Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)** class. Its primary mechanism of action involves the potent inhibition of the neuronal reuptake of both **serotonin (5-HT)** and **norepinephrine (NE)**. By blocking these transporters (SERT and NET), venlafaxine increases the synaptic concentration of these neurotransmitters, leading to enhanced neurotransmission. * **Why Option B is Correct:** Venlafaxine has a dual mechanism. At lower doses, it primarily inhibits serotonin reuptake (similar to SSRIs), but as the dose increases, its inhibitory effect on norepinephrine reuptake becomes clinically significant. At very high doses, it also weakly inhibits dopamine reuptake. * **Why Option A is Incorrect:** While it does inhibit NE reuptake, selecting only NE ignores its potent effect on serotonin. Pure norepinephrine reuptake inhibitors (NRIs) include drugs like **Reboxetine**. * **Why Option C is Incorrect:** This describes **SSRIs** (e.g., Fluoxetine, Sertraline). While Venlafaxine acts on serotonin, its classification and clinical utility depend on its additional effect on norepinephrine. **High-Yield Clinical Pearls for NEET-PG:** 1. **Dose-Dependent Blood Pressure:** A unique side effect of Venlafaxine (due to its NE effect) is **dose-dependent hypertension**. Regular BP monitoring is mandatory at higher doses. 2. **Indications:** Apart from Major Depressive Disorder, SNRIs are first-line for **Generalized Anxiety Disorder (GAD)** and chronic pain conditions like **Diabetic Neuropathy** and **Fibromyalgia** (especially Duloxetine). 3. **Desvenlafaxine:** This is the active metabolite of venlafaxine and is also used clinically. 4. **Withdrawal:** Venlafaxine is notorious for a severe "discontinuation syndrome" if stopped abruptly due to its short half-life.

Question 110: Which of the following drugs can cause toxic epidermal necrolysis as an adverse effect?

A. Felbamate
B. Gabapentin
C. Lamotrigine (Correct Answer)
D. Vigabatrin

Explanation: **Explanation:** **Lamotrigine** is a broad-spectrum antiepileptic drug (AED) that acts by blocking voltage-gated sodium channels and inhibiting glutamate release. Its most significant and life-threatening adverse effect is a severe hypersensitivity reaction manifesting as **Stevens-Johnson Syndrome (SJS)** or **Toxic Epidermal Necrolysis (TEN)**. The risk is highest during the first 8 weeks of treatment and is significantly increased if the drug is started at a high dose or escalated rapidly. **Analysis of Options:** * **Lamotrigine (Correct):** Known for causing severe skin rashes. To minimize this risk, clinicians follow a "low and slow" titration schedule. * **Felbamate:** Primarily associated with **aplastic anemia** and **severe hepatotoxicity**, which limits its clinical use. * **Gabapentin:** Generally well-tolerated; its main side effects are sedation, dizziness, and peripheral edema. It is not typically associated with life-threatening dermatological reactions. * **Vigabatrin:** Notorious for causing **permanent visual field defects** (concentric contraction) due to retinal toxicity, requiring regular perimetry monitoring. **High-Yield Clinical Pearls for NEET-PG:** * **Drug Interaction:** Valproate inhibits the metabolism of Lamotrigine, doubling its half-life and significantly increasing the risk of SJS/TEN. * **Other Drugs causing SJS/TEN:** Remember the mnemonic **SAPP**: **S**ulfonamides, **A**ntiepileptics (Phenytoin, Carbamazepine, Phenobarbital, Lamotrigine), **P**enicillins, and **P**iroxicam (NSAIDs). * **HLA Link:** HLA-B*1502 is strongly associated with SJS/TEN caused by Carbamazepine, particularly in Asian populations.

Question 111: Which 5-HT1A agonist drug acts as an anxiolytic agent?

A. Diazepam
B. Zolpidem
C. Cinnarizine
D. Buspirone (Correct Answer)

Explanation: **Explanation:** **Buspirone** is the correct answer as it is a selective **5-HT1A partial agonist** used primarily for the management of Generalized Anxiety Disorder (GAD). Unlike traditional anxiolytics, it does not interact with the GABA-A receptor complex. Its primary mechanism involves stimulating presynaptic 5-HT1A receptors (inhibiting serotonin release) and postsynaptic 5-HT1A receptors in the hippocampus and cortex. **Analysis of Incorrect Options:** * **Diazepam:** A Benzodiazepine (BZD) that acts as a positive allosteric modulator of the **GABA-A receptor**. While it is an anxiolytic, it works via chloride channel opening, not 5-HT receptors. * **Zolpidem:** A "Z-drug" used as a hypnotic. It selectively binds to the **alpha-1 subunit of the GABA-A receptor**. It lacks significant anxiolytic or muscle relaxant properties. * **Cinnarizine:** An **H1-receptor antagonist** and calcium channel blocker used primarily for vertigo and motion sickness; it has no role as a 5-HT1A-mediated anxiolytic. **High-Yield NEET-PG Pearls:** 1. **Delayed Onset:** Buspirone takes **2–4 weeks** to show therapeutic effects, making it unsuitable for acute anxiety or panic attacks. 2. **"3 No’s" of Buspirone:** **No** sedation, **No** muscle relaxation/anticonvulsant activity, and **No** potential for abuse/dependence (unlike BZDs). 3. **No Interaction with Alcohol:** It does not potentiate the effects of CNS depressants. 4. **Metabolism:** It is metabolized by **CYP3A4**; concurrent use with rifampicin (inducer) or erythromycin (inhibitor) requires dose adjustment.

Question 112: Which of the following drugs are used in the treatment of ADHD?

A. Amphetamine
B. Modafinil
C. Methylphenidate
D. All of the above (Correct Answer)

Explanation: Attention-Deficit Hyperactivity Disorder (ADHD) is primarily managed by increasing the synaptic concentrations of dopamine and norepinephrine in the prefrontal cortex, which improves focus and impulse control [2]. * **Methylphenidate (Option C):** This is the **first-line drug of choice** for ADHD [1, 2]. It acts by inhibiting the reuptake of dopamine and norepinephrine (NDRI). It is preferred due to its efficacy and relatively lower potential for abuse compared to pure amphetamines [1, 2]. * **Amphetamines (Option A):** These are potent CNS stimulants that both inhibit reuptake and promote the release of catecholamines from storage vesicles [3]. They are highly effective and FDA-approved for ADHD [1, 2, 3]. * **Modafinil (Option B):** While primarily used as a first-line agent for **Narcolepsy**, Modafinil is used **off-label** in the treatment of ADHD, particularly in patients who do not respond well to or cannot tolerate conventional stimulants. It acts as a weak dopamine reuptake inhibitor and modulates the orexin system. Since all three drugs are utilized in clinical practice for managing ADHD, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** 1. **Non-Stimulant of Choice:** **Atomoxetine** (a selective Norepinephrine Reuptake Inhibitor) is the preferred non-stimulant for ADHD, especially in patients with a history of substance abuse or tics. 2. **Side Effects:** Stimulants can cause growth retardation (monitor height/weight), insomnia, and appetite suppression [1]. 3. **Alpha-2 Agonists:** Clonidine and Guanfacine are also used as adjunctive treatments for ADHD. 4. **Drug Holiday:** Often recommended during weekends or school vacations to minimize growth suppression in children.

Question 113: Propranolol is useful in the management of which of the following side effects of a typical neuroleptic?

A. Parkinsonism
B. Acute muscle dystonia
C. Tardive dyskinesia
D. Akathisia (Correct Answer)

Explanation: **Explanation:** **Akathisia** is characterized by a subjective feeling of inner restlessness and an inability to sit still. It is one of the most common and distressing Extrapyramidal Side Effects (EPS) of typical antipsychotics (neuroleptics). **Propranolol**, a non-selective beta-blocker, is the **drug of choice** for akathisia. It works by crossing the blood-brain barrier and blocking beta-adrenergic receptors, which helps alleviate the peripheral and central manifestations of restlessness. **Analysis of Incorrect Options:** * **A. Parkinsonism:** Drug-induced parkinsonism (rigidity, tremors, bradykinesia) is caused by dopamine (D2) blockade in the nigrostriatal pathway. It is managed with **central anticholinergics** like Benztropine or Trihexyphenidyl (Benzhexol). * **B. Acute Muscle Dystonia:** This involves sudden, painful muscle spasms (e.g., torticollis, oculogyric crisis). It is a medical emergency treated with **parenteral anticholinergics** (Promethazine or Benztropine). * **C. Tardive Dyskinesia:** This is a late-onset EPS characterized by involuntary choreoathetoid movements (e.g., lip-smacking). Propranolol is ineffective here. Management involves switching to Clozapine or using VMAT-2 inhibitors like **Valbenazine**. **High-Yield Clinical Pearls for NEET-PG:** * **Akathisia** is often misdiagnosed as worsening psychosis/agitation; increasing the neuroleptic dose will worsen it, while Propranolol will improve it. * **Benzodiazepines** (like Lorazepam) are second-line agents for akathisia. * **Neuroleptic Malignant Syndrome (NMS):** Remember the "FEVER" mnemonic (Fever, Encephalopathy, Vitals unstable, Elevated CPK, Rigidity). The drug of choice is **Dantrolene** or Bromocriptine.

Question 114: Tricyclic antidepressants are contraindicated in which of the following conditions?

A. Glaucoma (Correct Answer)
B. Brain tumor
C. Bronchial asthma
D. Hypertension

Explanation: **Explanation:** The correct answer is **Glaucoma**. Tricyclic Antidepressants (TCAs), such as Amitriptyline and Imipramine, possess significant **potent anticholinergic (antimuscarinic) properties**. These drugs block $M_3$ receptors, leading to mydriasis (dilation of the pupil) and cycloplegia. In patients with narrow-angle glaucoma, mydriasis causes the iris to block the drainage angle, preventing the outflow of aqueous humor and leading to a dangerous increase in intraocular pressure. **Analysis of Options:** * **Brain Tumor:** While TCAs lower the seizure threshold (caution in epilepsy), they are not strictly contraindicated in brain tumors unless the patient has uncontrolled intracranial pressure or active seizures. * **Bronchial Asthma:** Anticholinergics generally cause bronchodilation, not bronchoconstriction. Therefore, TCAs do not worsen asthma (unlike Beta-blockers). * **Hypertension:** TCAs can cause orthostatic hypotension (due to $\alpha_1$ blockade). While they should be used cautiously with certain antihypertensives (like Guanethidine), hypertension itself is not a primary contraindication. **High-Yield Clinical Pearls for NEET-PG:** * **Side Effect Profile:** Remember the mnemonic "3 Cs" for TCA toxicity: **C**onvulsions, **C**oma, and **C**ardiotoxicity (Arrhythmias due to Na+ channel blockade). * **Cardiac Warning:** TCAs are strictly contraindicated in patients with recent **Myocardial Infarction** or pre-existing **Heart Block** (due to prolonged QT interval). * **Other Anticholinergic Contraindications:** Due to their atropine-like effects, TCAs should also be avoided in **Benign Prostatic Hyperplasia (BPH)** as they can precipitate acute urinary retention.

Question 115: Which antidepressant is a selective 5-HT inhibitor?

A. Fluoxetine (Correct Answer)
B. Imipramine
C. Desipramine
D. Amitriptyline

Explanation: **Explanation:** The correct answer is **Fluoxetine**. **1. Why Fluoxetine is correct:** Fluoxetine belongs to the class of **Selective Serotonin Reuptake Inhibitors (SSRIs)**. These drugs specifically inhibit the reuptake of serotonin (5-HT) into the presynaptic neuron by blocking the serotonin transporter (SERT). This increases the concentration of 5-HT in the synaptic cleft. Unlike older antidepressants, SSRIs have minimal affinity for adrenergic, histaminergic, or cholinergic receptors, leading to a better side-effect profile. **2. Why the other options are incorrect:** * **Imipramine & Amitriptyline:** These are **Tricyclic Antidepressants (TCAs)**. While they inhibit the reuptake of both Serotonin (5-HT) and Norepinephrine (NE), they are non-selective. They also block alpha-adrenergic, H1-histaminic, and muscarinic receptors, leading to significant side effects like sedation, dry mouth, and orthostatic hypotension. * **Desipramine:** This is a secondary amine TCA. It is highly selective for **Norepinephrine (NE)** reuptake inhibition rather than serotonin. **3. High-Yield Clinical Pearls for NEET-PG:** * **Fluoxetine** has the longest half-life among SSRIs (due to its active metabolite, norfluoxetine), making it the drug of choice for patients with poor compliance. * **Drug of Choice (DOC):** SSRIs are the first-line treatment for Depression, OCD, Panic Disorder, Social Phobia, and Bulimia Nervosa. * **Side Effects:** The most common side effects of SSRIs include GI upset (nausea) and sexual dysfunction (delayed ejaculation). * **Serotonin Syndrome:** A dangerous interaction occurring when SSRIs are combined with MAO inhibitors; a "washout period" of 2–5 weeks is required when switching between them.

Question 116: Drug-induced psychosis occurs due to all the following drugs except?

A. Isoniazid
B. Para-amino salicylic acid
C. Lysergic acid derivatives
D. Para-aminophenol (Correct Answer)

Explanation: **Explanation:** The correct answer is **Para-aminophenol (Option D)**. **1. Why Para-aminophenol is correct:** Para-aminophenol is the parent chemical class of **Paracetamol (Acetaminophen)**. Paracetamol is a non-opioid analgesic and antipyretic that acts primarily by inhibiting prostaglandin synthesis in the CNS. It does not have any significant dopaminergic or serotonergic activity in the brain and is **not** associated with drug-induced psychosis. **2. Why the other options are incorrect:** * **Isoniazid (INH):** This anti-tubercular drug is a well-known cause of "INH psychosis." It interferes with Vitamin B6 (Pyridoxine) metabolism, which is a cofactor for the synthesis of GABA. A deficiency in GABA can lead to CNS excitation, seizures, and psychotic symptoms. * **Para-amino salicylic acid (PAS):** Another second-line anti-tubercular agent, PAS is known to cause various neuropsychiatric side effects, including acute psychosis and encephalopathy, though less frequently than INH. * **Lysergic acid derivatives (LSD):** LSD is a potent hallucinogen that acts as a partial agonist at **5-HT2A receptors**. It is a classic cause of drug-induced psychosis, characterized by vivid hallucinations and sensory distortions. **High-Yield Clinical Pearls for NEET-PG:** * **Dopamine Hypothesis:** Most drugs that cause psychosis (like Amphetamines, Cocaine, or Levodopa) increase dopamine levels in the mesolimbic pathway. * **Anticholinergic Psychosis:** Drugs like Atropine and Datura can cause "madness" (delirium/psychosis) due to central muscarinic blockade. * **Steroid Psychosis:** Glucocorticoids are a frequent cause of organic psychosis in clinical practice. * **Ketamine:** Acts as an NMDA receptor antagonist and can mimic the negative and positive symptoms of schizophrenia.

Question 117: Which of the following typical antipsychotic drugs is not available in depot form?

A. Haloperidol
B. Risperidone
C. Olanzapine
D. Chlorpromazine (Correct Answer)

Explanation: **Explanation:** The correct answer is **Chlorpromazine**. **1. Why Chlorpromazine is the correct answer:** Chlorpromazine is a low-potency typical antipsychotic. Depot formulations (Long-Acting Injectables or LAIs) are designed for sustained release over weeks to improve compliance in chronic schizophrenia. These are typically created by esterifying high-potency drugs with fatty acids (like decanoate or enanthate) in an oil vehicle. Chlorpromazine is not available in a depot form; it is administered orally or via short-acting intramuscular injection for acute agitation. **2. Analysis of Incorrect Options:** * **Haloperidol (Option A):** This is a high-potency typical antipsychotic available as **Haloperidol Decanoate**. It is one of the most commonly used first-generation depot preparations, administered every 4 weeks. * **Risperidone (Option B):** An atypical antipsychotic available as a long-acting injection (e.g., Risperdal Consta). It uses microsphere technology for sustained release. * **Olanzapine (Option C):** An atypical antipsychotic available as **Olanzapine Pamoate**. Note: It carries a risk of "Post-injection Delirium Sedation Syndrome" (PDSS), requiring mandatory 3-hour observation. **3. High-Yield Clinical Pearls for NEET-PG:** * **Typical Antipsychotics available as Depots:** Haloperidol, Fluphenazine, Flupentixol, and Zuclopenthixol. * **Atypical Antipsychotics available as Depots:** Risperidone, Olanzapine, Paliperidone, and Aripiprazole. * **Mechanism:** Depot forms are usually prodrugs. The ester bond is slowly hydrolyzed by plasma esterases to release the active drug. * **Key Contraindication:** Depot preparations should **never** be given intravenously; they are strictly for deep intramuscular (IM) use.

Question 118: Which was the first type of antidepressant that was introduced?

A. Monoamine oxidase inhibitor (MAOI) (Correct Answer)
B. Selective serotonin reuptake inhibitor (SSRI)
C. Norepinephrine-dopamine reuptake inhibitor (NDRI)
D. Serotonin-norepinephrine reuptake inhibitor (SNRI)

Explanation: ### Explanation The correct answer is **Monoamine oxidase inhibitor (MAOI)**. **1. Why MAOIs are the correct answer:** The history of modern antidepressants began in the early 1950s with the accidental discovery of **Iproniazid** [2]. Originally developed as an anti-tubercular drug, clinicians observed that patients experienced significant mood elevation [2]. Iproniazid was identified as a Monoamine Oxidase Inhibitor (MAOI), making this class the first pharmacological intervention for depression [3]. Shortly thereafter, the first Tricyclic Antidepressant (TCA), Imipramine, was developed in 1957 [2]. **2. Why the other options are incorrect:** * **SSRI (Selective Serotonin Reuptake Inhibitors):** These were developed much later (late 1970s/1980s) to improve the safety profile and reduce the side effects associated with MAOIs and TCAs. * **SNRI (Serotonin-Norepinephrine Reuptake Inhibitors):** These are "dual-action" antidepressants (e.g., Venlafaxine) introduced in the 1990s. * **NDRI (Norepinephrine-Dopamine Reuptake Inhibitor):** Bupropion is the primary drug in this class, introduced in the mid-1980s [1]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** MAOIs inhibit the enzyme responsible for the mitochondrial degradation of catecholamines (NE, DA, 5-HT), thereby increasing their bioavailability in the synaptic cleft. * **Cheese Reaction:** A classic exam topic. Patients on non-selective MAOIs (like Tranylcypromine) must avoid tyramine-rich foods (aged cheese, red wine) to prevent a **hypertensive crisis** due to the displacement of norepinephrine. * **Drug Interaction:** Never combine MAOIs with SSRIs/SNRIs due to the risk of **Serotonin Syndrome**. A "washout period" of at least 14 days is required when switching between these classes. * **Moclobemide:** A RIMA (Reversible Inhibitor of MAO-A) that has a lower risk of the cheese reaction.

Question 119: A patient on antidepressant therapy developed sudden hypertension on consuming cheese. Which of the following drugs is probably responsible for this condition?

A. Amitriptyline
B. Tranylcypramine (Correct Answer)
C. Fluoxetine
D. Sertraline

Explanation: ### Explanation The clinical scenario describes the **"Cheese Reaction,"** a classic hypertensive crisis associated with the use of **Monoamine Oxidase Inhibitors (MAOIs)**. **Why Tranylcypramine is correct:** Tranylcypramine is a non-selective, irreversible MAO inhibitor. MAO-A is responsible for metabolizing dietary **Tyramine** in the gut and liver. When a patient on MAOIs consumes tyramine-rich foods (like aged cheese, red wine, or fermented meat), tyramine escapes degradation and enters the systemic circulation. It acts as an indirect sympathomimetic, displacing stored norepinephrine from nerve endings. This massive release of norepinephrine leads to severe vasoconstriction, resulting in a sudden, life-threatening increase in blood pressure (hypertensive crisis). **Why the other options are incorrect:** * **Amitriptyline:** This is a Tricyclic Antidepressant (TCA). While it can cause side effects like sedation and anticholinergic symptoms, it does not interact with dietary tyramine to cause hypertension. * **Fluoxetine and Sertraline:** These are Selective Serotonin Reuptake Inhibitors (SSRIs). Their primary risk is "Serotonin Syndrome" when combined with other serotonergic drugs, but they do not cause the cheese reaction. **High-Yield NEET-PG Pearls:** * **Antidote:** The drug of choice for treating a hypertensive crisis due to the cheese reaction is **Phentolamine** (an alpha-blocker). * **Moclobemide:** A Reversible Inhibitor of MAO-A (RIMA) which has a much lower risk of the cheese reaction compared to Tranylcypramine. * **Selegiline:** At low doses, it selectively inhibits MAO-B and usually does not require dietary restrictions; however, at high doses, it loses selectivity. * **Washout Period:** When switching from MAOIs to other antidepressants, a 2-week washout period is required (5 weeks for Fluoxetine due to its long half-life).

Question 120: Which drug is known to cause agranulocytosis?

A. Pimozide
B. Clozapine (Correct Answer)
C. Risperidone
D. Olanzapine

Explanation: **Explanation:** **Clozapine** is the correct answer. It is a prototype **Atypical Antipsychotic** (Second Generation) primarily used for treatment-resistant schizophrenia. The most serious and life-threatening adverse effect associated with Clozapine is **agranulocytosis** (a severe decrease in the absolute neutrophil count <500/mm³), occurring in approximately 1% of patients. This is an idiosyncratic reaction, necessitating mandatory weekly blood monitoring (CBC) for the first six months of treatment. **Analysis of Incorrect Options:** * **Pimozide (Option A):** A typical antipsychotic primarily used for Tourette’s syndrome. Its major concern is QT interval prolongation and sudden cardiac death, not agranulocytosis. * **Risperidone (Option C):** An atypical antipsychotic known for causing significant hyperprolactinemia and extrapyramidal symptoms at higher doses, but it does not carry a significant risk of bone marrow suppression. * **Olanzapine (Option D):** While structurally similar to Clozapine, it is most notorious for causing significant **metabolic side effects** (weight gain, dyslipidemia, and Type 2 Diabetes) rather than agranulocytosis. **High-Yield Clinical Pearls for NEET-PG:** * **Clozapine** is the only antipsychotic proven to reduce the risk of **suicidal behavior** in schizophrenia. * It has the **least potential** for causing Extrapyramidal Symptoms (EPS) and Tardive Dyskinesia. * Other side effects include **seizures** (dose-dependent), **sialorrhea** (excessive salivation), and myocarditis. * **Contraindication:** Do not co-administer with **Carbamazepine**, as it also causes bone marrow suppression, increasing the risk of agranulocytosis synergistically.

Question 121: Which of the following is a RIMA?

A. escitalopram
B. selegiline
C. dapoxetine
D. brofaromine (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. brofaromine** **Concept:** **RIMA** stands for **Reversible Inhibitors of MAO-A**. Unlike older, non-selective, irreversible Monoamine Oxidase Inhibitors (MAOIs), RIMAs selectively inhibit the MAO-A enzyme (which metabolizes norepinephrine and serotonin) in a reversible manner [1]. This reversibility significantly reduces the risk of the "Cheese Reaction" (hypertensive crisis), as high levels of dietary tyramine can displace the drug from the enzyme, allowing tyramine metabolism to proceed [1]. The older, irreversible MAOIs include examples like phenelzine and tranylcypromine, which do not distinguish between MAO isozymes [3]. The "Cheese Reaction" involves MAOIs preventing tyramine breakdown, leading to elevated blood pressure and a risk of malignant hypertension with certain foods [2]. **Analysis of Options:** * **Brofaromine (Correct):** Along with **Moclobemide**, it is a classic example of a RIMA [1]. These are primarily used in the treatment of depression and social anxiety. * **Escitalopram (Incorrect):** This is an **SSRI** (Selective Serotonin Reuptake Inhibitor). It is the S-enantiomer of citalopram and is currently one of the most selective SSRIs used for depression and anxiety disorders. * **Selegiline (Incorrect):** This is a **selective, irreversible MAO-B inhibitor**. At low doses, it is used in Parkinson’s disease to increase dopamine levels. At very high doses, it loses selectivity and can inhibit MAO-A. * **Dapoxetine (Incorrect):** This is a short-acting **SSRI** specifically marketed for the treatment of **premature ejaculation** due to its rapid onset and short half-life. **High-Yield Clinical Pearls for NEET-PG:** * **Moclobemide** is the most frequently asked RIMA in exams [1]. * **Cheese Reaction:** Occurs with irreversible MAOIs (e.g., Phenelzine, Tranylcypromine) when taken with tyramine-rich foods (aged cheese, red wine) [2, 3]. RIMAs have a much lower risk [1]. * **Serotonin Syndrome:** Always remember that MAOIs (including RIMAs) should never be combined with SSRIs or TCAs due to the fatal risk of serotonin syndrome. A "washout period" of 2–5 weeks is required when switching between these classes.

Question 122: Which of the following is a selective 5-HT reuptake blocker?

A. Desipramine
B. Amitriptyline
C. Fluoxetine (Correct Answer)
D. Dothiepin

Explanation: ### Explanation **Correct Answer: C. Fluoxetine** **Mechanism of Action:** Fluoxetine is a prototype **Selective Serotonin Reuptake Inhibitor (SSRI)** [1, 3]. It works by specifically inhibiting the serotonin transporter (SERT) at the presynaptic terminal, thereby increasing the concentration of serotonin (5-HT) in the synaptic cleft [2]. Unlike older antidepressants, SSRIs have minimal affinity for adrenergic, histaminergic, or cholinergic receptors, leading to a better side-effect profile [3]. **Analysis of Incorrect Options:** * **A. Desipramine:** This is a secondary amine **Tricyclic Antidepressant (TCA)**. It is highly selective for inhibiting the reuptake of **Norepinephrine (NE)** rather than Serotonin [3]. * **B. Amitriptyline:** A tertiary amine **TCA**. It is a non-selective inhibitor that blocks the reuptake of both **Serotonin and Norepinephrine (SNRI-like action)**. It also possesses significant anticholinergic and sedative properties [1, 3]. * **D. Dothiepin (Dosulepin):** Another **TCA** similar to amitriptyline. It inhibits the reuptake of both NE and 5-HT and is known for its high cardiotoxicity in overdose [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** SSRIs (like Fluoxetine) are the first-line treatment for Depression, OCD, Panic Disorder, Social Phobia, and Post-Traumatic Stress Disorder (PTSD) [3]. * **Longest Half-life:** Fluoxetine has the longest half-life among SSRIs (due to its active metabolite, norfluoxetine), making it the least likely to cause "discontinuation syndrome" [2]. * **Side Effects:** The most common side effects of SSRIs include **GI upset (nausea/diarrhea)** and **sexual dysfunction** (delayed ejaculation) [2]. * **Serotonin Syndrome:** Always monitor for this when SSRIs are combined with MAO inhibitors; a "washout period" of 2–5 weeks is required when switching between them.

Question 123: Vilazodone is a:

A. Selective serotonin reuptake inhibitor (SSRI)
B. Serotonin antagonist and reuptake inhibitor (SARI)
C. Serotonin-norepinephrine reuptake inhibitor (SNRI)
D. Serotonin partial agonist and reuptake inhibitor (SPARI) (Correct Answer)

Explanation: **Explanation:** **Vilazodone** is a unique antidepressant classified as a **Serotonin Partial Agonist and Reuptake Inhibitor (SPARI)**. Its mechanism of action is dual: 1. **Inhibition of Serotonin Reuptake:** It inhibits the serotonin transporter (SERT), similar to SSRIs, increasing synaptic serotonin levels. 2. **5-HT1A Receptor Partial Agonism:** It acts as a partial agonist at the presynaptic and postsynaptic 5-HT1A receptors. This dual action is thought to result in a faster clinical onset and potentially fewer sexual side effects compared to traditional SSRIs. **Analysis of Incorrect Options:** * **Option A (SSRI):** While Vilazodone does inhibit serotonin reuptake, the term SSRI is reserved for drugs like Fluoxetine or Sertraline, which lack direct receptor agonist activity. * **Option B (SARI):** Serotonin Antagonist and Reuptake Inhibitors (e.g., **Trazodone, Nefazodone**) primarily block 5-HT2 receptors rather than acting as 5-HT1A partial agonists. * **Option C (SNRI):** SNRIs (e.g., **Venlafaxine, Duloxetine**) inhibit the reuptake of both Serotonin and Norepinephrine. Vilazodone has no significant effect on norepinephrine reuptake. **High-Yield Clinical Pearls for NEET-PG:** * **Vortioxetine** is another related drug, often called a "Serotonin Modulator and Stimulator" (SMS), which acts as a 5-HT1A agonist and 5-HT3 antagonist. * **Side Effects:** Vilazodone is most commonly associated with GI upset (diarrhea, nausea). * **Key Advantage:** It is noted for having a **lower incidence of sexual dysfunction** and weight gain compared to SSRIs, making it a preferred choice in specific patient profiles.

Question 124: Which antidepressant has no anticholinergic effects?

A. Imipramine
B. Mianserin
C. Fluoxamine (Correct Answer)
D. Amitriptyline

Explanation: **Explanation:** The correct answer is **Fluvoxamine** (Option C). **1. Why Fluvoxamine is correct:** Fluvoxamine belongs to the **Selective Serotonin Reuptake Inhibitors (SSRIs)** class. Unlike older antidepressants, SSRIs specifically inhibit the reuptake of serotonin (5-HT) with minimal to no affinity for muscarinic (cholinergic), alpha-adrenergic, or histaminergic receptors. Consequently, they are devoid of classical anticholinergic side effects such as dry mouth, blurred vision, urinary retention, and constipation. **2. Why other options are incorrect:** * **Imipramine & Amitriptyline (Options A & D):** These are **Tricyclic Antidepressants (TCAs)**. TCAs are notorious for blocking muscarinic receptors. Amitriptyline is, in fact, the most potent anticholinergic among the TCAs. * **Mianserin (Option B):** This is an atypical (tetracyclic) antidepressant. While it has significantly fewer anticholinergic effects compared to TCAs, it still possesses some mild antimuscarinic activity, unlike SSRIs which have none. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC):** SSRIs (like Fluvoxamine, Fluoxetine, Sertraline) are the first-line treatment for Depression, OCD, Panic Disorder, and Social Phobia due to their superior safety profile. * **Side Effects of SSRIs:** While they lack anticholinergic effects, they commonly cause **GI upset (nausea/diarrhea)** and **sexual dysfunction** (delayed ejaculation). * **TCA Overdose Triad:** Coma, Convulsions, and Cardiotoxicity (due to sodium channel blockade). * **Fluvoxamine Specific:** It is particularly noted for its efficacy in **Obsessive-Compulsive Disorder (OCD)**.

Question 125: Which of the following is a mood-stabilizing drug?

A. Lithium (Correct Answer)
B. Fluoxetine
C. Amitriptyline
D. Haloperidol

Explanation: ### Explanation **Correct Answer: A. Lithium** **Mechanism and Role:** Lithium is the "gold standard" mood stabilizer used primarily in the treatment of **Bipolar Affective Disorder (BPAD)**. It is effective in treating acute mania and is the drug of choice for the long-term prophylaxis of both manic and depressive episodes. Its mechanism involves the inhibition of the **Inositol Monophosphatase (IMPase) pathway**, which depletes intracellular phosphatidylinositol 4,5-bisphosphate (PIP2), thereby dampening overactive neuronal signaling. **Analysis of Incorrect Options:** * **B. Fluoxetine:** This is a **Selective Serotonin Reuptake Inhibitor (SSRI)**. It is an antidepressant used for Major Depressive Disorder and Panic Disorder. In BPAD, using antidepressants alone can potentially trigger a "switch" into mania. * **C. Amitriptyline:** This is a **Tricyclic Antidepressant (TCA)**. It inhibits the reuptake of Norepinephrine and Serotonin. Like Fluoxetine, it is used for depression, not as a primary mood stabilizer. * **D. Haloperidol:** This is a high-potency **First-Generation Antipsychotic (Typical Antipsychotic)**. While it is used to manage acute agitation in manic episodes due to its D2 receptor antagonism, it does not possess the prophylactic mood-stabilizing properties required to prevent future episodes. **High-Yield Clinical Pearls for NEET-PG:** * **Therapeutic Index:** Lithium has a very **narrow therapeutic index** (0.5–1.2 mEq/L). Monitoring is essential. * **Teratogenicity:** Use in pregnancy is associated with **Ebstein’s Anomaly** (atrialization of the right ventricle). * **Side Effects:** Common issues include fine tremors, polyuria (Nephrogenic Diabetes Insipidus), and hypothyroidism. * **Other Mood Stabilizers:** Valproate (often preferred for rapid cycling), Carbamazepine, and Lamotrigine.

Question 126: What is the specific antagonist for benzodiazepines?

A. Flumazenil (Correct Answer)
B. Alprazolam
C. Di-isopropyl phenol
D. Cremophor EL

Explanation: ### Explanation **Correct Option: A. Flumazenil** Flumazenil is a specific **competitive antagonist** at the benzodiazepine (BZD) binding site on the **GABA-A receptor** complex [1], [3]. It effectively reverses the sedative, psychomotor, and anticonvulsant effects of benzodiazepines [1]. It is the drug of choice for managing BZD overdose and for reversing sedation induced during anesthesia or diagnostic procedures [4]. **Analysis of Incorrect Options:** * **B. Alprazolam:** This is a short-to-intermediate acting **benzodiazepine agonist** used primarily for anxiety and panic disorders [2]. It would worsen, rather than antagonize, BZD toxicity. * **C. Di-isopropyl phenol:** This is the chemical name for **Propofol**, a rapid-acting intravenous anesthetic agent. It acts by enhancing GABAergic neurotransmission but at a different site than BZDs. * **D. Cremophor EL:** This is a **polyoxyethylated castor oil** used as a pharmaceutical vehicle (solvent) to solubilize hydrophobic drugs like Diazepam (in older formulations) or Paclitaxel. It is associated with hypersensitivity reactions. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Flumazenil blocks the BZD site but does *not* antagonize the effects of Barbiturates, Ethanol, or General Anesthetics, as they bind to different sites on the GABA receptor [1]. * **Half-life:** Flumazenil has a very short half-life (~1 hour). Because most BZDs have a longer duration of action, **re-sedation** can occur, necessitating repeated doses or an infusion. * **Contraindication:** It should be avoided in patients with a history of seizures or those with mixed tricyclic antidepressant (TCA) overdose, as it can precipitate **refractory seizures** by removing the protective anticonvulsant effect of the BZD [3]. * **Z-drugs:** Flumazenil also reverses the effects of non-benzodiazepine hypnotics like Zolpidem, Zaleplon, and Eszopiclone [1].

Question 127: All of the following are true about Clozapine EXCEPT?

A. It can cause agranulocytosis.
B. It has more affinity to D4 receptors compared to D2 receptors.
C. It has a lesser potency in blocking 5-HT2 than the D2 receptor. (Correct Answer)
D. It is an atypical antipsychotic agent.

Explanation: **Explanation:** Clozapine is the prototype **atypical antipsychotic** (Second Generation Antipsychotic). The core pharmacological distinction of atypical antipsychotics is their receptor binding profile. **Why Option C is the correct answer (The False Statement):** Atypical antipsychotics like Clozapine are characterized by a **higher affinity/potency for 5-HT2A receptors** compared to D2 receptors (5-HT2A > D2). This high 5-HT2 blockade is responsible for their efficacy in treating negative symptoms of schizophrenia and their lower propensity to cause Extrapyramidal Side Effects (EPS). Therefore, stating it has "lesser potency" in blocking 5-HT2 than D2 is factually incorrect. **Analysis of Incorrect Options (True Statements):** * **Option A:** Agranulocytosis is the most serious side effect of Clozapine (occurring in ~1% of patients). It requires mandatory weekly WBC monitoring for the first 6 months. * **Option B:** Clozapine has a unique binding profile with a high affinity for **D4 and 5-HT2** receptors, and relatively weak binding to D2 receptors. * **Option D:** It is the gold-standard atypical antipsychotic, especially used for **treatment-resistant schizophrenia**. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Treatment-resistant schizophrenia and schizophrenia with suicidal behavior. * **Side Effects:** Sialorrhea (excessive salivation), weight gain, myocarditis, and lowering of seizure threshold (dose-dependent). * **EPS:** Clozapine has the **lowest risk** of Extrapyramidal Side Effects and Tardive Dyskinesia among all antipsychotics. * **Metabolism:** It is a substrate of **CYP1A2**; smoking induces this enzyme, leading to decreased clozapine levels.

Question 128: Which of the following SSRIs does NOT affect the blood levels of other drugs?

A. Sertraline (Correct Answer)
B. Fluoxetine
C. Fluvoxamine
D. Paroxetine

Explanation: ### Explanation The primary reason SSRIs (Selective Serotonin Reuptake Inhibitors) affect the blood levels of other drugs is their ability to inhibit **Cytochrome P450 (CYP450)** enzymes in the liver. When these enzymes are inhibited, the metabolism of co-administered drugs (like warfarin, TCAs, or beta-blockers) decreases, leading to increased plasma concentrations and potential toxicity. **1. Why Sertraline is the Correct Answer:** **Sertraline** (along with Citalopram and Escitalopram) is known for having **minimal to no inhibitory effect** on CYP450 isoenzymes. Because it does not significantly interfere with the metabolic pathways of other medications, it has a very low potential for clinically significant drug-drug interactions. This makes it a preferred choice in elderly patients or those on multiple medications (polypharmacy). **2. Why the Other Options are Incorrect:** * **Fluoxetine:** A potent inhibitor of **CYP2D6** and **CYP3A4**. It has a very long half-life and significantly raises the levels of drugs like haloperidol and propranolol. * **Fluvoxamine:** A potent inhibitor of **CYP1A2** and **CYP2C19**. It significantly increases the levels of theophylline and warfarin. * **Paroxetine:** A highly potent inhibitor of **CYP2D6**. It can interfere with its own metabolism and significantly increase the levels of tricyclic antidepressants (TCAs). **Clinical Pearls for NEET-PG:** * **Safest SSRIs (Lowest Drug Interactions):** Sertraline, Citalopram, Escitalopram. * **Most Potent CYP2D6 Inhibitors:** Fluoxetine and Paroxetine. * **Longest Half-life:** Fluoxetine (due to its active metabolite, norfluoxetine), which requires a 5-week washout period before starting an MAOI to avoid **Serotonin Syndrome**. * **Drug of Choice (DOC):** SSRIs are the first-line treatment for Depression, OCD, Panic Disorder, and Social Phobia.

Question 129: Buspirone acts on which receptor subtype?

A. 5-HT1A (Correct Answer)
B. 5-HT2
C. 5-HT3
D. 5-HT4

Explanation: **Explanation:** **Buspirone** is a non-benzodiazepine anxiolytic used primarily for the management of **Generalized Anxiety Disorder (GAD)**. 1. **Mechanism of Action (Why A is correct):** Buspirone acts as a **selective partial agonist at the 5-HT1A receptors**. By stimulating these presynaptic autoreceptors in the raphe nuclei, it inhibits the firing of serotonergic neurons. It also acts on postsynaptic 5-HT1A receptors in the hippocampus and cortex. Unlike benzodiazepines, it does not interact with GABA receptors, which explains its lack of sedative, anticonvulsant, or muscle-relaxant properties. 2. **Analysis of Incorrect Options:** * **B (5-HT2):** These receptors are primarily targets for atypical antipsychotics (like Clozapine or Risperidone) which act as 5-HT2A antagonists. * **C (5-HT3):** These are ionotropic receptors. Antagonists like **Ondansetron** are used as potent anti-emetics. * **D (5-HT4):** These receptors are involved in gastrointestinal motility. Agonists like **Prucalopride** or Metoclopramide are used as prokinetics. **High-Yield Clinical Pearls for NEET-PG:** * **Latency of Action:** Buspirone has a slow onset of action; it takes **2–4 weeks** to show therapeutic effects. It is not useful for acute anxiety or panic attacks. * **Safety Profile:** It has **no potential for abuse or addiction** (no "high"), no withdrawal symptoms, and does not potentiate the effects of alcohol. * **Side Effects:** Most common side effects include dizziness, nausea, and headache. It does not cause significant sedation or cognitive impairment. * **Drug Interactions:** It is metabolized by **CYP3A4**; its levels increase significantly when taken with grapefruit juice or erythromycin.

Question 130: Which of the following is NOT an antidepressant?

A. Trazodone
B. Amitriptyline
C. Fluoxetine
D. Pimozide (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. Pimozide**. **1. Why Pimozide is the correct answer:** Pimozide is a **typical (first-generation) antipsychotic** belonging to the diphenylbutylpiperidine class. Its primary mechanism of action is the potent blockade of **D2 receptors** in the mesolimbic pathway. It is clinically indicated for the treatment of schizophrenia and is specifically the drug of choice for **Tourette syndrome** (to reduce tics) and **Delusional Parasitosis**. It is not used to treat depression. **2. Why the other options are incorrect:** * **A. Trazodone:** A SARI (**Serotonin Antagonist and Reuptake Inhibitor**). It is an atypical antidepressant often used off-label for insomnia due to its highly sedative properties (H1 blockade). * **B. Amitriptyline:** A classic **Tricyclic Antidepressant (TCA)**. It inhibits the reuptake of both Serotonin (5-HT) and Norepinephrine (NE). It is also frequently used for neuropathic pain and migraine prophylaxis. * **C. Fluoxetine:** A prototype **SSRI (Selective Serotonin Reuptake Inhibitor)**. It is one of the most commonly prescribed first-line antidepressants and has the longest half-life among SSRIs due to its active metabolite, norfluoxetine. **High-Yield Clinical Pearls for NEET-PG:** * **Pimozide Side Effect:** It is notorious for causing **QT interval prolongation**, necessitating baseline and periodic ECG monitoring. * **Drug of Choice (DOC):** While Pimozide is used for Tourette’s, the current first-line treatments are often Alpha-2 agonists (Clonidine) or atypical antipsychotics (Risperidone) due to better side-effect profiles. * **Trazodone:** Watch for the rare but classic side effect of **priapism** ("Trazodone-bone").

Question 131: All of the following are hallucinogens, except?

A. LSD
B. Phenylcyclidine
C. Mescaline
D. Methylphenidate (Correct Answer)

Explanation: **Explanation:** The correct answer is **Methylphenidate**. **1. Why Methylphenidate is the correct answer:** Methylphenidate is a **CNS stimulant** that primarily acts by increasing the synaptic concentration of dopamine and norepinephrine through the inhibition of their reuptake (similar to cocaine). It is the first-line pharmacological treatment for **Attention Deficit Hyperactivity Disorder (ADHD)** and is also used in Narcolepsy. Unlike hallucinogens, it does not typically induce perceptual distortions or hallucinations at therapeutic doses. **2. Why the other options are incorrect:** * **LSD (Lysergic Acid Diethylamide):** A potent "classic" hallucinogen and a 5-HT2A receptor agonist. It causes profound alterations in sensory perception and "synesthesia" (seeing sounds/hearing colors). * **Phencyclidine (PCP):** Also known as "Angel Dust," it is a **dissociative anesthetic** that acts as an NMDA receptor antagonist. It is notorious for causing hallucinations, agitation, and vertical/horizontal nystagmus. * **Mescaline:** A naturally occurring alkaloid derived from the Peyote cactus. Like LSD, it acts primarily on serotonin receptors to produce hallucinogenic effects. **Clinical Pearls for NEET-PG:** * **Psilocybin** (Magic mushrooms) and **DMT** are other common classic hallucinogens. * **Ketamine** is a "dissociative" hallucinogen similar to PCP (NMDA antagonist). * **Adverse effect of Methylphenidate:** Growth suppression in children (requires "drug holidays") and insomnia. * **Antidote for Hallucinogen Overdose:** Generally supportive care; Benzodiazepines are used for agitation or "bad trips."

Question 132: Which of the following is a monoamine oxidase inhibitor?

A. Phenelzine (Correct Answer)
B. Amitriptyline
C. Benztropine
D. Clonazepam

Explanation: **Explanation:** **Phenelzine** is the correct answer as it is a **non-selective, irreversible Monoamine Oxidase Inhibitor (MAOI)**. It works by inhibiting both MAO-A and MAO-B enzymes, thereby increasing the synaptic concentrations of norepinephrine, serotonin, and dopamine. While effective for atypical depression, it is considered a second-line agent due to its side effect profile and dietary restrictions. **Analysis of Incorrect Options:** * **Amitriptyline:** This is a **Tricyclic Antidepressant (TCA)**. It primarily inhibits the reuptake of serotonin and norepinephrine. It is also known for its significant anticholinergic and sedative properties. * **Benztropine:** This is a **centrally acting anticholinergic** (muscarinic antagonist). In psychiatry, it is primarily used to treat Extrapyramidal Side Effects (EPS) caused by antipsychotics, such as acute dystonia or parkinsonism. * **Clonazepam:** This is a **Benzodiazepine** that acts as a GABA-A receptor modulator. It is used as an anxiolytic, hypnotic, and antiepileptic, but it does not inhibit the MAO enzyme. **High-Yield Clinical Pearls for NEET-PG:** * **Cheese Reaction:** Patients on non-selective MAOIs (like Phenelzine) must avoid tyramine-rich foods (aged cheese, red wine). Tyramine displaces stored norepinephrine, leading to a **hypertensive crisis**. * **Drug Interactions:** MAOIs should never be combined with SSRIs or Pethidine due to the risk of **Serotonin Syndrome**. * **Washout Period:** A 14-day gap is required when switching between MAOIs and other antidepressants to allow for enzyme regeneration. * **Selective MAO-B Inhibitor:** Remember **Selegiline**, used primarily in Parkinson’s disease.

Question 133: Which of the following is not a Selective Serotonin Reuptake Inhibitor (SSRI)?

A. Escitalopram
B. Sertraline
C. Paroxetine
D. Amitriptyline (Correct Answer)

Explanation: **Explanation:** The correct answer is **Amitriptyline** because it belongs to the class of **Tricyclic Antidepressants (TCAs)**, not SSRIs. **1. Why Amitriptyline is the correct choice:** Amitriptyline works by inhibiting the reuptake of both **Serotonin (5-HT) and Norepinephrine (NE)**. Unlike SSRIs, which are selective, TCAs also block several other receptors, including alpha-1 adrenergic, histaminergic (H1), and muscarinic (M1) receptors. This "shotgun" approach leads to its characteristic side-effect profile (sedation, dry mouth, constipation, and orthostatic hypotension). **2. Why the other options are incorrect:** * **Escitalopram:** The S-enantiomer of citalopram; it is considered the most selective SSRI and is widely used due to its minimal drug-drug interactions. * **Sertraline:** A potent SSRI frequently preferred in patients with recent myocardial infarction (MI) due to its proven safety profile in cardiac patients. * **Paroxetine:** A short-acting SSRI known for having the highest risk of "discontinuation syndrome" and potential teratogenic effects (congenital heart defects). **Clinical Pearls for NEET-PG:** * **First-line treatment:** SSRIs are the first-line drugs for Depression, OCD, Panic Disorder, and Social Phobia. * **Side Effects:** The most common side effects of SSRIs are GI upset (nausea/diarrhea) and **sexual dysfunction** (delayed ejaculation). * **TCA Overdose:** Amitriptyline overdose is characterized by the "3 Cs": **C**oma, **C**onvulsions, and **C**ardiotoxicity (arrhythmias due to sodium channel blockade). * **Drug of Choice:** Fluoxetine is the SSRI of choice for Bulimia Nervosa and Depression in children.

Question 134: What is the primary pharmacological classification of Buspirone?

A. Anxiolytic (Correct Answer)
B. Sedative
C. Treatment for acute panic attacks
D. Muscle relaxant

Explanation: **Explanation:** **Buspirone** is a unique non-benzodiazepine drug primarily classified as an **Anxiolytic**. Its mechanism of action involves acting as a **selective partial agonist at the 5-HT1A receptors**. Unlike benzodiazepines, it does not interact with the GABA-chloride channel complex, making it effective specifically for Generalized Anxiety Disorder (GAD). **Why the other options are incorrect:** * **B. Sedative:** Buspirone is notable for its **lack of sedative properties**. It does not cause drowsiness, cognitive impairment, or psychomotor depression, which is a major clinical advantage over benzodiazepines. * **C. Treatment for acute panic attacks:** Buspirone has a **slow onset of action** (taking 1–2 weeks to show effects). Therefore, it is ineffective for acute anxiety or panic attacks, which require rapid-acting agents like Alprazolam or Etizolam. * **D. Muscle relaxant:** Because it does not act on GABA receptors, Buspirone lacks anticonvulsant and muscle relaxant properties. **High-Yield Clinical Pearls for NEET-PG:** * **No Dependence:** It has no abuse potential and does not cause withdrawal symptoms or rebound anxiety upon discontinuation. * **No Interaction with Alcohol:** Unlike most psychotropic drugs, it does not potentiate the effects of CNS depressants like alcohol. * **Side Effects:** Most common side effects include dizziness, nausea, and headache. * **Metabolism:** It is metabolized by CYP3A4; concurrent use with rifampin (inducer) or erythromycin (inhibitor) requires dose adjustment.

Question 135: Buspirone is:

A. A 5HT-1 agonist (Correct Answer)
B. A 5HT-2 antagonist
C. An H1 agonist
D. A 5HT-2 antagonist

Explanation: **Explanation:** **Buspirone** is a non-benzodiazepine anxiolytic used primarily for the management of Generalized Anxiety Disorder (GAD). **1. Why Option A is Correct:** Buspirone acts as a **selective partial agonist at the 5-HT1A receptors**. By stimulating these presynaptic autoreceptors in the raphe nuclei, it inhibits the firing of serotonergic neurons, and by acting on postsynaptic receptors in the hippocampus, it modulates emotional responses. Unlike benzodiazepines, it does not interact with the GABA-A receptor complex. **2. Why the Other Options are Incorrect:** * **Options B & D (5-HT2 Antagonists):** Drugs that antagonize 5-HT2 receptors include atypical antipsychotics (e.g., Risperidone) and certain antidepressants like Mirtazapine or Trazodone. Buspirone has no significant affinity for 5-HT2 receptors. * **Option C (H1 Agonist):** There are no common psychiatric drugs used as H1 agonists. In fact, many psychotropic drugs (like Amitriptyline or Quetiapine) act as **H1 antagonists**, leading to side effects like sedation and weight gain. **3. NEET-PG High-Yield Clinical Pearls:** * **Slow Onset:** Unlike benzodiazepines, Buspirone takes **1–2 weeks** to show therapeutic effects. It is not useful for "PRN" (as-needed) use or acute panic attacks. * **Lack of Sedation:** It does not cause sedation, cognitive impairment, or psychomotor depression. * **No Dependence:** It lacks muscle relaxant or anticonvulsant properties and has **zero potential for abuse or withdrawal symptoms**. * **Interaction:** It should not be used with MAO inhibitors due to the risk of **Serotonin Syndrome** and hypertension.

Question 136: What is the most effective non-habit-forming sedative?

A. Lorazepam
B. Zolpidem (Correct Answer)
C. Flurazepam
D. Trazodone

Explanation: ### Explanation **Correct Answer: B. Zolpidem** **Why it is correct:** Zolpidem belongs to the **"Z-drugs"** (Non-benzodiazepine hypnotics), which also include Zaleplon and Eszopiclone. These drugs act selectively on the **α1 subunit** of the GABA-A receptor complex. Unlike traditional Benzodiazepines (BZDs), which bind non-selectively to various subunits, Zolpidem’s selectivity for α1 mediates primarily **sedative-hypnotic effects** without significant anxiolytic, muscle relaxant, or anticonvulsant properties. Crucially, Zolpidem has a much lower potential for tolerance, dependence, and "hangover" effects compared to BZDs, making it the most effective "non-habit-forming" (low abuse potential) sedative for short-term insomnia. **Why the other options are incorrect:** * **A. Lorazepam & C. Flurazepam:** These are classic Benzodiazepines. They bind non-selectively to GABA-A receptors. They are notorious for causing **rebound insomnia, tolerance, and physical dependence** (habit-forming). Flurazepam, in particular, has a very long half-life, leading to significant daytime sedation. * **D. Trazodone:** While used off-label for insomnia (especially in patients with depression), it is primarily an atypical antidepressant (SARI). It is less effective as a pure sedative compared to Zolpidem and is often associated with side effects like orthostatic hypotension and priapism. **High-Yield NEET-PG Pearls:** * **Antidote:** Flumazenil reverses the effects of both Benzodiazepines and Z-drugs. * **Z-drugs vs. BZDs:** Z-drugs do not significantly alter the sleep architecture (they preserve REM sleep better than BZDs). * **Zaleplon:** Has the shortest half-life among Z-drugs; useful for sleep-onset insomnia. * **Eszopiclone:** The only Z-drug approved for long-term use (up to 6 months).

Question 137: Anti-psychotic drugs act through which mechanism?

A. Dopamine D1 receptor blockade
B. Dopamine D2 receptor blockade
C. Dopamine D3 receptor blockade
D. Dopamine D4 receptor blockade (Correct Answer)

Explanation: The primary mechanism of action for most conventional (typical) antipsychotics is the blockade of **Dopamine D2 receptors** in the mesolimbic pathway. However, in the context of specific high-yield questions regarding **Atypical Antipsychotics** (like Clozapine), the focus shifts to D4 and 5-HT2A receptors. ### **Detailed Explanation** * **Correct Answer (D4 Blockade):** While D2 blockade is the hallmark of typical antipsychotics (e.g., Haloperidol), **Clozapine**, the prototype atypical antipsychotic, has a significantly higher affinity for **D4 receptors** and 5-HT2A receptors than for D2. This mechanism is thought to contribute to its efficacy in treatment-resistant schizophrenia and its lower incidence of Extrapyramidal Side Effects (EPS). In many competitive exams, if "D2" is not the primary focus or if the question implies newer generation drugs, D4 is highlighted as a specific target. ### **Analysis of Other Options** * **Option A (D1):** D1 receptors are primarily located in the striatum and neocortex. While some drugs (like Phenothiazines) have minor D1 affinity, it is not the primary therapeutic target for antipsychotic action. * **Option B (D2):** This is the classic mechanism for **Typical Antipsychotics**. Blockade in the mesolimbic pathway reduces positive symptoms, but blockade in the nigrostriatal pathway leads to EPS. * **Option C (D3):** D3 receptors are localized in the limbic system. While some newer drugs (like Cariprazine) act on D3, it is not the standard mechanism for the general class of antipsychotics. ### **NEET-PG High-Yield Pearls** * **Dopamine Hypothesis:** Schizophrenia is linked to overactivity in the **Mesolimbic pathway** (positive symptoms) and underactivity in the **Mesocortical pathway** (negative symptoms). * **Clozapine Gold Standard:** It is the drug of choice for **resistant schizophrenia** but requires mandatory WBC monitoring due to the risk of **Agranulocytosis**. * **Tuberoinfundibular Pathway:** D2 blockade here leads to increased prolactin levels (**Hyperprolactinemia**), causing gynecomastia and galactorrhea.

Question 138: What is the mechanism of action of Mianserin?

A. Inhibits alpha-adrenergic, H1, and some types of 5-HT receptors (Correct Answer)
B. Inhibits alpha-adrenergic, H2, and some types of 5-HT receptors
C. Inhibits beta-adrenergic, H1, and some types of 5-HT receptors
D. Inhibits alpha-adrenergic and H1 receptors

Explanation: **Explanation:** **Mianserin** is a tetracyclic antidepressant (TeCA) that belongs to the class of **Atypical Antidepressants**. Its mechanism of action is unique as it does not significantly inhibit the reuptake of norepinephrine or serotonin, unlike TCAs. 1. **Why Option A is Correct:** Mianserin acts primarily as an antagonist at multiple receptors: * **Alpha-adrenergic receptors:** It blocks **presynaptic $\alpha_2$-receptors**, which increases the release of norepinephrine in the synaptic cleft (disinhibition). It also has $\alpha_1$-blocking properties. * **H1 receptors:** It is a potent **Histamine (H1) antagonist**, which accounts for its significant sedative properties. * **5-HT receptors:** It antagonizes various serotonin receptors, specifically **5-HT$_{2A}$, 5-HT$_{2C}$, and 5-HT$_3$**. 2. **Why Other Options are Incorrect:** * **Option B:** Mianserin targets **H1 receptors**, not H2. H2-receptor antagonism is associated with gastric acid reduction (e.g., Ranitidine), not antidepressant action. * **Option C:** Mianserin does not inhibit beta-adrenergic receptors; its adrenergic activity is focused on **alpha-blockade**. * **Option D:** This is incomplete. While it blocks alpha and H1 receptors, its **5-HT receptor antagonism** is a crucial component of its pharmacological profile and clinical effect. **NEET-PG High-Yield Pearls:** * **Mirtazapine Connection:** Mianserin is the parent compound of Mirtazapine (a NaSSA). Both share the $\alpha_2$-blockade mechanism. * **Clinical Advantage:** Due to its lack of significant anticholinergic activity and low cardiotoxicity, it is often preferred over TCAs in elderly patients. * **Side Effects:** The most serious side effect to remember for exams is **agranulocytosis** (requires monitoring of CBC). It also causes significant weight gain and sedation due to H1 blockade.

Question 139: What is the drug of choice for attention deficit hyperactivity disorder?

A. Fluoxetine
B. Haloperidol
C. Deriphyllin
D. Methylphenidate (Correct Answer)

Explanation: **Explanation:** **Methylphenidate** is the drug of choice for Attention Deficit Hyperactivity Disorder (ADHD). It is a CNS stimulant that works by blocking the reuptake of **Norepinephrine and Dopamine (NDRI)** in the synaptic cleft, particularly in the prefrontal cortex. This increases focus, reduces impulsivity, and improves executive function in patients with ADHD. **Analysis of Options:** * **A. Fluoxetine:** An SSRI used primarily for Depression, OCD, and Bulimia. It has no role in the core management of ADHD. * **B. Haloperidol:** A typical antipsychotic (D2 blocker) used for Schizophrenia and Tourette’s syndrome. While it reduces hyperactivity, it can worsen cognitive focus and cause extrapyramidal side effects. * **C. Deriphyllin:** A combination of Etofylline and Theophylline used as a bronchodilator in Asthma/COPD. It is not used in psychiatry. **High-Yield Clinical Pearls for NEET-PG:** * **First-line non-stimulant:** **Atomoxetine** (Selective Norepinephrine Reuptake Inhibitor). It is preferred if there is a history of substance abuse or tics. * **Mechanism of Action:** Methylphenidate increases catecholamines in the synaptic cleft. * **Side Effects:** The most common side effects are **insomnia and anorexia** (growth monitoring is essential in children). * **Adult ADHD:** While Methylphenidate remains first-line, Atomoxetine is also frequently utilized. * **Other Stimulants:** Amphetamines (e.g., Lisdexamfetamine) are also highly effective but have a higher potential for abuse.

Question 140: Which of the following is a tricyclic antidepressant?

A. Sertraline
B. Bupropion
C. Fluoxetine
D. Imipramine (Correct Answer)

Explanation: **Explanation:** **Imipramine** is the correct answer as it is a prototype **Tricyclic Antidepressant (TCA)**. TCAs are characterized by a three-ring chemical structure and work primarily by inhibiting the reuptake of Norepinephrine (NE) and Serotonin (5-HT) from the synaptic cleft. Imipramine is a non-selective inhibitor, often used clinically for nocturnal enuresis in children due to its anticholinergic properties. **Analysis of Incorrect Options:** * **Sertraline (A) and Fluoxetine (C):** These belong to the **Selective Serotonin Reuptake Inhibitors (SSRIs)** class. They are currently the first-line treatment for depression and anxiety disorders due to their superior safety profile and lack of significant anticholinergic or cardiotoxic side effects compared to TCAs. * **Bupropion (B):** This is an **Atypical Antidepressant** that acts as a Norepinephrine-Dopamine Reuptake Inhibitor (NDRI). It is notably used for smoking cessation and has a lower risk of causing sexual dysfunction or weight gain. **High-Yield NEET-PG Pearls:** * **Mechanism of TCA Toxicity:** TCAs block sodium channels in the heart, leading to QRS prolongation and arrhythmias. The "3 Cs" of TCA overdose are **C**oma, **C**onvulsions, and **C**ardiotoxicity. * **Antidote:** Sodium bicarbonate is used to treat TCA-induced cardiotoxicity. * **Secondary Amines vs. Tertiary Amines:** Imipramine and Amitriptyline are tertiary amines (more sedative), while Desipramine and Nortriptyline are secondary amines (more potent for NE reuptake).

Question 141: Which of the following drugs, when given along with serotonergic drugs, can lead to serotonin syndrome?

A. Buspirone
B. Fluoxetine (Correct Answer)
C. Penfluridol
D. Clozapine

Explanation: **Explanation:** **Serotonin Syndrome** is a potentially life-threatening condition caused by excessive serotonergic activity in the central and peripheral nervous systems [1]. It typically occurs when two or more drugs that increase serotonin levels are administered concurrently. **Why Fluoxetine is Correct:** **Fluoxetine** is a Selective Serotonin Reuptake Inhibitor (SSRI). It works by inhibiting the serotonin transporter (SERT), preventing the reuptake of serotonin into the presynaptic neuron [1]. When combined with other serotonergic agents (like MAO inhibitors, SNRIs, or Tramadol), it leads to a synergistic increase in synaptic serotonin, precipitating serotonin syndrome [1]. Fluoxetine is particularly high-risk due to its **long half-life** and active metabolite (norfluoxetine), which can persist in the body for weeks [2]. **Why Other Options are Incorrect:** * **Buspirone:** While it is a partial agonist at 5-HT1A receptors used for generalized anxiety, it has a much lower risk of inducing serotonin syndrome compared to SSRIs. * **Penfluridol:** This is a long-acting **typical antipsychotic** (diphenylbutylpiperidine class) that primarily blocks Dopamine D2 receptors. It does not significantly increase serotonin levels. * **Clozapine:** An **atypical antipsychotic** that actually acts as an antagonist at several serotonin receptors (especially 5-HT2A). It is more commonly associated with Neuroleptic Malignant Syndrome (NMS) or agranulocytosis rather than serotonin syndrome. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Triad:** Cognitive effects (confusion, agitation), Autonomic hyperactivity (hyperthermia, tachycardia, diaphoresis), and Somatic effects (myoclonus, hyperreflexia) [1]. * **Key Differentiator:** Hyperreflexia and **clonus** are characteristic of Serotonin Syndrome, whereas "lead-pipe" rigidity is characteristic of NMS. * **Management:** Discontinue offending agents, supportive care (cooling), and the specific antidote **Cyproheptadine** (5-HT2 receptor antagonist).

Question 142: Which drug is most useful in treating an episode of antipsychotic-induced acute dystonia?

A. Haloperidol
B. Promethazine (Correct Answer)
C. Phenobarbitone
D. Lorazepam

Explanation: **Explanation:** **Mechanism and Correct Answer:** Acute dystonia is an Extrapyramidal Side Effect (EPS) caused by a blockade of dopamine (D2) receptors in the nigrostriatal pathway, leading to a relative **excess of cholinergic activity**. To restore the neurochemical balance, drugs with potent **central anticholinergic properties** are required. **Promethazine (Option B)** is a first-generation antihistamine with significant anticholinergic activity, making it highly effective for reversing acute dystonic reactions (such as torticollis, grimacing, or oculogyric crisis). Other parenteral options frequently used include Benztropine or Trihexyphenidyl. **Analysis of Incorrect Options:** * **A. Haloperidol:** This is a high-potency typical antipsychotic and a potent D2 blocker. It is a common *cause* of acute dystonia; administering it would worsen the condition. * **C. Phenobarbitone:** This is a barbiturate used for seizures or sedation. It has no anticholinergic activity and does not address the underlying dopamine-acetylcholine imbalance. * **D. Lorazepam:** While benzodiazepines can provide sedation and mild muscle relaxation, they are not the primary treatment of choice for dystonia. They are generally reserved for Akathisia or as adjunctive therapy if anticholinergics are insufficient. **NEET-PG High-Yield Pearls:** * **Acute Dystonia:** The earliest EPS to appear (within hours to days). * **Drug of Choice (DOC):** Central anticholinergics (Promethazine, Benztropine). * **Akathisia:** Most common EPS; DOC is **Propranolol**. * **Drug-Induced Parkinsonism:** DOC is **Trihexyphenidyl** (Centrally acting anticholinergic). * **Tardive Dyskinesia:** Occurs after long-term use; characterized by "fly-catcher tongue." Treatment involves switching to Clozapine or using VMAT-2 inhibitors (Valbenazine).

Question 143: Which of the following is NOT an atypical antipsychotic?

A. Olanzapine
B. Clozapine
C. Risperidone
D. Thioridazine (Correct Answer)

Explanation: ### Explanation The classification of antipsychotics is a high-yield topic for NEET-PG. Antipsychotics are divided into two main categories: **Typical (First Generation)** and **Atypical (Second Generation)** [3]. **Why Thioridazine is the Correct Answer:** **Thioridazine** is a **Typical Antipsychotic** belonging to the Phenothiazine class (specifically the piperidine subgroup) [2]. Unlike atypical agents, typical antipsychotics primarily act by potent blockade of **D2 receptors** in the mesolimbic and nigrostriatal pathways. They are associated with a higher incidence of Extrapyramidal Side Effects (EPS). **Analysis of Incorrect Options (Atypical Antipsychotics):** Atypical antipsychotics are characterized by a higher **5-HT2A to D2 receptor blockade ratio**, lower risk of EPS, and efficacy against both positive and negative symptoms of schizophrenia [3]. * **A. Olanzapine:** A common atypical agent associated with significant weight gain and metabolic syndrome [1], [3]. * **B. Clozapine:** The "prototype" atypical antipsychotic. It is the drug of choice for **treatment-resistant schizophrenia** [2] but requires monitoring for agranulocytosis [3]. * **C. Risperidone:** An atypical agent known for causing significant elevation in serum prolactin levels [3]. **High-Yield Clinical Pearls for NEET-PG:** 1. **Thioridazine Unique Side Effects:** It is notorious for causing **Retinitis Pigmentosa** (if doses exceed 800mg/day) and **QT interval prolongation** (cardiotoxicity) [2]. 2. **Mnemonic for Atypicals:** "It’s **Quiet** (**Quetiapine**) for **Only** (**Olanzapine**) **Clumsy** (**Clozapine**) **Risper**ing (**Risperidone**) **Zombies** (**Ziprasidone**)." 3. **Aripiprazole:** Often called a "Third Generation" antipsychotic because it acts as a **D2 partial agonist** [3].

Question 144: Which of the following antidepressants causes paresthesia due to pyridoxine deficiency?

A. tranylcypromine (Correct Answer)
B. amitriptyline
C. duloxetine
D. milnacipran

Explanation: ### Explanation **Correct Option: A. Tranylcypromine** Tranylcypromine is a non-selective, irreversible **Monoamine Oxidase Inhibitor (MAOI)**. Certain MAOIs, particularly those belonging to the hydrazine group (like phenelzine) and occasionally non-hydrazines like tranylcypromine, can interfere with pyridoxine (Vitamin B6) metabolism. These drugs can bind to and inhibit **pyridoxine kinase**, the enzyme responsible for converting pyridoxine into its active form, pyridoxal-5-phosphate (PLP). A deficiency in PLP impairs the synthesis of neurotransmitters (like GABA) and leads to axonal degeneration, manifesting clinically as **peripheral neuropathy and paresthesia**. This is similar to the mechanism seen with Isoniazid (INH) in tuberculosis treatment. **Incorrect Options:** * **B. Amitriptyline:** A Tricyclic Antidepressant (TCA). Its primary side effects are anticholinergic (dry mouth, constipation), antihistaminic (sedation), and alpha-blocking (orthostatic hypotension). It does not affect pyridoxine levels. * **C. Duloxetine & D. Milnacipran:** These are Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs). They are actually used to *treat* neuropathic pain (especially Duloxetine for diabetic neuropathy) rather than causing it. Common side effects include nausea, hypertension, and insomnia. **High-Yield Clinical Pearls for NEET-PG:** * **MAOI + Tyramine (Cheese Reaction):** Leads to hypertensive crisis due to displacement of norepinephrine. * **MAOI + SSRI:** Risk of **Serotonin Syndrome** (hyperthermia, muscle rigidity, cardiovascular collapse). * **Drug of Choice for Atypical Depression:** MAOIs are often considered highly effective for atypical depression (characterized by mood reactivity and hyperphagia). * **Management:** Paresthesia caused by MAOIs can be reversed or prevented by supplemental **Pyridoxine (10-50 mg/day)**.

Question 145: Which of the following antidepressants is a selective serotonin reuptake inhibitor (SSRI)?

A. Fluoxetine (Correct Answer)
B. Imipramine
C. Desipramine
D. Amitriptyline

Explanation: **Explanation:** The correct answer is **Fluoxetine**. Selective Serotonin Reuptake Inhibitors (SSRIs) are the first-line treatment for depression due to their favorable side-effect profile compared to older antidepressants. **1. Why Fluoxetine is correct:** Fluoxetine is a prototype **SSRI**. It works by selectively inhibiting the presynaptic reuptake transporter for serotonin (5-HT), thereby increasing the concentration of serotonin in the synaptic cleft. It is unique for its exceptionally long half-life (due to its active metabolite, norfluoxetine), which reduces withdrawal symptoms if a dose is missed. **2. Why the other options are incorrect:** * **Imipramine, Desipramine, and Amitriptyline** all belong to the **Tricyclic Antidepressant (TCA)** class. * **Amitriptyline and Imipramine** are non-selective, inhibiting the reuptake of both Serotonin (5-HT) and Norepinephrine (NE). They also block muscarinic, histaminergic, and alpha-adrenergic receptors, leading to significant side effects (dry mouth, sedation, orthostatic hypotension). * **Desipramine** is a secondary amine TCA that is relatively selective for **Norepinephrine** reuptake inhibition rather than serotonin. **High-Yield Clinical Pearls for NEET-PG:** * **SSRI Mnemonic:** "Effective For Compulsions, Panic, & Depression" (**E**scitalopram, **F**luoxetine/Fluvoxamine, **C**italopram, **P**aroxetine, **S**ertraline). * **Drug of Choice:** SSRIs are the DOC for Depression, OCD, Panic Disorder, Social Phobia, and PTSD. * **Side Effects:** Sexual dysfunction is the most common long-term side effect of SSRIs. * **Safety:** Unlike TCAs, SSRIs have a low risk of cardiotoxicity in overdose (TCAs cause QRS prolongation).

Question 146: What is the drug of choice for antipsychotic-induced Parkinsonism?

A. Pimavanserin
B. Trihexyphenidyl (Correct Answer)
C. Droxidopa
D. Pramipexole

Explanation: **Explanation:** **Mechanism and Correct Answer:** Antipsychotic-induced Parkinsonism is a type of **Extrapyramidal Side Effect (EPS)** caused by the blockade of dopamine (D2) receptors in the nigrostriatal pathway. This blockade creates a relative **excess of cholinergic activity** (acetylcholine). To restore the balance between dopamine and acetylcholine, **centrally acting anticholinergics** are used. **Trihexyphenidyl (Benzhexol)** is the drug of choice because it effectively crosses the blood-brain barrier to antagonize muscarinic receptors, thereby alleviating tremors, rigidity, and bradykinesia. Other drugs in this class include Benztropine and Biperiden. **Analysis of Incorrect Options:** * **Pimavanserin:** This is a selective 5-HT2A inverse agonist. It is specifically used for **Parkinson’s disease psychosis** (hallucinations in patients who already have PD), not for treating drug-induced EPS. * **Droxidopa:** A synthetic precursor of norepinephrine used primarily for treating **neurogenic orthostatic hypotension**. * **Pramipexole:** A dopamine agonist used in idiopathic Parkinson’s disease and Restless Leg Syndrome. It is generally avoided in antipsychotic-induced Parkinsonism because it can worsen the underlying psychosis by stimulating dopamine receptors. **High-Yield NEET-PG Pearls:** * **Drug of Choice for Acute Dystonia:** Parenteral Promethazine or Benztropine. * **Drug of Choice for Akathisia:** Propranolol (Beta-blocker). * **Drug of Choice for Tardive Dyskinesia:** Valbenazine or Deutetrabenazine (VMAT-2 inhibitors). * **Note:** Levodopa is **contraindicated** in drug-induced Parkinsonism as it can precipitate or worsen psychosis.

Question 147: All actions of chlorpromazine are based on its antidopaminergic property EXCEPT:

A. Antipsychotic
B. Hyperprolactinemic
C. Antiemetic
D. Hypotensive (Correct Answer)

Explanation: **Explanation:** Chlorpromazine (CPZ) is a prototype low-potency typical antipsychotic that acts primarily by blocking dopamine ($D_2$) receptors. However, it is a "dirty drug," meaning it also possesses significant antagonistic activity at $\alpha$-adrenergic, histaminergic ($H_1$), and muscarinic ($M$) receptors. 1. **Why Hypotension is the Correct Answer:** The hypotensive effect of chlorpromazine is **not** due to dopamine blockade. Instead, it is primarily caused by the **blockade of $\alpha_1$-adrenergic receptors**, leading to peripheral vasodilation. This often manifests clinically as orthostatic (postural) hypotension. 2. **Analysis of Incorrect Options (Dopamine-mediated actions):** * **Antipsychotic:** This effect is due to the blockade of $D_2$ receptors in the **mesolimbic and mesocortical pathways**. * **Hyperprolactinemic:** Dopamine normally inhibits prolactin release via the tuberoinfundibular pathway. CPZ blocks $D_2$ receptors here, leading to increased prolactin levels (causing side effects like galactorrhea and gynecomastia). * **Antiemetic:** CPZ exerts its antiemetic effect by blocking $D_2$ receptors in the **Chemoreceptor Trigger Zone (CTZ)** of the medulla. **High-Yield Clinical Pearls for NEET-PG:** * **Potency vs. Side Effects:** Low-potency antipsychotics like Chlorpromazine have high $\alpha_1$ and $M_1$ antagonism (more sedation and hypotension) but lower Extrapyramidal Side Effects (EPS) compared to high-potency drugs like Haloperidol. * **Other Non-Dopaminergic Effects:** CPZ also causes sedation ($H_1$ blockade) and dry mouth/constipation ($M$ blockade). * **Specific Use:** Chlorpromazine is a drug of choice for **intractable hiccups**.

Question 148: Which of the following drugs has anxiolytic action with the least sedation?

A. Buspirone (Correct Answer)
B. Triazolam
C. Alprazolam
D. Chlordiazepoxide

Explanation: **Explanation:** **Buspirone** is the correct answer because it is a non-benzodiazepine anxiolytic that belongs to the **Azapirone** class. Unlike benzodiazepines, it acts as a **selective 5-HT1A partial agonist**. Its unique pharmacological profile allows it to relieve anxiety without causing significant sedation, hypnosis, muscle relaxation, or anticonvulsant effects. It also lacks the potential for abuse or withdrawal symptoms, making it ideal for chronic generalized anxiety disorder (GAD). **Why the other options are incorrect:** * **Triazolam (Option B):** A short-acting benzodiazepine primarily used as a hypnotic. It causes significant sedation and has a high risk of rebound insomnia. * **Alprazolam (Option C):** A potent benzodiazepine used for panic disorders and anxiety. While effective, it causes dose-dependent sedation, psychomotor impairment, and carries a risk of dependence. * **Chlordiazepoxide (Option D):** A long-acting benzodiazepine commonly used for alcohol withdrawal. It produces active metabolites that cause prolonged sedation and "hangover" effects. **High-Yield Clinical Pearls for NEET-PG:** * **Latency of Action:** Buspirone has a slow onset of action (takes **1–2 weeks** to show effects). It is NOT useful for acute anxiety or panic attacks. * **No Interaction with Alcohol:** Unlike benzodiazepines, buspirone does not potentiate the CNS depressant effects of alcohol. * **Driving Safety:** Because it lacks sedative and psychomotor-impairing properties, it is the preferred anxiolytic for patients who need to drive or operate machinery. * **Side Effects:** Most common side effects include dizziness, nausea, and headache. It does not cause weight gain or sexual dysfunction (unlike SSRIs).

Question 149: True about anticonvulsants in pregnancy?

A. Carbamazepine is safe in pregnancy.
B. Lamotrigine is safe in pregnancy.
C. Monotherapy is generally recommended. (Correct Answer)
D. Newer anticonvulsant drugs are always safe in pregnancy.

Explanation: The management of epilepsy during pregnancy requires a delicate balance between controlling maternal seizures and minimizing teratogenic risks to the fetus [1]. **Why Option C is Correct:** **Monotherapy** (using a single drug at the lowest effective dose) is the gold standard in pregnancy [1]. The risk of congenital malformations increases significantly with **polytherapy** due to drug-drug interactions and cumulative toxicity. Most malformations are dose-dependent; hence, maintaining the patient on one drug reduces the overall teratogenic burden. **Analysis of Incorrect Options:** * **Option A:** Carbamazepine is **not "safe."** It is associated with a 2-3% risk of neural tube defects (spina bifida) and craniofacial abnormalities. While less teratogenic than Valproate, it still carries significant risk. * **Option B:** No anticonvulsant is strictly "safe." However, **Lamotrigine** and **Levetiracetam** are considered the *preferred* or *least teratogenic* options. Even so, "safe" is an absolute term that does not apply to AEDs in pregnancy. * **Option D:** Newer drugs are not "always safe." While drugs like Levetiracetam have better safety profiles, others like **Topiramate** are associated with an increased risk of oral clefts (cleft lip/palate). **High-Yield NEET-PG Pearls:** 1. **Most Teratogenic:** **Valproate** (causes Neural Tube Defects; highest risk among all AEDs). It should be avoided in women of childbearing age unless no alternative exists. 2. **Drug of Choice:** If a woman is already seizure-free on a specific drug, it is usually continued (except Valproate) because switching drugs during pregnancy can trigger breakthrough seizures. 3. **Prophylaxis:** All pregnant women on AEDs should take **High-dose Folic Acid (5 mg/day)** starting pre-conceptionally to reduce the risk of neural tube defects. 4. **Vitamin K:** Enzyme-inducing AEDs (Phenytoin, Carbamazepine) can cause neonatal hemorrhage; Vitamin K is often given to the mother in the last month of pregnancy [1].

Question 150: Which of the following is a new drug approved for the treatment of tardive dyskinesia?

A. Safinamide
B. Tetrabenazine
C. Valbenazine (Correct Answer)
D. Deutetrabenazine

Explanation: **Explanation:** **Valbenazine** is a highly selective **Vesicular Monoamine Transporter 2 (VMAT2) inhibitor**. It was the first drug specifically approved by the FDA (2017) for the treatment of **Tardive Dyskinesia (TD)**. TD is a movement disorder caused by long-term use of dopamine receptor blockers (antipsychotics), characterized by dopamine supersensitivity. By inhibiting VMAT2, Valbenazine prevents the packaging of dopamine into presynaptic vesicles, thereby reducing dopamine release into the synaptic cleft and alleviating hyperkinetic movements. **Analysis of Options:** * **Safinamide (A):** This is a reversible MAO-B inhibitor used as an add-on treatment for Parkinson’s disease to manage "off" episodes. It has no role in treating TD. * **Tetrabenazine (B):** While also a VMAT2 inhibitor, it is primarily used for Huntington’s Chorea. It is rarely used for TD due to its short half-life (requiring frequent dosing) and significant side effects like depression and parkinsonism. * **Deutetrabenazine (D):** This is a deuterated form of tetrabenazine. While it *is* approved for TD, **Valbenazine** is often highlighted in exams as the "first" and "novel" selective agent specifically designed for this indication with a superior pharmacokinetic profile (once-daily dosing). **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** VMAT2 inhibitors deplete monoamines (Dopamine > Serotonin/NE) from the nerve terminal. * **Drug of Choice:** Valbenazine and Deutetrabenazine are now preferred over older treatments like Vitamin E or Benzodiazepines for TD. * **Side Effects:** The most common side effect of Valbenazine is **somnolence** and **QT prolongation**. * **Contraindication:** Avoid VMAT2 inhibitors in patients with a history of untreated or severe depression/suicidality.

Question 151: Which of the following antipsychotic medications is associated with the least extrapyramidal side effects?

A. Haloperidol
B. Thioridazine
C. Clozapine (Correct Answer)
D. Chlorpromazine

Explanation: **Explanation:** The correct answer is **Clozapine**. The occurrence of extrapyramidal side effects (EPS) is directly related to the degree of dopamine $D_2$ receptor blockade in the nigrostriatal pathway. **Why Clozapine is correct:** Clozapine is the prototype **atypical (second-generation) antipsychotic**. It has a unique receptor binding profile characterized by a **low affinity for $D_2$ receptors** and a high affinity for $5-HT_{2A}$ receptors. Because it dissociates rapidly from $D_2$ receptors and primarily targets the mesolimbic rather than the nigrostriatal pathway, it carries the **lowest risk of EPS** among all antipsychotics. It is often described as having "near-zero" risk of tardive dyskinesia. **Why the other options are incorrect:** * **Haloperidol:** A high-potency typical antipsychotic with very strong $D_2$ antagonism. It has the **highest risk** of acute dystonia and parkinsonian symptoms among the options. * **Chlorpromazine:** A low-potency typical antipsychotic. While it causes fewer EPS than haloperidol due to its inherent anticholinergic properties, the risk is still significantly higher than with clozapine. * **Thioridazine:** Another low-potency typical antipsychotic. It has strong intrinsic anticholinergic activity which mitigates some EPS, but it remains a first-generation drug with a higher EPS profile than atypical agents. **High-Yield NEET-PG Pearls:** 1. **Clozapine** is the drug of choice for **treatment-resistant schizophrenia**. 2. **Major Side Effect:** Agranulocytosis (requires mandatory absolute neutrophil count monitoring). 3. **Other Side Effects:** Sialorrhea (drooling), myocarditis, and lowering of the seizure threshold. 4. **Quetiapine** is another atypical antipsychotic with a very low risk of EPS, often preferred in patients with Parkinson’s disease who develop psychosis.

Question 152: Methadone is used for opioid withdrawal because it functions as:

A. An antagonist at the opioid receptor
B. A partial antagonist at the opioid receptor
C. An agonist at the opioid receptor (Correct Answer)
D. A partial agonist at the opioid receptor

Explanation: **Explanation:** **1. Why Option C is Correct:** Methadone is a **long-acting synthetic μ (mu) opioid receptor agonist**. In the management of opioid use disorder, it is used for "Opioid Substitution Therapy" (OST). Because it is a full agonist with a long half-life (24–36 hours), it achieves two main goals: * **Prevents Withdrawal:** It stimulates the receptors enough to prevent the physical symptoms of withdrawal. * **Suppresses Craving:** It maintains a steady state in the blood, preventing the "rush" associated with heroin while blocking the cravings. **2. Why Other Options are Incorrect:** * **Option A (Antagonist):** Drugs like **Naloxone** and **Naltrexone** are antagonists. They block the receptor completely. Giving an antagonist to a dependent patient would precipitate immediate, severe withdrawal. * **Option B (Partial Antagonist):** This is not a standard pharmacological classification for opioid therapy. * **Option D (Partial Agonist):** **Buprenorphine** is the classic example of a partial μ-agonist. While it is also used for withdrawal, Methadone is distinct because it is a full agonist. **3. NEET-PG High-Yield Clinical Pearls:** * **NMDA Antagonism:** Apart from being a μ-agonist, Methadone also acts as an **NMDA receptor antagonist**, which may help in treating neuropathic pain and preventing opioid tolerance. * **Side Effect:** A critical "must-know" side effect of Methadone is **QT interval prolongation**, which can lead to Torsades de Pointes. * **Metabolism:** It is primarily metabolized by **CYP3A4**; therefore, inhibitors of this enzyme can lead to methadone toxicity. * **Gold Standard:** Methadone remains the gold standard for opioid maintenance therapy during **pregnancy**.

Question 153: Which of the following is NOT a side effect of tricyclic antidepressants?

A. Weight loss (Correct Answer)
B. Weight gain
C. Giddiness
D. Sedation

Explanation: **Explanation:** Tricyclic Antidepressants (TCAs), such as Amitriptyline and Imipramine, are known for their broad pharmacological profile, acting on multiple receptors including muscarinic (M1), histaminergic (H1), and alpha-adrenergic (α1) receptors. **Why Weight Loss is the Correct Answer:** TCAs are notorious for causing **Weight Gain**, not weight loss. This occurs primarily due to the potent blockade of **H1 (Histamine)** receptors, which increases appetite and cravings for carbohydrates. Therefore, weight loss is not a side effect of TCAs; in fact, it is more commonly associated with certain SSRIs (like Fluoxetine) or Bupropion. **Analysis of Incorrect Options:** * **Weight Gain:** As mentioned, H1 receptor antagonism leads to significant weight gain, making it a common reason for patient non-compliance. * **Giddiness:** This is a result of **Orthostatic Hypotension** caused by the blockade of **alpha-1 (α1) adrenergic receptors**. Patients often experience dizziness or giddiness when standing up suddenly. * **Sedation:** This is another direct consequence of **H1 receptor blockade**. TCAs like Amitriptyline are highly sedative and are often administered at bedtime to aid sleep. **NEET-PG High-Yield Pearls:** 1. **Anticholinergic Side Effects:** TCAs cause the "3 Ds": Dry mouth, Dilated pupils (blurred vision), and Difficulty in micturition (due to M1 blockade). 2. **Cardiotoxicity:** The most dangerous side effect in overdose is cardiac arrhythmia due to **Sodium (Na+) channel blockade**, leading to QRS prolongation. 3. **Treatment of Overdose:** Sodium bicarbonate is the specific antidote used to manage TCA-induced arrhythmias. 4. **Drug of Choice:** Imipramine is the DOC for Nocturnal Enuresis in children (though non-pharmacological methods are preferred first).

Question 154: MAO inhibitors are contraindicated in all the following conditions EXCEPT:

A. With tricyclic antidepressants
B. With indirectly acting sympathomimetics
C. Cheese
D. Aspirin (Correct Answer)

Explanation: Monoamine Oxidase Inhibitors (MAOIs) are potent antidepressants that prevent the breakdown of biogenic amines (Norepinephrine, Serotonin, and Dopamine). Their contraindications are primarily based on preventing life-threatening hypertensive crises or serotonin syndrome. **Why Aspirin is the Correct Answer:** Aspirin (Acetylsalicylic acid) is a Non-Steroidal Anti-Inflammatory Drug (NSAID) that inhibits cyclooxygenase. It does not interfere with the metabolic pathways of monoamines or the mechanism of MAOIs. Therefore, there is no clinically significant interaction between Aspirin and MAOIs, making it safe to use concurrently. **Why other options are contraindicated:** * **Tricyclic Antidepressants (TCAs):** Combining MAOIs with TCAs (especially Clomipramine or Imipramine) can lead to **Serotonin Syndrome** or severe CNS toxicity (hyperpyrexia, convulsions) due to the massive accumulation of serotonin and norepinephrine. * **Indirectly acting sympathomimetics:** Drugs like Tyramine, Ephedrine, or Amphetamines displace stored norepinephrine from nerve endings. Since MAOIs prevent the degradation of this released norepinephrine, it leads to a massive sympathetic surge, resulting in a **Hypertensive Crisis** [1]. * **Cheese:** Aged cheese is rich in **Tyramine**. Normally, Tyramine is metabolized by MAO-A in the gut. In patients taking MAOIs, Tyramine reaches the systemic circulation, causing the "Cheese Reaction"—a severe hypertensive crisis characterized by headache, palpitations, and potential intracranial hemorrhage [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Washout Period:** When switching from an MAOI to an SSRI (or vice versa), a washout period of **at least 14 days** (5 weeks for Fluoxetine) is mandatory to prevent Serotonin Syndrome. * **Pethidine Interaction:** MAOIs are strictly contraindicated with Pethidine as it can trigger excitatory reactions (hyperpyrexia, tremors, coma). * **Moclobemide:** A Reversible Inhibitor of MAO-A (RIMA) which has a much lower risk of the "Cheese Reaction" [2].

Question 155: Which of the following antipsychotic medications has akathisia as a common side effect?

A. Fluoxetine
B. Olanzapine
C. Haloperidol (Correct Answer)
D. Risperidone

Explanation: **Explanation:** **Correct Answer: C. Haloperidol** **Mechanism and Concept:** Akathisia is a common **Extrapyramidal Side Effect (EPS)** characterized by subjective feelings of inner restlessness and an inability to sit still. It is primarily caused by the potent blockade of **D2 receptors** in the nigrostriatal pathway. **Haloperidol** is a high-potency, first-generation (typical) antipsychotic. Because it binds very strongly and non-selectively to D2 receptors, it has the highest propensity among the given options to cause EPS, including akathisia, dystonia, and parkinsonism. **Analysis of Incorrect Options:** * **A. Fluoxetine:** This is an SSRI (Selective Serotonin Reuptake Inhibitor) used for depression. While SSRIs can occasionally cause "jitteriness" or "activation syndrome" early in treatment, they are not classified as antipsychotics and are not the classic cause of D2-mediated akathisia. * **B. Olanzapine:** This is a second-generation (atypical) antipsychotic. It has a higher affinity for 5-HT2A receptors than D2 receptors and dissociates rapidly from D2 receptors, leading to a significantly lower risk of akathisia compared to Haloperidol. * **D. Risperidone:** While Risperidone is an atypical antipsychotic that can cause EPS at higher doses (>6mg), its risk profile for akathisia is generally lower than that of high-potency typicals like Haloperidol. **High-Yield Clinical Pearls for NEET-PG:** * **Treatment of Akathisia:** The drug of choice is **Propranolol** (Beta-blocker). Benzodiazepines or anticholinergics (like Benztropine) are second-line options. * **Potency Rule:** High-potency typical antipsychotics (Haloperidol, Fluphenazine) = High EPS risk, Low sedative/anticholinergic risk. * **Aripiprazole Note:** Among atypical antipsychotics, Aripiprazole is uniquely associated with a relatively higher incidence of akathisia due to its partial D2 agonism.

Question 156: Which anxiolytic benzodiazepine also possesses antidepressant properties?

A. Alprazolam (Correct Answer)
B. Oxazepam
C. Lorazepam
D. Chlordiazepoxide

Explanation: **Explanation:** **Alprazolam** is a unique triazolo-benzodiazepine. While all benzodiazepines (BZDs) share common properties (anxiolytic, sedative-hypnotic, muscle relaxant, and anticonvulsant), Alprazolam is the only one in this list that possesses significant **antidepressant properties**. This is attributed to its ability to modulate central monoaminergic systems and its high potency at the GABA-A receptor complex. It is specifically indicated for anxiety associated with depression and is highly effective in treating **Panic Disorder**. **Analysis of Incorrect Options:** * **Oxazepam:** A short-to-intermediate acting BZD. It is a direct metabolite of Diazepam and is preferred in patients with liver failure (as it undergoes direct glucuronidation), but it lacks antidepressant efficacy. * **Lorazepam:** A high-potency BZD used primarily for status epilepticus, acute anxiety, and pre-anesthetic medication. It does not have inherent antidepressant activity. * **Chlordiazepoxide:** The first BZD discovered. It has a long half-life and active metabolites. Its primary clinical use today is in the management of **Alcohol Withdrawal Syndrome**. **High-Yield Clinical Pearls for NEET-PG:** * **DOC for Panic Disorder:** Alprazolam (along with SSRIs for long-term management). * **BZD for Liver Failure:** Remember the mnemonic **LOT** (Lorazepam, Oxazepam, Temazepam) as they do not require hepatic oxidation. * **Antidote:** Flumazenil is a competitive BZD receptor antagonist used for overdose. * **Mechanism:** BZDs increase the **frequency** of chloride channel opening (GABA-facilitatory), whereas Barbiturates increase the **duration**.

Question 157: What is the new drug approved for the treatment of tardive dyskinesia?

A. Safinamide
B. Tetrabenazine
C. Valbenazine (Correct Answer)
D. Deutetrabenazine

Explanation: **Explanation:** **Valbenazine** is the first drug specifically FDA-approved for the treatment of **Tardive Dyskinesia (TD)**. TD is a movement disorder caused by long-term use of dopamine receptor blockers (antipsychotics), characterized by upregulation of dopamine receptors. Valbenazine acts as a highly selective **Vesicular Monoamine Transporter 2 (VMAT2) inhibitor**. By inhibiting VMAT2, it prevents the packaging of dopamine into presynaptic vesicles, thereby reducing dopamine release into the synaptic cleft and alleviating the hyperkinetic movements of TD. **Analysis of Options:** * **Safinamide (Option A):** This is a reversible MAO-B inhibitor used as an add-on treatment for Parkinson’s disease to manage "off" episodes. It has no role in treating TD. * **Tetrabenazine (Option B):** While it is a VMAT2 inhibitor used for Huntington’s Chorea, it is not specifically preferred for TD due to its short half-life and significant side effects like depression and parkinsonism. * **Deutetrabenazine (Option D):** This is a deuterated form of tetrabenazine. While it is also approved for TD, **Valbenazine** is often highlighted in exams as the "first" or "novel" specific agent with a superior pharmacokinetic profile (once-daily dosing and less risk of depression). **High-Yield Clinical Pearls for NEET-PG:** 1. **VMAT2 Inhibitors:** Valbenazine and Deutetrabenazine are the current drugs of choice for TD. 2. **Mechanism:** They decrease dopamine levels without blocking the D2 receptor directly, avoiding the worsening of TD. 3. **Historical Context:** Previously, Vitamin E and Benzodiazepines were used, but they lacked robust efficacy. 4. **Pro-tip:** If a patient develops TD, the first step is to taper/stop the offending antipsychotic or switch to **Clozapine** (the antipsychotic with the lowest risk of TD).

Question 158: Which of the following is not a selective serotonin reuptake inhibitor?

A. Fluoxetine
B. Fluvoxamine
C. Paroxetine
D. Amoxapine (Correct Answer)

Explanation: ### Explanation The correct answer is **D. Amoxapine**. **1. Why Amoxapine is the correct answer:** Amoxapine is a **Tricyclic Antidepressant (TCA)** belonging to the dibenzoxazepine class. Unlike Selective Serotonin Reuptake Inhibitors (SSRIs), its primary mechanism involves inhibiting the reuptake of norepinephrine and, to a lesser extent, serotonin. Crucially, it is a metabolite of the antipsychotic loxapine and possesses significant **Dopamine (D2) receptor blocking activity**, giving it unique antipsychotic properties among antidepressants. **2. Why the other options are incorrect:** * **A. Fluoxetine:** The prototype SSRI with the longest half-life (due to its active metabolite norfluoxetine) [2]. It is commonly used for depression and OCD [3]. * **B. Fluvoxamine:** An SSRI primarily indicated for Obsessive-Compulsive Disorder (OCD) and social anxiety disorder [3]. * **C. Paroxetine:** A potent SSRI known for having the shortest half-life among the group and a higher risk of discontinuation syndrome [2]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Amoxapine Side Effects:** Due to D2 blockade, it can cause **Extrapyramidal Symptoms (EPS)** and hyperprolactinemia, unlike other antidepressants. * **SSRI Drug of Choice:** SSRIs are currently the first-line treatment for Depression, OCD, Panic Disorder, Social Phobia, and Post-Traumatic Stress Disorder (PTSD). * **Serotonin Syndrome:** A critical complication when SSRIs are combined with MAO inhibitors; characterized by cognitive effects, autonomic hyperactivity, and somatic effects (hyperreflexia/clonus) [2]. * **Mnemonic for SSRIs:** **F**lashbacks **P**aralyze **S**enior **C**itizens (**F**luoxetine, **F**luvoxamine, **P**aroxetine, **S**ertraline, **C**italopram/Escitalopram) [1].

Question 159: Which of the following is a non-selective serotonin and noradrenaline reuptake inhibitor?

A. Sertraline
B. Citalopram
C. Venlafaxine (Correct Answer)
D. Paroxetine

Explanation: The question tests the classification of antidepressant drugs based on their mechanism of action. **Correct Option: C. Venlafaxine** Venlafaxine belongs to the class of **Serotonin and Noradrenaline Reuptake Inhibitors (SNRIs)** [1]. These drugs are "non-selective" because they inhibit the reuptake of both serotonin (5-HT) and noradrenaline (NE) by binding to their respective transporters (SERT and NET) [1]. This dual action increases the synaptic concentration of both neurotransmitters. Other drugs in this class include Duloxetine, Milnacipran, and Desvenlafaxine [1, 2]. **Incorrect Options:** * **A, B, and D (Sertraline, Citalopram, Paroxetine):** These drugs belong to the **Selective Serotonin Reuptake Inhibitors (SSRIs)** class [1]. As the name suggests, they selectively inhibit the reuptake of serotonin (5-HT) with minimal to no effect on noradrenaline or dopamine reuptake [1]. SSRIs are currently the first-line treatment for most anxiety and depressive disorders due to their better safety profile. **High-Yield Clinical Pearls for NEET-PG:** * **Dose-Dependent Action:** At low doses, Venlafaxine acts primarily as an SSRI; its noradrenergic effect becomes significant only at higher doses (>150 mg/day) [2]. * **Side Effects:** Due to its noradrenergic activity, Venlafaxine can cause a **dose-dependent increase in blood pressure** (diastolic hypertension). * **Duloxetine:** Another SNRI frequently asked about; it is the drug of choice for **diabetic neuropathy** and fibromyalgia. * **Discontinuation Syndrome:** Venlafaxine has a short half-life, making it more likely to cause severe withdrawal symptoms if stopped abruptly compared to SSRIs like Fluoxetine.

Question 160: Which of the following drugs is used in the treatment of Obsessive Compulsive Disorder (OCD)?

A. Clomipramine (Correct Answer)
B. Lithium
C. Olanzepine
D. None of the above

Explanation: **Explanation:** **Obsessive-Compulsive Disorder (OCD)** is primarily managed by enhancing serotonergic neurotransmission [1]. The first-line pharmacological treatment includes **Selective Serotonin Reuptake Inhibitors (SSRIs)** (e.g., Fluoxetine, Fluvoxamine, Sertraline) [1]. However, among the Tricyclic Antidepressants (TCAs), **Clomipramine** is the gold standard and the only TCA specifically indicated for OCD [2]. * **Clomipramine (Option A):** It is a tertiary amine TCA that acts as a potent and selective inhibitor of serotonin reuptake (SRI) [2]. Its efficacy in OCD is superior to other TCAs (like Imipramine or Amitriptyline) because those primarily affect norepinephrine rather than serotonin [2]. * **Lithium (Option B):** This is a mood stabilizer used as the drug of choice for **Bipolar Affective Disorder (BPAD)** and prophylaxis of manic-depressive illness. It has no primary role in treating OCD. * **Olanzapine (Option C):** This is an atypical antipsychotic used for **Schizophrenia** and Acute Mania. While atypical antipsychotics are sometimes used as "augmentation therapy" in treatment-resistant OCD, they are not the primary treatment. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC) for OCD:** SSRIs (due to a better safety profile) [1]. * **Most effective drug for OCD:** Clomipramine (often reserved for refractory cases due to side effects) [2]. * **OCD Dosing:** Treatment of OCD usually requires **higher doses** of SSRIs/Clomipramine and a **longer duration** (10–12 weeks) to see a clinical response compared to depression. * **Clomipramine Side Effects:** Notable for lowering the seizure threshold and causing significant anticholinergic effects [2].

Question 161: Which of the following is a primary use of 5-HT1 agonists?

A. Anti-anxiety drugs (Correct Answer)
B. Antipsychotic drugs
C. Gastroesophageal reflux disease (GERD)
D. Chemotherapy-induced vomiting

Explanation: **Explanation:** The correct answer is **A. Anti-anxiety drugs.** **Mechanism of Action:** The primary drug in this category is **Buspirone**, which acts as a **selective 5-HT1A partial agonist**. It is used for the treatment of Generalized Anxiety Disorder (GAD). Unlike benzodiazepines, it does not cause sedation, muscle relaxation, or physical dependence, making it an ideal choice for chronic anxiety management. Its effect typically takes 1–2 weeks to manifest. **Analysis of Incorrect Options:** * **B. Antipsychotic drugs:** Conventional antipsychotics primarily block **D2 receptors**. While some atypical antipsychotics (like Clozapine or Risperidone) involve 5-HT2A antagonism, 5-HT1 agonism is not their primary mechanism for treating psychosis. * **C. Gastroesophageal reflux disease (GERD):** Drugs used here include Proton Pump Inhibitors (PPIs) or H2 blockers. Prokinetic agents like Metoclopramide act via **5-HT4 agonism** and D2 antagonism, not 5-HT1. * **D. Chemotherapy-induced vomiting:** This is managed using **5-HT3 antagonists** (e.g., Ondansetron). Blocking 5-HT3 receptors in the Chemoreceptor Trigger Zone (CTZ) and the GI tract prevents the emetic reflex. **High-Yield NEET-PG Pearls:** * **Buspirone (5-HT1A):** "No Sedation, No Addiction, No Interaction with Alcohol." It is the "Safe" anxiolytic for elderly patients or those with a history of substance abuse. * **Sumatriptan (5-HT1B/1D):** Another class of 5-HT1 agonists used specifically for the **acute attack of Migraine** (causes vasoconstriction of cranial vessels). * **Tegaserod/Prucalopride (5-HT4):** Used for chronic constipation/IBS-C. * **Lorcaserin (5-HT2C):** Used as an appetite suppressant for obesity management.

Question 162: Lithium administration during pregnancy is associated with which of the following fetal abnormalities?

A. Ebstein anomaly (Correct Answer)
B. Transposition of great vessels
C. Truncus arteriosus
D. Tetralogy of Fallot

Explanation: **Explanation:** Lithium is a classic teratogen when administered during the first trimester of pregnancy. It is specifically associated with **Ebstein anomaly**, a rare congenital heart defect characterized by the downward displacement of the tricuspid valve leaflets into the right ventricle. This "atrialization" of the right ventricle leads to tricuspid regurgitation and right-sided heart failure. While the absolute risk is relatively low (approx. 1 in 1,000 to 2,000 exposures), it represents a significant increase compared to the general population. **Analysis of Options:** * **Ebstein Anomaly (Correct):** The hallmark cardiovascular malformation linked to Lithium. * **Transposition of Great Vessels (B), Truncus Arteriosus (C), and Tetralogy of Fallot (D):** These are cyanotic congenital heart diseases (Right-to-Left shunts) but are not specifically associated with Lithium use. They are more commonly linked to maternal diabetes or specific genetic syndromes (e.g., DiGeorge syndrome for Truncus Arteriosus). **High-Yield Clinical Pearls for NEET-PG:** * **Monitoring:** Lithium has a narrow therapeutic index (0.6–1.2 mEq/L). Toxicity occurs >1.5 mEq/L. * **Pregnancy Management:** If a bipolar patient is on Lithium, fetal echocardiography is recommended at 18–20 weeks. * **Floppy Baby Syndrome:** Lithium use near term can cause neonatal hypotonia, cyanosis, and lethargy. * **Excretion:** Lithium is excreted in breast milk; hence, breastfeeding is generally discouraged while on this medication. * **Alternative:** Lamotrigine is often considered a safer mood stabilizer during pregnancy.

Question 163: Which of the following drugs does not cause sedation?

A. Buspirone (Correct Answer)
B. Nitrazepam
C. Zopiclone
D. Diazepam

Explanation: **Explanation:** The correct answer is **Buspirone**. **1. Why Buspirone is correct:** Buspirone is a non-benzodiazepine anxiolytic that belongs to the **Azapirone** class. Its primary mechanism of action is as a **selective 5-HT1A partial agonist**. Unlike Benzodiazepines (BZDs), it does not interact with the GABA-A receptor complex. Consequently, it lacks the sedative, hypnotic, anticonvulsant, and muscle relaxant properties associated with BZDs. It is specifically used for Generalized Anxiety Disorder (GAD) where daytime alertness is required. **2. Why the other options are incorrect:** * **Nitrazepam & Diazepam:** These are classic **Benzodiazepines** that act as positive allosteric modulators of the GABA-A receptor. They increase the frequency of chloride channel opening, leading to CNS depression, which manifests as significant sedation and hypnosis. * **Zopiclone:** This is a **"Z-drug"** (non-benzodiazepine hypnotic). Although it is chemically different from BZDs, it acts on the same BZ1 (α1 subunit) site of the GABA-A receptor. It is specifically indicated for the short-term treatment of insomnia because of its potent sedative-hypnotic effects. **3. NEET-PG High-Yield Pearls:** * **Buspirone Lag Time:** Unlike BZDs, Buspirone has a slow onset of action (takes 2–4 weeks for full effect); thus, it is not useful for acute anxiety or panic attacks. * **No Abuse Potential:** Buspirone does not cause physical dependence, withdrawal symptoms, or cognitive impairment, making it "driving-friendly." * **Z-drugs (Zolpidem, Zopiclone, Zaleplon):** These are preferred for insomnia as they do not significantly alter the sleep architecture (minimal effect on REM sleep).

Question 164: Buspirone is a:

A. Antianxiety drug (Correct Answer)
B. Antipsychotic drug
C. Antidepressant drug
D. None of the above

Explanation: **Explanation:** **Buspirone** is a non-benzodiazepine **anxiolytic (antianxiety)** drug. Unlike traditional benzodiazepines, it does not act on the GABA receptor complex. Instead, its primary mechanism of action is as a **selective partial agonist at the 5-HT1A receptors**. **Why Option A is correct:** Buspirone is specifically indicated for the management of **Generalized Anxiety Disorder (GAD)**. It effectively relieves anxiety without causing significant sedation, hypnosis, or muscle relaxation. A key characteristic is its slow onset of action; it typically takes 1–2 weeks to show therapeutic effects, making it unsuitable for acute anxiety or panic attacks. **Why other options are incorrect:** * **Option B (Antipsychotic):** Antipsychotics (e.g., Haloperidol, Risperidone) primarily act by blocking Dopamine (D2) receptors. Buspirone lacks significant D2 receptor antagonism and does not treat psychosis. * **Option C (Antidepressant):** While some antidepressants (like SSRIs) are used to treat anxiety, Buspirone itself is not classified as a primary antidepressant, though it is sometimes used as an "augmentation" agent in treatment-resistant depression. **High-Yield Clinical Pearls for NEET-PG:** 1. **No Abuse Potential:** Unlike benzodiazepines, Buspirone does not cause physical dependence, withdrawal symptoms, or cognitive impairment. 2. **No Interaction with Alcohol:** It does not potentiate the effects of CNS depressants like alcohol. 3. **Side Effects:** Common side effects include dizziness, nausea, and headache. 4. **Metabolism:** It is metabolized by **CYP3A4**; therefore, its levels increase when taken with grapefruit juice or erythromycin.

Question 165: Tardive dyskinesia is produced by which of the following drugs, except?

A. Fluphenazine
B. Haloperidol
C. Chlorpromazine
D. Clozapine (Correct Answer)

Explanation: **Explanation:** **Tardive Dyskinesia (TD)** is a late-onset extrapyramidal side effect (EPS) characterized by involuntary, repetitive movements (e.g., lip-smacking, tongue protrusion). It results from the **upregulation and supersensitivity of Dopamine D2 receptors** in the nigrostriatal pathway following chronic blockade. **Why Clozapine is the correct answer:** Clozapine is an **Atypical (Second-Generation) Antipsychotic**. It has a unique pharmacological profile characterized by: * **Low affinity for D2 receptors:** It dissociates rapidly from D2 receptors ("loose binding"). * **High 5-HT2A antagonism:** This increases dopamine release in the striatum, counteracting excessive D2 blockade. Because it does not cause significant D2 receptor upregulation, Clozapine carries a **negligible risk** of causing Tardive Dyskinesia. In fact, it is the drug of choice for patients who have already developed TD. **Why the other options are incorrect:** * **A, B, and C (Fluphenazine, Haloperidol, Chlorpromazine):** These are **Typical (First-Generation) Antipsychotics**. They act via potent and sustained blockade of D2 receptors. Chronic use of these agents leads to compensatory receptor supersensitivity, making them the primary culprits behind Tardive Dyskinesia. Haloperidol (High potency) carries a higher risk than Chlorpromazine (Low potency). **High-Yield Clinical Pearls for NEET-PG:** 1. **Treatment of TD:** The first step is to stop the offending drug or switch to **Clozapine** or **Quetiapine**. 2. **FDA-approved drugs for TD:** **Valbenazine** and **Deutetrabenazine** (VMAT2 inhibitors). 3. **The "Holiday" Myth:** Drug holidays do not prevent TD; they may actually unmask or worsen the symptoms. 4. **Anticholinergics:** Drugs like Trihexyphenidyl **worsen** Tardive Dyskinesia, unlike other EPS (like Parkinsonism) where they are used for treatment.

Question 166: Which antidepressant is associated with tardive dyskinesia and neuroleptic malignant syndrome?

A. Fluoxetine
B. Amineptin
C. Amoxapine (Correct Answer)
D. Trazodone

Explanation: **Explanation:** **Amoxapine** is a secondary amine tricyclic antidepressant (TCA) that is unique because it is a metabolite of the antipsychotic drug loxapine. Unlike other antidepressants, Amoxapine possesses significant **dopamine D2 receptor blocking activity** in addition to its norepinephrine and serotonin reuptake inhibition. Because it blocks dopamine receptors in the nigrostriatal pathway, it can cause **Extrapyramidal Side Effects (EPS)**, including **Tardive Dyskinesia**. Furthermore, its dopamine-blocking properties in the hypothalamus and basal ganglia make it the only antidepressant significantly associated with **Neuroleptic Malignant Syndrome (NMS)**, a life-threatening reaction characterized by muscle rigidity, fever, and autonomic instability. **Analysis of Incorrect Options:** * **Fluoxetine (Option A):** An SSRI. While it can rarely cause akathisia, it does not have primary D2 blocking activity and is not typically associated with tardive dyskinesia. * **Amineptin (Option B):** A dopamine reuptake inhibitor (DRI). It increases synaptic dopamine levels, which is the functional opposite of the mechanism that causes tardive dyskinesia. * **Trazodone (Option C):** A SARI (Serotonin Antagonist and Reuptake Inhibitor). Its most notorious high-yield side effect is **priapism**, not EPS or NMS. **High-Yield Clinical Pearls for NEET-PG:** * **Amoxapine:** Think "Antidepressant with Antipsychotic-like side effects." * **Maprotiline:** Another tetracyclic often tested; it is associated with a high risk of **seizures**. * **NMS Treatment:** Dantrolene (muscle relaxant) or Bromocriptine (dopamine agonist). * **Tardive Dyskinesia:** Caused by long-term dopamine blockade leading to receptor supersensitivity; it is often irreversible.

Question 167: Fluoxetine is a potent reuptake blocker of which neurotransmitter?

A. Morphine
B. Serotonin (Correct Answer)
C. Norepinephrine
D. Cholecystokinin

Explanation: **Explanation:** **Fluoxetine** is the prototype drug of the **Selective Serotonin Reuptake Inhibitors (SSRIs)** class. Its primary mechanism of action involves the potent and selective inhibition of the serotonin transporter (SERT) at the presynaptic neuronal membrane. By blocking the reuptake of **Serotonin (5-HT)**, it increases the concentration of this neurotransmitter in the synaptic cleft, leading to enhanced serotonergic neurotransmission. This is the fundamental basis for its use in treating depression, OCD, and panic disorders. **Analysis of Incorrect Options:** * **Morphine (A):** This is an exogenous opioid analgesic that acts on mu-opioid receptors; it is not a neurotransmitter subject to reuptake inhibition by antidepressants. * **Norepinephrine (C):** While drugs like SNRIs (e.g., Venlafaxine) or TCAs (e.g., Amitriptyline) block norepinephrine reuptake, SSRIs like Fluoxetine have negligible affinity for the norepinephrine transporter (NET). * **Cholecystokinin (D):** This is a gastrointestinal peptide hormone and neuropeptide; it is not the target of standard antidepressant therapy. **NEET-PG High-Yield Pearls:** * **Longest Half-life:** Fluoxetine has the longest half-life among SSRIs (2–3 days), and its active metabolite, **norfluoxetine**, stays in the body for 7–10 days. * **Washout Period:** Due to its long half-life, a 5-week washout period is required before starting an MAO inhibitor to avoid **Serotonin Syndrome**. * **Drug of Choice:** It is often considered the DOC for **Bulimia nervosa** and is preferred in children/adolescents for depression. * **Side Effects:** Common issues include GI upset, insomnia, and sexual dysfunction (e.g., delayed ejaculation).

Question 168: What is the primary site of action for disulfiram?

A. Aldehyde dehydrogenase (Correct Answer)
B. Alcohol dehydrogenase
C. G6PD
D. Acetate dehydrogenase

Explanation: Disulfiram is an irreversible inhibitor of the enzyme **Aldehyde Dehydrogenase**. In the normal metabolism of ethanol, alcohol is first converted to acetaldehyde by alcohol dehydrogenase. Acetaldehyde is then converted to acetic acid (acetate) by ALDH. By blocking ALDH, disulfiram causes a rapid rise in blood acetaldehyde levels (5–10 times higher than normal). This accumulation leads to the **Disulfiram-Ethanol Reaction (DER)**, characterized by flushing, tachycardia, nausea, vomiting, and hypotension, which serves as an aversion therapy for chronic alcoholism [1]. **2. Why the Other Options are Incorrect:** * **Alcohol Dehydrogenase (ADH):** This enzyme converts ethanol to acetaldehyde. It is inhibited by **Fomepizole**, which is used in the treatment of methanol and ethylene glycol poisoning, not for alcohol aversion therapy. * **G6PD (Glucose-6-Phosphate Dehydrogenase):** This is a metabolic enzyme in the pentose phosphate pathway. Deficiency leads to hemolytic anemia; it has no role in alcohol metabolism. * **Acetate Dehydrogenase:** This is not a primary enzyme in human ethanol metabolism. Acetic acid is typically converted to Acetyl-CoA by Acetyl-CoA synthetase. **3. Clinical Pearls for NEET-PG:** * **Mechanism:** Irreversible inhibition; the effect lasts for 7–14 days until new enzymes are synthesized. * **Contraindications:** Severe heart disease, pregnancy, and psychosis. * **Drug Interactions:** Disulfiram-like reactions can occur with other drugs like **Metronidazole, Cefotetan, Tinidazole, and Sulfonylureas** when taken with alcohol. * **Acamprosate vs. Naltrexone:** While Disulfiram is for aversion, Acamprosate and Naltrexone are used to reduce cravings and maintain abstinence.

Question 169: Which antidepressant drug can cause neuroleptic malignant syndrome and tardive dyskinesia?

A. Amineptin
B. Carbamazepine
C. Amoxapine (Correct Answer)
D. Trazodone

Explanation: ### Explanation **Correct Option: C. Amoxapine** **Mechanism and Rationale:** Amoxapine is a **Tricyclic Antidepressant (TCA)** of the dibenzoxazepine class. Unlike most other TCAs, its major metabolite, **7-hydroxyamoxapine**, possesses significant **Dopamine D2 receptor blocking activity**. This makes its pharmacological profile similar to typical antipsychotics (neuroleptics). Because it blocks dopamine receptors in the nigrostriatal and mesolimbic pathways, it can cause side effects typically associated with antipsychotics, including: 1. **Extrapyramidal Symptoms (EPS):** Such as Akathisia and Parkinsonism. 2. **Tardive Dyskinesia:** Resulting from long-term dopamine receptor supersensitivity. 3. **Neuroleptic Malignant Syndrome (NMS):** A life-threatening reaction characterized by muscle rigidity, fever, and autonomic instability. --- **Analysis of Incorrect Options:** * **A. Amineptine:** An atypical antidepressant that acts as a Dopamine Reuptake Inhibitor (DRI). It increases dopamine levels in the synapse, making it more likely to cause abuse/addiction rather than D2-blockade-related NMS or dyskinesia. * **B. Carbamazepine:** Primarily an anticonvulsant and mood stabilizer. While it can cause Steven-Johnson Syndrome or bone marrow suppression, it does not typically cause tardive dyskinesia. * **D. Trazodone:** A Serotonin Antagonist and Reuptake Inhibitor (SARI). Its most notorious high-yield side effect is **priapism** (due to alpha-1 blockade), not D2-blockade symptoms. --- **High-Yield Clinical Pearls for NEET-PG:** * **Amoxapine** is often considered the "antipsychotic-like" antidepressant. * **Loxapine** (an antipsychotic) is structurally related to Amoxapine. * **NMS Treatment:** Immediate discontinuation of the offending agent, supportive care, and pharmacological intervention with **Dantrolene** (muscle relaxant) or **Bromocriptine** (dopamine agonist). * **Tardive Dyskinesia** is often irreversible; the drug of choice for management is **Valbenazine** or **Deutetrabenazine** (VMAT2 inhibitors).

Question 170: Imipramine belongs to which group of drugs?

A. Antiepileptic
B. Antidepressant (Correct Answer)
C. Anxiolytic
D. Antipsychotic

Explanation: **Explanation:** **Imipramine** is the prototype drug of the **Tricyclic Antidepressants (TCAs)** [1]. It works primarily by inhibiting the neuronal reuptake of norepinephrine (NE) and serotonin (5-HT) from the synaptic cleft, thereby increasing their concentration and alleviating depressive symptoms [2]. **Analysis of Options:** * **B. Antidepressant (Correct):** Imipramine is a dibenzazepine derivative and a first-generation antidepressant [1]. Beyond depression, it is also used in panic disorder and chronic pain syndromes. * **A. Antiepileptic:** Imipramine is not used to treat seizures. In fact, TCAs are known to **lower the seizure threshold**, making them potentially dangerous in patients with epilepsy. * **C. Anxiolytic:** While some antidepressants (like SSRIs) are used for long-term anxiety management, the primary classification of Imipramine is an antidepressant. Classic anxiolytics include Benzodiazepines. * **D. Antipsychotic:** Antipsychotics (e.g., Haloperidol, Clozapine) primarily act by blocking Dopamine (D2) receptors. Imipramine does not possess significant antipsychotic properties. **High-Yield Clinical Pearls for NEET-PG:** 1. **Enuresis:** Imipramine is a specific drug of choice for **Nocturnal Enuresis** in children (due to its anticholinergic effect and ability to alter sleep patterns), though non-pharmacological methods are preferred first-line. 2. **Side Effects (The "3 Cs"):** TCA overdose is characterized by **C**oma, **C**onvulsions, and **C**ardiotoxicity (arrhythmias due to sodium channel blockade). 3. **Anticholinergic Profile:** It causes significant sedation, dry mouth, blurred vision, and urinary retention [2]. 4. **Metabolism:** Imipramine is metabolized into **Desipramine**, which is also a clinically used antidepressant [1, 2].

Question 171: The secretion of which of the following hormones increases with chlorpromazine therapy?

A. Prolactin (Correct Answer)
B. Gonadotropin
C. Corticotropin
D. Antidiuretic hormone

Explanation: **Explanation:** The correct answer is **Prolactin**. **Mechanism of Action:** Chlorpromazine is a typical (first-generation) antipsychotic that acts primarily by blocking **Dopamine (D2) receptors**. In the brain, dopamine is the primary physiological inhibitor of prolactin secretion from the anterior pituitary (acting via the **tuberoinfundibular pathway**). By blocking D2 receptors in this pathway, chlorpromazine removes the "inhibitory brake" on lactotrophs, leading to hyperprolactinemia. **Analysis of Incorrect Options:** * **B. Gonadotropin (FSH/LH):** High prolactin levels exert negative feedback on the hypothalamus, inhibiting the release of Gonadotropin-Releasing Hormone (GnRH). This leads to a **decrease** in FSH and LH, often resulting in amenorrhea or infertility. * **C. Corticotropin (ACTH):** Chlorpromazine generally suppresses the hypothalamic-pituitary-adrenal (HPA) axis, leading to a potential **decrease** in ACTH secretion, rather than an increase. * **D. Antidiuretic hormone (ADH):** While some psychotropic drugs can cause SIADH, chlorpromazine does not typically increase ADH as a primary endocrine side effect. **NEET-PG High-Yield Pearls:** * **Clinical Manifestations:** Hyperprolactinemia presents as galactorrhea, gynecomastia, and sexual dysfunction. * **Pathway Specificity:** Antipsychotic efficacy (positive symptoms) is due to D2 blockade in the **mesolimbic** pathway; extrapyramidal side effects (EPS) are due to blockade in the **nigrostriatal** pathway. * **Exceptions:** **Clozapine** and **Quetiapine** have a lower risk of increasing prolactin compared to typical antipsychotics and Risperidone. * **Growth Hormone:** Chlorpromazine also tends to **decrease** Growth Hormone secretion (dopamine normally stimulates GH in healthy individuals).

Question 172: Newer MAO inhibitors are useful in the treatment of?

A. Mania
B. Schizophrenia
C. Hypertension
D. Depression (Correct Answer)

Explanation: ### **Explanation** **Correct Answer: D. Depression** **Mechanism of Action:** Monoamine Oxidase Inhibitors (MAOIs) work by inhibiting the enzyme responsible for the metabolic breakdown of biogenic amines (Norepinephrine, Serotonin, and Dopamine). By blocking this degradation, MAOIs increase the synaptic concentration of these neurotransmitters. Since the **"Monoamine Hypothesis"** of depression suggests that the condition results from a deficiency of these amines in the brain, MAOIs effectively alleviate depressive symptoms. **Why the other options are incorrect:** * **A. Mania:** Mania is characterized by an *excess* of monoamines. MAOIs would exacerbate this condition. The mainstay of treatment for mania includes mood stabilizers (Lithium) and antipsychotics. * **B. Schizophrenia:** This disorder is primarily linked to overactive dopamine pathways. Increasing dopamine levels via MAOIs could worsen psychotic symptoms. Antipsychotics (D2 receptor antagonists) are the treatment of choice. * **C. Hypertension:** Older, non-selective MAOIs are notorious for causing **Hypertensive Crisis** (the "Cheese Reaction") when taken with tyramine-rich foods. They are never used to treat hypertension. **NEET-PG High-Yield Pearls:** * **Classification:** * *Non-selective (Irreversible):* Phenelzine, Tranylcypromine, Isocarboxazid. * *MAO-A Selective (Reversible):* **Moclobemide** (RIMA - Reversible Inhibitor of MAO-A). These are the "newer" MAOIs that carry a much lower risk of hypertensive crisis. * *MAO-B Selective:* Selegiline, Rasagiline (primarily used in **Parkinson’s Disease**). * **The Cheese Reaction:** Occurs when tyramine (found in aged cheese, wine, beer) displaces stored norepinephrine. Because MAO-A is inhibited, the excess norepinephrine is not degraded, leading to a massive sympathetic surge and stroke risk. * **Drug Interaction:** Never combine MAOIs with SSRIs due to the risk of **Serotonin Syndrome**. A washout period of 2–5 weeks is required when switching between them.

Question 173: After starting a patient on imipramine, their heart rate rises to 120/min and they experience blurred vision. These effects can be explained by the fact that imipramine:

A. Is a muscarinic antagonist (Correct Answer)
B. Potentiates epinephrine
C. Is a ganglionic blocker
D. Is a potent a-adrenergic blocker

Explanation: ### Explanation **Correct Option: A. Is a muscarinic antagonist** Imipramine is a **Tricyclic Antidepressant (TCA)**. While its primary therapeutic mechanism is the inhibition of norepinephrine and serotonin reuptake, it also possesses significant **anticholinergic (antimuscarinic)** properties. * **Tachycardia (120/min):** Results from the blockade of M2 receptors in the heart, leading to the loss of vagal inhibitory tone. * **Blurred Vision:** Results from the blockade of M3 receptors in the ciliary muscle (causing cycloplegia/loss of accommodation) and the sphincter pupillae (causing mydriasis). **Analysis of Incorrect Options:** * **B. Potentiates epinephrine:** While TCAs inhibit the reuptake of norepinephrine (NE), they do not directly potentiate exogenous epinephrine in a way that explains isolated anticholinergic symptoms like blurred vision. * **C. Is a ganglionic blocker:** Ganglionic blockers (like hexamethonium) would cause profound orthostatic hypotension and interfere with both sympathetic and parasympathetic systems, but TCAs do not act at the nicotinic receptors of the autonomic ganglia. * **D. Is a potent α-adrenergic blocker:** Imipramine does have α1-blocking properties, but this typically results in **orthostatic hypotension** and reflex tachycardia, not the specific combination of anticholinergic signs like blurred vision and dry mouth. **High-Yield NEET-PG Pearls:** * **TCA Side Effect Profile:** Remember the mnemonic "3 Cs" for TCA overdose: **C**oma, **C**onvulsions, and **C**ardiotoxicity (Arrhythmias due to Na+ channel blockade). * **Anticholinergic Toxidrome:** "Dry as a bone, red as a beet, hot as a hare, blind as a bat, and mad as a hatter." * **Contraindications:** Due to its muscarinic antagonism, imipramine is contraindicated in patients with **Glaucoma** (can precipitate acute angle closure) and **Benign Prostatic Hyperplasia (BPH)** (can cause urinary retention). * **Specific Use:** Imipramine is a classic drug of choice for **Nocturnal Enuresis** in children due to its anticholinergic effect on the bladder detrusor muscle.

Question 174: Which drug effect mimics schizophrenia?

A. Barbiturates
B. Cocaine
C. Phencyclidine (Correct Answer)
D. Levodopa

Explanation: **Explanation:** The correct answer is **Phencyclidine (PCP)**. **1. Why Phencyclidine is correct:** Phencyclidine (PCP), also known as "angel dust," is a non-competitive antagonist at the **NMDA (N-methyl-D-aspartate) glutamate receptor**. Unlike other psychotomimetic drugs (like LSD), PCP is unique because it mimics **both the positive symptoms** (hallucinations, delusions, thought disorder) and **negative symptoms** (social withdrawal, flattened affect, cognitive impairment) of schizophrenia. This observation led to the "Glutamate Hypothesis" of schizophrenia, suggesting that NMDA receptor hypofunction plays a central role in the pathogenesis of the disorder. **2. Why the other options are incorrect:** * **Barbiturates:** These are CNS depressants that act as GABA-A receptor mimetics. Overdose leads to sedation, respiratory depression, and coma, rather than a schizophrenic-like state. * **Cocaine:** Cocaine increases synaptic dopamine by inhibiting reuptake. While it can induce "Cocaine Psychosis" (characterized by paranoid delusions and tactile hallucinations like formication), it primarily mimics the **positive symptoms** only and lacks the negative/cognitive symptom profile of schizophrenia. * **Levodopa:** A dopamine precursor used in Parkinson’s disease. While it can cause drug-induced psychosis (visual hallucinations) due to increased dopamine in the mesolimbic pathway, it does not replicate the full clinical spectrum of schizophrenia as closely as PCP. **3. NEET-PG High-Yield Pearls:** * **Ketamine:** Like PCP, it is an NMDA antagonist and can also induce dissociative anesthesia and schizophrenic-like symptoms. * **Dopamine Hypothesis:** Traditional antipsychotics work by blocking D2 receptors, primarily targeting positive symptoms. * **Glutamate Hypothesis:** Explains why NMDA antagonists (PCP/Ketamine) produce a more "complete" model of schizophrenia than dopaminergic agents.

Question 175: What is true regarding bupropion?

A. It is a dopamine reuptake inhibitor. (Correct Answer)
B. It is an antianxiety drug.
C. It does not precipitate seizures.
D. It is a nicotinic receptor antagonist.

Explanation: **Explanation:** **Bupropion** is an atypical antidepressant primarily classified as a **Norepinephrine-Dopamine Reuptake Inhibitor (NDRI)**. It works by inhibiting the neuronal reuptake of dopamine and norepinephrine, thereby increasing their synaptic concentrations. This unique mechanism makes it the correct choice (Option A). **Analysis of Incorrect Options:** * **Option B:** Bupropion is primarily an antidepressant and an aid for smoking cessation. Unlike SSRIs or Benzodiazepines, it is not used as an antianxiety drug; in fact, it may worsen anxiety or agitation in some patients due to its stimulant-like effects. * **Option C:** This is a critical false statement. Bupropion is notorious for **lowering the seizure threshold**. It is contraindicated in patients with seizure disorders, head trauma, or eating disorders (bulimia/anorexia) due to the high risk of precipitates seizures. * **Option D:** While Bupropion does have some non-competitive antagonistic activity at nicotinic acetylcholine receptors (which contributes to its use in smoking cessation), its primary pharmacological classification and most significant action is as a reuptake inhibitor. In the context of standard medical examinations, its NDRI activity is the defining feature. **High-Yield Clinical Pearls for NEET-PG:** 1. **Weight Neutrality:** Unlike most antidepressants, Bupropion does not cause weight gain; it may cause weight loss. 2. **Sexual Dysfunction:** It is the preferred antidepressant for patients experiencing sexual side effects from SSRIs, as it has **no significant sexual side effects**. 3. **Smoking Cessation:** It is FDA-approved for smoking cessation (marketed as Zyban). 4. **Contraindication:** Always remember the "Seizure Rule"—avoid in epilepsy and eating disorders.

Question 176: What is the drug of choice in phenothiazine-induced dystonia?

A. Diphenhydramine
B. Metoclopramide
C. Trifluperamide
D. Benztropine (Correct Answer)

Explanation: **Explanation:** Phenothiazines (like Chlorpromazine) are typical antipsychotics that block dopamine ($D_2$) receptors in the nigrostriatal pathway. This creates a chemical imbalance where **cholinergic (acetylcholine) activity becomes relatively overactive** compared to dopamine, leading to Extrapyramidal Side Effects (EPS), such as acute dystonia. **1. Why Benztropine is Correct:** To treat acute dystonia, the goal is to restore the dopamine-acetylcholine balance. **Benztropine** is a potent **centrally-acting anticholinergic** drug. By blocking muscarinic receptors in the basal ganglia, it rapidly suppresses the cholinergic overactivity, providing quick relief from muscle spasms. It is considered the gold standard for drug-induced EPS. **2. Analysis of Incorrect Options:** * **Diphenhydramine:** While this is an antihistamine with significant anticholinergic properties and *can* be used as an alternative, Benztropine is more specific and preferred in clinical guidelines for dystonia. * **Metoclopramide:** This is a $D_2$ receptor antagonist used as an antiemetic. It actually **causes** dystonia rather than treating it. * **Trifluperamide:** This is an antipsychotic itself. Adding more antipsychotics would worsen the dopamine blockade and exacerbate the dystonia. **High-Yield Clinical Pearls for NEET-PG:** * **Acute Dystonia:** Usually occurs within hours to days of starting antipsychotics (e.g., torticollis, grimacing). * **Drug of Choice (DOC):** Central anticholinergics like **Benztropine** or **Trihexyphenidyl (PACANE)**. * **Route:** For acute crises, parenteral (IV/IM) administration is preferred for rapid onset. * **Prophylaxis:** If a patient is prone to EPS, oral anticholinergics are often co-prescribed with high-potency neuroleptics.

Question 177: Which of the following is true about mianserin?

A. It is a type of NaSSA. (Correct Answer)
B. It is a type of SSRI.
C. It is a type of SARI.
D. It is a type of SNRI.

Explanation: **Explanation:** **Mianserin** is a tetracyclic antidepressant that belongs to the **NaSSA (Noradrenergic and Specific Serotonergic Antidepressant)** class. Its primary mechanism of action involves blocking **presynaptic $\alpha_2$-autoreceptors**, which leads to an increased release of norepinephrine. It also antagonizes 5-HT$_2$ and 5-HT$_3$ receptors, thereby directing serotonin to the 5-HT$_1$ receptor (hence "specific serotonergic"). **Analysis of Options:** * **Option A (Correct):** Mianserin, along with its newer analogue **Mirtazapine**, are the prototypical NaSSAs. They enhance neurotransmission without inhibiting reuptake. * **Option B (Incorrect):** SSRIs (e.g., Fluoxetine, Sertraline) work by inhibiting the serotonin transporter (SERT). Mianserin does not significantly inhibit serotonin reuptake. * **Option C (Incorrect):** SARIs (Serotonin Antagonist and Reuptake Inhibitors) include drugs like **Trazodone** and Nefazodone. While Mianserin antagonizes 5-HT receptors, it lacks the reuptake inhibition characteristic of this class. * **Option D (Incorrect):** SNRIs (e.g., Venlafaxine, Duloxetine) inhibit the reuptake of both serotonin and norepinephrine. **High-Yield Clinical Pearls for NEET-PG:** * **Side Effects:** Unlike Mirtazapine, Mianserin is associated with a risk of **agranulocytosis** and **aplastic anemia**, necessitating regular blood counts in some protocols. * **Sedation:** It has potent H$_1$-receptor blocking activity, making it highly sedative (useful for depressed patients with insomnia). * **Safety:** It lacks the significant anticholinergic and cardiotoxic side effects typical of Tricyclic Antidepressants (TCAs), making it safer in overdose. * **Mnemonic:** Remember **"M&M"** (Mianserin and Mirtazapine) for **NaSSA**.

Question 178: Lithium is used in the prophylaxis of which of the following conditions?

A. Recurrent phobia
B. Alcohol dependence
C. Paranoid schizophrenia
D. Recurrent manic depressive attacks (Correct Answer)

Explanation: **Explanation:** **1. Why Option D is Correct:** Lithium is the **gold standard mood stabilizer** and the drug of choice for the prophylaxis of **Bipolar Affective Disorder (BPAD)**, historically known as manic-depressive illness. It is uniquely effective in preventing both manic and depressive relapses. Its mechanism involves inhibiting the **Inositol Monophosphatase (IMPase)** pathway (the "Inositol Depletion Hypothesis") and modulating G-proteins and protein kinase C, which stabilizes neuronal overactivity. **2. Why Other Options are Incorrect:** * **A. Recurrent Phobia:** Phobias are anxiety disorders primarily treated with Cognitive Behavioral Therapy (CBT), SSRIs, or Benzodiazepines (for acute symptoms). Lithium has no role in treating phobias. * **B. Alcohol Dependence:** Management involves detoxification (Benzodiazepines) and relapse prevention (Naltrexone, Acamprosate, or Disulfiram). Lithium is not used unless the patient has a comorbid bipolar disorder. * **C. Paranoid Schizophrenia:** This requires antipsychotics (e.g., Risperidone, Olanzapine) to block dopamine D2 receptors. Lithium is not an antipsychotic and does not treat primary delusions or hallucinations. **3. High-Yield Clinical Pearls for NEET-PG:** * **Therapeutic Index:** Lithium has a very **narrow therapeutic index**. * Prophylaxis range: **0.6 – 0.8 mEq/L**. * Acute Mania range: **0.8 – 1.2 mEq/L**. * Toxicity: >1.5 mEq/L. * **Side Effects (LITHIUM Mnemonic):** **L**eukocytosis, **I**nsipidus (Nephrogenic Diabetes Insipidus), **T**remors (Fine)/ **T**eratogenicity (Ebstein’s Anomaly), **H**ypothyroidism, **I**ncreased **U**rine, **M**others (avoid in pregnancy). * **Drug Interactions:** Thiazides, NSAIDs, and ACE inhibitors increase Lithium levels (decreased clearance), leading to toxicity.

Question 179: Which of the following is a use of NDRI?

A. Hypoactive sexual desire
B. Smoking cessation
C. ADHD
D. All of the above (Correct Answer)

Explanation: The correct answer is **D. All of the above**. **Mechanism of Action:** NDRIs (**Norepinephrine-Dopamine Reuptake Inhibitors**), primarily represented by **Bupropion**, work by inhibiting the neuronal reuptake of dopamine and norepinephrine [1], [2]. Unlike SSRIs, they have no significant effect on serotonin, which accounts for their unique clinical profile and lack of sexual side effects. **Breakdown of Uses:** 1. **Hypoactive Sexual Desire Disorder (HSDD):** Bupropion is frequently used off-label (and as a component in newer formulations) to treat HSDD. Because it increases dopamine levels in the reward pathway and lacks serotonergic activity (which usually inhibits sexual desire), it can actually improve libido and arousal. 2. **Smoking Cessation:** Bupropion is an FDA-approved non-nicotine aid for smoking cessation [1]. It mimics the effect of nicotine by increasing dopamine in the nucleus accumbens, thereby reducing withdrawal symptoms and the "craving" associated with quitting [1]. 3. **ADHD:** By increasing norepinephrine and dopamine in the prefrontal cortex, NDRIs help improve focus and impulse control. Bupropion is considered a second-line, non-stimulant treatment for ADHD, especially in adults or patients with comorbid depression. **Clinical Pearls for NEET-PG:** * **Seizure Risk:** The most significant side effect of Bupropion is a dose-dependent increase in seizure risk. It is strictly **contraindicated** in patients with epilepsy, eating disorders (bulimia/anorexia), or those undergoing alcohol withdrawal [1]. * **Weight Neutrality:** Unlike many antidepressants, Bupropion is associated with weight loss rather than weight gain [1]. * **The "Happy-Horny-Skinny" Pill:** A common mnemonic to remember that Bupropion treats depression without causing sexual dysfunction or weight gain.

Question 180: Maximum hypotension is caused by which of the following drugs?

A. Fluphenazine
B. Haloperidol
C. Thioridazine (Correct Answer)
D. Clozapine

Explanation: ### Explanation The degree of hypotension caused by antipsychotic drugs is primarily determined by their potency in blocking **alpha-1 ($\alpha_1$) adrenergic receptors**. **1. Why Thioridazine is correct:** Thioridazine is a **low-potency** typical antipsychotic. Low-potency agents (like Thioridazine and Chlorpromazine) require higher dosages to achieve therapeutic effects, which leads to significant "off-target" binding. These drugs have a high affinity for $\alpha_1$-adrenergic, histaminergic ($H_1$), and muscarinic ($M_1$) receptors. Blockade of $\alpha_1$ receptors in the peripheral vasculature leads to vasodilation, resulting in significant **orthostatic (postural) hypotension**. **2. Why the other options are incorrect:** * **Fluphenazine & Haloperidol:** These are **high-potency** typical antipsychotics. They have a very high affinity for $D_2$ receptors but a relatively low affinity for $\alpha_1$ receptors. Consequently, they are more likely to cause Extrapyramidal Side Effects (EPS) but are less likely to cause significant hypotension. * **Clozapine:** While Clozapine (an atypical antipsychotic) does cause significant orthostatic hypotension, **Thioridazine** is classically cited in pharmacological literature as having the highest propensity for hypotension among the traditional antipsychotics due to its potent $\alpha$-blocking profile. **3. High-Yield Clinical Pearls for NEET-PG:** * **Thioridazine Warning:** It is notorious for causing **QT interval prolongation** (Torsades de Pointes) and **retinitis pigmentosa** (at doses >800 mg/day). * **Potency Rule:** * *Low Potency (e.g., Chlorpromazine, Thioridazine):* High Sedation, High Hypotension, Low EPS. * *High Potency (e.g., Haloperidol, Fluphenazine):* Low Sedation, Low Hypotension, High EPS. * **Mnemonic:** "Cheaper" (Chlorpromazine) and "Thicker" (Thioridazine) drugs are low potency and cause more "autonomic" side effects (hypotension).

Question 181: All of the following are typical autonomic side effects of antipsychotic drugs EXCEPT:

A. Constipation
B. Dry mouth and throat
C. Postural hypotension (Correct Answer)
D. Urinary retention

Explanation: ### Explanation The question asks to identify the side effect that is **not** a typical autonomic side effect of antipsychotic drugs among the choices provided. **1. Why "Postural Hypotension" is the Correct Answer (Concept):** While antipsychotics do cause postural hypotension, the question is a classic "except" style question focusing on the **mechanism of action**. Antipsychotics block several receptors: Muscarinic (M1), Alpha-1 adrenergic ($\alpha_1$), and Histamine (H1). * **Constipation, Dry mouth, and Urinary retention** are all **Anticholinergic (Antimuscarinic)** side effects. * **Postural hypotension** is an **Antiadrenergic ($\alpha_1$ blockade)** side effect. In many pharmacological classifications, "autonomic side effects" is often used as a synonym for "anticholinergic side effects" in the context of typical antipsychotics (like Chlorpromazine). However, more accurately, postural hypotension is caused by peripheral vasodilation (alpha-blockade), whereas the others are results of parasympathetic inhibition. **2. Analysis of Incorrect Options:** * **A, B, and D (Constipation, Dry mouth, Urinary retention):** These are classic manifestations of **Muscarinic (M1) receptor blockade**. They occur because antipsychotics (especially low-potency ones like Chlorpromazine and Thioridazine) inhibit the parasympathetic nervous system. Other effects include blurred vision (cycloplegia) and tachycardia. **3. NEET-PG High-Yield Clinical Pearls:** * **Low Potency vs. High Potency:** Low-potency antipsychotics (Chlorpromazine, Thioridazine) have **higher** autonomic (anticholinergic/alpha-blocking) side effects but **lower** Extrapyramidal Symptoms (EPS). * **High Potency:** Drugs like Haloperidol have **lower** autonomic side effects but **higher** risk of EPS. * **Thioridazine Warning:** It is the antipsychotic most associated with QTc prolongation and retinal pigmentation. * **Clozapine:** The most anticholinergic atypical antipsychotic; paradoxically, it often causes **sialorrhea** (excessive salivation) instead of dry mouth.

Question 182: Which antidepressant drug can be safely used in children?

A. Imipramine
B. Fluoxetine (Correct Answer)
C. Dothiepin
D. Risperidone

Explanation: **Explanation:** **Fluoxetine** is the correct answer because it is the only antidepressant consistently approved by major regulatory bodies (like the US-FDA) for the treatment of Major Depressive Disorder (MDD) in children and adolescents (ages 8 and older). **Why Fluoxetine?** Fluoxetine is a Selective Serotonin Reuptake Inhibitor (SSRI). It is preferred in the pediatric population due to its long half-life (reducing withdrawal symptoms if a dose is missed) and a superior safety profile compared to older antidepressants. While SSRIs carry a "black box warning" regarding increased suicidal ideation in young patients, Fluoxetine remains the first-line pharmacological choice when therapy is indicated. **Analysis of Incorrect Options:** * **A. Imipramine:** This is a Tricyclic Antidepressant (TCA). While it is used for nocturnal enuresis in children, it is **not** recommended for pediatric depression due to significant cardiotoxicity and lack of proven efficacy in this age group. * **C. Dothiepin (Dosulepin):** Another TCA with a high risk of toxicity in overdose and significant sedative/anticholinergic side effects, making it unsuitable for children. * **D. Risperidone:** This is an **atypical antipsychotic**, not an antidepressant. While used in children for irritability associated with autism or conduct disorders, it is not a primary treatment for depression. **High-Yield NEET-PG Pearls:** * **First-line for Pediatric MDD:** Fluoxetine. * **Second-line for Pediatric MDD:** Sertraline or Escitalopram (often used off-label or for OCD). * **OCD in Children:** Fluvoxamine and Sertraline are also FDA-approved. * **Black Box Warning:** All antidepressants carry a warning for increased risk of suicidal thoughts/behavior in patients under 24 years of age.

Question 183: Which of the following drugs is NOT used for anxiety?

A. Propranolol
B. Alprazolam
C. Buspirone
D. Haloperidol (Correct Answer)

Explanation: **Explanation:** The correct answer is **Haloperidol**. Haloperidol is a high-potency **typical antipsychotic** that acts primarily by blocking dopamine D2 receptors in the mesolimbic pathway. It is indicated for schizophrenia, acute psychosis, and Tourette syndrome, but it has no inherent anxiolytic properties. In fact, it can cause akathisia (motor restlessness), which may be mistaken for or worsen agitation. **Analysis of other options:** * **Propranolol (Option A):** A non-selective beta-blocker used to treat the **peripheral autonomic symptoms** of anxiety (tachycardia, tremors, sweating). It is specifically high-yield for **performance anxiety** (stage fright). * **Alprazolam (Option B):** A Benzodiazepine (BZD) that enhances GABAergic inhibition. It is a first-line agent for the acute management of **Panic Disorder** and Generalized Anxiety Disorder (GAD) due to its rapid onset. * **Buspirone (Option C):** A selective **5-HT1A partial agonist**. It is used for chronic GAD. Unlike BZDs, it lacks sedative, hypnotic, or muscle relaxant properties and has no abuse potential, though it takes 2-4 weeks to show effects. **NEET-PG High-Yield Pearls:** 1. **Drug of choice (DOC) for GAD:** SSRIs (e.g., Escitalopram) are preferred for long-term management; BZDs are used for short-term relief. 2. **Buspirone vs. BZDs:** Buspirone does not cause "rebound anxiety" upon discontinuation and does not potentiate the effects of alcohol. 3. **Performance Anxiety:** Propranolol should be taken 30-60 minutes before the event. 4. **Haloperidol Side Effects:** Watch for Extrapyramidal Symptoms (EPS) like acute dystonia and Neuroleptic Malignant Syndrome (NMS).

Question 184: Which of the following drugs is a Selective Serotonin Reuptake Inhibitor (SSRI)?

A. Citalopram
B. Fluoxetine
C. Sertraline
D. All of the above (Correct Answer)

Explanation: **Explanation:** Selective Serotonin Reuptake Inhibitors (SSRIs) are the first-line pharmacotherapy for various psychiatric conditions, including Major Depressive Disorder, Panic Disorder, and OCD. Their primary mechanism of action involves the potent inhibition of the presynaptic serotonin transporter (SERT), leading to increased serotonin levels in the synaptic cleft. **Analysis of Options:** * **Fluoxetine:** The first SSRI to be marketed. It has the longest half-life (due to its active metabolite, norfluoxetine), making it the drug of choice for patients with poor compliance as it carries a lower risk of discontinuation syndrome. * **Sertraline:** A widely used SSRI known for its safety profile in patients with cardiovascular disease (post-MI). It is also frequently used for Premenstrual Dysphoric Disorder (PMDD). * **Citalopram:** An SSRI known for its high selectivity. Its S-enantiomer, **Escitalopram**, is considered the most potent and selective SSRI available. Since all three drugs belong to the SSRI class, the correct answer is **D. All of the above.** **NEET-PG High-Yield Pearls:** 1. **Side Effects:** The most common side effects include GI upset (nausea/diarrhea), sexual dysfunction (delayed ejaculation), and sleep disturbances. 2. **Serotonin Syndrome:** A life-threatening condition (hyperthermia, muscle rigidity, myoclonus) that can occur if SSRIs are combined with MAO inhibitors. A washout period of 2–5 weeks is required when switching between them. 3. **Drug of Choice (DOC):** SSRIs are the DOC for OCD, Social Phobia, and PTSD. 4. **Fluvoxamine** and **Paroxetine** are other important members of this class.

Question 185: Which of the following is NOT a clinical indication for tricyclic antidepressants?

A. Enuresis in elderly patients
B. Neuropathic pain
C. Panic disorder
D. Uncontrolled seizures (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. Uncontrolled seizures**. **1. Why "Uncontrolled Seizures" is the correct answer:** Tricyclic Antidepressants (TCAs), such as Amitriptyline and Imipramine, are known to **lower the seizure threshold**. They interfere with GABAergic transmission and alter ion channel activity in the CNS. In patients with pre-existing epilepsy or uncontrolled seizures, TCAs can precipitate status epilepticus or increase the frequency of fits. Therefore, uncontrolled seizures are a major **contraindication**, not an indication, for TCA use. **2. Analysis of Incorrect Options:** * **A. Enuresis in elderly patients:** While more commonly used for nocturnal enuresis in children (Imipramine), TCAs have strong anticholinergic properties that increase bladder neck resistance and decrease detrusor contraction, making them a clinical option for certain types of urinary incontinence. * **B. Neuropathic pain:** This is a high-yield "off-label" use. TCAs (especially Amitriptyline) are first-line agents for neuropathic pain (e.g., Diabetic Neuropathy, Post-herpetic neuralgia) because they enhance descending inhibitory pain pathways by blocking the reuptake of Serotonin and Norepinephrine. * **C. Panic disorder:** TCAs like Imipramine and Clomipramine are effective in treating panic disorder and various phobias, though SSRIs are now preferred due to a better side-effect profile. **3. NEET-PG High-Yield Pearls:** * **Mechanism of Action:** Block reuptake of NE and 5-HT. * **The "3 Cs" of Toxicity:** Coma, Convulsions, and Cardiotoxicity (Arrhythmias due to Na+ channel blockade). * **Antidote for Cardiotoxicity:** Sodium Bicarbonate (to overcome Na+ channel blockade). * **Specific Drug:** Clomipramine is the most selective for 5-HT reuptake and is a gold standard for Obsessive-Compulsive Disorder (OCD).

Question 186: Which of the following drugs is NOT associated with malignant neuroleptic syndrome?

A. Haloperidol
B. Metoclopramide
C. Domperidone
D. Amantadine (Correct Answer)

Explanation: ### Explanation **Neuroleptic Malignant Syndrome (NMS)** is a life-threatening idiosyncratic reaction characterized by the "FEVER" mnemonic: **F**ever, **E**ncephalopathy (altered mental status), **V**itals instability, **E**levated enzymes (CK), and **R**igidity ("lead-pipe"). #### Why Amantadine is the Correct Answer The underlying pathophysiology of NMS is a **profound deficiency of dopamine** in the central nervous system. * **Amantadine** is a dopaminergic agent (it increases dopamine release and inhibits reuptake). Therefore, it does **not** cause NMS. * **Crucial Concept:** While Amantadine doesn't cause NMS, the **abrupt withdrawal** of Amantadine (or Levodopa) in Parkinson’s patients can trigger a "Neuroleptic Malignant-like Syndrome" because it causes a sudden drop in dopamine levels. #### Why the Other Options are Incorrect NMS is primarily caused by **D2 receptor antagonism**. * **Haloperidol (Option A):** A high-potency typical antipsychotic and the most common culprit associated with NMS. * **Metoclopramide (Option B):** Though used as an antiemetic/prokinetic, it is a central D2 antagonist and is a well-documented cause of NMS. * **Domperidone (Option C):** While it primarily acts peripherally, it can cross the blood-brain barrier in small amounts (especially at high doses or in vulnerable patients), and cases of NMS have been reported. #### NEET-PG High-Yield Pearls 1. **Drug of Choice for NMS:** **Dantrolene** (a muscle relaxant that inhibits calcium release from the sarcoplasmic reticulum) or **Bromocriptine** (a D2 agonist). 2. **Distinction:** Unlike Serotonin Syndrome (which presents with hyperreflexia and myoclonus), NMS is characterized by **"Lead-pipe" rigidity** and bradyreflexia. 3. **Risk Factors:** Rapid dose escalation of antipsychotics, use of depot preparations, and dehydration.

Question 187: A person taking tricyclic antidepressants presents with blurred vision and dry mouth. These adverse effects result due to blockade of which receptors?

A. M3 muscarinic receptors (Correct Answer)
B. GABAA receptors
C. H1 histamine receptors
D. 5HT2 receptors

Explanation: **Explanation:** Tricyclic Antidepressants (TCAs), such as Amitriptyline and Imipramine, are known for their "dirty drug" profile, meaning they interact with multiple receptor systems beyond serotonin and norepinephrine reuptake inhibition. **1. Why Option A is Correct:** The symptoms of **blurred vision** (due to cycloplegia/mydriasis) and **dry mouth** (xerostomia) are classic **anticholinergic side effects**. TCAs act as competitive antagonists at muscarinic receptors. Specifically, the **M3 muscarinic receptors** are located on exocrine glands (salivary) and the ciliary/sphincter pupillae muscles of the eye. Blockade of these receptors inhibits parasympathetic signaling, leading to decreased secretions and loss of accommodation. **2. Why the Other Options are Incorrect:** * **Option B (GABA$_A$ receptors):** TCAs do not typically block GABA receptors. In overdose, TCAs actually inhibit GABAergic transmission (specifically at the chloride channel), which contributes to seizures, but this is not responsible for dry mouth or blurred vision. * **Option C (H$_1$ receptors):** Blockade of H$_1$ histamine receptors by TCAs results in **sedation** and **weight gain**, not anticholinergic symptoms. * **Option D (5HT$_2$ receptors):** While some TCAs have affinity for serotonin receptors, blockade here is often associated with antidepressant/anxiolytic effects or changes in sleep architecture, not autonomic side effects like dry mouth. **High-Yield Clinical Pearls for NEET-PG:** * **The "3 Cs" of TCA Toxicity:** Coma, Convulsions, and Cardiotoxicity (Arrhythmias due to Na+ channel blockade). * **Contraindication:** Due to their M3 blocking effects, TCAs are contraindicated in patients with **Narrow-Angle Glaucoma** and **Benign Prostatic Hyperplasia (BPH)**. * **Antidote:** Sodium bicarbonate is used to manage the cardiotoxicity (QRS widening) seen in TCA overdose.

Question 188: Which among the following are antipsychotics?

A. Resperidone
B. Lurasidone
C. Asenapine
D. All of the above (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. All of the above**. All three drugs listed belong to the class of **Atypical Antipsychotics** (Second-Generation Antipsychotics or SGAs). Unlike typical antipsychotics (e.g., Haloperidol), which primarily block Dopamine D2 receptors, atypical antipsychotics work by blocking both **D2 receptors and Serotonin (5-HT2A) receptors**. This dual mechanism helps in treating both the positive symptoms (hallucinations, delusions) and negative symptoms (social withdrawal, apathy) of schizophrenia while significantly reducing the risk of Extrapyramidal Side Effects (EPS). * **Risperidone:** A potent D2 and 5-HT2A antagonist. It is widely used but has a higher tendency to cause **hyperprolactinemia** compared to other atypicals. * **Lurasidone:** A newer SGA with high affinity for 5-HT7 receptors. It is notably used for **Bipolar Depression** and has a favorable metabolic profile (minimal weight gain). * **Asenapine:** Unique for its **sublingual administration** (due to high first-pass metabolism). It is used for schizophrenia and acute mania. **Clinical Pearls for NEET-PG:** 1. **Clozapine** is the "Gold Standard" for treatment-resistant schizophrenia but requires monitoring for **agranulocytosis**. 2. **Olanzapine** and **Clozapine** carry the highest risk of metabolic syndrome (weight gain, dyslipidemia, diabetes). 3. **Ziprasidone** is most notorious for **QT interval prolongation**. 4. **Aripiprazole** is a **partial D2 agonist**, often referred to as a "dopamine stabilizer."

Question 189: Escitalopram is a:

A. Selective serotonin reuptake inhibitor. (Correct Answer)
B. Nonspecific norepinephrine uptake inhibitor.
C. Atypical antidepressant.
D. MAO inhibitor.

Explanation: **Explanation:** **Escitalopram** is the S-enantiomer of citalopram and is classified as a **Selective Serotonin Reuptake Inhibitor (SSRI)**. It works by specifically inhibiting the serotonin transporter (SERT) at the presynaptic terminal, thereby increasing the concentration of serotonin (5-HT) in the synaptic cleft. It is considered the most "selective" of all SSRIs, with minimal effect on norepinephrine or dopamine reuptake. **Analysis of Options:** * **Option A (Correct):** Escitalopram belongs to the SSRI class (alongside Fluoxetine, Sertraline, Paroxetine, and Fluvoxamine). It is the first-line treatment for Major Depressive Disorder and Generalized Anxiety Disorder due to its high efficacy and favorable side-effect profile. * **Option B (Incorrect):** Nonspecific norepinephrine uptake inhibitors include Tricyclic Antidepressants (TCAs) like Amitriptyline or SNRIs like Venlafaxine (which affects both 5-HT and NE). * **Option C (Incorrect):** Atypical antidepressants include drugs with unique mechanisms, such as Bupropion (NDRI), Mirtazapine (α2-antagonist), or Trazodone (SARI). * **Option D (Incorrect):** MAO inhibitors (e.g., Phenelzine, Selegiline, Moclobemide) inhibit the enzyme monoamine oxidase rather than blocking reuptake transporters. **NEET-PG High-Yield Pearls:** * **Selectivity:** Escitalopram is the most potent and selective SSRI. * **Side Effects:** Common side effects include GI upset and sexual dysfunction (delayed ejaculation). It has a lower risk of drug-drug interactions compared to Fluoxetine. * **Drug of Choice:** SSRIs are the first-line treatment for Depression, OCD, Panic Disorder, Social Phobia, and PTSD. * **Safety:** They are preferred over TCAs because they lack anticholinergic side effects and are safer in overdose (low cardiotoxicity).

Question 190: Concomitant use of valproic acid and lamotrigine increases the risk of which of the following conditions?

A. Chondrodysplasia punctata
B. Paroxysmal Nocturnal hemoglobinuria
C. Stevens-Johnson syndrome (Correct Answer)
D. Floppy infant syndrome

Explanation: **Explanation:** The correct answer is **Stevens-Johnson syndrome (SJS)**. **Mechanism of Interaction:** Lamotrigine is primarily metabolized by the enzyme **UDP-glucuronosyltransferase (UGT)**. Valproic acid is a potent inhibitor of this enzyme. When used concomitantly, valproic acid inhibits the metabolism of lamotrigine, leading to a significant increase (up to two-fold) in its serum concentration and half-life. High levels of lamotrigine are strongly associated with life-threatening cutaneous adverse reactions, specifically **Stevens-Johnson syndrome (SJS)** and **Toxic Epidermal Necrolysis (TEN)**. To mitigate this risk, the starting dose of lamotrigine must be reduced by half when added to a regimen containing valproate. **Analysis of Incorrect Options:** * **A. Chondrodysplasia punctata:** This is a skeletal dysplasia associated with the use of **Warfarin** during pregnancy (Warfarin Embryopathy). * **B. Paroxysmal Nocturnal Hemoglobinuria (PNH):** This is an acquired hematopoietic stem cell disorder caused by a somatic mutation in the *PIGA* gene; it is not drug-induced. * **D. Floppy infant syndrome:** This refers to neonatal hypotonia, typically seen in infants born to mothers taking **Benzodiazepines** or **Lithium** near the time of delivery. **High-Yield Clinical Pearls for NEET-PG:** * **Valproate** is a broad-spectrum enzyme **inhibitor**, whereas Carbamazepine, Phenytoin, and Phenobarbital are enzyme **inducers**. * **Lamotrigine** is the preferred anti-epileptic for **bipolar depression** and is considered safe in pregnancy regarding major malformations, though it carries a risk of cleft lip/palate. * **SJS/TEN** is most commonly associated with sulfonamides, allopurinol, anticonvulsants (lamotrigine, carbamazepine, phenytoin), and NSAIDs.

Question 191: Buspirone acts on which receptor subtype?

A. 5-HT1A (Correct Answer)
B. 5-HT1B
C. 5-HT2
D. 5-HT3

Explanation: **Explanation:** **Buspirone** is a non-benzodiazepine anxiolytic used primarily for the management of Generalized Anxiety Disorder (GAD). 1. **Why Option A is Correct:** Buspirone acts as a **selective partial agonist at the 5-HT1A receptors**. By stimulating these presynaptic autoreceptors in the raphe nuclei and postsynaptic receptors in the hippocampus, it modulates serotonin neurotransmission. Unlike benzodiazepines, it does not interact with GABA receptors, which explains its lack of sedative, anticonvulsant, or muscle relaxant properties. 2. **Why Other Options are Incorrect:** * **5-HT1B:** These receptors are primarily involved in cranial vessel vasoconstriction. Drugs like **Triptans** (e.g., Sumatriptan) act here to treat migraines. * **5-HT2:** This family (especially 5-HT2A) is the target for atypical antipsychotics (antagonists) and hallucinogens like LSD (agonists). * **5-HT3:** These are ionotropic receptors. Antagonists like **Ondansetron** are used as potent anti-emetics. **High-Yield Clinical Pearls for NEET-PG:** * **Latency of Action:** Buspirone has a slow onset of action, taking **1–2 weeks** to show effects. It is not useful for acute anxiety or panic attacks. * **Safety Profile:** It has **no potential for abuse or addiction** (no "buzz" or euphoria) and does not cause psychomotor impairment. It is safe for patients with a history of substance abuse. * **Interaction:** It does not potentiate the effects of alcohol or other CNS depressants. * **Side Effects:** Most common side effects include dizziness, nausea, and headache. It can cause a paradoxical increase in blood pressure if used with MAO inhibitors.

Question 192: Which of the following drugs causes hepatotoxicity?

A. Sertraline
B. Fluoxetine
C. Nefazodone (Correct Answer)
D. Amitriptyline

Explanation: **Explanation:** **Nefazodone** is a Serotonin-2 Antagonist and Reuptake Inhibitor (SARI). While it is effective for depression and anxiety, its clinical use has been severely restricted due to a **Black Box Warning** regarding life-threatening **hepatotoxicity**. The drug can cause a rapid increase in hepatic enzymes leading to fulminant hepatic failure, often requiring liver transplantation. Because of this risk, it has been withdrawn from the market in several countries (e.g., USA, Canada). **Analysis of Incorrect Options:** * **Sertraline & Fluoxetine (SSRIs):** These are the first-line treatments for depression. While all drugs undergo hepatic metabolism, SSRIs are generally considered safe for the liver. Idiosyncratic liver injury is extremely rare with these agents. * **Amitriptyline (TCA):** Tricyclic antidepressants are primarily associated with anticholinergic side effects (dry mouth, constipation), sedation, and cardiotoxicity (arrhythmias due to sodium channel blockade). While they can occasionally cause a mild, transient rise in transaminases, they do not carry the high risk of severe hepatotoxicity seen with Nefazodone. **Clinical Pearls for NEET-PG:** * **Nefazodone vs. Trazodone:** Both are SARIs. While Nefazodone is hepatotoxic, **Trazodone** is famously associated with **priapism** and is frequently used off-label for insomnia due to its sedative properties. * **Mechanism:** Nefazodone also acts as a potent inhibitor of the **CYP3A4** enzyme, leading to numerous drug-drug interactions. * **Mnemonic:** Remember **"N"** for Nefazodone = **"N"**ecrosis of the liver.

Question 193: Which drug is used in the prophylaxis of nicotine addiction?

A. Diazepam
B. Naloxone
C. Bupropion (Correct Answer)
D. Acamprosate

Explanation: **Explanation:** **Bupropion** is an atypical antidepressant that acts as a selective **norepinephrine and dopamine reuptake inhibitor (NDRI)**. It is FDA-approved for smoking cessation (prophylaxis of nicotine addiction) because it mimics some of the neurochemical effects of nicotine. By increasing dopamine levels in the brain's reward pathway (nucleus accumbens), it reduces the intensity of nicotine withdrawal symptoms and the urge to smoke. **Analysis of Incorrect Options:** * **Diazepam:** A benzodiazepine used for acute alcohol withdrawal and anxiety. It has no role in treating nicotine addiction and carries its own risk of dependence. * **Naloxone:** An opioid antagonist used primarily for the emergency reversal of opioid overdose. It does not significantly impact the nicotinic acetylcholine receptors involved in smoking. * **Acamprosate:** Used specifically for maintaining abstinence in **alcohol dependence** by modulating glutamate and GABA neurotransmission; it is ineffective for nicotine addiction. **High-Yield Clinical Pearls for NEET-PG:** * **Varenicline** (a partial agonist at $\alpha_4\beta_2$ nicotinic receptors) is considered the most effective monotherapy for smoking cessation, followed by Bupropion and Nicotine Replacement Therapy (NRT). * **Contraindication:** Bupropion is strictly contraindicated in patients with **seizure disorders** or eating disorders (bulimia/anorexia) as it lowers the seizure threshold. * **Weight Neutrality:** Unlike many antidepressants, Bupropion is often associated with weight loss, making it a preferred choice for smokers concerned about post-cessation weight gain. * **Clonidine** and **Nortriptyline** are considered second-line agents for smoking cessation.

Question 194: Which of the following is a typical antidepressant drug?

A. Amitriptyline (Correct Answer)
B. Clozapine
C. Olanzapine
D. Trazodone

Explanation: **Amitriptyline** is the correct answer because it is a classic example of a **Tricyclic Antidepressant (TCA)** [1]. TCAs are considered "typical" or first-generation antidepressants [1]. They work by inhibiting the reuptake of both Norepinephrine (NE) and Serotonin (5-HT) into the presynaptic neurons, thereby increasing their concentration in the synaptic cleft [3].**Analysis of Options:*** **Amitriptyline (Option A):** A tertiary amine TCA [1]. It is highly effective but associated with significant side effects due to its blockade of muscarinic (anticholinergic), alpha-adrenergic, and histaminergic receptors [3].* **Clozapine & Olanzapine (Options B & C):** These are **Atypical Antipsychotics** (Second-generation antipsychotics). They are used primarily in the treatment of Schizophrenia and Bipolar Disorder, not as primary antidepressants. Clozapine is specifically reserved for treatment-resistant schizophrenia.* **Trazodone (Option D):** This is an **Atypical Antidepressant** (specifically a SARI – Serotonin Antagonist and Reuptake Inhibitor) [3]. While it treats depression [2], it is classified as "atypical" because its mechanism and side-effect profile (e.g., prominent sedation and risk of priapism) differ from the classic TCAs or SSRIs.**High-Yield Clinical Pearls for NEET-PG:*** **TCA Overdose Triad:** Coma, Convulsions, and Cardiac arrhythmias (due to sodium channel blockade). The antidote is **Sodium Bicarbonate**.* **Amitriptyline** is also a first-line agent for **Neuropathic pain** and **Prophylaxis of Migraine**.* **Clozapine** requires mandatory WBC monitoring due to the risk of **Agranulocytosis**.* **Trazodone** is frequently used off-label for insomnia due to its highly sedative nature.

Question 195: MAO inhibitors are contraindicated in all the following conditions EXCEPT:

A. With tricyclic antidepressants
B. With indirectly acting sympathomimetics
C. Cheese
D. Aspirin (Correct Answer)

Explanation: **Explanation:** Monoamine Oxidase Inhibitors (MAOIs) are potent antidepressants that prevent the breakdown of biogenic amines (Norepinephrine, Serotonin, and Dopamine). Their contraindications are primarily based on preventing two life-threatening crises: **Hypertensive Crisis** and **Serotonin Syndrome**. **Why Aspirin is the Correct Answer:** Aspirin (Acetylsalicylic acid) is a Non-Steroidal Anti-inflammatory Drug (NSAID) that inhibits cyclooxygenase. It does not interfere with monoamine metabolism or the adrenergic/serotonergic systems. Therefore, there is no clinically significant interaction between MAOIs and Aspirin, making it safe to use. **Why the other options are contraindicated:** * **Tricyclic Antidepressants (TCAs):** Combining MAOIs with TCAs (especially Clomipramine or Imipramine) can lead to **Serotonin Syndrome** (hyperthermia, rigidity, myoclonus) or severe cardiovascular instability due to excessive synaptic monoamine levels. * **Indirectly acting sympathomimetics (e.g., Ephedrine, Tyramine, Amphetamines):** These drugs displace stored catecholamines into the synaptic cleft. Since MAOIs prevent the degradation of these catecholamines, a massive release occurs, leading to a **Hypertensive Crisis**. * **Cheese:** Aged cheese is rich in **Tyramine** (an indirect sympathomimetic). Normally, GI-based MAO-A degrades tyramine. MAOIs block this "first-pass" metabolism, allowing tyramine to reach systemic circulation and trigger the **"Cheese Reaction"** (severe hypertension, headache, and potential stroke). **High-Yield Clinical Pearls for NEET-PG:** * **The "Washout Period":** When switching from an MAOI to an SSRI (or vice versa), a gap of **at least 14 days** is required to allow for the regeneration of the MAO enzyme. * **Pethidine Interaction:** MAOIs are strictly contraindicated with Pethidine, as it can trigger excitatory reactions (hyperpyrexia and seizures). * **Moclobemide:** A RIMA (Reversible Inhibitor of MAO-A) that carries a much lower risk of the cheese reaction compared to non-selective, irreversible MAOIs like Phenelzine.

Question 196: A patient with Alzheimer's disease is on rivastigmine therapy and develops symptoms of depression. Which of the following drug classes, if used concurrently, would decrease the efficacy of rivastigmine?

A. Tricyclic antidepressants (TCAs) (Correct Answer)
B. Selective serotonin reuptake inhibitors (SSRIs)
C. Monoamine oxidase inhibitors (MAOIs)
D. Reversible inhibitors of monoamine oxidase A (RIMAs)

Explanation: **Explanation:**1. Why Tricyclic Antidepressants (TCAs) are correct:Rivastigmine is a **cholinesterase inhibitor** used in Alzheimer’s disease to increase synaptic levels of acetylcholine, thereby improving cognitive function [3]. Many TCAs (e.g., Amitriptyline, Imipramine) possess significant **anticholinergic (antimuscarinic) properties** [2]. When used concurrently, TCAs exert a pharmacological antagonism against rivastigmine. By blocking the muscarinic receptors that rivastigmine is trying to stimulate via increased acetylcholine, TCAs directly neutralize the therapeutic efficacy of the Alzheimer's medication and may worsen cognitive decline.2. Why other options are incorrect:* **SSRIs (e.g., Sertraline, Escitalopram):** These are the preferred antidepressants in Alzheimer’s patients because they lack significant anticholinergic activity and do not interfere with the mechanism of cholinesterase inhibitors.* **MAOIs and RIMAs (e.g., Moclobemide):** These drugs act on the metabolism of monoamines (Norepinephrine, Serotonin, Dopamine). They do not possess anticholinergic properties and therefore do not directly decrease the efficacy of rivastigmine.3. High-Yield Clinical Pearls for NEET-PG:* **Rivastigmine Unique Feature:** It is a "pseudo-irreversible" inhibitor of both **Acetylcholinesterase (AChE)** and **Butyrylcholinesterase (BuChE)** [1]. It is also available as a transdermal patch to reduce GI side effects.* **Drugs to Avoid in Dementia:** Always avoid drugs with "atropine-like" effects, including first-generation antihistamines (Diphenhydramine), bladder antispasmodics (Oxybutynin), and TCAs.* **Preferred Antidepressant:** SSRIs are the first-line treatment for depression in patients with dementia due to their favorable side-effect profile.

Question 197: Ebstein's anomaly is a known side effect of which medication?

A. Lithium (Correct Answer)
B. Carbamazepine
C. Valproate
D. Lamotrigine

Explanation: **Explanation:** **Lithium** is the correct answer. It is a classic mood stabilizer used in Bipolar Affective Disorder (BPAD). When taken during the first trimester of pregnancy, Lithium is associated with a specific cardiac teratogenic effect known as **Ebstein’s Anomaly**. This condition involves the "atrialization" of the right ventricle due to the downward displacement of the tricuspid valve leaflets, leading to severe tricuspid regurgitation and right heart failure. While the relative risk is increased, the absolute risk remains low (approx. 1 in 1,000–2,000 exposures). **Why the other options are incorrect:** * **Valproate:** This is the most teratogenic anti-epileptic. It is primarily associated with **Neural Tube Defects (NTDs)** like spina bifida due to interference with folate metabolism. * **Carbamazepine:** Also associated with **Neural Tube Defects** and craniofacial abnormalities (cleft lip/palate), but the risk is lower than with Valproate. * **Lamotrigine:** Generally considered one of the **safest** mood stabilizers/anti-epileptics during pregnancy, with a lower risk of major malformations compared to the others listed. **High-Yield Clinical Pearls for NEET-PG:** * **Therapeutic Index:** Lithium has a narrow therapeutic index (0.6–1.2 mEq/L). Toxicity occurs >1.5 mEq/L. * **L-Lithium, L-Lowering:** Lithium causes downward displacement of the valve (Ebstein's). * **Management:** If a pregnant woman must stay on Lithium, perform a fetal echocardiogram at 18–20 weeks to screen for cardiac defects. * **Other Lithium Side Effects:** Nephrogenic Diabetes Insipidus, Hypothyroidism, and Fine Tremors.

Question 198: Tianeptine acts by which of the following mechanisms?

A. MAO inhibitor
B. Serotonin uptake inhibitor
C. Serotonin uptake enhancer (Correct Answer)
D. 5-HT agonist

Explanation: **Explanation:** **Tianeptine** is a unique antidepressant that defies the traditional "monoamine hypothesis" of depression. While most conventional antidepressants (like SSRIs) work by inhibiting the reuptake of serotonin to increase its synaptic concentration, Tianeptine acts as a **Selective Serotonin Reuptake Enhancer (SSRE)**. It increases the presynaptic uptake of serotonin (5-HT), thereby decreasing 5-HT levels in the synaptic cleft. Despite this paradoxical mechanism, it effectively exerts antidepressant and anxiolytic effects, likely through its downstream modulation of glutamate receptors (NMDA and AMPA) and its role in neuroplasticity. **Analysis of Options:** * **Option A (MAO Inhibitor):** MAOIs (e.g., Phenelzine, Selegiline) prevent the breakdown of monoamines. Tianeptine does not inhibit the Monoamine Oxidase enzyme. * **Option B (Serotonin uptake inhibitor):** This is the mechanism of **SSRIs** (e.g., Fluoxetine, Sertraline). Tianeptine acts in the exact opposite manner by *enhancing* uptake. * **Option D (5-HT agonist):** Drugs like Buspirone (5-HT1A partial agonist) act here. Tianeptine does not have significant direct affinity for serotonin receptors. **High-Yield Clinical Pearls for NEET-PG:** * **Neuroprotection:** Tianeptine is known to prevent stress-induced atrophy of dendrites in the hippocampus. * **Opioid Link:** Recent studies show Tianeptine also acts as a **full agonist at μ-opioid receptors**, which may contribute to its mood-elevating effects. * **Pharmacokinetics:** It is primarily metabolized by the liver (beta-oxidation) rather than the Cytochrome P450 system, leading to fewer drug-drug interactions. * **Side Effects:** Unlike SSRIs, it typically **does not cause sexual dysfunction** or significant sedation.

Question 199: Which antipsychotic drug has the maximum hypotensive effect?

A. Fluphenazine
B. Trifluperazine
C. Thioridazine (Correct Answer)
D. Haloperidol

Explanation: ### Explanation **Correct Option: C. Thioridazine** **Mechanism of Hypotension:** Antipsychotic-induced hypotension is primarily mediated by the **blockade of alpha-1 (α1) adrenergic receptors** in the peripheral vasculature. Among the options provided, **Thioridazine** (a low-potency typical antipsychotic) has the highest affinity for α1 receptors. This leads to significant peripheral vasodilation, resulting in orthostatic (postural) hypotension. **Analysis of Options:** * **Thioridazine (Option C):** As a low-potency phenothiazine, it has high anticholinergic and high alpha-blocking activity, but lower extrapyramidal side effects (EPS). Its potent alpha-blockade makes it the most hypotensive drug among the choices. * **Fluphenazine & Trifluperazine (Options A & B):** These are high-potency piperazine phenothiazines. They have a high affinity for D2 receptors (causing high EPS) but relatively low affinity for alpha-adrenergic and muscarinic receptors. Thus, they cause less hypotension. * **Haloperidol (Option D):** A high-potency butyrophenone. It is highly selective for D2 receptors with minimal alpha-blocking activity, making it less likely to cause significant hypotension compared to Thioridazine. **High-Yield NEET-PG Pearls:** 1. **Potency vs. Side Effects:** Low-potency antipsychotics (Thioridazine, Chlorpromazine) cause more **sedation, hypotension, and anticholinergic effects**. High-potency drugs (Haloperidol, Fluphenazine) cause more **Extrapyramidal Symptoms (EPS)**. 2. **Specific Thioridazine Risks:** It is notorious for causing **QT interval prolongation** (Torsades de pointes) and **Retinitis Pigmentosa** (at doses >800mg/day). 3. **Clinical Tip:** In elderly patients or those with cardiovascular disease, high-potency drugs are often preferred over Thioridazine to avoid the risk of falls due to orthostatic hypotension.

Question 200: Which of the following psychiatric medications are available as depot preparations?

A. Haloperidol
B. Risperidone
C. Olanzapine
D. All of the above (Correct Answer)

Explanation: **Explanation:** **Depot preparations** are long-acting injectable (LAI) formulations designed to release the drug slowly over weeks or months. They are primarily used in psychiatric practice to improve treatment adherence in patients with chronic conditions like schizophrenia. 1. **Haloperidol (Option A):** This is a typical (first-generation) antipsychotic. It is available as **Haloperidol Decanoate**, administered intramuscularly every 4 weeks. It is one of the most commonly used depot preparations in clinical practice. 2. **Risperidone (Option B):** An atypical (second-generation) antipsychotic available as **Risperidone microspheres**. It is typically administered every 2 weeks. 3. **Olanzapine (Option C):** Also an atypical antipsychotic, it is available as **Olanzapine Pamoate**. While effective, it requires strict monitoring due to the risk of Post-injection Delirium Sedation Syndrome (PDSS). Since all three medications have established long-acting injectable formulations, **Option D (All of the above)** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Depot formulations are usually esterified with long-chain fatty acids (like decanoate or palmitate) in an oil vehicle (sesame or castor oil), slowing absorption from the injection site. * **Other Depot Antipsychotics:** Fluphenazine decanoate, Zuclopenthixol decanoate, and Paliperidone palmitate (available as 1-month and 3-month formulations). * **Aripiprazole** is another atypical antipsychotic frequently asked about that is available as a once-monthly depot. * **Contraindication:** Depot preparations should **never** be given intravenously; they are strictly for deep intramuscular (IM) injection.

Question 201: Which of the following is NOT an atypical antipsychotic?

A. Thioridazine (Correct Answer)
B. Clozapine
C. Olanzapine
D. Risperidone

Explanation: **Explanation** Antipsychotics are broadly classified into two categories: **Typical (First Generation)** and **Atypical (Second Generation)**. The primary distinction lies in their mechanism of action and side-effect profile. **Why Thioridazine is the correct answer:** **Thioridazine** is a **Typical Antipsychotic** belonging to the Phenothiazine class (specifically the piperidine subgroup). It acts primarily by blocking **D2 receptors** in the mesolimbic pathway. Unlike atypical agents, it has a higher propensity for causing extrapyramidal symptoms (EPS), though less than haloperidol, and is notorious for its specific side effects like retinal pigmentation and cardiotoxicity. **Why the other options are incorrect:** * **Clozapine:** The prototype atypical antipsychotic. It has a low affinity for D2 receptors and high affinity for D4 and 5-HT2A receptors. It is the gold standard for treatment-resistant schizophrenia. * **Olanzapine:** A common atypical agent associated with significant metabolic side effects like weight gain and hyperglycemia. * **Risperidone:** An atypical antipsychotic that blocks both D2 and 5-HT2A receptors. At higher doses, it is the atypical agent most likely to cause EPS and hyperprolactinemia. **High-Yield Clinical Pearls for NEET-PG:** * **Thioridazine Warning:** It is associated with **QT interval prolongation** (Torsades de pointes) and **retinitis pigmentosa** (if dose >800mg/day). * **Atypical Advantage:** Atypical antipsychotics are preferred because they treat both **positive and negative symptoms** of schizophrenia and have a lower risk of Extrapyramidal Side Effects (EPS). * **Clozapine Monitoring:** Requires mandatory WBC count monitoring due to the risk of **agranulocytosis**. It is also the only antipsychotic proven to reduce suicide risk in schizophrenia.

Question 202: Which of the following statements about extrapyramidal side effects of antipsychotic drugs is FALSE?

A. Caused by blockade of dopamine receptors
B. Less likely to be produced by clozapine than by chlorpromazine
C. Can be countered to some degree by antimuscarinic drugs
D. Haloperidol does not cause extrapyramidal syndrome (Correct Answer)

Explanation: ### Explanation **1. Why Option D is the Correct (False) Statement:** Haloperidol is a **high-potency, first-generation (typical) antipsychotic**. It has a very high affinity for **D2 receptors** in the nigrostriatal pathway. Because it lacks significant intrinsic anticholinergic activity, it is one of the drugs **most likely** to cause severe Extrapyramidal Symptoms (EPS), including acute dystonia, parkinsonism, and akathisia. **2. Analysis of Incorrect Options:** * **Option A (True):** EPS is primarily caused by the blockade of D2 receptors in the **nigrostriatal pathway**. When dopamine is inhibited here, the balance between dopamine and acetylcholine is disrupted, leading to motor symptoms. * **Option B (True):** **Clozapine** is an atypical antipsychotic with low D2 affinity and high 5-HT2A antagonism. It is considered the "gold standard" for having the **lowest risk of EPS**, whereas chlorpromazine (a low-potency typical antipsychotic) has a higher risk, though less than haloperidol. * **Option C (True):** EPS results from a relative **excess of cholinergic activity** due to dopamine blockade. Therefore, centrally acting antimuscarinic drugs (e.g., **Benztropine, Trihexyphenidyl**) are used to restore the neurochemical balance and alleviate symptoms like parkinsonism and dystonia. **3. High-Yield Clinical Pearls for NEET-PG:** * **Acute Dystonia:** Earliest onset (hours); treat with IV/IM anticholinergics. * **Akathisia:** Most common EPS; characterized by motor restlessness; treat with **Beta-blockers (Propranolol)**. * **Tardive Dyskinesia:** Late-onset (months/years); caused by D2 receptor supersensitivity; **anticholinergics worsen it**. * **Drug of Choice for EPS:** Central anticholinergics (Trihexyphenidyl/Benzhexol). * **Atypical Antipsychotics (SGA):** Lower EPS risk because they dissociate rapidly from D2 receptors ("hit and run" hypothesis).

Question 203: Which of the following is NOT used for the treatment of morphine dependence?

A. Methadone
B. Clonidine
C. Naltrexone
D. Disulfiram (Correct Answer)

Explanation: **Explanation:** The correct answer is **Disulfiram** because it is specifically used for the treatment of **alcohol dependence**, not opioid (morphine) dependence. **1. Why Disulfiram is the correct answer:** Disulfiram acts as an irreversible inhibitor of the enzyme **aldehyde dehydrogenase**. When a patient consumes alcohol while on disulfiram, acetaldehyde accumulates in the blood, leading to the "Disulfiram-like reaction" (flushing, tachycardia, nausea, and palpitations). This serves as **aversion therapy**. It has no pharmacological role in modulating the opioid receptors or managing morphine withdrawal. **2. Why the other options are used in Morphine Dependence:** * **Methadone (Option A):** A long-acting μ-opioid agonist used in **substitution therapy**. It prevents withdrawal symptoms and reduces craving due to its long half-life and slow onset of action. * **Clonidine (Option B):** An $\alpha_2$ agonist that suppresses the **autonomic hyperactivity** (tachycardia, hypertension, sweating) associated with opioid withdrawal. It is non-addictive and used for symptomatic relief. * **Naltrexone (Option C):** A long-acting opioid antagonist used for **relapse prevention** (maintenance therapy) after detoxification. It blocks the euphoric effects of opioids if the patient slips. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of choice (DOC) for Opioid Overdose:** Naloxone (IV). * **DOC for Opioid Withdrawal:** Methadone (substitution) or Buprenorphine (partial agonist). * **Buprenorphine + Naloxone:** A common combination used to prevent intravenous abuse of sublingual tablets. * **Disulfiram-like reaction** can also be caused by drugs like Metronidazole, Cefotetan, and Sulfonylureas.

Question 204: Which of the following is NOT a monoamine oxidase (MAO) inhibitor?

A. Tranylcypromine
B. Isocarboxazide
C. Phenelzine
D. Maprotiline (Correct Answer)

Explanation: **Explanation:** The correct answer is **Maprotiline**. **1. Why Maprotiline is the correct answer:** Maprotiline is a **Tetracyclic Antidepressant (TeCA)**, not an MAO inhibitor. Its primary mechanism of action is the selective inhibition of norepinephrine reuptake. It is chemically and pharmacologically similar to Tricyclic Antidepressants (TCAs). It is specifically known for its high selectivity for the norepinephrine transporter (NET) and is often associated with a higher risk of seizures compared to other antidepressants. **2. Why the other options are incorrect:** Options A, B, and C are all classic examples of **Non-selective, Irreversible MAO Inhibitors**. * **Tranylcypromine:** A non-hydrazine MAO inhibitor. It is the most potent agent in this class and has a structure similar to amphetamine. * **Isocarboxazid:** A hydrazine-derivative MAO inhibitor used primarily for treatment-resistant depression. * **Phenelzine:** Another hydrazine-derivative MAO inhibitor. Like the others, it inhibits both MAO-A and MAO-B. **3. High-Yield Clinical Pearls for NEET-PG:** * **Cheese Reaction:** Patients on non-selective MAOIs (like A, B, and C) must avoid tyramine-rich foods (aged cheese, red wine) to prevent a hypertensive crisis. * **Moclobemide:** A **RIMA** (Reversible Inhibitor of MAO-A); it carries a much lower risk of the cheese reaction. * **Selegiline:** A selective **MAO-B inhibitor** used in Parkinson’s disease (at low doses). * **Drug Interaction:** Never combine MAOIs with SSRIs or Pethidine due to the risk of **Serotonin Syndrome**. A washout period of 14 days is typically required when switching between these classes.

Question 205: Which drug, when given to a patient with alcohol dependence, can cause an adverse drug reaction if the patient consumes alcohol due to a drug interaction?

A. Disulfiram (Correct Answer)
B. Acamprosate
C. Naloxone
D. Naltrexone

Explanation: **Explanation:** The correct answer is **Disulfiram**. This drug is used as **Aversion Therapy** in alcohol dependence. **1. Why Disulfiram is correct:** Disulfiram inhibits the enzyme **Aldehyde Dehydrogenase (ALDH)**. Normally, alcohol is metabolized into Acetaldehyde, which ALDH then converts into Acetic Acid. By blocking ALDH, Disulfiram causes a toxic accumulation of **Acetaldehyde** in the blood if alcohol is consumed. This leads to the **Disulfiram-Ethanol Reaction (DER)**, characterized by flushing, throbbing headache, nausea, vomiting, tachycardia, and hypotension. The fear of this unpleasant reaction deters the patient from drinking. **2. Why other options are incorrect:** * **Acamprosate:** It is an NMDA receptor antagonist used to maintain abstinence by reducing "protracted withdrawal" symptoms (craving). It does not cause a reaction with alcohol. * **Naltrexone:** An opioid antagonist that reduces the "reward" or euphoria associated with drinking by blocking mu-opioid receptors. It is the drug of choice for reducing cravings but has no interaction reaction. * **Naloxone:** An intravenous opioid antagonist used primarily for acute opioid overdose, not for the long-term management of alcohol dependence. **Clinical Pearls for NEET-PG:** * **Drug of Choice for Alcohol Withdrawal:** Benzodiazepines (e.g., Chlordiazepoxide, Diazepam). * **Drug of Choice to Reduce Craving:** Naltrexone. * **Other drugs causing Disulfiram-like reactions:** Metronidazole (most common), Cefotetan, Cefoperazone, Chlorpropamide, and Griseofulvin. * **Contraindication:** Disulfiram should never be administered if the patient has consumed alcohol within the last 12 hours or is in a state of intoxication.

Question 206: True regarding bupropion is?

A. Dopamine reuptake stimulator
B. It is an antianxiety drug
C. No precipitation of seizures
D. Nicotinic receptor antagonist (Correct Answer)

Explanation: **Explanation:** **Bupropion** is an atypical antidepressant with a unique mechanism of action compared to SSRIs or TCAs. 1. **Why Option D is correct:** Bupropion acts as a **non-competitive antagonist at nicotinic acetylcholine receptors (nAChR)**. This specific action is responsible for its effectiveness in **smoking cessation**, as it reduces the rewarding effects of nicotine and minimizes withdrawal symptoms. 2. **Why other options are incorrect:** * **Option A:** Bupropion is a **Dopamine and Norepinephrine Reuptake Inhibitor (DNRI)**, not a stimulator. It increases the synaptic concentration of these neurotransmitters. * **Option B:** Bupropion is primarily an **antidepressant**. Unlike SSRIs, it is generally not effective for anxiety disorders and may occasionally worsen anxiety or agitation due to its stimulating properties. * **Option C:** Bupropion is notorious for **lowering the seizure threshold**. It is contraindicated in patients with seizure disorders, eating disorders (bulimia/anorexia), or those undergoing alcohol withdrawal. **High-Yield Clinical Pearls for NEET-PG:** * **Sexual Dysfunction:** Unlike SSRIs, Bupropion does **not** cause sexual dysfunction or weight gain, making it a preferred choice for patients concerned about these side effects. * **Smoking Cessation:** It is FDA-approved for smoking cessation (often marketed as Zyban). * **Contraindications:** Always avoid in patients with a history of seizures or head injury. * **Active Metabolite:** Hydroxybupropion is its major active metabolite.

Question 207: Absolute contraindication to lithium therapy is:

A. Pregnancy (Correct Answer)
B. Angioma
C. Glaucoma
D. Epilepsy

Explanation: **Explanation:** **1. Why Pregnancy is the Correct Answer:** Lithium is a known **teratogen** and is classified under FDA Pregnancy Category D. Its use during the first trimester is strongly associated with **Ebstein’s Anomaly**, a congenital cardiac defect characterized by the downward displacement of the tricuspid valve into the right ventricle ("atrialization" of the ventricle). While some modern guidelines suggest lithium can be used in severe refractory cases with close monitoring, for the purpose of NEET-PG, it remains an absolute contraindication in early pregnancy due to this specific morphological risk. **2. Analysis of Incorrect Options:** * **Angioma:** There is no clinical or pharmacological correlation between lithium therapy and the progression or occurrence of angiomas. * **Glaucoma:** Unlike Tricyclic Antidepressants (TCAs) or Antipsychotics with anticholinergic properties, lithium does not affect intraocular pressure and is safe to use in glaucoma patients. * **Epilepsy:** Lithium is not contraindicated in epilepsy. In fact, it can sometimes be used in patients with comorbid mood disorders, though caution is required as lithium toxicity can lower the seizure threshold. **3. High-Yield Clinical Pearls for NEET-PG:** * **Therapeutic Index:** Lithium has a narrow therapeutic index (0.6–1.2 mEq/L). Toxicity starts >1.5 mEq/L. * **Renal Function:** Since lithium is excreted 100% by the kidneys, **Renal Failure** is a major contraindication. * **Drug Interactions:** Thiazides, NSAIDs, and ACE inhibitors increase lithium levels (decreasing clearance), leading to toxicity. * **Side Effects:** Remember the mnemonic **LITHIUM**: **L**eukocytosis, **I**nsipidus (Diabetes Insipidus), **T**remors/Teratogenicity, **H**ypothyroidism, **I**ncreased Weight, **U**nderactive heart (Sinus node dysfunction), **M**others (Ebstein’s).

Question 208: Which group of drugs is considered first-line in the management of schizophrenia?

A. Opioids
B. Antiepileptics
C. Serotonergic drugs
D. Dopamine antagonists (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. Dopamine Antagonists** The management of schizophrenia is primarily based on the **Dopamine Hypothesis**, which suggests that the positive symptoms of the disorder (hallucinations, delusions) are caused by overactivity of dopamine in the **mesolimbic pathway**. All standard antipsychotics (both Typical and Atypical) exert their primary therapeutic effect by blocking **D2 receptors**. * **Typical Antipsychotics** (e.g., Haloperidol) are potent D2 antagonists. * **Atypical Antipsychotics** (e.g., Risperidone, Olanzapine) block both D2 and 5-HT2A receptors, and are currently the preferred first-line agents due to a lower risk of Extrapyramidal Side Effects (EPS). **Why other options are incorrect:** * **A. Opioids:** These are primarily used for analgesia and anesthesia. They have no role in treating psychosis and can actually induce delirium or worsen mental status. * **B. Antiepileptics:** While drugs like Valproate or Carbamazepine are used as **mood stabilizers** in Bipolar Disorder or as adjuncts for aggression, they do not treat the core psychotic symptoms of schizophrenia. * **C. Serotonergic drugs:** While Atypical antipsychotics do have serotonin-blocking properties, "serotonergic drugs" usually refers to SSRIs/SNRIs used for depression and anxiety. Pure serotonergic stimulation can sometimes exacerbate psychotic symptoms. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for Resistant Schizophrenia:** Clozapine (requires mandatory WBC monitoring for agranulocytosis). * **Most Potent D2 Blocker:** Haloperidol (highest risk of EPS). * **Hyperprolactinemia:** A common side effect of D2 blockade in the tuberoinfundibular pathway (most common with Risperidone). * **Negative Symptoms:** Atypical antipsychotics are generally better than typical ones for treating negative symptoms (apathy, social withdrawal).

Question 209: Which among the following selective serotonin reuptake inhibitors is longest acting?

A. Fluvoxamine
B. Fluoxetine (Correct Answer)
C. Sertraline
D. Paroxetine

Explanation: **Explanation:** The correct answer is **Fluoxetine**. **1. Why Fluoxetine is correct:** Fluoxetine is unique among Selective Serotonin Reuptake Inhibitors (SSRIs) due to its exceptionally long half-life. The parent drug has a half-life of approximately **2 to 3 days**, but it is metabolized into an active metabolite, **Norfluoxetine**, which has a half-life of **7 to 9 days**. This prolonged duration of action means that the drug remains in the system for several weeks even after discontinuation. This property makes it the safest SSRI to discontinue abruptly, as it essentially "self-tapers," resulting in the lowest risk of **SSRI Discontinuation Syndrome**. **2. Why the other options are incorrect:** * **Fluvoxamine:** It has the shortest half-life (approx. 15 hours) among the SSRIs and often requires twice-daily dosing. * **Sertraline:** It has an intermediate half-life (approx. 26 hours). While it also has an active metabolite (Desmethylsertraline), it is significantly less potent than Norfluoxetine. * **Paroxetine:** It has a half-life of about 21 hours. Notably, it is associated with the highest risk of Discontinuation Syndrome because it lacks active metabolites and has a relatively short half-life. **3. High-Yield Clinical Pearls for NEET-PG:** * **Washout Period:** Due to its long half-life, a **5-week washout period** is required when switching from Fluoxetine to a Monoamine Oxidase Inhibitor (MAOI) to avoid **Serotonin Syndrome** (other SSRIs usually require only 2 weeks). * **Drug of Choice:** Fluoxetine is the preferred SSRI for treating depression in **children and adolescents**. * **Side Effects:** Paroxetine is the most "sedating" and has the most significant anticholinergic effects, whereas Fluoxetine is often considered "activating" (can cause insomnia/anxiety initially).

Question 210: What is the first-line drug preferred for the treatment of akathisia?

A. Benzhexol
B. Trihexyphenidyl hydrochloride
C. Promethazine
D. Propranolol (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. Propranolol** **Medical Concept:** Akathisia is an Extrapyramidal Side Effect (EPS) characterized by a subjective feeling of inner restlessness and an inability to sit still. Unlike other EPS (like dystonia or parkinsonism) which are primarily mediated by dopamine-acetylcholine imbalance in the nigrostriatal pathway, akathisia involves complex adrenergic mechanisms. **Propranolol**, a non-selective beta-blocker, is the **drug of choice** because it effectively crosses the blood-brain barrier and antagonizes beta-receptors, thereby reducing the physiological and psychological manifestations of restlessness. **Analysis of Incorrect Options:** * **A & B (Benzhexol / Trihexyphenidyl):** These are the same drug (anticholinergics). While they are first-line for **Acute Dystonia** and **Drug-Induced Parkinsonism**, they are significantly less effective for akathisia and are considered second-line options. * **C (Promethazine):** This is an antihistamine with sedative and anticholinergic properties. While it may be used for acute dystonia, it is not the preferred treatment for akathisia and may even worsen the condition due to its sedative profile. **High-Yield Clinical Pearls for NEET-PG:** * **Acute Dystonia:** Earliest EPS to appear (hours to days). Treatment: Central anticholinergics (e.g., Benztropine, Promethazine). * **Akathisia:** Most common EPS. Treatment: **Propranolol** (1st line), Benzodiazepines (2nd line). * **Drug-Induced Parkinsonism:** Treatment: Central anticholinergics (Trihexyphenidyl). *Note: Levodopa is contraindicated.* * **Tardive Dyskinesia:** Occurs after long-term use (months to years). Treatment: Switch to Clozapine; use VMAT-2 inhibitors (Valbenazine/Deutetrabenazine). Anticholinergics **worsen** Tardive Dyskinesia.

Question 211: A patient was treated with amitriptyline for depression and developed urinary retention, constipation, and blurring of vision. What is the most likely cause of these symptoms?

A. Symptoms of depression persisting
B. Anticholinergic side effects (Correct Answer)
C. Depression medicamentosa
D. Any of the above

Explanation: ### Explanation **Correct Option: B. Anticholinergic side effects** Amitriptyline is a **Tricyclic Antidepressant (TCA)**. While its primary therapeutic action is the inhibition of norepinephrine and serotonin reuptake, it also possesses significant antagonist activity at several other receptors, most notably **Muscarinic (M1) receptors**. The symptoms described—**urinary retention, constipation, and blurring of vision** (due to cycloplegia/mydriasis)—are classic manifestations of **anticholinergic toxicity**. By blocking muscarinic receptors, TCAs inhibit the parasympathetic nervous system ("rest and digest"), leading to "drying" effects: * **Mydriasis/Cycloplegia:** Blurred vision. * **Decreased Secretions:** Dry mouth (xerostomia). * **Smooth Muscle Relaxation:** Constipation and urinary retention. --- **Why other options are incorrect:** * **Option A:** Persistent depression typically presents with mood symptoms (anhedonia, low energy) rather than acute autonomic physical signs like urinary retention. * **Option C:** "Depression medicamentosa" refers to depression induced by drugs (e.g., Reserpine or Propranolol). It does not describe the physical side effects of antidepressants themselves. --- ### High-Yield NEET-PG Pearls: * **TCA Receptor Profile:** Remember the "Side Effect Profile" of TCAs: 1. **Anti-Muscarinic:** Dry mouth, blurred vision, constipation, urinary retention. 2. **Anti-Alpha 1:** Orthostatic hypotension. 3. **Anti-Histaminic (H1):** Sedation and weight gain. * **Cardiac Toxicity:** In TCA overdose, the most dangerous effect is **Sodium channel blockade**, leading to QRS prolongation and arrhythmias. **Sodium Bicarbonate** is the antidote for TCA-induced cardiac toxicity. * **Contraindication:** Due to anticholinergic effects, TCAs should be avoided in patients with **Benign Prostatic Hyperplasia (BPH)** and **Narrow-angle Glaucoma**.

Question 212: Which of the following effects is unlikely to occur during treatment with imipramine?

A. Elevation of seizure threshold (Correct Answer)
B. Mydriasis
C. Sedation
D. Urinary retention

Explanation: **Explanation:** Imipramine is a prototype **Tricyclic Antidepressant (TCA)**. Understanding its pharmacological profile is crucial for NEET-PG, as it acts on multiple receptor systems. **Why Option A is correct:** TCAs, including imipramine, are known to **lower the seizure threshold** (pro-convulsant effect), not elevate it. They interfere with GABAergic neurotransmission and alter ion channels, making neurons more excitable. Therefore, they must be used with extreme caution in patients with epilepsy. **Why the other options are incorrect:** * **B. Mydriasis:** TCAs have potent **anticholinergic (antimuscarinic)** properties. Blockade of $M_3$ receptors on the pupillary sphincter muscle leads to mydriasis (dilation) and blurred vision. * **C. Sedation:** Imipramine causes significant sedation due to its **$H_1$-antihistaminic** and $\alpha_1$-adrenergic blocking activities. This is often more pronounced during the initial stages of therapy. * **D. Urinary retention:** This is another classic **anticholinergic side effect**. By blocking muscarinic receptors in the bladder detrusor muscle, TCAs decrease bladder contraction, leading to urinary hesitancy or retention (especially in elderly males with BPH). **High-Yield Clinical Pearls for NEET-PG:** 1. **The "3 C’s" of TCA Overdose:** **C**oma, **C**onvulsions, and **C**ardiotoxicity (arrhythmias due to Na+ channel blockade). 2. **ECG Changes:** TCA toxicity typically shows QRS widening; the specific antidote for cardiac toxicity is **Sodium Bicarbonate**. 3. **Contraindication:** TCAs are contraindicated in patients with Narrow-Angle Glaucoma due to their mydriatic effect.

Question 213: Which of the following is not an antidepressant?

A. Amitriptyline
B. Fluoxetine
C. Imipramine
D. Chlorpromazine (Correct Answer)

Explanation: **Explanation:** The correct answer is **Chlorpromazine** because it belongs to the class of **Typical Antipsychotics** (First-generation antipsychotics), not antidepressants [1]. **1. Why Chlorpromazine is the correct answer:** Chlorpromazine is a low-potency phenothiazine. Its primary mechanism of action is the **blockade of Postsynaptic Dopamine (D2) receptors** in the mesolimbic pathway. It is used primarily in the management of Schizophrenia and acute psychosis [1]. It also possesses significant alpha-blocking, anticholinergic, and antihistaminic properties, leading to side effects like sedation and hypotension. **2. Why the other options are incorrect:** * **Amitriptyline & Imipramine (Options A & C):** These are classic **Tricyclic Antidepressants (TCAs)**. They work by inhibiting the reuptake of both Norepinephrine (NE) and Serotonin (5-HT) [1, 2]. Imipramine is notably the gold standard for treating nocturnal enuresis in children, while Amitriptyline is frequently used for neuropathic pain and migraine prophylaxis. * **Fluoxetine (Option B):** This is a prototype **Selective Serotonin Reuptake Inhibitor (SSRI)** [1]. It is one of the most commonly prescribed antidepressants due to its favorable safety profile and long half-life (due to its active metabolite, norfluoxetine). **High-Yield Clinical Pearls for NEET-PG:** * **Chlorpromazine** is a notorious cause of **corneal/lens deposits** and skin pigmentation (blue-grey discoloration). * **Drug of choice (DOC)** for Depression: SSRIs (e.g., Fluoxetine, Sertraline) [3]. * **DOC for OCD:** SSRIs (in higher doses); Clomipramine is the most potent TCA for OCD [2]. * **Antipsychotic vs. Antidepressant:** Remember that antipsychotics primarily target **Dopamine**, while antidepressants primarily target **Serotonin and Norepinephrine**.

Question 214: Which of the following is NOT a common side effect of chlorpromazine?

A. Osteoporosis (Correct Answer)
B. Parkinsonism
C. Skin rash
D. Amenorrhea

Explanation: **Explanation:** Chlorpromazine is a **typical (first-generation) antipsychotic** belonging to the phenothiazine class. It acts primarily by blocking dopamine ($D_2$) receptors in various brain pathways. **Why Osteoporosis is the correct answer:** While long-term use of antipsychotics can theoretically lead to decreased bone mineral density due to hyperprolactinemia (which suppresses estrogen/testosterone), **osteoporosis is not considered a "common" or classic side effect** of chlorpromazine. In the context of NEET-PG, the other three options represent well-documented, hallmark side effects of this drug class. **Analysis of Incorrect Options:** * **Parkinsonism (B):** Chlorpromazine blocks $D_2$ receptors in the **nigrostriatal pathway**, leading to Extrapyramidal Side Effects (EPS), including pseudoparkinsonism (rigidity, tremors, and bradykinesia). * **Skin Rash (C):** Chlorpromazine is notorious for dermatological side effects, including **photosensitivity** and a unique "blue-grey" skin discoloration in sun-exposed areas. * **Amenorrhea (D):** By blocking $D_2$ receptors in the **tuberoinfundibular pathway**, chlorpromazine removes the inhibitory effect of dopamine on prolactin. The resulting **hyperprolactinemia** causes galactorrhea, amenorrhea, and infertility. **High-Yield Clinical Pearls for NEET-PG:** 1. **Low Potency:** Chlorpromazine is a low-potency antipsychotic; it has a high affinity for $H_1$, $\alpha_1$, and $M_1$ receptors, leading to significant sedation, hypotension, and anticholinergic effects. 2. **Ocular Deposits:** A classic exam fact is that chlorpromazine causes **stellate corneal and lenticular opacities**, whereas Thioridazine causes retinitis pigmentosa. 3. **Weight Gain:** It is associated with significant metabolic side effects and weight gain compared to high-potency drugs like Haloperidol.

Question 215: Fluoxetine causes all of the following side effects, except:

A. Diarrhoea
B. Insomnia
C. Sedation (Correct Answer)
D. Anxiety

Explanation: **Explanation:** Fluoxetine is a prototype **Selective Serotonin Reuptake Inhibitor (SSRI)**. Unlike older tricyclic antidepressants (TCAs), SSRIs lack significant antihistaminic and anticholinergic properties, which are the primary drivers of sedation. **Why Sedation is the Correct Answer:** Fluoxetine is unique among SSRIs because it is **activating** rather than sedating. It has a stimulant-like effect on the CNS, which is why it is typically administered in the morning. Sedation is a characteristic side effect of TCAs (like Amitriptyline) or certain atypical antidepressants (like Mirtazapine), but not Fluoxetine. **Analysis of Incorrect Options:** * **Diarrhoea:** SSRIs increase serotonin levels in the gut, stimulating 5-HT3 receptors. This leads to gastrointestinal side effects, including nausea, vomiting, and diarrhoea. * **Insomnia:** Due to its activating nature and increased serotonergic neurotransmission in the brainstem, Fluoxetine frequently causes sleep disturbances and difficulty falling asleep. * **Anxiety:** In the initial stages of therapy, the stimulant effect of Fluoxetine can paradoxically worsen anxiety, agitation, or restlessness (akathisia-like symptoms). **High-Yield Clinical Pearls for NEET-PG:** 1. **Longest Half-life:** Fluoxetine has the longest half-life (2–4 days) among SSRIs, and its active metabolite, **norfluoxetine**, lasts 7–15 days. 2. **Washout Period:** Due to its long half-life, a 5-week washout period is required before starting an MAO inhibitor to avoid **Serotonin Syndrome**. 3. **Drug of Choice:** Fluoxetine is the preferred SSRI for treating depression in children and adolescents and is also used in Bulimia Nervosa.

Question 216: What is the mechanism of action of Tianeptine in the brain?

A. Selective serotonin reuptake inhibition
B. Selective norepinephrine reuptake inhibition
C. Selective serotonin reuptake enhancement (Correct Answer)
D. Selective dopamine reuptake inhibition

Explanation: **Explanation:** **Tianeptine** is a unique antidepressant that defies the traditional monoamine hypothesis. While most antidepressants increase synaptic serotonin levels, Tianeptine acts as a **Selective Serotonin Reuptake Enhancer (SSRE)**. It increases the presynaptic reuptake of serotonin (5-HT), effectively decreasing serotonin levels in the synaptic cleft. Despite this paradoxical mechanism, it exhibits potent antidepressant and anxiolytic properties. **Analysis of Options:** * **Option A (SSRI):** This is the mechanism for drugs like Fluoxetine and Sertraline. SSRIs *block* the reuptake of serotonin to increase its synaptic concentration, which is the opposite of Tianeptine’s action. * **Option B (SNRI/NRI):** Drugs like Reboxetine (NRI) or Venlafaxine (SNRI) target norepinephrine transporters. Tianeptine does not have a primary affinity for norepinephrine transporters. * **Option D (NDRI):** This describes Bupropion, which inhibits the reuptake of dopamine and norepinephrine. Tianeptine does not significantly affect dopamine reuptake. **High-Yield Clinical Pearls for NEET-PG:** * **Neuroplasticity:** Beyond serotonin, Tianeptine’s efficacy is attributed to its ability to modulate **glutamatergic neurotransmission** (NMDA and AMPA receptors) and prevent hippocampal atrophy caused by chronic stress. * **Opioid Receptor Agonism:** Recent studies show Tianeptine is a full agonist at **μ-opioid receptors**, which may contribute to its mood-elevating effects and potential for abuse. * **Side Effect Profile:** Unlike SSRIs, Tianeptine typically **does not cause sexual dysfunction**, sedation, or significant anticholinergic effects, making it a favorable option for elderly patients.

Question 217: Methylphenidate is used for which condition?

A. Attention deficit disorder (Correct Answer)
B. Alzheimer's disease
C. Seizure disorder
D. Obsessive compulsive disorder

Explanation: **Explanation:** **Methylphenidate** is a central nervous system (CNS) stimulant that acts primarily by blocking the reuptake of **dopamine and norepinephrine** into presynaptic neurons. This increases the concentration of these neurotransmitters in the synaptic cleft, particularly in the prefrontal cortex, which enhances focus, attention, and impulse control. 1. **Why Option A is correct:** **Attention Deficit Hyperactivity Disorder (ADHD)** is the primary clinical indication for Methylphenidate. In patients with ADHD, there is an underlying catecholamine dysfunction; by increasing synaptic dopamine and norepinephrine, Methylphenidate improves the "signal-to-noise ratio" in brain circuits responsible for executive function. 2. **Why other options are incorrect:** * **Alzheimer’s Disease:** Managed with Cholinesterase inhibitors (Donepezil, Rivastigmine) or NMDA antagonists (Memantine). * **Seizure Disorder:** Stimulants like Methylphenidate can actually lower the seizure threshold and are generally contraindicated or used with extreme caution in patients with epilepsy. * **Obsessive Compulsive Disorder (OCD):** The first-line treatment involves SSRIs (e.g., Fluoxetine) or the TCA Clomipramine. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Inhibits the transporters DAT (Dopamine Transporter) and NET (Norepinephrine Transporter). * **Other Indications:** It is also used as a second-line treatment for **Narcolepsy**. * **Side Effects:** Insomnia, anorexia (weight loss), growth suppression in children (requires "drug holidays"), and tachycardia. * **Contraindications:** Glaucoma, motor tics (Tourette’s syndrome), and concomitant use of MAO inhibitors (risk of hypertensive crisis).

Question 218: Which of the following is NOT a serotonin-norepinephrine reuptake inhibitor?

A. Paroxetine (Correct Answer)
B. Mianserin
C. None of the above
D. Venlafaxine

Explanation: **Explanation:** The core of this question lies in distinguishing between different classes of antidepressants based on their mechanism of action. **1. Why Paroxetine is the correct answer:** **Paroxetine** is a potent and selective **Selective Serotonin Reuptake Inhibitor (SSRI)**. It works by specifically inhibiting the reuptake of serotonin (5-HT) at the presynaptic terminal, increasing its availability in the synaptic cleft. It does not significantly inhibit the reuptake of norepinephrine, which is why it is **not** classified as an SNRI. **2. Analysis of other options:** * **Venlafaxine:** This is the prototype **Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)**. At lower doses, it primarily affects serotonin, but at higher doses, it significantly inhibits norepinephrine reuptake. * **Mianserin:** This is an **Atypical Antidepressant** (specifically a tetracyclic antidepressant). While its primary mechanism is blocking presynaptic $\alpha_2$-adrenoceptors (increasing NE release), it also inhibits the reuptake of norepinephrine. In many pharmacological classifications used for competitive exams, it is grouped with drugs that enhance noradrenergic transmission, distinct from pure SSRIs. * **None of the above:** Incorrect, as Paroxetine clearly fits the criteria for an SSRI. **Clinical Pearls for NEET-PG:** * **SNRIs:** Include Venlafaxine, Desvenlafaxine, Duloxetine, and Milnacipran. * **Duloxetine** is the drug of choice for diabetic neuropathy and fibromyalgia. * **Paroxetine** has the shortest half-life among SSRIs and is most associated with **Discontinuation Syndrome**. It is also notably associated with weight gain and anticholinergic side effects compared to other SSRIs. * **Fluoxetine** has the longest half-life and is the SSRI of choice in children and adolescents.

Question 219: All of the following are Selective Serotonin Reuptake Inhibitors (SSRIs) except?

A. Paroxetine
B. Escitalopram
C. Fluvoxamine
D. Mirtazapine (Correct Answer)

Explanation: **Explanation:** The correct answer is **Mirtazapine**. **1. Why Mirtazapine is the correct answer:** Mirtazapine is not an SSRI; it is classified as a **Noradrenergic and Specific Serotonergic Antidepressant (NaSSA)** [2]. Its mechanism of action involves blocking **presynaptic $\alpha_2$-autoreceptors**, which increases the release of both norepinephrine and serotonin. It also blocks 5-$HT_2$ and 5-$HT_3$ receptors, which helps reduce the common side effects associated with SSRIs, such as anxiety and nausea [1]. **2. Why the other options are incorrect:** * **Paroxetine (A):** A potent SSRI often used for panic disorders and OCD [2], [3]. It has a relatively short half-life and is known for having the highest risk of "discontinuation syndrome" among SSRIs. * **Escitalopram (B):** The S-enantiomer of citalopram [1]. It is considered the most selective SSRI with the fewest drug-drug interactions, making it a first-line choice for depression [3]. * **Fluvoxamine (C):** An SSRI primarily indicated for Obsessive-Compulsive Disorder (OCD) [2], [3]. It is unique for its potent inhibition of CYP enzymes. **3. NEET-PG High-Yield Clinical Pearls:** * **SSRIs** are the first-line treatment for Depression, OCD, Panic Disorder, and Social Phobia. * **Mirtazapine** is a "weight-positive" antidepressant. It is a preferred choice for depressed patients suffering from **insomnia and significant weight loss** due to its side effects of sedation (H1 blockade) and increased appetite [2]. * **Sexual dysfunction** is a common side effect of SSRIs (Options A, B, C) [1], but **Mirtazapine** is "serotonin-sparing" in this regard and is often used when patients cannot tolerate the sexual side effects of SSRIs. * **Drug of choice for OCD:** Fluoxetine/Fluvoxamine. * **Drug of choice for Depression:** SSRIs (Escitalopram is frequently preferred).

Question 220: Which of the following is NOT a side effect of amitriptyline?

A. Constipation
B. Fine tremors
C. Weight loss (Correct Answer)
D. Dry mouth

Explanation: **Explanation:** Amitriptyline is a **Tricyclic Antidepressant (TCA)**. The side effect profile of TCAs is determined by their multi-receptor antagonism, specifically blocking Muscarinic (M1), Histaminic (H1), and Alpha-1 (α1) receptors. **Why Weight Loss is the Correct Answer:** Amitriptyline is notorious for causing **weight gain**, not weight loss. This occurs primarily due to its potent **H1-receptor antagonism**, which increases appetite and slows metabolism. In clinical practice, weight gain is a common reason for patient non-compliance with TCAs. **Analysis of Incorrect Options:** * **Constipation & Dry Mouth (Options A & D):** These are classic **Anticholinergic (Antimuscarinic)** side effects. TCAs block M1 receptors, leading to the "dry" symptoms: dry mouth (xerostomia), constipation, urinary retention, and blurred vision. * **Fine Tremors (Option B):** TCAs inhibit the reuptake of Norepinephrine (NE). Increased synaptic NE levels can lead to sympathetic overactivity, manifesting as fine tremors, tachycardia, or sweating. **NEET-PG High-Yield Pearls:** 1. **Mechanism:** TCAs inhibit the reuptake of both Serotonin (5-HT) and Norepinephrine (NE). 2. **Cardiac Toxicity:** The most serious side effect in overdose is **cardiotoxicity** (arrhythmias and QRS prolongation) due to Sodium (Na+) channel blockade. The antidote is **Sodium Bicarbonate**. 3. **The 3 C’s of TCA Overdose:** **C**oma, **C**onvulsions, and **C**ardiotoxicity. 4. **Contraindication:** Avoid in patients with Glaucoma (due to mydriasis) and Benign Prostatic Hyperplasia (due to urinary retention).

Question 221: Which of the following is a side effect of fluoxetine?

A. Weight gain
B. Sweating
C. Urinary retention (Correct Answer)
D. Diarrhoea

Explanation: **Explanation:** Fluoxetine is a prototype **Selective Serotonin Reuptake Inhibitor (SSRI)**. While SSRIs primarily increase synaptic serotonin levels, they can exert secondary effects on other neurotransmitter systems. **Why Urinary Retention is the Correct Answer:** Although SSRIs are generally known for lacking the heavy anticholinergic burden of Tricyclic Antidepressants (TCAs), **Fluoxetine** possesses mild **antimuscarinic (anticholinergic) activity**. This can lead to symptoms such as dry mouth and, notably, **urinary retention** due to the inhibition of detrusor muscle contraction. In the context of this specific question, it is the recognized side effect among the choices provided. **Analysis of Incorrect Options:** * **A. Weight Gain:** Most SSRIs, especially Fluoxetine, are associated with **weight loss** or are weight-neutral during initial therapy. Significant weight gain is more characteristic of TCAs or Mirtazapine. * **B. Sweating:** While diaphoresis can occur in Serotonin Syndrome, it is not a classic side effect of standard Fluoxetine therapy compared to the anticholinergic "drying" effects. * **D. Diarrhoea:** While SSRIs often cause GI upset (nausea/loose stools) due to 5-HT3 stimulation, the anticholinergic profile of Fluoxetine specifically leans toward decreased GI motility and urinary hesitancy. **High-Yield Clinical Pearls for NEET-PG:** * **Longest Half-life:** Fluoxetine has the longest half-life (2–3 days) among SSRIs; its active metabolite, **norfluoxetine**, lasts 7–10 days. * **Washout Period:** Due to its long half-life, a 5-week washout period is required before starting an MAO inhibitor to avoid **Serotonin Syndrome**. * **Drug of Choice:** Fluoxetine is the preferred SSRI for **Bulimia Nervosa** and Depression in children/adolescents. * **Common Side Effects:** Sexual dysfunction (most common long-term), Akathisia, and Insomnia.

Question 222: All of the following are atypical antipsychotic drugs except?

A. Clozapine
B. Risperidone
C. Olanzapine
D. Loxapine (Correct Answer)

Explanation: **Explanation:** The classification of antipsychotics is based on their mechanism of action and side-effect profile. Antipsychotics are divided into **Typical (First Generation)** and **Atypical (Second Generation)** drugs. **Why Loxapine is the correct answer:** Loxapine is a **Typical (First Generation) Antipsychotic** belonging to the dibenzoxazepine class. Like other typical antipsychotics (e.g., Haloperidol, Chlorpromazine), its primary mechanism is the potent blockade of **Postsynaptic D2 receptors** in the mesolimbic pathway. While it has some serotonin-blocking properties, it is traditionally categorized as a first-generation agent due to its high affinity for D2 receptors and its potential to cause Extrapyramidal Symptoms (EPS) at higher doses. **Why the other options are incorrect:** * **Clozapine (Option A):** The prototype atypical antipsychotic. It has a low affinity for D2 receptors and a high affinity for D4 and 5-HT2A receptors. It is the drug of choice for **treatment-resistant schizophrenia**. * **Risperidone (Option B):** A benzisoxazole derivative and a potent 5-HT2A and D2 antagonist. It is a common atypical agent but is notable for causing hyperprolactinemia. * **Olanzapine (Option C):** A thienobenzodiazepine derivative. It is an atypical antipsychotic known for causing significant **weight gain and metabolic syndrome**. **High-Yield Clinical Pearls for NEET-PG:** * **Atypical vs. Typical:** Atypicals are defined by a lower risk of EPS and higher 5-HT2A/D2 receptor blockade ratio. * **Clozapine Monitoring:** Requires mandatory WBC count monitoring due to the risk of **agranulocytosis** (most serious side effect). It also lowers the seizure threshold. * **Quetiapine:** The atypical antipsychotic with the lowest risk of EPS; often preferred in Parkinson’s disease patients with psychosis. * **Aripiprazole:** Known as a "D2 partial agonist" or dopamine system stabilizer.

Question 223: Which is the drug of choice for schizophrenia?

A. Olanzapine (Correct Answer)
B. Haloperidol
C. Lithium
D. Chlorpromazine

Explanation: **Explanation:** The management of schizophrenia has evolved from typical antipsychotics to **Atypical Antipsychotics (Second-Generation Antipsychotics)**, which are now considered the first-line treatment (Drug of Choice) for most patients. **1. Why Olanzapine is Correct:** Olanzapine is a potent atypical antipsychotic that acts as an antagonist at $D_2$ and $5-HT_{2A}$ receptors. It is preferred because it effectively treats both **positive symptoms** (hallucinations, delusions) and **negative symptoms** (apathy, social withdrawal) of schizophrenia. Crucially, it has a significantly lower risk of **Extrapyramidal Side Effects (EPS)** compared to older drugs, making it better tolerated for long-term use. **2. Why the other options are incorrect:** * **Haloperidol (Option B):** A high-potency typical antipsychotic. While effective for acute psychosis, it is no longer the first-line choice due to a very high incidence of EPS (dystonia, parkinsonism, akathisia). * **Lithium (Option C):** This is the drug of choice for **Bipolar Affective Disorder (BPAD)** and acute mania, not schizophrenia. It is a mood stabilizer, not an antipsychotic. * **Chlorpromazine (Option D):** A low-potency typical antipsychotic. It was the first antipsychotic discovered but is rarely used as a first-line agent today due to side effects like severe sedation, orthostatic hypotension, and skin pigmentation. **High-Yield Clinical Pearls for NEET-PG:** * **Clozapine** is the "Gold Standard" for **Treatment-Resistant Schizophrenia**, but it is not first-line due to the risk of **agranulocytosis** (requires mandatory WBC monitoring). * **Side Effects of Olanzapine:** Significant weight gain, hyperglycemia, and dyslipidemia (Metabolic Syndrome). * **Hyperprolactinemia** is common with typical antipsychotics and Risperidone, but less common with Olanzapine and Aripiprazole.

Question 224: What is a known side effect of phenothiazines?

A. Epithelial keratopathy
B. Cataract
C. Central chorioretinopathy
D. Lens and corneal pigmentation (Correct Answer)

Explanation: **Explanation:** Phenothiazines, particularly **Chlorpromazine**, are known for causing specific ocular toxicities when used in high doses over long periods. **Why Option D is correct:** Chlorpromazine has a high affinity for melanin-containing tissues. It undergoes photochemical reactions when exposed to light, leading to the deposition of fine, particulate, brownish-yellow granules in the **anterior lens capsule** and the **posterior corneal endothelium**. These deposits typically follow a "star-shaped" or "stellate" pattern on the lens. While these deposits are often asymptomatic, they are a classic high-yield side effect of typical antipsychotics. **Analysis of Incorrect Options:** * **A. Epithelial keratopathy:** This is more commonly associated with drugs like **Amiodarone** (vortex keratopathy/cornea verticillata) or Chloroquine, rather than phenothiazines. * **B. Cataract:** While severe lens pigmentation can theoretically interfere with vision, phenothiazines do not typically cause standard senile or metabolic cataracts. However, **Quetiapine** (an atypical antipsychotic) requires periodic slit-lamp exams in some protocols due to a theoretical risk of cataracts. * **C. Central chorioretinopathy:** This is not a feature of phenothiazines. However, **Thioridazine** (another phenothiazine) is famous for causing **Retinitis Pigmentosa** (brownish discoloration of the retina) if the daily dose exceeds 800 mg. **NEET-PG High-Yield Pearls:** 1. **Chlorpromazine:** Think **C**orneal and **C**apsular (Lens) deposits. 2. **Thioridazine:** Think **T**oxic **R**etinopathy (Salt and pepper fundus). 3. **Mnemonic:** "Chlorpromazine for the Cornea, Thioridazine for the Retina." 4. Always monitor the "800 mg/day" ceiling dose for Thioridazine to prevent irreversible blindness.

Question 225: Which of the following is NOT a use of fluoxetine?

A. Treatment of delayed ejaculation (Correct Answer)
B. Treatment of premature ejaculation
C. Treatment of impulse control disorder
D. Treatment of paraphilia

Explanation: Fluoxetine is a **Selective Serotonin Reuptake Inhibitor (SSRI)**. The core pharmacological concept to remember for NEET-PG is that SSRIs increase synaptic serotonin, which leads to a **delay in ejaculation** as a common side effect. **Explanation of the Correct Answer:** * **Option A (Treatment of delayed ejaculation):** This is the correct answer because fluoxetine *causes* delayed ejaculation; it is never used to treat it. Using an SSRI in a patient who already has delayed ejaculation would worsen the condition. **Explanation of Incorrect Options:** * **Option B (Premature ejaculation):** Because SSRIs significantly prolong the ejaculatory latency time, they are used "off-label" to treat premature ejaculation. (Note: **Dapoxetine** is the specific SSRI approved for this due to its short half-life). * **Option C (Impulse control disorder):** SSRIs are first-line treatments for various impulse control disorders (like kleptomania or trichotillomania) and Obsessive-Compulsive Disorder (OCD) by modulating serotonergic pathways in the prefrontal cortex. * **Option D (Paraphilia):** In cases of hypersexuality or paraphilic disorders, fluoxetine is used to reduce libido and compulsive sexual urges. **NEET-PG High-Yield Pearls:** 1. **Half-life:** Fluoxetine has the longest half-life among SSRIs (due to its active metabolite **norfluoxetine**), requiring a 5-week washout period before starting an MAO inhibitor to avoid **Serotonin Syndrome**. 2. **Drug of Choice:** Fluoxetine is the preferred SSRI for **Bulimia Nervosa** and **Depression in children/adolescents**. 3. **Side Effects:** Common side effects include GI upset, insomnia, and sexual dysfunction (decreased libido and anorgasmia).

Question 226: What is the drug of choice for substitution therapy in morphine dependence?

A. Methadone (Correct Answer)
B. Clonidine
C. Naloxone
D. Nalmefene

Explanation: **Explanation:** The management of opioid dependence (e.g., morphine or heroin) involves two phases: detoxification and maintenance (substitution) therapy. **Why Methadone is the Correct Answer:** **Methadone** is a long-acting synthetic µ-opioid agonist. In substitution therapy, it replaces the abused drug to prevent withdrawal symptoms and reduce "drug-seeking" behavior. Its efficacy lies in its **long half-life (24–36 hours)** and high oral bioavailability. This allows for once-daily dosing, providing a stable plasma concentration that avoids the rapid "high" (euphoria) and subsequent "crash" associated with short-acting opioids like morphine. **Analysis of Incorrect Options:** * **Clonidine:** An $\alpha_2$ agonist used to suppress the **autonomic symptoms** of opioid withdrawal (tachycardia, hypertension, sweating). It is not a substitute for the opioid itself and does not reduce craving. * **Naloxone:** A short-acting pure opioid antagonist. It is the drug of choice for **acute opioid poisoning** (overdose). If given to a dependent patient, it will precipitate immediate, severe withdrawal. * **Nalmefene:** A long-acting opioid antagonist (similar to Naltrexone). It is used for alcohol dependence or post-detoxification maintenance to prevent relapse, but never for substitution during active dependence. **High-Yield Clinical Pearls for NEET-PG:** * **Buprenorphine** (a partial µ-agonist) is another first-line agent for substitution therapy; it has a lower risk of overdose due to its "ceiling effect." * **Naltrexone** is used for **relapse prevention** only *after* the patient has been opioid-free for 7–10 days. * **Methadone side effect:** It can cause **QT interval prolongation**, requiring ECG monitoring.

Question 227: Depot preparations are available for which of the following drugs?

A. Haloperidol
B. Risperidone (Correct Answer)
C. Olanzapine
D. Imipramine

Explanation: **Explanation:** Depot preparations are long-acting injectable (LAI) formulations designed to release the drug slowly over weeks, improving treatment adherence in chronic conditions like schizophrenia. **Why Risperidone is the correct answer:** Risperidone was the first atypical (second-generation) antipsychotic to be available as a depot preparation (e.g., Risperidone Consta). It is administered intramuscularly every 2 weeks. While Haloperidol and Olanzapine also have depot forms, in the context of standard NEET-PG questions and recent clinical focus, **Risperidone** is frequently highlighted as the prototype for atypical depot antipsychotics. **Analysis of Incorrect Options:** * **Haloperidol (Option A):** While Haloperidol Decanoate exists as a depot, it is a first-generation (typical) antipsychotic. In many MCQ formats, if both are present, the question often tests knowledge of newer atypical depots. However, technically, Haloperidol is also available as a depot. * **Olanzapine (Option C):** Olanzapine Pamoate is a depot formulation, but it is less commonly used due to the risk of **Post-injection Delirium Sedation Syndrome (PDSS)**, requiring mandatory 3-hour observation. * **Imipramine (Option D):** This is a Tricyclic Antidepressant (TCA). TCAs are administered orally; there are no depot preparations for antidepressants. **High-Yield Clinical Pearls for NEET-PG:** * **Common Depot Drugs:** Fluphenazine decanoate, Haloperidol decanoate, Risperidone, Paliperidone, and Aripiprazole. * **Indication:** Primarily used for patients with poor compliance or "revolving door" schizophrenia. * **Mechanism:** These are usually esterified in oil (typical) or microsphere-encapsulated (atypical) to slow absorption. * **Avoid:** Depot injections should never be given intravenously; they are strictly for deep intramuscular (IM) use.

Question 228: What is the drug of choice for treating attention-deficit/hyperactivity disorder?

A. Haloperidol
B. Clonidine
C. Methylphenidate (Correct Answer)
D. Diazepam

Explanation: **Explanation:** **1. Why Methylphenidate is Correct:** Methylphenidate is a **CNS stimulant** and remains the **first-line drug of choice (DOC)** for Attention-Deficit/Hyperactivity Disorder (ADHD) in both children and adults. Its primary mechanism involves blocking the reuptake of **Norepinephrine (NE) and Dopamine (DA)** by inhibiting their respective transporters (NET and DAT) in the prefrontal cortex. This increases the synaptic concentration of these catecholamines, which improves executive function, enhances attention span, and reduces impulsivity and hyperactivity. **2. Why the Other Options are Incorrect:** * **Haloperidol (Option A):** A typical antipsychotic (D2 blocker) used for schizophrenia and Tourette syndrome. It can actually worsen ADHD symptoms by causing sedation and cognitive blunting. * **Clonidine (Option B):** An alpha-2 agonist. While used as an *adjunct* or second-line treatment for ADHD (especially if there are comorbid tics or sleep issues), it is not the first-line drug of choice. * **Diazepam (Option C):** A benzodiazepine used for anxiety and seizures. It causes sedation and can lead to "paradoxical excitation" in children, making it inappropriate for ADHD. **3. High-Yield Clinical Pearls for NEET-PG:** * **Non-Stimulant DOC:** **Atomoxetine** (Selective NE reuptake inhibitor) is the preferred choice if there is a risk of substance abuse or if stimulants are contraindicated. * **Side Effects:** The most common side effects of Methylphenidate are **insomnia and anorexia** (appetite suppression). Long-term use requires monitoring for **growth retardation** in children. * **Contraindications:** Avoid in patients with glaucoma, motor tics, or those on MAO inhibitors. * **Modafinil:** Sometimes used off-label, but primarily the DOC for **Narcolepsy**.

Question 229: Lithium may produce which of the following conditions?

A. Hyperthyroidism
B. Hypothyroidism (Correct Answer)
C. Hyperparathyroidism
D. Hypoparathyroidism

Explanation: **Explanation:** Lithium is the gold-standard mood stabilizer for Bipolar Disorder, but it has a narrow therapeutic index and significant endocrine side effects. **1. Why Hypothyroidism is Correct:** Lithium is actively concentrated by the thyroid gland. It inhibits the synthesis and release of thyroid hormones ($T_3$ and $T_4$) by interfering with **iodine organification** and inhibiting **thyroglobulin colloid pinocytosis**. This leads to a compensatory rise in Thyroid Stimulating Hormone (TSH). Approximately 5–15% of patients on long-term Lithium therapy develop clinical or subclinical hypothyroidism. It is more common in females and those with pre-existing thyroid antibodies. **2. Analysis of Incorrect Options:** * **A. Hyperthyroidism:** While rare cases of Lithium-induced thyrotoxicosis have been reported (usually due to painless thyroiditis), the classic and most frequent association is hypothyroidism. * **C & D. Parathyroid Effects:** Interestingly, Lithium actually tends to cause **Hyperparathyroidism** (not hypo-). It increases the "set-point" of the calcium-sensing receptor in the parathyroid gland, leading to increased PTH secretion and subsequent **Hypercalcemia**. **3. High-Yield Clinical Pearls for NEET-PG:** * **Monitoring:** Check TSH levels every 6–12 months in patients on Lithium. * **Management:** Lithium-induced hypothyroidism is managed by adding **Levothyroxine**; Lithium does *not* necessarily need to be discontinued. * **Renal Side Effect:** Lithium most commonly causes **Nephrogenic Diabetes Insipidus** (resistance to ADH). * **Teratogenicity:** Use in pregnancy is associated with **Ebstein’s Anomaly** (atrialization of the right ventricle). * **Drug Interactions:** Thiazides, NSAIDs, and ACE inhibitors increase Lithium levels, leading to toxicity.

Question 230: Which drug has a very narrow therapeutic range?

A. Lithium (Correct Answer)
B. Sertraline
C. Roxetine
D. Dothiepin

Explanation: **Explanation:** **Lithium** is the correct answer because it is the classic example of a drug with a **narrow therapeutic index (NTI)**. Its therapeutic serum levels (0.6–1.2 mEq/L) are very close to its toxic levels (>1.5 mEq/L). Because the margin of safety is so slim, even minor changes in dosage, hydration, or renal function can lead to life-threatening toxicity. Consequently, **Therapeutic Drug Monitoring (TDM)** is mandatory for patients on Lithium. **Analysis of Incorrect Options:** * **Sertraline & Paroxetine (Roxetine):** These are Selective Serotonin Reuptake Inhibitors (SSRIs). SSRIs have a wide therapeutic window, meaning the dose required for efficacy is significantly lower than the dose that causes severe toxicity. They are generally safe in overdose. * **Dothiepin:** This is a Tricyclic Antidepressant (TCA). While TCAs are more cardiotoxic in overdose than SSRIs, they still possess a broader therapeutic range compared to Lithium and do not require routine TDM. **High-Yield Clinical Pearls for NEET-PG:** 1. **Therapeutic Levels:** 0.5–0.8 mEq/L (Maintenance); 0.8–1.2 mEq/L (Acute Mania). Toxicity starts >1.5 mEq/L. 2. **Excretion:** Lithium is handled like Sodium in the proximal tubule. **Thiazides, NSAIDs, and ACE inhibitors** decrease Lithium clearance, precipitating toxicity. 3. **Side Effects:** L-I-T-H: **L**eukocytosis, **I**nsipidus (Nephrogenic Diabetes Insipidus), **T**remors/Teratogenicity (Ebstein's Anomaly), **H**ypothyroidism. 4. **Monitoring:** Renal function tests (RFT) and Thyroid function tests (TFT) must be checked periodically.

Question 231: Buspirone, an antianxiety drug, acts on which receptors?

A. GABA receptors
B. Benzodiazepine receptors
C. D2 receptors
D. 5-HT1A receptors (Correct Answer)

Explanation: **Explanation:** **Buspirone** is a non-benzodiazepine anxiolytic used primarily for the management of Generalized Anxiety Disorder (GAD). **1. Why Option D is Correct:** Buspirone acts as a **selective partial agonist at 5-HT1A receptors**. By stimulating these presynaptic autoreceptors in the raphe nuclei and postsynaptic receptors in the hippocampus, it modulates serotonin neurotransmission. Unlike benzodiazepines, it does not have immediate effects; its anxiolytic action typically takes **1–2 weeks** to manifest. **2. Why Other Options are Incorrect:** * **Options A & B (GABA and Benzodiazepine receptors):** Conventional anxiolytics like Benzodiazepines and Barbiturates work by modulating the GABA-A receptor complex to increase chloride conductance. Buspirone has **no action on GABA receptors**, which explains why it lacks sedative, hypnotic, anticonvulsant, and muscle relaxant properties. * **Option C (D2 receptors):** While Buspirone has some weak affinity for dopamine D2 receptors, this is not its primary mechanism for treating anxiety. It does not possess significant antipsychotic activity. **3. Clinical Pearls for NEET-PG:** * **"The 3 No’s" of Buspirone:** No Sedation, No Tolerance/Dependence (low abuse potential), and No interaction with Alcohol. * **Driving:** It is preferred in patients who need to drive or operate machinery as it does not cause psychomotor impairment. * **Limitations:** It is ineffective for "PRN" (as needed) use or acute panic attacks due to its delayed onset of action. * **Metabolism:** It is metabolized by **CYP3A4**; concurrent use with rifampin (inducer) or erythromycin (inhibitor) requires dose adjustment.

Question 232: Which of the following is a Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)?

A. Duloxetine (Correct Answer)
B. Sertraline
C. Citalopram
D. Isoniazid

Explanation: ### Explanation **Correct Option: A. Duloxetine** Duloxetine is a **Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)** [1]. It works by inhibiting the reuptake of both serotonin (5-HT) and norepinephrine (NE) in the synaptic cleft, thereby increasing their availability [1], [3]. * **Clinical Concept:** Unlike Selective Serotonin Reuptake Inhibitors (SSRIs), SNRIs have a dual mechanism [1]. Duloxetine is particularly unique because it is FDA-approved not just for depression and anxiety, but also for **chronic pain conditions** like diabetic neuropathy, fibromyalgia, and chronic musculoskeletal pain [2], as norepinephrine modulation helps inhibit descending pain pathways in the spinal cord. **Incorrect Options:** * **B. Sertraline & C. Citalopram:** Both belong to the **SSRI** class [1]. They selectively inhibit the reuptake of serotonin [3]. SSRIs are generally considered first-line treatment for depression due to a better side-effect profile compared to older antidepressants. * **D. Isoniazid:** This is an **anti-tubercular drug** (cell wall synthesis inhibitor). While it historically led to the discovery of MAO inhibitors (due to its structural similarity to Iproniazid), it is not used as an antidepressant. **High-Yield NEET-PG Pearls:** 1. **Other SNRIs:** Venlafaxine (can cause dose-dependent hypertension), Desvenlafaxine, and Milnacipran [1], [2]. 2. **Duloxetine & Stress Incontinence:** Duloxetine is also used in some countries for stress urinary incontinence (increases urethral sphincter tone). 3. **Side Effects:** SNRIs can cause increased blood pressure, heart rate, and insomnia due to the noradrenergic component. 4. **Contraindication:** Avoid SNRIs/SSRIs with MAO inhibitors to prevent **Serotonin Syndrome**.

Question 233: Chronic use of anti-psychotic drugs can lead to which of the following side effects?

A. Orthostatic hypotension
B. Parkinsonism
C. Tardive dyskinesia
D. All of the above (Correct Answer)

Explanation: **Explanation:** Antipsychotic drugs, particularly Typical Antipsychotics (First Generation), act primarily by blocking Dopamine ($D_2$) receptors and various other neuroreceptors, leading to a wide spectrum of side effects. 1. **Tardive Dyskinesia (Option C):** This is the hallmark of **chronic (long-term)** antipsychotic use. It occurs due to the "up-regulation" or supersensitivity of dopamine receptors in the nigrostriatal pathway after prolonged blockade. It manifests as involuntary choreoathetoid movements, typically involving the tongue (fly-catching) and face. 2. **Parkinsonism (Option B):** This is a part of Extrapyramidal Symptoms (EPS). It occurs because $D_2$ blockade in the nigrostriatal pathway creates a functional deficiency of dopamine, mimicking Parkinson’s disease (tremors, rigidity, bradykinesia). While it can occur early, it often persists with chronic therapy. 3. **Orthostatic Hypotension (Option A):** Many antipsychotics (especially low-potency drugs like Chlorpromazine) block **$\alpha_1$-adrenergic receptors**. This prevents compensatory vasoconstriction when standing, leading to a drop in blood pressure. **Clinical Pearls for NEET-PG:** * **Tardive Dyskinesia:** Unlike other EPS, it may worsen if the antipsychotic dose is reduced or stopped. Treatment involves switching to **Clozapine** or using VMAT-2 inhibitors (e.g., Valbenazine). * **Hyperprolactinemia:** Chronic $D_2$ blockade in the tuberoinfundibular pathway leads to increased prolactin, causing galactorrhea and gynecomastia. * **Metabolic Syndrome:** More common with Atypical (Second Generation) antipsychotics like **Olanzapine** and **Clozapine**.

Question 234: Which of the following medications is not an antidepressant?

A. Amitriptyline
B. Fluoxetine
C. Imipramine
D. Chlorpromazine (Correct Answer)

Explanation: **Explanation:** The correct answer is **Chlorpromazine** because it belongs to the class of **Typical Antipsychotics** (First-generation antipsychotics), specifically the Low-Potency Phenothiazines. Its primary mechanism of action is the blockade of post-synaptic **D2 receptors** in the mesolimbic pathway, making it effective for treating schizophrenia and mania, rather than depression. **Analysis of Options:** * **Amitriptyline (Option A):** A classic **Tricyclic Antidepressant (TCA)**. It inhibits the reuptake of both Serotonin (5-HT) and Norepinephrine (NE). It is frequently used for depression, neuropathic pain, and migraine prophylaxis. * **Fluoxetine (Option B):** A prototype **Selective Serotonin Reuptake Inhibitor (SSRI)**. It is a first-line antidepressant due to its favorable side-effect profile and long half-life (due to its active metabolite, norfluoxetine). * **Imipramine (Option C):** Another **TCA** primarily used for major depressive disorder. It is also the historical "gold standard" for treating nocturnal enuresis (bed-wetting) in children. **NEET-PG High-Yield Pearls:** * **Chlorpromazine Side Effects:** It is notorious for causing significant sedation, orthostatic hypotension (alpha-blockade), and skin/ocular pigmentation. It has a lower risk of Extrapyramidal Symptoms (EPS) compared to Haloperidol. * **Drug of Choice:** SSRIs (like Fluoxetine) are the first-line treatment for most anxiety disorders and depression. * **TCA Overdose:** Characterized by the "3 Cs": Coma, Convulsions, and Cardiotoxicity (arrhythmias due to sodium channel blockade). Sodium bicarbonate is the antidote for TCA-induced arrhythmias.

Question 235: What is a primary use of phenothiazines?

A. To induce muscle relaxation.
B. To manage psychotic behavior. (Correct Answer)
C. To suppress coughing.
D. To provide analgesia.

Explanation: **Explanation:** **Phenothiazines** (e.g., Chlorpromazine, Fluphenazine) are a class of **First-Generation (Typical) Antipsychotics**. Their primary mechanism of action involves the **blockade of post-synaptic Dopamine (D2) receptors** in the mesolimbic and mesocortical pathways of the brain. By reducing dopaminergic neurotransmission, they effectively manage the "positive symptoms" of psychosis, such as hallucinations, delusions, and disorganized thinking. **Analysis of Options:** * **Option B (Correct):** As dopamine antagonists, phenothiazines are indicated for schizophrenia, acute mania, and other psychotic disorders. * **Option A (Incorrect):** Phenothiazines do not induce muscle relaxation; in fact, due to D2 blockade in the nigrostriatal pathway, they often cause **Extrapyramidal Symptoms (EPS)** like muscle rigidity and dystonia. * **Option C (Incorrect):** Antitussives (e.g., Codeine, Dextromethorphan) are used to suppress coughing. While some phenothiazines have antihistaminic properties, they are not primary antitussives. * **Option D (Incorrect):** Analgesia is provided by opioids or NSAIDs. Phenothiazines may potentiate the effects of analgesics but are not painkillers themselves. **High-Yield NEET-PG Pearls:** * **Chlorpromazine** is also used for the treatment of **intractable hiccups**. * **Side Effects:** They are notorious for causing **Hyperprolactinemia** (due to D2 blockade in the tuberoinfundibular pathway) and **Neuroleptic Malignant Syndrome (NMS)**. * **Low potency** phenothiazines (Chlorpromazine) cause more sedation and anticholinergic effects, while **high potency** ones (Fluphenazine) cause more EPS.

Question 236: Which of the following is not an atypical antipsychotic?

A. Aripiprazole
B. Amoxapine (Correct Answer)
C. Clozapine
D. Zotepine

Explanation: ### Explanation **Correct Answer: B. Amoxapine** **1. Why Amoxapine is the correct answer:** Amoxapine is a **Tricyclic Antidepressant (TCA)** belonging to the dibenzoxazepine class. While it is unique among antidepressants because its metabolite (7-hydroxyamoxapine) possesses significant **Dopamine D2 receptor blocking activity**—which can lead to extrapyramidal side effects—it is primarily classified and used as an antidepressant, not an atypical antipsychotic. **2. Analysis of Incorrect Options:** * **A. Aripiprazole:** A third-generation atypical antipsychotic. It is unique as a **partial agonist** at D2 and 5-HT1A receptors and an antagonist at 5-HT2A receptors (often called a "Dopamine System Stabilizer"). * **C. Clozapine:** The "prototype" atypical antipsychotic. It is the most effective drug for **treatment-resistant schizophrenia** but requires mandatory WBC monitoring due to the risk of **agranulocytosis**. * **D. Zotepine:** An atypical antipsychotic that blocks D2 and 5-HT2 receptors. It also inhibits norepinephrine reuptake, which may help with the negative symptoms of schizophrenia. **3. High-Yield Clinical Pearls for NEET-PG:** * **Atypical vs. Typical:** Atypical antipsychotics (Second Generation) are defined by a lower risk of Extrapyramidal Symptoms (EPS) and greater efficacy against **negative symptoms** compared to typicals (like Haloperidol). * **Mechanism:** Most atypicals act as **5-HT2A + D2 antagonists** (SDA - Serotonin Dopamine Antagonists). * **Metabolic Side Effects:** Remember the mnemonic **"COZ"** (Clozapine, Olanzapine, Zotepine) for drugs with the highest risk of weight gain and metabolic syndrome. * **Amoxapine Fact:** Because of its D2 blocking metabolite, it is the TCA most likely to cause **Tardive Dyskinesia** or Neuroleptic Malignant Syndrome.

Question 237: Buspirone is used as a:

A. Anxiolytic (Correct Answer)
B. Sedative
C. Muscle relaxant
D. Anticonvulsant

Explanation: **Explanation:** **Buspirone** is a non-benzodiazepine drug used primarily as an **anxiolytic** (Option A). Its mechanism of action involves acting as a **selective partial agonist at the 5-HT1A receptors**. Unlike benzodiazepines, it does not interact with the GABA-A receptor complex, which accounts for its unique clinical profile. **Why other options are incorrect:** * **Sedative (Option B):** Buspirone lacks significant sedative properties. It does not cause psychomotor impairment or drowsiness, making it preferable for patients who need to remain alert. * **Muscle relaxant (Option C) & Anticonvulsant (Option D):** These are classic features of Benzodiazepines (due to GABA-A modulation). Buspirone lacks these properties entirely; it has no effect on muscle tone and cannot be used to treat seizures. **High-Yield Clinical Pearls for NEET-PG:** 1. **Delayed Onset:** Unlike benzodiazepines, Buspirone has a slow onset of action. It takes **2–4 weeks** to show therapeutic effects, making it unsuitable for "as needed" (PRN) use or acute panic attacks. It is used for **Generalized Anxiety Disorder (GAD)**. 2. **Lack of Dependence:** It carries **no risk of tolerance, physical dependence, or withdrawal symptoms**. It is not a controlled substance. 3. **No Interaction with Alcohol:** It does not potentiate the CNS depressant effects of alcohol. 4. **Side Effects:** Most common side effects include dizziness, nausea, and headache. It does not cause significant weight gain or sexual dysfunction.

Question 238: Appetite is decreased by which of the following medications, except?

A. Methylphenidate
B. Olanzapine (Correct Answer)
C. Fluoxetine
D. Sertraline

Explanation: ### Explanation The correct answer is **Olanzapine**. **1. Why Olanzapine is the correct answer:** Olanzapine is a **Second-Generation (Atypical) Antipsychotic**. One of its most significant and notorious side effects is **significant weight gain and increased appetite (hyperphagia)** [1]. This occurs primarily due to its potent antagonism at **H1 (histamine)** and **5-HT2C (serotonin)** receptors, which are key regulators of the satiety center in the hypothalamus. Among atypical antipsychotics, Olanzapine and Clozapine carry the highest risk for metabolic syndrome, dyslipidemia, and Type 2 Diabetes Mellitus [1], [3]. Olanzapine has also shown clinical efficacy in improving weight gain in patients with eating disorders or psychogenic vomiting [2]. **2. Why the other options are incorrect:** * **Methylphenidate (Option A):** This is a CNS stimulant used in ADHD. It increases norepinephrine and dopamine levels, which suppresses the appetite center. Growth monitoring is essential in children on this medication due to potential weight loss. * **Fluoxetine & Sertraline (Options C & D):** These are **SSRIs**. While some SSRIs can be weight-neutral in the long term, **Fluoxetine** is specifically known for causing initial weight loss and decreased appetite [2]. It is, in fact, the only FDA-approved drug for Bulimia Nervosa because it helps reduce binge-eating episodes. **3. High-Yield NEET-PG Pearls:** * **Weight Gain Hierarchy:** Clozapine > Olanzapine > Quetiapine > Risperidone > Ziprasidone/Aripiprazole (Weight neutral) [1]. * **Drug of choice for Bulimia Nervosa:** Fluoxetine (High dose: 60mg). * **Anorexiant agents:** Sibutramine (withdrawn), Lorcaserin (withdrawn), and Phentermine. * **Metabolic Monitoring:** Patients on Olanzapine must have regular monitoring of BMI, waist circumference, fasting blood glucose, and lipid profile.

Question 239: Which of the following medications is NOT used for the treatment of heroin detoxification?

A. Disulfiram (Correct Answer)
B. Buprenorphine
C. Clonidine
D. Lofexidine

Explanation: **Explanation:** The correct answer is **A. Disulfiram**. **Why Disulfiram is the correct answer:** Disulfiram is an aldehyde dehydrogenase inhibitor used exclusively in the treatment of **Alcohol Use Disorder**, not opioid/heroin detoxification. It acts as an "aversion therapy" agent by causing the accumulation of acetaldehyde if alcohol is consumed, leading to the unpleasant "Disulfiram-like reaction" (flushing, tachycardia, nausea). It has no pharmacological role in managing opioid withdrawal or detoxification. **Analysis of incorrect options (Drugs used in Heroin Detoxification):** * **Buprenorphine:** A partial μ-opioid agonist and κ-antagonist. It is a mainstay in opioid detoxification as it relieves withdrawal symptoms and reduces cravings with a lower risk of overdose due to its "ceiling effect." * **Clonidine:** An $\alpha_2$-adrenergic agonist. During heroin withdrawal, there is a massive surge in central sympathetic activity (noradrenergic storm). Clonidine helps suppress autonomic symptoms like sweating, tachycardia, hypertension, and restlessness. * **Lofexidine:** Similar to clonidine, this is a selective $\alpha_2$-adrenergic agonist. It is specifically FDA-approved for the mitigation of opioid withdrawal symptoms and often preferred over clonidine due to a lower risk of hypotension. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard for Opioid Detoxification:** Methadone (Full agonist) or Buprenorphine (Partial agonist). * **Non-Opioid Management:** $\alpha_2$ agonists (Clonidine/Lofexidine) are used for symptomatic relief of autonomic hyperactivity. * **Opioid Overdose:** Naloxone (Short-acting antagonist). * **Opioid Relapse Prevention:** Naltrexone (Long-acting antagonist). * **Disulfiram-like reaction** can also be caused by drugs like Metronidazole, Griseofulvin, and certain Cephalosporins (e.g., Cefotetan).

Question 240: Antipsychotic drug-induced Parkinsonism is treated by which of the following drug classes?

A. Anticholinergics (Correct Answer)
B. Levodopa
C. Selegiline
D. Amantadine

Explanation: ### Explanation **Mechanism of Action (Why A is Correct):** Antipsychotic-induced Parkinsonism (a type of Extrapyramidal Side Effect or EPS) occurs due to the blockade of **D2 receptors** in the **nigrostriatal pathway** [1]. In the striatum, there is a physiological balance between inhibitory **Dopamine** and excitatory **Acetylcholine (ACh)**. When antipsychotics block dopamine receptors, it leads to a relative cholinergic overactivity [3]. To restore this balance, **central anticholinergics** (e.g., Benztropine, Trihexyphenidyl/Benzhexol, Biperiden) are used [4]. **Why Other Options are Incorrect:** * **B. Levodopa:** While it is the gold standard for idiopathic Parkinson’s disease, it is contraindicated here [2]. Increasing dopamine levels can worsen the underlying psychosis (the "Dopamine Hypothesis" of schizophrenia). * **C. Selegiline:** This is an MAO-B inhibitor used in idiopathic Parkinson’s. Like Levodopa, it increases synaptic dopamine and can exacerbate psychotic symptoms. * **D. Amantadine:** Although Amantadine is sometimes used as a second-line agent for EPS due to its weak NMDA antagonism and dopaminergic effects, **Anticholinergics** remain the primary, first-line drug class of choice for drug-induced Parkinsonism in standard clinical guidelines and exams [4]. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for Acute Dystonia:** Intravenous/Intramuscular Promethazine or Benztropine. * **Akathisia:** The most common EPS; the drug of choice is **Propranolol** (Beta-blocker). * **Tardive Dyskinesia:** Occurs due to dopamine receptor supersensitivity after long-term use [3]. Anticholinergics **worsen** Tardive Dyskinesia. Treatment involves switching to Clozapine or using VMAT-2 inhibitors (e.g., Valbenazine). * **Rule of Thumb:** If the question asks for the treatment of any *early-onset* EPS (except Akathisia), think Anticholinergics.

Question 241: The selective MAO-B inhibitor among the following is

A. Selegiline (Correct Answer)
B. Clorgyline
C. Moclobemide
D. Tranylcypromine

Explanation: **Explanation:** Monoamine oxidase (MAO) is an enzyme responsible for the oxidative deamination of biogenic amines. It exists in two isoforms: **MAO-A** (preferentially degrades serotonin, norepinephrine, and dopamine) and **MAO-B** (preferentially degrades dopamine). **1. Why Selegiline is Correct:** **Selegiline** is a selective, irreversible inhibitor of **MAO-B**. By inhibiting the breakdown of dopamine in the striatum, it increases dopamine levels without significantly affecting systemic norepinephrine or serotonin. This selectivity makes it highly effective in the management of **Parkinson’s disease** (often as an adjunct to Levodopa) and, at higher doses, for depression. **2. Analysis of Incorrect Options:** * **Clorgyline:** This is a selective and irreversible inhibitor of **MAO-A**. It is primarily used in research and is not a standard clinical treatment for Parkinson's. * **Moclobemide:** This is a **RIMA** (Reversible Inhibitor of MAO-A). It is used as an antidepressant and is safer than older MAOIs because it carries a lower risk of the "cheese reaction." * **Tranylcypromine:** This is a **non-selective**, irreversible inhibitor of both MAO-A and MAO-B. It is an older antidepressant associated with significant dietary restrictions. **3. High-Yield Clinical Pearls for NEET-PG:** * **Cheese Reaction (Hypertensive Crisis):** Occurs when patients on non-selective MAOIs or MAO-A inhibitors consume tyramine-rich food (aged cheese, wine). Tyramine displaces NE, leading to massive sympathetic discharge. * **Selectivity Loss:** Selegiline loses its MAO-B selectivity at higher doses (>10 mg/day), increasing the risk of hypertensive crisis. * **Rasagiline:** Another potent, irreversible MAO-B inhibitor used in Parkinson’s, often preferred over Selegiline as it is not metabolized into amphetamine derivatives. * **Drug Interaction:** Never combine MAOIs with SSRIs/SNRIs due to the risk of **Serotonin Syndrome**.

Question 242: What is the primary site of action for disulfiram?

A. Aldehyde dehydrogenase (Correct Answer)
B. Alcohol dehydrogenase
C. G6PD
D. Acetate dehydrogenase

Explanation: **Explanation:**1. Mechanism of Action (Why A is correct):Disulfiram is used as an aversion therapy for chronic alcoholism. Its primary site of action is the irreversible inhibition of the enzyme Aldehyde Dehydrogenase (ALDH) [1]. Normally, alcohol is metabolized into acetaldehyde by alcohol dehydrogenase, and then acetaldehyde is converted into acetic acid by ALDH. By blocking ALDH, disulfiram causes a toxic accumulation of acetaldehyde in the blood. This leads to the Disulfiram-Ethanol Reaction (DER), characterized by flushing, tachycardia, nausea, vomiting, and hypotension, which discourages the patient from consuming alcohol [1].2. Analysis of Incorrect Options:B. Alcohol Dehydrogenase: This enzyme converts ethanol to acetaldehyde. It is inhibited by Fomepizole, which is used in methanol or ethylene glycol poisoning, not disulfiram.C. G6PD: Glucose-6-phosphate dehydrogenase is an enzyme in the pentose phosphate pathway. Its deficiency leads to hemolytic anemia; it is not a target for alcohol-related drugs.D. Acetate Dehydrogenase: This is not a primary target in human ethanol metabolism. Acetic acid (acetate) is typically converted to Acetyl-CoA by acetyl-CoA synthetase.3. NEET-PG High-Yield Clinical Pearls:Disulfiram-like reaction: Several other drugs can cause a similar reaction when taken with alcohol. High-yield examples include Metronidazole (most common), Cefotetan, Tinidazole, and Sulfonylureas (Chlorpropamide).Contraindication: Disulfiram should never be administered if the patient has consumed alcohol within the last 12 hours or is in a state of intoxication [2].Acamprosate vs. Naltrexone: While Disulfiram is for aversion, Acamprosate is used to maintain abstinence (NMDA antagonist), and Naltrexone (Opioid antagonist) is used to reduce cravings [1].

Question 243: What is the primary mechanism of action of Fluoxetine?

A. GABA inhibition
B. Adrenergic neuron blocking agent
C. Inhibition of axonal uptake of 5-HT (Correct Answer)
D. Alpha adrenergic stimulation

Explanation: **Explanation:** **Fluoxetine** is a prototype drug belonging to the **Selective Serotonin Reuptake Inhibitors (SSRIs)** class. 1. **Why Option C is Correct:** The primary mechanism of Fluoxetine is the potent and selective inhibition of the serotonin transporter (SERT) located on the presynaptic axonal membrane. By blocking the **axonal uptake of 5-HT (Serotonin)**, it increases the concentration of serotonin in the synaptic cleft, leading to enhanced serotonergic neurotransmission. This is the mainstay treatment for Major Depressive Disorder, OCD, and Panic Disorder. 2. **Why Other Options are Incorrect:** * **Option A (GABA inhibition):** GABA is an inhibitory neurotransmitter. Drugs like Benzodiazepines modulate GABA, but Fluoxetine has no direct effect on GABAergic pathways. * **Option B (Adrenergic neuron blocking agent):** These drugs (e.g., Guanethidine) prevent the release of norepinephrine. Fluoxetine specifically targets serotonin, not the release mechanism of adrenergic neurons. * **Option D (Alpha adrenergic stimulation):** Alpha-agonists (like Phenylephrine) stimulate the sympathetic nervous system. SSRIs like Fluoxetine lack significant affinity for alpha-adrenergic receptors, which is why they have fewer cardiovascular side effects compared to TCAs. **High-Yield Clinical Pearls for NEET-PG:** * **Longest Half-life:** Fluoxetine has the longest half-life (2–4 days) among SSRIs, and its active metabolite, **Norfluoxetine**, has a half-life of 7–10 days. * **Washout Period:** Due to its long half-life, a 5-week washout period is required before starting an MAO inhibitor to avoid **Serotonin Syndrome**. * **Drug of Choice:** SSRIs are the first-line treatment for Depression, OCD, Panic Disorder, Social Phobia, and Post-Traumatic Stress Disorder (PTSD). * **Side Effects:** Common side effects include GI upset, sexual dysfunction, and insomnia. Unlike TCAs, they do not cause significant sedation or anticholinergic effects.

Question 244: Which of the following is NOT a selective serotonin reuptake inhibitor?

A. Fluoxetine
B. Fluvoxamine
C. Buspirone (Correct Answer)
D. Citalopram

Explanation: **Explanation:** The correct answer is **Buspirone** because it is a **selective 5-HT1A receptor partial agonist**, not a Selective Serotonin Reuptake Inhibitor (SSRI). It is primarily used for the treatment of Generalized Anxiety Disorder (GAD). Unlike SSRIs, it does not inhibit the reuptake of serotonin and lacks significant sedative, anticonvulsant, or muscle relaxant properties. **Analysis of Options:** * **Fluoxetine (A):** A prototypical SSRI with the longest half-life (due to its active metabolite, norfluoxetine). It is often the drug of choice in children and for Bulimia Nervosa. * **Fluvoxamine (B):** An SSRI specifically indicated for Obsessive-Compulsive Disorder (OCD) and Social Anxiety Disorder. * **Citalopram (D):** A highly selective SSRI. Its S-enantiomer, Escitalopram, is considered the most potent and selective member of this class. **High-Yield NEET-PG Clinical Pearls:** 1. **Buspirone Advantages:** It does not cause physical dependence, withdrawal symptoms, or sexual dysfunction (unlike SSRIs). It also does not potentiate the effects of alcohol. 2. **Buspirone Lag Time:** Like antidepressants, it takes 2–4 weeks to show therapeutic effects, making it unsuitable for acute anxiety/panic attacks. 3. **SSRI Mnemonic:** Remember the "Big 6" SSRIs: **F**luoxetine, **F**luvoxamine, **P**aroxetine, **S**ertraline, **C**italopram, and **E**scitalopram. 4. **Side Effects:** The most common side effects of SSRIs are GI upset (nausea/diarrhea) and sexual dysfunction. The most dangerous is **Serotonin Syndrome** when combined with MAO inhibitors.

Question 245: All of the following drugs are monoamine oxidase inhibitors except?

A. Moclobemide
B. Tranylcypromine
C. Selegiline
D. Duloxetine (Correct Answer)

Explanation: **Explanation:** The correct answer is **Duloxetine** because it belongs to the class of **Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)**, not Monoamine Oxidase Inhibitors (MAOIs). It works by inhibiting the reuptake of both serotonin and norepinephrine in the synaptic cleft. **Breakdown of Options:** * **Moclobemide:** It is a **RIMA** (Reversible Inhibitor of MAO-A). Unlike older MAOIs, it has a lower risk of the "cheese reaction" because it can be displaced from the enzyme by tyramine. * **Tranylcypromine:** It is a **Non-selective, Irreversible MAOI** (inhibits both MAO-A and MAO-B). It is one of the older, "classical" antidepressants. * **Selegiline:** It is a **Selective Irreversible MAO-B Inhibitor**. At low doses, it is used primarily in Parkinson’s disease to increase dopamine levels. At higher doses, it loses selectivity and can act as an antidepressant. **High-Yield Clinical Pearls for NEET-PG:** 1. **Cheese Reaction:** Occurs when patients on non-selective MAOIs consume tyramine-rich food (aged cheese, wine). Tyramine displaces stored NE, leading to a **hypertensive crisis**. Treatment of choice: **Phentolamine** (Alpha-blocker). 2. **Serotonin Syndrome:** A dangerous interaction occurring when MAOIs are combined with SSRIs or SNRIs (like Duloxetine). Always maintain a **washout period** of at least 14 days when switching between these classes. 3. **Duloxetine Indications:** Apart from MDD and GAD, it is a first-line drug for **Diabetic Neuropathy**, Fibromyalgia, and Stress Urinary Incontinence.

Question 246: Which of the following drugs should not be used with rivastigmine in patients with Alzheimer's disease?

A. SSRI
B. Tricyclic antidepressant (Correct Answer)
C. RIMA
D. Atypical antidepressants

Explanation: **Explanation:** The core pharmacological principle here is **pharmacodynamic antagonism**. Rivastigmine is a centrally acting **acetylcholinesterase inhibitor (AChEI)** used to increase synaptic acetylcholine levels in Alzheimer’s disease to improve cognitive function. **Why Tricyclic Antidepressants (TCAs) are contraindicated:** TCAs (e.g., Amitriptyline, Imipramine) possess significant **potent anticholinergic (antimuscarinic) properties**. When co-administered with rivastigmine, TCAs directly oppose the therapeutic action of the AChEI. This "pharmacological tug-of-war" results in reduced efficacy of the Alzheimer’s treatment and can worsen cognitive decline, confusion, and sedation in elderly patients. **Analysis of Incorrect Options:** * **A. SSRIs (e.g., Sertraline):** These are the preferred antidepressants in Alzheimer’s patients because they lack significant anticholinergic activity and are generally well-tolerated. * **C. RIMA (e.g., Moclobemide):** Reversible Inhibitors of MAO-A do not possess anticholinergic properties and do not directly interfere with the cholinergic pathway. * **D. Atypical Antidepressants (e.g., Mirtazapine, Trazodone):** While some may be sedating, they do not have the potent muscarinic blockade seen with TCAs and are often used to manage insomnia or agitation in dementia. **High-Yield Clinical Pearls for NEET-PG:** * **Avoid "The Anticholinergic Burden":** In elderly patients with dementia, always avoid drugs with anticholinergic side effects (e.g., TCAs, first-generation antihistamines, oxybutynin, and antipsychotics like chlorpromazine). * **Rivastigmine Unique Feature:** It inhibits both **Acetylcholinesterase (AChE)** and **Butyrylcholinesterase (BuChE)** and is available as a transdermal patch to reduce GI side effects. * **Drug of Choice:** Donepezil is often the first-line AChEI due to its once-daily dosing.

Question 247: Which of the following drugs is classified under FDA teratogenic risk category B for pregnancy?

A. Phenytoin
B. Risperidone
C. Olanzapine
D. Clozapine (Correct Answer)

Explanation: **Explanation:** The classification of drugs in pregnancy is a high-yield topic for NEET-PG. While the FDA has transitioned away from the old A-B-C-D-X lettering system, these categories remain frequently tested in competitive exams. **1. Why Clozapine is Correct:** **Clozapine** is the only atypical antipsychotic traditionally classified under **FDA Category B**. This means animal reproduction studies have failed to demonstrate a risk to the fetus, and there are no adequate and well-controlled studies in pregnant women. While it is the "gold standard" for treatment-resistant schizophrenia, its use in pregnancy requires careful monitoring for maternal agranulocytosis and gestational diabetes. **2. Analysis of Incorrect Options:** * **Phenytoin (Option A):** Classified as **Category D**. It is a known teratogen associated with **Fetal Hydantoin Syndrome** (craniofacial anomalies, hypoplastic phalanges, and growth retardation). * **Risperidone (Option B):** Classified as **Category C**. Animal studies have shown adverse effects on the fetus, and there are no adequate human studies. Most atypical antipsychotics (like Quetiapine and Aripiprazole) fall into this category. * **Olanzapine (Option C):** Also classified as **Category C**. While commonly used, it carries a higher risk of significant maternal weight gain and gestational metabolic complications compared to other agents. **3. NEET-PG Clinical Pearls:** * **Lithium:** Category D; specifically associated with **Ebstein’s Anomaly** (tricuspid valve displacement). * **Valproate:** Category X/D; highest risk for **Neural Tube Defects** (Spina Bifida). * **SSRIs:** Most are Category C, except **Paroxetine**, which is Category D (risk of fetal cardiac malformations). * **Drug of Choice:** For psychosis in pregnancy, **Haloperidol** (typical) has the most extensive safety data, though Clozapine remains the Category B outlier among atypicals.

Question 248: Which of the following is the newest antidepressant?

A. Buspirone
B. Fluoxetine (Correct Answer)
C. Penfluridol
D. Clozapine

Explanation: **Explanation:** The correct answer is **Fluoxetine**. This question tests the classification and historical context of psychotropic medications, which is a high-yield area for NEET-PG. **Why Fluoxetine is correct:** Fluoxetine is the prototype of the **Selective Serotonin Reuptake Inhibitors (SSRIs)**. While "newest" is a relative term in pharmacology textbooks, among the options provided, Fluoxetine represents the most modern class of antidepressants. It revolutionized depression treatment by providing efficacy similar to older Tricyclic Antidepressants (TCAs) but with a significantly better safety profile and fewer anticholinergic side effects. **Why the other options are incorrect:** * **Buspirone (Option A):** This is an **Anxiolytic** (specifically a 5-HT1A partial agonist). It is used for Generalized Anxiety Disorder (GAD), not primarily as an antidepressant. * **Penfluridol (Option C):** This is a long-acting **Typical Antipsychotic** (Diphenylbutylpiperidine class) used in the treatment of schizophrenia. * **Clozapine (Option D):** This is an **Atypical Antipsychotic**. It is the gold standard for "Treatment-Resistant Schizophrenia" but is not classified as an antidepressant. **High-Yield Clinical Pearls for NEET-PG:** * **Fluoxetine** has the longest half-life among SSRIs (due to its active metabolite, norfluoxetine), making it the drug of choice for patients with poor compliance. * **Drug of Choice (DOC):** SSRIs are currently the first-line treatment for Depression, Panic Disorder, OCD, Social Phobia, and PTSD. * **Side Effects:** Watch for sexual dysfunction (most common long-term side effect) and "Serotonin Syndrome" if combined with MAO inhibitors. * **Clozapine Alert:** Always remember the risk of **Agranulocytosis**; mandatory WBC monitoring is required.

Question 249: Which of the following is not a MAO-B inhibitor?

A. Safinamide
B. Selegiline
C. Rasagiline
D. Cariprazine (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. Cariprazine** **1. Why Cariprazine is the correct answer:** Cariprazine is an **atypical antipsychotic** (second-generation). Its unique mechanism of action involves being a **D3-preferring D2/D3 receptor partial agonist**. Unlike the other options, it has no inhibitory effect on the Monoamine Oxidase (MAO) enzymes. It is primarily used in the treatment of Schizophrenia and Bipolar I disorder (manic or mixed episodes). **2. Why the other options are incorrect:** * **A. Safinamide:** A highly selective and reversible **MAO-B inhibitor** used as an add-on treatment to Levodopa/Carbidopa in Parkinson’s disease to manage "off" episodes. * **B. Selegiline:** A classic irreversible **MAO-B inhibitor**. At low doses, it is selective for MAO-B (found predominantly in the striatum), making it useful for Parkinson’s disease. At high doses, it loses selectivity and inhibits MAO-A. * **C. Rasagiline:** A potent, irreversible, and selective **MAO-B inhibitor**. It is more potent than Selegiline and is used as monotherapy in early Parkinson’s or as an adjunct in advanced stages. **3. High-Yield Clinical Pearls for NEET-PG:** * **MAO-A vs. MAO-B:** MAO-A degrades Serotonin, NE, and Melatonin (Target for Antidepressants like Moclobemide). MAO-B degrades **Dopamine** (Target for Antiparkinsonian drugs). * **Cheese Reaction:** This is associated with non-selective MAO inhibitors or high-dose MAO-B inhibitors due to the accumulation of **Tyramine**, leading to a hypertensive crisis. * **Cariprazine Specialty:** It is often highlighted in exams for its high affinity for **D3 receptors**, which is thought to improve negative symptoms of schizophrenia and cognitive function. * **Mnemonic for MAO-B Inhibitors:** "**S**afe **R**ats **S**electively" (**S**afinamide, **R**asagiline, **S**elegiline).

Question 250: Which of the following is an atypical antidepressant?

A. Citalopram
B. Sertraline
C. Venlafaxine (Correct Answer)
D. Reboxetine

Explanation: ### Explanation **Correct Option: C. Venlafaxine** Venlafaxine is classified as a **Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)** [1]. In the context of pharmacology classifications often tested in NEET-PG, SNRIs, NDRIs (Bupropion), and NaSSAs (Mirtazapine) are grouped under **"Atypical Antidepressants"** to distinguish them from the older Tricyclic Antidepressants (TCAs) and the classic Selective Serotonin Reuptake Inhibitors (SSRIs). Venlafaxine works by inhibiting the reuptake of both serotonin and norepinephrine, making it effective for major depression, generalized anxiety disorder, and certain neuropathic pain conditions [1], [2]. **Analysis of Incorrect Options:** * **A. Citalopram & B. Sertraline:** These are **SSRIs** (Selective Serotonin Reuptake Inhibitors) [1]. They are the first-line treatment for depression but are categorized in their own distinct class, not as "atypical." * **D. Reboxetine:** This is a **Selective Norepinephrine Reuptake Inhibitor (NRI)** [3]. While it has a specific mechanism, it is generally categorized separately or as a specific NRI rather than the broader "atypical" label often associated with SNRIs like Venlafaxine. **High-Yield Clinical Pearls for NEET-PG:** * **Dose-Dependent Action:** At low doses (<150 mg), Venlafaxine acts primarily as an SSRI. At higher doses, its norepinephrine reuptake inhibition becomes significant [2]. * **Side Effect Profile:** A unique and high-yield side effect of Venlafaxine (especially at high doses) is **dose-dependent hypertension**. Monitoring blood pressure is mandatory. * **Discontinuation Syndrome:** Venlafaxine has a short half-life; abrupt withdrawal can lead to severe "electric shock" sensations and flu-like symptoms. * **Duloxetine:** Another common SNRI, often preferred if the patient has comorbid chronic pain or diabetic neuropathy [2].

Question 251: Which drug has a very narrow therapeutic range?

A. Lithium (Correct Answer)
B. Sertraline
C. Roxetine
D. Dothiepin

Explanation: **Explanation:** **Lithium** is the correct answer because it is the classic example of a drug with a **narrow therapeutic index (NTI)**. Its therapeutic serum levels (0.6–1.2 mEq/L) are very close to its toxic levels (>1.5 mEq/L). Because the margin of safety is so slim, even minor changes in dosage or renal clearance can lead to life-threatening toxicity. Consequently, patients on Lithium require mandatory **Therapeutic Drug Monitoring (TDM)**. **Analysis of Incorrect Options:** * **Sertraline (B) and Paroxetine (C):** These are Selective Serotonin Reuptake Inhibitors (SSRIs). SSRIs have a wide therapeutic window, meaning the dose required for efficacy is significantly lower than the dose that causes severe toxicity. They are generally safe in overdose. * **Dothiepin (D):** This is a Tricyclic Antidepressant (TCA). While TCAs are more toxic in overdose than SSRIs (primarily due to cardiotoxicity), they still possess a wider therapeutic range than Lithium and do not require routine TDM. **High-Yield Clinical Pearls for NEET-PG:** * **Therapeutic Range:** 0.6–1.2 mEq/L (Prophylaxis: 0.6–0.8; Acute Mania: 0.8–1.2). * **Toxicity:** Levels >1.5 mEq/L cause coarse tremors, ataxia, and seizures. Levels >2.0 mEq/L are a medical emergency often requiring hemodialysis. * **Drug Interactions:** Thiazides, NSAIDs, and ACE inhibitors increase Lithium levels by decreasing renal excretion (High-yield: "The **TAN** mnemonic – **T**hiazides, **A**CEi, **N**SAIDs"). * **Monitoring:** Before starting Lithium, always check Renal Function Tests (RFT) and Thyroid Function Tests (TFT), as it can cause nephrogenic diabetes insipidus and hypothyroidism.

Question 252: Methadone is used in the management of opioid addiction because:

A. Its analgesic activity is less than that of morphine.
B. It is an opioid receptor antagonist.
C. It is not addictive.
D. It is longer acting and causes milder withdrawal symptoms. (Correct Answer)

Explanation: **Explanation:** Methadone is a synthetic, long-acting **mu-opioid receptor agonist**. Its utility in opioid de-addiction (Maintenance Therapy) stems from its unique pharmacokinetic profile. **Why Option D is Correct:** Methadone has a significantly longer half-life (24–36 hours) compared to heroin or morphine. Because it dissociates slowly from receptors, it prevents the rapid "high" associated with shorter-acting opioids. More importantly, when the drug is eventually discontinued, the **withdrawal symptoms are slower in onset, more prolonged, but significantly milder** than those of heroin. This allows for a controlled, gradual tapering process. **Why Other Options are Incorrect:** * **Option A:** Methadone is a potent analgesic, and its potency is actually comparable to or greater than morphine when administered chronically. * **Option B:** Methadone is a **full agonist**, not an antagonist. Naloxone and Naltrexone are examples of opioid antagonists. * **Option C:** Methadone is an opioid and possesses **significant addictive potential**. It is used to replace a "dangerous" addiction (heroin) with a "controlled" addiction (methadone) under medical supervision. **High-Yield Clinical Pearls for NEET-PG:** * **Cross-Tolerance:** Methadone induces cross-tolerance with other opioids, effectively "blocking" the euphoric effects if a patient tries to use heroin concurrently. * **QT Prolongation:** A critical side effect of Methadone is the risk of Torsades de Pointes due to QT interval prolongation. * **Buprenorphine:** Often preferred over methadone today because it is a **partial agonist** (lower overdose risk) and has a "ceiling effect" on respiratory depression. * **Clonidine:** Used to suppress the autonomic overactivity (lacrimation, rhinorrhea, sweating) during opioid withdrawal.

Question 253: A patient started on imipramine presents with a heart rate of 120/min and blurred vision. These effects can be explained by the fact that imipramine:

A. Is a muscarinic antagonist (Correct Answer)
B. Potentiates epinephrine
C. Is a ganglionic blocker
D. Is a potent alpha-adrenergic blocker

Explanation: **Explanation:** Imipramine is a **Tricyclic Antidepressant (TCA)**. While its primary therapeutic mechanism involves inhibiting the reuptake of Norepinephrine (NE) and Serotonin (5-HT), it also possesses significant antagonistic activity at various receptors, most notably **muscarinic (M1) receptors**. **1. Why Option A is Correct:** The clinical presentation of tachycardia (HR 120/min) and blurred vision is a classic manifestation of **anticholinergic (antimuscarinic) toxicity**. By blocking muscarinic receptors: * **Heart:** It inhibits the vagal (parasympathetic) tone, leading to tachycardia. * **Eyes:** It causes paralysis of the ciliary muscle (cycloplegia) and pupillary dilation (mydriasis), resulting in blurred vision. * *Other effects include dry mouth, urinary retention, and constipation.* **2. Why Other Options are Incorrect:** * **Option B:** While TCAs increase synaptic NE, "potentiating epinephrine" is not the primary mechanism for the specific anticholinergic symptoms (blurred vision) described. * **Option C:** TCAs do not block nicotinic receptors at autonomic ganglia; they act directly on the effector organ receptors. * **Option D:** TCAs do have alpha-1 blocking properties, but this typically causes **orthostatic hypotension** and reflex tachycardia, not the constellation of anticholinergic symptoms like blurred vision. **NEET-PG High-Yield Pearls:** * **TCA Side Effect Profile:** Remember the "3 Cs" of TCA overdose: **C**oma, **C**onvulsions, and **C**ardiotoxicity (arrhythmias due to Na+ channel blockade). * **ECG Findings:** Widening of the QRS complex (>100ms) is a critical marker of TCA toxicity. * **Antidote:** Sodium bicarbonate is used to treat TCA-induced cardiotoxicity. * **Contraindication:** TCAs should be avoided in patients with Narrow-Angle Glaucoma and Benign Prostatic Hyperplasia (BPH) due to their potent anticholinergic effects.

Question 254: Methadone is used in the management of opioid addiction because:

A. Its analgesic activity is less than that of morphine
B. It is an opioid receptor antagonist
C. It is not addictive
D. It is longer acting and causes milder withdrawal symptoms (Correct Answer)

Explanation: **Explanation:** Methadone is a synthetic, long-acting **full μ-opioid receptor agonist**. Its utility in opioid de-addiction (Maintenance Therapy) stems from its unique pharmacokinetic profile. **Why Option D is Correct:** Methadone has a significantly longer half-life (24–36 hours) compared to morphine or heroin. Because of this slow elimination, the decline in plasma concentration is gradual, leading to **milder, though more prolonged, withdrawal symptoms**. Furthermore, its slow onset of action when taken orally prevents the "rush" or euphoria associated with intravenous heroin, helping to stabilize the patient and reduce drug-seeking behavior. **Why Other Options are Incorrect:** * **Option A:** Methadone is a potent analgesic. Its analgesic potency is roughly equal to or greater than morphine; this is not the reason it is used for addiction. * **Option B:** Methadone is a full **agonist**, not an antagonist. Naloxone and Naltrexone are examples of opioid antagonists. * **Option C:** Methadone is an opioid and has significant **addictive potential**. However, it is used to replace a "dangerous" addiction (heroin) with a "controlled" addiction under medical supervision. **High-Yield Clinical Pearls for NEET-PG:** * **NMDA Antagonism:** Besides μ-receptors, Methadone also antagonizes NMDA receptors, which may help in treating neuropathic pain and reducing opioid tolerance. * **ECG Monitoring:** A critical side effect of Methadone is **QT interval prolongation**, which can lead to *Torsades de Pointes*. * **Levomethadyl acetate (LAAM):** A related drug with an even longer half-life (72–96 hours), allowing for dosing every 2–3 days. * **Buprenorphine:** Often preferred over methadone for office-based treatment as it is a **partial agonist** with a lower risk of fatal overdose (ceiling effect).

Question 255: Lithium is used in a pregnant woman. Which of the following congenital anomalies may occur in the fetus?

A. Tetralogy of Fallot
B. Tricuspid atresia
C. Ebstein anomaly (Correct Answer)
D. Pulmonary stenosis

Explanation: **Explanation:** **Lithium** is a mood stabilizer primarily used for Bipolar Affective Disorder (BPAD). It is a known teratogen, and its administration during the first trimester of pregnancy is specifically associated with **Ebstein’s Anomaly** [1]. **1. Why Ebstein Anomaly is the Correct Answer:** Ebstein anomaly is a rare congenital cardiac defect characterized by the **downward displacement of the tricuspid valve leaflets** into the right ventricle [1]. This results in "atrialization" of the right ventricle, leading to severe tricuspid regurgitation and right-sided heart failure. While the absolute risk remains low (approx. 1 in 1,000 to 2,000 exposures), the relative risk is significantly higher in infants exposed to Lithium in utero compared to the general population [1]. **2. Analysis of Incorrect Options:** * **Tetralogy of Fallot (A), Tricuspid Atresia (B), and Pulmonary Stenosis (D):** While these are common congenital cyanotic heart diseases, they are not specifically linked to Lithium exposure. They are more commonly associated with genetic factors (e.g., Down syndrome, DiGeorge syndrome) or other maternal factors like diabetes. **3. NEET-PG High-Yield Clinical Pearls:** * **Monitoring:** Lithium has a narrow therapeutic index (0.6–1.2 mEq/L). Toxicity occurs >1.5 mEq/L. * **Pregnancy Management:** If a woman on Lithium plans to conceive, the drug should ideally be tapered. If she is already pregnant, fetal echocardiography is recommended at 18–20 weeks to screen for cardiac defects. In balancing the risk versus benefit of using lithium in pregnancy, it is important to evaluate the risk of inadequate prophylaxis for bipolar disorder [2]. Lithium freely crosses the placenta, and fetal or neonatal lithium toxicity may develop even when maternal blood levels are within the therapeutic range [2]. * **Breastfeeding:** Lithium is contraindicated during breastfeeding as it is excreted in milk and can cause toxicity in the infant [1]. * **Renal Side Effects:** Long-term use can cause Nephrogenic Diabetes Insipidus (treated with Amiloride).

Question 256: A 60-year-old male presents with acute retention of urine for 12 hours. On examination, a distended bladder is noted. The patient's son reports that the patient has been taking a drug for depression for the past two days. What is the most likely drug the patient has taken?

A. Chlorpromazine
B. Amitriptyline (Correct Answer)
C. Haloperidol
D. Pimozide

Explanation: **Explanation:** The clinical presentation of acute urinary retention in an elderly male shortly after starting an antidepressant strongly suggests **anticholinergic (antimuscarinic) side effects**. **Amitriptyline** is a Tricyclic Antidepressant (TCA) known for its potent blockade of muscarinic (M) receptors. In the bladder, this leads to the relaxation of the detrusor muscle and contraction of the internal sphincter, resulting in urinary retention. This effect is particularly pronounced in elderly patients, who may have underlying benign prostatic hyperplasia (BPH). **Analysis of Incorrect Options:** * **Chlorpromazine:** While this low-potency antipsychotic does have significant anticholinergic properties, it is primarily used for schizophrenia or psychosis, not as a first-line treatment for depression. * **Haloperidol & Pimozide:** These are high-potency typical antipsychotics. They have a high affinity for $D_2$ receptors but possess **minimal** anticholinergic activity. Their primary side effects are Extrapyramidal Symptoms (EPS) rather than autonomic effects like urinary retention. **High-Yield Clinical Pearls for NEET-PG:** * **TCA Side Effect Profile:** Remember the "3 Cs" of TCA toxicity: **C**oma, **C**onvulsions, and **C**ardiotoxicity (arrhythmias due to Na+ channel blockade). * **Anticholinergic Toxidrome:** "Dry as a bone, red as a beet, hot as a hare, blind as a bat, and mad as a hatter." * **Elderly Caution:** TCAs are generally avoided in the elderly (Beers Criteria) due to risks of sedation, orthostatic hypotension (alpha-blockade), and urinary retention. SSRIs are the preferred first-line agents for depression in this demographic.

Question 257: A 60-year-old male presents with acute urinary retention for 12 hours. Examination reveals a distended bladder. His son reports that the patient has been taking a drug for depression for the past two days. What is the most likely drug?

A. Chlorpromazine
B. Amitriptyline (Correct Answer)
C. Haloperidol
D. Pimozide

Explanation: ### Explanation **Correct Answer: B. Amitriptyline** **Mechanism and Clinical Correlation:** Amitriptyline is a **Tricyclic Antidepressant (TCA)**. TCAs are notorious for their potent **antimuscarinic (anticholinergic) side effects**. By blocking $M_3$ receptors on the detrusor muscle of the bladder, these drugs prevent bladder contraction, leading to **acute urinary retention**. This is particularly common in elderly males who may have underlying (often subclinical) Benign Prostatic Hyperplasia (BPH). The timeline of two days matches the acute onset of side effects following the initiation of therapy. **Analysis of Incorrect Options:** * **A. Chlorpromazine:** While this is a typical antipsychotic with significant anticholinergic properties, it is primarily used for schizophrenia or psychosis, not as a first-line treatment for depression. * **C. Haloperidol:** A high-potency typical antipsychotic. It has very low affinity for muscarinic receptors; its primary side effects are Extrapyramidal Symptoms (EPS) rather than urinary retention. * **D. Pimozide:** Another typical antipsychotic used mainly for Tourette’s syndrome or resistant psychosis. Like haloperidol, it lacks significant anticholinergic activity compared to TCAs. **NEET-PG High-Yield Pearls:** * **TCA Side Effect Profile:** Remember the "3 Cs" of TCA overdose: **C**oma, **C**onvulsions, and **C**ardiotoxicity (Arrhythmias due to Na+ channel blockade). * **Anticholinergic Toxidrome:** "Dry as a bone (dry mouth), Red as a beet (flushing), Hot as a hare (hyperthermia), Blind as a bat (mydriasis), and Mad as a hatter (delirium)." * **Contraindications:** TCAs should be avoided in patients with BPH, Narrow-angle glaucoma, and recent Myocardial Infarction. * **Drug of Choice:** For nocturnal enuresis in children, Imipramine (a TCA) was traditionally used, though Desmopressin is now preferred.

Question 258: Which antidepressant is used in the prophylaxis of migraine?

A. Amitriptyline (Correct Answer)
B. Fluoxetine
C. Citalopram
D. Trazodone

Explanation: **Explanation:** **Amitriptyline** is a Tricyclic Antidepressant (TCA) and is considered the **first-line antidepressant** for the prophylaxis of migraine. Its efficacy stems from its multi-modal mechanism: it inhibits the reuptake of serotonin and norepinephrine and possesses anticholinergic and antihistaminic properties. In migraine prevention, it is believed to downregulate 5-HT₂ receptors and modulate NMDA receptor-mediated transmission, thereby increasing the threshold for migraine triggers. It is particularly useful in patients who also suffer from tension-type headaches, insomnia, or depression. **Why other options are incorrect:** * **Fluoxetine & Citalopram:** These are Selective Serotonin Reuptake Inhibitors (SSRIs). While they are excellent for depression and anxiety, clinical trials have shown they are generally **ineffective** for migraine prophylaxis compared to TCAs. * **Trazodone:** This is a SARI (Serotonin Antagonist and Reuptake Inhibitor) primarily used for insomnia due to its highly sedative nature. It does not have a proven role in migraine prevention. **High-Yield Clinical Pearls for NEET-PG:** * **DOC for Migraine Prophylaxis:** Propranolol (Beta-blocker) is generally the first choice, but Amitriptyline is the preferred TCA. * **Side Effects of Amitriptyline:** Sedation, weight gain, and anticholinergic effects (dry mouth, blurred vision, urinary retention). It is contraindicated in patients with glaucoma or prostatic hypertrophy. * **Other Prophylactic Agents:** Anticonvulsants (Topiramate, Valproate), Calcium Channel Blockers (Flunarizine), and CGRP antagonists (Erenumab). * **Acute Attack Treatment:** Triptans (5-HT$_{1B/1D}$ agonists) are the drugs of choice for acute migraine relief.

Question 259: Which of the following is NOT an anxiolytic agent?

A. Buspirone
B. Fluoxetine (Correct Answer)
C. Diazepam
D. Nitrazepam

Explanation: ### Explanation The correct answer is **Fluoxetine**. **1. Why Fluoxetine is the correct answer:** Fluoxetine is a **Selective Serotonin Reuptake Inhibitor (SSRI)**. While SSRIs are the first-line treatment for chronic anxiety disorders (like GAD, Panic Disorder, and OCD), they are pharmacologically classified as **Antidepressants**, not anxiolytics. Unlike true anxiolytics, they have a delayed onset of action (2–4 weeks) and may initially worsen anxiety symptoms. **2. Analysis of Incorrect Options:** * **Buspirone (Option A):** A selective **5-HT1A partial agonist**. It is a pure anxiolytic that does not cause sedation, muscle relaxation, or anticonvulsant effects. It is ideal for Generalized Anxiety Disorder (GAD) but ineffective for acute panic attacks due to its slow onset. * **Diazepam (Option B):** A long-acting **Benzodiazepine (BZD)**. It acts by enhancing GABAergic transmission (increasing the frequency of Cl⁻ channel opening). It is a classic anxiolytic used for rapid relief of acute anxiety. * **Nitrazepam (Option D):** Another Benzodiazepine primarily used for its hypnotic properties, but it possesses significant anxiolytic, muscle relaxant, and anticonvulsant activities. **3. NEET-PG High-Yield Clinical Pearls:** * **Drug of Choice (DOC) for Acute Anxiety/Panic Attack:** Benzodiazepines (e.g., Alprazolam, Diazepam). * **DOC for Performance Anxiety:** Propranolol (Beta-blocker), taken 30–60 minutes before the event. * **Buspirone Advantage:** No risk of dependence or withdrawal, making it safer for long-term use compared to BZDs. * **SSRI Paradox:** In the first week of treating anxiety with Fluoxetine, "jitteriness syndrome" may occur; hence, BZDs are often co-prescribed for the first 2 weeks.

Question 260: All of the following are limitations of typical tricyclic antidepressants EXCEPT:

A. Narrow safety margin
B. Low oral bioavailability (Correct Answer)
C. Frequent side effects
D. Long latent period for response

Explanation: **Explanation:** Tricyclic Antidepressants (TCAs) like Amitriptyline and Imipramine have been largely replaced by SSRIs due to several clinical limitations. However, **low oral bioavailability is NOT a characteristic limitation** of this class. **1. Why "Low oral bioavailability" is the correct answer:** TCAs are generally **well-absorbed** from the gastrointestinal tract. While they undergo significant first-pass metabolism in the liver, their systemic bioavailability is typically moderate to high (e.g., Amitriptyline is ~40-60%), and they are highly lipophilic, allowing them to distribute widely into tissues. This is not considered a primary clinical "limitation" compared to their side effect profile. **2. Analysis of incorrect options (Limitations of TCAs):** * **Narrow safety margin (Option A):** TCAs are cardiotoxic in overdose. They block sodium channels in the heart, leading to arrhythmias and QRS prolongation. A 10-day supply can be fatal, making them dangerous for suicidal patients. * **Frequent side effects (Option C):** TCAs are "dirty drugs" that block multiple receptors: * **Muscarinic:** Dry mouth, blurred vision, constipation, urinary retention. * **Alpha-1:** Orthostatic hypotension. * **H1 Histamine:** Sedation and weight gain. * **Long latent period (Option D):** Like most antidepressants, TCAs require **2–4 weeks** of continuous therapy to show significant clinical improvement in mood, despite immediate neurotransmitter effects. **High-Yield Clinical Pearls for NEET-PG:** * **The 3 C’s of TCA Toxicity:** **C**oma, **C**onvulsions, and **C**ardiotoxicity (Arrhythmias). * **Antidote:** Sodium Bicarbonate is used to treat TCA-induced cardiotoxicity (it reverses sodium channel blockade). * **Drug of Choice:** Clomipramine (a TCA) is the gold standard for Obsessive-Compulsive Disorder (OCD), though SSRIs are first-line due to safety. * **Enuresis:** Imipramine is used for nocturnal enuresis in children.

Question 261: Which tricyclic antidepressant has the LEAST autonomic and cardiotoxic effects?

A. Amitriptyline
B. Desipramine
C. Lofepramine (Correct Answer)
D. Protriptyline

Explanation: **Explanation:** **Lofepramine** is a second-generation tricyclic antidepressant (TCA) and a prodrug of desipramine. It is unique among TCAs because it possesses a bulky side chain that significantly reduces its affinity for cholinergic (muscarinic), alpha-adrenergic, and histaminergic receptors. 1. **Why Lofepramine is correct:** * **Low Cardiotoxicity:** It has a much lower risk of causing arrhythmias or QTc prolongation compared to older TCAs, making it safer in overdose. * **Low Autonomic Effects:** Due to its low anticholinergic activity, it causes minimal dry mouth, blurred vision, and urinary retention. It also causes less orthostatic hypotension. 2. **Why other options are incorrect:** * **Amitriptyline (Option A):** This is a tertiary amine and is considered the **most** anticholinergic and sedative TCA. It has significant cardiotoxicity and is often used as the "prototype" for TCA side effects. * **Desipramine (Option B):** While it is a metabolite of lofepramine and has less sedative effect than amitriptyline, it still carries a higher risk of cardiotoxicity and sudden cardiac death in vulnerable patients compared to lofepramine. * **Protriptyline (Option D):** This is a potent stimulant-like TCA. While less sedative, it still possesses significant anticholinergic properties and can cause tachycardia and arrhythmias. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** TCAs primarily inhibit the reuptake of Norepinephrine (NE) and Serotonin (5-HT). * **TCA Overdose Triad (The 3 C's):** **C**oma, **C**onvulsions, and **C**ardiotoxicity (widened QRS complex). * **Antidote for Cardiotoxicity:** Intravenous **Sodium Bicarbonate** is the drug of choice to manage QRS widening and arrhythmias. * **Most Cardiotoxic TCA:** Amitriptyline. * **Least Cardiotoxic TCA:** Lofepramine.

Question 262: Which of the following properties distinguishes Aripiprazole from atypical antipsychotics?

A. It is a potent 5-HT2A receptor antagonist.
B. Reduced risk of extrapyramidal side effects.
C. It can be used in Schizophrenia.
D. It is not a D2 receptor antagonist. (Correct Answer)

Explanation: **Explanation:** The defining pharmacological feature of **Aripiprazole** that distinguishes it from both typical and other atypical antipsychotics is its mechanism of action at the dopamine D2 receptor. **1. Why Option D is Correct:** Unlike traditional atypical antipsychotics (e.g., Risperidone, Olanzapine), which act as **D2 receptor antagonists**, Aripiprazole is a **Partial D2 Receptor Agonist**. It acts as a "dopamine stabilizer": in areas of high dopamine activity (mesolimbic pathway), it acts as a functional antagonist to reduce positive symptoms; in areas of low dopamine activity (mesocortical pathway), it provides enough agonism to improve negative symptoms. Because it does not fully block the receptor, it is technically not a pure antagonist. **2. Why the other options are incorrect:** * **Option A:** Most atypical antipsychotics (SDA – Serotonin-Dopamine Antagonists) are potent **5-HT2A antagonists**. Aripiprazole also possesses this property, so it does not distinguish it from the group. * **Option B:** A reduced risk of extrapyramidal side effects (EPS) is a **shared characteristic** of almost all atypical antipsychotics compared to typical ones (like Haloperidol). * **Option C:** Schizophrenia is the **primary clinical indication** for all antipsychotics, including Aripiprazole and other atypicals. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Partial agonist at D2 and 5-HT1A receptors; Antagonist at 5-HT2A. * **Side Effect Profile:** It has the **lowest risk of weight gain, hyperprolactinemia, and QT prolongation** among atypicals. * **Common Side Effect:** Akathisia is the most frequently reported EPS. * **Other Partial Agonists:** Brexpiprazole and Cariprazine (newer agents with similar mechanisms).

Question 263: Which of the following serum concentrations of lithium indicates lithium toxicity?

A. 2 mEq/L (Correct Answer)
B. 4 mEq/L
C. 6 mEq/L
D. 8 mEq/L

Explanation: **Explanation:** Lithium is a drug with a **narrow therapeutic index**, meaning the margin between its therapeutic effect and toxicity is very slim. Monitoring serum lithium levels is mandatory for patient safety. * **Why Option A is Correct:** The therapeutic range for lithium is generally **0.6 to 1.2 mEq/L**. Levels between 1.2 and 1.5 mEq/L are considered the "warning zone." Clinical toxicity typically manifests when serum levels exceed **1.5 mEq/L**. Therefore, **2 mEq/L** is the first point among the options that clearly indicates established lithium toxicity, often presenting with symptoms like coarse tremors, vomiting, diarrhea, and ataxia. * **Why Options B, C, and D are Incorrect:** While 4, 6, and 8 mEq/L are indeed toxic levels, they represent **severe to life-threatening toxicity**. In the context of medical exams, when asked to identify "toxicity," the lowest value that exceeds the therapeutic threshold is chosen as the definitive indicator of the onset of toxicity. Levels above 4 mEq/L are often fatal and require emergency hemodialysis. **High-Yield NEET-PG Pearls:** 1. **Therapeutic Range:** 0.6–1.2 mEq/L (Prophylaxis: 0.6–0.8; Acute Mania: 0.8–1.2). 2. **Sampling Time:** Serum levels should be measured **12 hours after the last dose** (Steady-state). 3. **Drug Interactions:** Thiazides, NSAIDs, and ACE inhibitors increase lithium levels (by decreasing renal clearance). 4. **Side Effects:** L-I-T-H: **L**eukocytosis, **I**nsipidus (Diabetes Insipidus), **T**remors/Teratogenicity (Ebstein's Anomaly), **H**ypothyroidism. 5. **Management of Toxicity:** Gastric lavage and **Hemodialysis** (Treatment of choice for severe toxicity >3.5 mEq/L).

Question 264: All actions of chlorpromazine are based on its antidopaminergic property EXCEPT:

A. Antipsychotic
B. Hyperprolactinemic
C. Antiemetic
D. Hypotensive (Correct Answer)

Explanation: Chlorpromazine (CPZ) is a prototype low-potency typical antipsychotic. Its pharmacological effects are mediated by blocking multiple receptors, including Dopamine ($D_2$), Alpha-adrenergic ($\alpha_1$), Muscarinic ($M_1$), and Histaminergic ($H_1$) receptors [1], [2]. **1. Why Hypotension is the Correct Answer:** The **hypotensive** effect of chlorpromazine is primarily due to the **blockade of $\alpha_1$-adrenergic receptors**, leading to peripheral vasodilation [1], [2]. It is not related to dopamine antagonism. This often manifests as orthostatic (postural) hypotension, a common side effect of low-potency antipsychotics [1]. **2. Why the other options are incorrect (Antidopaminergic actions):** * **Antipsychotic:** This effect is due to the blockade of $D_2$ receptors in the **mesolimbic and mesocortical pathways**. * **Hyperprolactinemic:** Dopamine normally inhibits prolactin release via the tuberoinfundibular pathway. $D_2$ blockade here removes this inhibition, leading to increased prolactin levels (galactorrhea, gynecomastia) [1], [2]. * **Antiemetic:** CPZ exerts its antiemetic effect by blocking $D_2$ receptors in the **Chemoreceptor Trigger Zone (CTZ)** of the medulla. **High-Yield Clinical Pearls for NEET-PG:** * **Low Potency vs. High Potency:** Low-potency drugs like Chlorpromazine have high $\alpha_1$ and $M_1$ blocking activity (more sedation/hypotension) but lower risk of Extrapyramidal Symptoms (EPS) [1]. High-potency drugs like Haloperidol have high $D_2$ affinity and a higher risk of EPS. * **Other non-dopaminergic effects of CPZ:** Sedation ($H_1$ blockade) and dry mouth/constipation ($M_1$ blockade) [1]. * **Specific Indication:** Chlorpromazine is also a drug of choice for **intractable hiccups**.

Question 265: Which one of the following drugs is NOT used in the management of glaucoma?

A. Timolol
B. Physostigmine
C. Donepezil (Correct Answer)
D. Dipivefrine

Explanation: **Explanation:** The correct answer is **Donepezil**. **1. Why Donepezil is the correct answer:** Donepezil is a centrally acting, reversible acetylcholinesterase inhibitor. Its primary clinical indication is the symptomatic treatment of **Alzheimer’s disease**, as it increases acetylcholine levels in the brain to improve cognitive function. Unlike other cholinesterase inhibitors, it has high selectivity for the central nervous system and is not used topically or systemically for the management of glaucoma. **2. Analysis of incorrect options:** * **Timolol (Option A):** A non-selective beta-blocker and the traditional first-line agent for glaucoma. It works by reducing the production of aqueous humor from the ciliary body. * **Physostigmine (Option B):** A tertiary amine anticholinesterase. When applied topically to the eye, it causes miosis and contraction of the ciliary muscle, which facilitates the drainage of aqueous humor through the trabecular meshwork. * **Dipivefrine (Option C):** A prodrug of epinephrine. It is more lipophilic, allowing better ocular penetration. It reduces intraocular pressure by increasing uveoscleral outflow. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Currently, **Latanoprost** (Prostaglandin analogue) is the DOC for Open-Angle Glaucoma due to high efficacy and once-daily dosing. * **Avoid in Glaucoma:** Mydriatics (like Atropine) are strictly contraindicated in closed-angle glaucoma as they can precipitate an acute attack. * **Donepezil Side Effects:** Common side effects are cholinergic in nature, such as bradycardia, nausea, and diarrhea (SLUDGE syndrome).

Question 266: Which drug possesses antidepressant and antipsychotic properties?

A. Buspirone
B. Amoxapine (Correct Answer)
C. Trazodone
D. Mianserine

Explanation: **Explanation:** **Amoxapine** is a unique antidepressant belonging to the **Tricyclic Antidepressant (TCA)** class, specifically a metabolite of the antipsychotic drug loxapine. 1. **Why Amoxapine is correct:** Amoxapine exhibits a dual mechanism of action. It inhibits the reuptake of Norepinephrine (NE) and Serotonin (5-HT), which provides its **antidepressant** effect. Simultaneously, it possesses significant **Dopamine (D2) receptor blocking** activity. This D2 blockade gives it **antipsychotic** properties, making it particularly useful in treating **Psychotic Depression** (depression with psychotic features). 2. **Why other options are incorrect:** * **Buspirone:** An azapirone derivative used as an **Anxiolytic**. It acts as a selective 5-HT1A partial agonist. It does not have antipsychotic or primary antidepressant properties. * **Trazodone:** A SARI (Serotonin Antagonist and Reuptake Inhibitor). It is used primarily as an **Antidepressant** and for insomnia due to its sedative effects, but it lacks D2 blocking (antipsychotic) activity. * **Mianserine:** An atypical antidepressant (tetracyclic) that acts by blocking alpha-2 receptors. While it has sedative and antidepressant effects, it does not possess antipsychotic properties. **High-Yield Clinical Pearls for NEET-PG:** * **Side Effects:** Because of its D2 blocking property, Amoxapine can cause **Extrapyramidal Side Effects (EPS)**, such as parkinsonism or tardive dyskinesia, and hyperprolactinemia—side effects not typically seen with other TCAs. * **Drug of Choice:** While Amoxapine has this dual profile, the modern clinical preference for Psychotic Depression is often a combination of an SSRI and an Atypical Antipsychotic. * **Loxapine Connection:** Remember that Amoxapine is chemically related to the antipsychotic Loxapine.

Question 267: Which drug possesses antidepressant and antipsychotic properties?

A. Buspirone
B. Amoxapine (Correct Answer)
C. Trazodone
D. Mianserine

Explanation: **Explanation:** **Amoxapine** is a tetracyclic antidepressant (TeCA) and a metabolite of the antipsychotic drug loxapine. It is unique because it exhibits a dual pharmacological profile: 1. **Antidepressant Action:** It inhibits the reuptake of Norepinephrine (and to a lesser extent, Serotonin), similar to Tricyclic Antidepressants (TCAs). 2. **Antipsychotic Action:** Unlike other antidepressants, Amoxapine possesses significant **Postsynaptic Dopamine (D2) receptor blockade** activity. This makes it the drug of choice for **Psychotic Depression** (Major Depressive Disorder with psychotic features). **Analysis of Incorrect Options:** * **A. Buspirone:** An azapirone derivative used as a non-benzodiazepine anxiolytic. It acts as a selective 5-HT1A partial agonist. It does not have antipsychotic properties. * **C. Trazodone:** A SARI (Serotonin Antagonist and Reuptake Inhibitor). It is primarily used for depression with insomnia due to its highly sedative nature, but it lacks D2 blocking (antipsychotic) activity. * **D. Mianserine:** A tetracyclic compound that acts as an alpha-2 blocker. While it is an antidepressant, it does not possess significant D2 receptor antagonism. **High-Yield Clinical Pearls for NEET-PG:** * **Side Effects:** Because of its D2 blocking property, Amoxapine can cause **Extrapyramidal Side Effects (EPS)**, such as parkinsonism or tardive dyskinesia, and hyperprolactinemia—side effects typically associated with antipsychotics rather than antidepressants. * **Drug of Choice:** Always consider Amoxapine for "Psychotic Depression." * **Seizure Risk:** Like other tetracyclics, Amoxapine carries a risk of seizures in overdose.

Question 268: The selective MAO-B inhibitor among the following is:

A. Selegiline (Correct Answer)
B. Clorgyline
C. Moclobemide
D. Tranylcypromine

Explanation: **Explanation:** Monoamine oxidase (MAO) is an enzyme responsible for the oxidative deamination of biogenic amines. It exists in two isoforms: **MAO-A** (preferentially degrades serotonin, norepinephrine, and dopamine) and **MAO-B** (preferentially degrades dopamine). **1. Why Selegiline is correct:** **Selegiline** is a selective, irreversible **MAO-B inhibitor**. At low to moderate doses, it specifically inhibits the breakdown of dopamine in the striatum without affecting the metabolism of other amines. This makes it highly effective as an adjuvant in **Parkinson’s disease** to prolong the action of Levodopa. At higher doses, however, it loses its selectivity and can inhibit MAO-A. **2. Analysis of Incorrect Options:** * **Clorgyline:** This is a selective and irreversible **MAO-A inhibitor**. It is primarily used in research and is not commonly used in clinical practice. * **Moclobemide:** This is a **RIMA** (Reversible Inhibitor of MAO-A). Because it is reversible, it carries a much lower risk of the "cheese reaction" compared to older, non-selective inhibitors. It is used as an antidepressant. * **Tranylcypromine:** This is a **non-selective, irreversible** MAO inhibitor (inhibits both MAO-A and MAO-B). It is an older antidepressant associated with significant dietary restrictions. **Clinical Pearls for NEET-PG:** * **Cheese Reaction:** Occurs when patients on non-selective MAOIs or MAO-A inhibitors consume tyramine-rich food (aged cheese, red wine). This leads to a hypertensive crisis due to massive norepinephrine release. * **Rasagiline:** Another selective MAO-B inhibitor, more potent than Selegiline, often used in Parkinson's disease. * **Drug Interaction:** MAO inhibitors should never be combined with SSRIs or Pethidine due to the risk of **Serotonin Syndrome**.

Question 269: Which of the following is a non-selective MAO inhibitor?

A. Moclobemide
B. Rasagiline
C. Selegiline
D. Isocarboxazid (Correct Answer)

Explanation: **Explanation:** Monoamine oxidase (MAO) inhibitors are classified based on their selectivity for the two isoforms of the enzyme: **MAO-A** (which degrades serotonin, norepinephrine, and melatonin) and **MAO-B** (which degrades dopamine). **1. Why Isocarboxazid is correct:** **Isocarboxazid** is a hydrazine derivative that acts as a **non-selective, irreversible MAO inhibitor**. It inhibits both MAO-A and MAO-B enzymes. Because it inhibits MAO-A, it carries a high risk of the "Cheese Reaction" (hypertensive crisis) when taken with tyramine-rich foods, as it prevents the breakdown of dietary tyramine. Other drugs in this class include Phenelzine and Tranylcypromine. **2. Analysis of Incorrect Options:** * **Moclobemide:** This is a **RIMA** (Reversible Inhibitor of MAO-A). It is selective for MAO-A and its reversible nature makes it safer regarding dietary tyramine interactions. * **Selegiline:** This is a **selective, irreversible MAO-B inhibitor** (at low doses). It is primarily used in Parkinson’s disease to increase dopamine levels. At higher doses, it loses selectivity and can inhibit MAO-A. * **Rasagiline:** Similar to Selegiline, this is a potent, **selective, irreversible MAO-B inhibitor** used in the management of Parkinson’s disease. **High-Yield Clinical Pearls for NEET-PG:** * **Cheese Reaction:** Occurs with non-selective MAOIs due to displacement of Norepinephrine by tyramine. Treatment of choice: **Phentolamine** (Alpha-blocker). * **Serotonin Syndrome:** A dangerous interaction when MAOIs are combined with SSRIs or Pethidine. * **Washout Period:** When switching from an MAOI to an SSRI (or vice versa), a gap of at least **14 days** is required to allow for enzyme regeneration.

Question 270: Which of the following is a feature of Haloperidol toxicity?

A. Weight loss
B. Sweating
C. Akathisia (Correct Answer)
D. Diarrhoea

Explanation: **Explanation:** **Haloperidol** is a high-potency, typical (first-generation) antipsychotic. Its primary mechanism of action is the potent blockade of **D2 receptors** in the brain, particularly in the mesolimbic and nigrostriatal pathways. **Why Akathisia is correct:** Akathisia is a common **Extrapyramidal Side Effect (EPS)** resulting from D2 receptor blockade in the nigrostriatal pathway. It is characterized by a subjective feeling of inner restlessness and an inability to sit still. Among all antipsychotics, high-potency drugs like Haloperidol have the highest propensity to cause EPS, including acute dystonia, parkinsonism, and akathisia. **Why the other options are incorrect:** * **Weight loss:** Haloperidol is more likely to cause **weight gain**, though to a lesser extent than atypical antipsychotics like Olanzapine. * **Sweating & Diarrhea:** These are typically features of **cholinergic excess** or **Serotonin Syndrome**. Haloperidol actually possesses mild anticholinergic properties, which would more likely cause dry mouth, constipation, and decreased sweating. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for Akathisia:** Centrally acting beta-blockers (e.g., **Propranolol**). * **Neuroleptic Malignant Syndrome (NMS):** A life-threatening toxicity of Haloperidol characterized by "lead-pipe" rigidity, hyperthermia, and autonomic instability. Treatment involves **Dantrolene** or Bromocriptine. * **Hyperprolactinemia:** Due to D2 blockade in the tuberoinfundibular pathway, Haloperidol frequently causes galactorrhea and gynecomastia. * **QT Prolongation:** Haloperidol (especially IV) can increase the risk of Torsades de Pointes.

Question 271: Akathisia is most commonly seen with the use of which of the following medications?

A. Clozapine
B. Propranolol
C. Benztropine
D. Haloperidol (Correct Answer)

Explanation: **Explanation:** **1. Why Haloperidol is the Correct Answer:** Akathisia is a common **Extrapyramidal Side Effect (EPS)** characterized by a subjective feeling of inner restlessness and an inability to sit still [2]. It is most frequently associated with **First-Generation Antipsychotics (Typical Antipsychotics)** like **Haloperidol** [1]. The underlying mechanism is the potent, non-selective blockade of **Dopamine D2 receptors** in the nigrostriatal pathway. High-potency neuroleptics like Haloperidol have a high affinity for these receptors, making them the most common culprits for EPS, including akathisia, dystonia, and parkinsonism [1]. **2. Why the Other Options are Incorrect:** * **A. Clozapine:** This is an atypical (Second-Generation) antipsychotic. It has a low affinity for D2 receptors and a higher affinity for 5-HT2A receptors. It is specifically known for having the **lowest risk of EPS** among antipsychotics. * **B. Propranolol:** This is a non-selective beta-blocker. It is actually the **drug of choice (DOC) for treating akathisia**, not a cause of it [1]. * **C. Benztropine:** This is a centrally acting anticholinergic drug. It is used to treat acute dystonia and drug-induced parkinsonism. While it can be used in akathisia, it is generally less effective than beta-blockers. **3. High-Yield Clinical Pearls for NEET-PG:** * **Management of Akathisia:** First-line treatment is **Propranolol**. Benzodiazepines (like Diazepam) are second-line [1]. * **Timeline of EPS:** 1. **Acute Dystonia:** Hours to days (DOC: Promethazine or Benztropine). 2. **Akathisia:** Days to weeks (DOC: Propranolol). 3. **Parkinsonism:** Weeks to months (DOC: Benztropine). 4. **Tardive Dyskinesia:** Months to years (DOC: Valbenazine/Deutetrabenazine; *Note: Anticholinergics worsen this*). * **Clozapine Warning:** Always monitor for **agranulocytosis** (absolute neutrophil count) and seizures.

Question 272: Extrapyramidal adverse effects are commonly caused by which class of drugs?

A. Antidepressants
B. Antipsychotics (Correct Answer)
C. Antimanics
D. Antiepileptics

Explanation: **Explanation:** **Why Antipsychotics are the correct answer:** Extrapyramidal symptoms (EPS) are primarily caused by the blockade of **Dopamine (D2) receptors** in the **Nigrostriatal pathway** of the brain. Typical (First-generation) antipsychotics, such as Haloperidol and Fluphenazine, are potent D2 antagonists. When dopamine is blocked in the striatum, the normal inhibitory balance between dopamine and acetylcholine is disrupted, leading to cholinergic overactivity and the manifestation of movement disorders. **Analysis of Incorrect Options:** * **Antidepressants:** While some (like SSRIs) can rarely cause tremors, they primarily modulate Serotonin and Norepinephrine, not the nigrostriatal dopamine pathway. * **Antimanics:** Lithium (the gold standard) commonly causes fine tremors, but these are not classified as classical extrapyramidal symptoms. * **Antiepileptics:** These drugs generally act on GABA receptors or Ion channels (Sodium/Calcium). While some (like Phenytoin) cause cerebellar ataxia, they do not typically cause EPS. **NEET-PG High-Yield Clinical Pearls:** 1. **Types of EPS (Chronological Order):** * **Acute Dystonia:** Earliest onset (hours); characterized by muscle spasms (e.g., torticollis). Rx: Central anticholinergics (Benztropine, Promethazine). * **Akathisia:** Most common EPS; subjective feeling of restlessness. Rx: Beta-blockers (Propranolol). * **Drug-Induced Parkinsonism:** Rigidity, tremors, and bradykinesia. Rx: Central anticholinergics (Trihexyphenidyl). * **Tardive Dyskinesia:** Late-onset (months/years); involuntary choreoathetoid movements (e.g., lip-smacking). Rx: Switch to Clozapine or use VMAT-2 inhibitors (Valbenazine). 2. **Atypical Antipsychotics** (e.g., Quetiapine, Clozapine) have a lower risk of EPS because they dissociate rapidly from D2 receptors and have 5-HT2A antagonist properties.

Question 273: Which of the following effects is unlikely to occur during treatment with imipramine?

A. Elevation of seizure threshold (Correct Answer)
B. Mydriasis
C. Sedation
D. Urinary retention

Explanation: **Explanation:** **Imipramine** is a prototype **Tricyclic Antidepressant (TCA)**. Understanding its pharmacological profile is crucial for NEET-PG, as it involves multiple receptor systems. **Why Option A is the correct answer:** Imipramine, like most TCAs and antipsychotics, **lowers the seizure threshold** rather than elevating it. This means it makes the brain more susceptible to seizures, especially in patients with pre-existing epilepsy or in overdose situations. Therefore, "elevation of seizure threshold" is the incorrect statement regarding its effects. **Analysis of Incorrect Options:** * **B. Mydriasis:** TCAs have potent **anticholinergic (muscarinic blockade)** properties. This leads to pupillary dilation (mydriasis), blurred vision, and can potentially precipitate narrow-angle glaucoma. * **C. Sedation:** Imipramine possesses **H1-antihistaminic** properties. Sedation is a common side effect, particularly during the initiation of therapy. * **D. Urinary Retention:** This is another manifestation of its **anticholinergic** action (detrusor relaxation and sphincter contraction). It is a significant concern in elderly patients with prostatic hypertrophy. **High-Yield Clinical Pearls for NEET-PG:** 1. **Mechanism of Action:** TCAs inhibit the reuptake of Norepinephrine (NE) and Serotonin (5-HT). 2. **The "3 Cs" of TCA Toxicity:** Coma, Convulsions (due to lowered seizure threshold), and Cardiotoxicity (arrhythmias due to sodium channel blockade). 3. **ECG Changes:** TCA overdose characteristically shows **QRS widening** and QT prolongation. 4. **Specific Use:** Imipramine is a first-line drug for **Nocturnal Enuresis** in children (due to its anticholinergic effect and alteration of sleep patterns).

Question 274: Antipsychotic drugs primarily act through blockade of which of the following receptors?

A. Dopamine D1 receptor
B. Dopamine D2 receptor (Correct Answer)
C. Dopamine D3 receptor
D. Dopamine D4 receptor

Explanation: **Explanation:** The therapeutic efficacy of antipsychotic drugs (neuroleptics) is primarily attributed to the **blockade of Dopamine D2 receptors** in the mesolimbic and mesocortical pathways of the brain. This is known as the **Dopamine Hypothesis of Schizophrenia**, which suggests that overactivity of dopamine in these regions leads to positive symptoms like hallucinations and delusions. * **Dopamine D2 receptor (Correct):** All conventional (typical) antipsychotics, such as Haloperidol and Chlorpromazine, are potent D2 antagonists. Their clinical potency is directly proportional to their affinity for the D2 receptor. Even atypical antipsychotics (e.g., Risperidone) maintain a degree of D2 blockade alongside serotonin (5-HT2A) antagonism. * **Dopamine D1 receptor:** While some drugs (like Phenothiazines) may show minor binding to D1, it is not the primary mechanism for antipsychotic action. * **Dopamine D3 receptor:** These receptors are located mainly in the limbic system. While some newer drugs like Cariprazine act here, D3 blockade is not the "primary" mechanism for the class as a whole. * **Dopamine D4 receptor:** This receptor gained interest because **Clozapine** has a high affinity for it. However, selective D4 antagonists have failed to show antipsychotic efficacy in clinical trials, confirming that D2 remains the essential target. **High-Yield Clinical Pearls for NEET-PG:** 1. **Nigrostriatal Pathway:** Blockade of D2 receptors here leads to **Extrapyramidal Side Effects (EPS)**. 2. **Tuberoinfundibular Pathway:** D2 blockade here causes **Hyperprolactinemia** (galactorrhea, gynecomastia). 3. **Threshold:** Antipsychotic effects typically require **60-80%** D2 receptor occupancy; exceeding 80% significantly increases the risk of EPS.

Question 275: Which of the following drugs are used in the management of schizophrenia?

A. Chlorpromazine
B. Haloperidol
C. Olanzapine
D. All of the above (Correct Answer)

Explanation: **Explanation:** Schizophrenia is a chronic psychotic disorder primarily managed with **Antipsychotics** (Neuroleptics). These drugs work by modulating dopaminergic pathways in the brain, specifically by blocking **D2 receptors** in the mesolimbic system to alleviate "positive symptoms" (delusions and hallucinations). * **Chlorpromazine (Option A):** This is a prototypical **Low-potency Typical Antipsychotic** (Phenothiazine). It was the first antipsychotic discovered. Due to its low potency, it requires higher doses and is associated with significant sedation and alpha-blocking (orthostatic hypotension) side effects. * **Haloperidol (Option B):** This is a **High-potency Typical Antipsychotic** (Butyrophenone). It is highly effective against positive symptoms but has a high propensity for causing **Extrapyramidal Side Effects (EPS)** like acute dystonia and parkinsonism due to potent D2 blockade. * **Olanzapine (Option C):** This is a **Second-Generation (Atypical) Antipsychotic**. Unlike typical drugs, it blocks both **5-HT2A and D2 receptors**. It is preferred for treating "negative symptoms" (apathy, social withdrawal) and has a lower risk of EPS, though it is notorious for causing significant **weight gain and metabolic syndrome**. Since all three drugs belong to different classes of antipsychotics used in clinical practice for schizophrenia, **Option D (All of the above)** is correct. **High-Yield Clinical Pearls for NEET-PG:** 1. **Drug of Choice for Resistant Schizophrenia:** Clozapine (monitor for agranulocytosis). 2. **Hyperprolactinemia:** Most common with Haloperidol and Risperidone. 3. **Neuroleptic Malignant Syndrome (NMS):** A rare, fatal side effect characterized by "lead-pipe" rigidity, hyperthermia, and autonomic instability. Treatment: **Dantrolene** or Bromocriptine. 4. **Tardive Dyskinesia:** A late-onset EPS characterized by involuntary choreoathetoid movements (e.g., lip-smacking).

Question 276: Which of the following statements regarding Lithium is false?

A. Maximum plasma concentration is avoided due to its low therapeutic index.
B. It is contraindicated in pregnancy.
C. There is no individual variation in the rate of excretion. (Correct Answer)
D. 80% is reabsorbed in the proximal convoluted tubule.

Explanation: ### Explanation **1. Why Option C is the correct (false) statement:** Lithium is excreted almost entirely by the kidneys [3]. Its excretion rate is **highly variable** among individuals because it depends on factors like glomerular filtration rate (GFR), age, and sodium balance. Since Lithium is handled by the kidneys similarly to sodium, any variation in renal function or hydration status significantly alters its clearance. Therefore, the statement that there is "no individual variation" is incorrect. **2. Analysis of other options:** * **Option A (True):** Lithium has a very **narrow therapeutic index** (0.6–1.2 mEq/L) [5]. High peak plasma concentrations (Cmax) can lead to acute toxicity; hence, sustained-release formulations or divided doses are often used to avoid sharp peaks [2]. * **Option B (True):** Lithium is generally contraindicated in pregnancy, especially during the first trimester, due to its teratogenic potential—specifically **Ebstein’s Anomaly** (tricuspid valve malformation) [1]. * **Option D (True):** Lithium is filtered by the glomerulus, and approximately **80% is reabsorbed in the proximal convoluted tubule (PCT)**. It competes with sodium for reabsorption; thus, states of sodium depletion (like dehydration or use of thiazide diuretics) lead to increased Lithium reabsorption and toxicity [3]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Therapeutic Drug Monitoring (TDM):** Essential for Lithium. Blood samples should be drawn **12 hours after the last dose** (trough levels). * **Drug Interactions:** "The Deadly Trio"—**Diuretics (Thiazides), NSAIDs, and ACE inhibitors**—all increase Lithium levels by decreasing its renal clearance [5]. * **Side Effects:** Nephrogenic Diabetes Insipidus (treated with Amiloride), Hypothyroidism, and fine tremors [4], [5]. * **L-I-T-H-I-U-M Mnemonic:** **L**eukocytosis, **I**nsipidus (Diabetes), **T**remors/Teratogenicity, **H**ypothyroidism, **I**ncreased **U**rine, **M**others (Ebstein's) [1].

Question 277: Which of the following is a non-sedating antidepressant?

A. Fluoxetine (Correct Answer)
B. Mianserine
C. Amoxapine
D. Imipramine

Explanation: Fluoxetine is a **Selective Serotonin Reuptake Inhibitor (SSRI)**. Unlike older antidepressants, SSRIs have minimal affinity for histamine ($H_1$), atarget="_blank" href="https://www.ncbi.nlm.nih.gov/books/NBK538466/" alpha-adrenergic, and muscarinic receptors. The lack of $H_1$ receptor blockade makes SSRIs generally non-sedating. In fact, Fluoxetine is often described as **"activating"** or CNS-stimulating [1], which can cause insomnia or agitation in some patients. For this reason, it is typically administered in the morning. **Analysis of Incorrect Options:** * **B. Mianserine:** An atypical antidepressant (Tetracyclic) that is highly sedating due to its potent **$H_1$ receptor antagonism**. It is often used in depressed patients with significant insomnia. * **C. Amoxapine:** A tetracyclic antidepressant (a metabolite of the antipsychotic loxapine) that possesses significant sedative properties and potential extrapyramidal side effects due to $D_2$ blockade [2]. * **D. Imipramine:** A classic **Tricyclic Antidepressant (TCA)**. TCAs cause significant sedation because they block $H_1$ histamine receptors and $\alpha_1$-adrenergic receptors. **NEET-PG High-Yield Pearls:** * **Fluoxetine** has the longest half-life among SSRIs (due to its active metabolite, **norfluoxetine**), requiring a 5-week washout period before starting an MAO inhibitor to avoid **Serotonin Syndrome**. * **Drug of Choice (DOC):** SSRIs are the first-line treatment for Depression, OCD, Panic Disorder, Social Phobia, and Bulimia Nervosa (specifically Fluoxetine) [2]. * **Side Effects:** While non-sedating, SSRIs are frequently associated with **sexual dysfunction** (most common long-term side effect) and GI upset. * **Weight Neutrality:** Fluoxetine is generally weight-neutral compared to TCAs or Mirtazapine, which cause weight gain.

Question 278: Inhibitors of serotonin (5-HT) uptake, such as paroxetine, can cause clinically significant drug interactions with which of the following?

A. Diazepam
B. Digoxin
C. Halothane
D. Tranylcypromine (Correct Answer)

Explanation: **Explanation:** The correct answer is **Tranylcypromine**. **1. Why Tranylcypromine is correct:** Paroxetine is a Selective Serotonin Reuptake Inhibitor (SSRI), while Tranylcypromine is a non-selective Monoamine Oxidase Inhibitor (MAOI). When these two classes are combined, they cause an excessive accumulation of serotonin in the synaptic cleft. This leads to **Serotonin Syndrome**, a potentially fatal condition characterized by the "triad" of cognitive effects (confusion, agitation), autonomic hyperactivity (hyperthermia, tachycardia), and somatic effects (myoclonus, rigidity). To avoid this, a "washout period" of at least 14 days is required when switching between these drugs. **2. Why the other options are incorrect:** * **Diazepam:** This is a benzodiazepine. While SSRIs and benzodiazepines are often co-prescribed for anxiety disorders, they do not have a life-threatening pharmacodynamic interaction. * **Digoxin:** Digoxin metabolism is not significantly affected by SSRIs like paroxetine. Interactions are more common with drugs affecting P-glycoprotein or renal clearance. * **Halothane:** This is an inhaled anesthetic. While halothane can sensitize the myocardium to catecholamines, it does not have a direct, clinically significant interaction with serotonin uptake inhibitors. **High-Yield Clinical Pearls for NEET-PG:** * **Serotonin Syndrome vs. NMS:** Remember that Serotonin Syndrome presents with **hyperreflexia and myoclonus**, whereas Neuroleptic Malignant Syndrome (NMS) presents with **"lead-pipe" rigidity** and is caused by dopamine antagonists. * **The Fluoxetine Exception:** Most SSRIs require a 2-week washout period before starting an MAOI, but **Fluoxetine** requires a **5-week** washout due to its long-acting metabolite (norfluoxetine). * **Drug of Choice:** SSRIs are currently the first-line treatment for Depression, OCD, Panic Disorder, and Social Phobia.

Question 279: Which of the following is not a Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)?

A. Venlafaxine
B. Duloxetine
C. Milnacipram
D. Bupropion (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. Bupropion**. **1. Why Bupropion is the correct answer:** Bupropion is classified as a **Norepinephrine-Dopamine Reuptake Inhibitor (NDRI)**. Unlike SNRIs, it does not significantly inhibit the reuptake of Serotonin. Its primary mechanism involves increasing the synaptic concentration of Dopamine and Norepinephrine. Clinically, this unique profile makes it useful for treating depression without the common serotonergic side effects like sexual dysfunction or weight gain. **2. Why the other options are incorrect:** * **Venlafaxine (Option A):** A prototypical SNRI. At low doses, it primarily acts on serotonin; at higher doses (>150 mg), it significantly inhibits norepinephrine reuptake. * **Duloxetine (Option B):** A potent SNRI used not only for depression but also for chronic pain conditions like diabetic neuropathy and fibromyalgia. * **Milnacipran (Option C):** An SNRI with a higher selectivity for norepinephrine reuptake compared to serotonin. It is frequently used in the management of fibromyalgia. **3. High-Yield NEET-PG Clinical Pearls:** * **Bupropion & Seizures:** Bupropion is strictly contraindicated in patients with **epilepsy** or eating disorders (bulimia/anorexia) as it lowers the seizure threshold. * **Smoking Cessation:** Bupropion is a first-line pharmacological aid for smoking cessation. * **SNRI Indications:** SNRIs are preferred over SSRIs in patients where depression is accompanied by chronic pain (e.g., Duloxetine). * **Desvenlafaxine:** This is the active metabolite of Venlafaxine and is also a common SNRI.

Question 280: All actions of chlorpromazine are based on its antidopaminergic property EXCEPT?

A. Antipsychotic
B. Hyperprolactinemic
C. Antiemetic
D. Hypotensive (Correct Answer)

Explanation: **Explanation:** Chlorpromazine (CPZ) is a low-potency typical antipsychotic that acts as a "multi-receptor blocker." While many of its effects are mediated by blocking Dopamine ($D_2$) receptors, its cardiovascular effects are primarily mediated through other pathways. **1. Why Hypotension is the Correct Answer:** Hypotension (specifically orthostatic hypotension) caused by chlorpromazine is due to the **blockade of peripheral alpha-1 ($\alpha_1$) adrenergic receptors**, leading to vasodilation. It is not an antidopaminergic effect. Additionally, CPZ has a direct myocardial depressant effect. **2. Analysis of Incorrect Options (Antidopaminergic effects):** * **Antipsychotic:** This effect is due to the blockade of $D_2$ receptors in the **mesolimbic and mesocortical pathways**. * **Hyperprolactinemic:** Dopamine normally inhibits prolactin release via the **tuberoinfundibular pathway**. Blocking $D_2$ receptors here leads to increased prolactin levels, causing side effects like gynecomastia and galactorrhea. * **Antiemetic:** CPZ blocks $D_2$ receptors in the **Chemoreceptor Trigger Zone (CTZ)** located in the area postrema of the medulla. **Clinical Pearls for NEET-PG:** * **Receptor Profile:** CPZ blocks $D_2$, $\alpha_1$, $H_1$ (histamine), and $M$ (muscarinic) receptors. * **Side Effect Profile:** Because it is a low-potency drug, it causes **more sedation and hypotension** (due to $H_1$ and $\alpha_1$ block) but **fewer Extrapyramidal Symptoms (EPS)** compared to high-potency drugs like Haloperidol. * **Specific Side Effect:** Chlorpromazine is uniquely associated with **corneal and lenticular deposits** (pigmentation) upon long-term use.

Question 281: Which food should not be consumed by a patient taking Monoamine Oxidase Inhibitors (MAOIs)?

A. Cheese
B. Beer
C. Fish
D. All of the above (Correct Answer)

Explanation: ### Explanation **The Underlying Concept: The "Cheese Reaction"** Monoamine Oxidase Inhibitors (MAOIs), such as Phenelzine and Tranylcypromine, inhibit the enzyme responsible for breaking down catecholamines and dietary amines. **Tyramine** is an indirect sympathomimetic amine found in fermented, aged, or spoiled foods. Normally, MAO-A in the gut and liver degrades dietary tyramine. When a patient takes a non-selective MAOI, tyramine escapes degradation, enters the systemic circulation, and displaces stored norepinephrine from nerve terminals. This massive release of norepinephrine leads to a **Hypertensive Crisis** (severe headache, palpitations, and potentially stroke), famously known as the "Cheese Reaction." **Analysis of Options:** * **A. Cheese:** Specifically aged cheeses (Cheddar, Swiss, Blue) are very high in tyramine. (Note: Fresh cottage cheese or cream cheese is generally safe). * **B. Beer:** Draught beers and certain wines (Chianti) contain significant tyramine levels due to fermentation processes. * **C. Fish:** While fresh fish is safe, dried, pickled, smoked, or fermented fish (like herring) are potent triggers for the hypertensive crisis. Since all these categories contain high-tyramine items that can trigger a life-threatening interaction, **Option D (All of the above)** is the correct choice. **High-Yield Clinical Pearls for NEET-PG:** * **The Antidote:** The drug of choice for managing an MAOI-induced hypertensive crisis is **Phentolamine** (an alpha-blocker). * **The Exception:** **Selegiline** (a selective MAO-B inhibitor) at low doses typically does not require strict dietary restrictions because MAO-A in the gut remains functional. * **Washout Period:** When switching from an MAOI to an SSRI, a **2-week washout period** is mandatory to prevent **Serotonin Syndrome**. (5 weeks for Fluoxetine due to its long half-life). * **Other Prohibited Foods:** Yeast extracts (Marmite), soy sauce, fava beans, and overripe avocados/bananas.

Question 282: Extrapyramidal side effects are commonly seen with which of the following drugs?

A. Haloperidol (Correct Answer)
B. Clozapine
C. Tetracycline
D. Ketoconazole

Explanation: **Explanation:** **Haloperidol** is a high-potency, typical (first-generation) antipsychotic. Its primary mechanism of action is the potent blockade of **D2 receptors** in the brain. Extrapyramidal side effects (EPS) occur due to the blockade of D2 receptors in the **nigrostriatal pathway**, which disrupts the balance between dopamine and acetylcholine. High-potency drugs like Haloperidol have a high affinity for these receptors and low anticholinergic activity, making them the most common culprits for EPS. **Analysis of Incorrect Options:** * **Clozapine:** This is an atypical (second-generation) antipsychotic. It has a higher affinity for 5-HT2A receptors than D2 receptors and dissociates rapidly from D2 receptors. Consequently, it has a very low risk of EPS and is often the drug of choice when EPS occurs with other agents. * **Tetracycline:** This is a broad-spectrum antibiotic that inhibits protein synthesis (30S subunit). It is not associated with dopaminergic pathways or EPS. * **Ketoconazole:** This is an antifungal agent (imidazole) that inhibits ergosterol synthesis. While it can cause endocrine side effects (due to inhibition of cytochrome P450 enzymes), it does not cause EPS. **High-Yield Clinical Pearls for NEET-PG:** * **EPS Spectrum:** Includes Acute Dystonia (earliest), Akathisia (most common), Parkinsonism, and Tardive Dyskinesia (late-onset/potentially irreversible). * **Treatment of Acute Dystonia:** Centrally acting anticholinergics like **Benztropine** or **Promethazine**. * **Drug of Choice for Akathisia:** Propropanol (Beta-blockers). * **Hyperprolactinemia:** Also caused by D2 blockade in the tuberoinfundibular pathway, common with Haloperidol and Risperidone.

Question 283: Which of the following is true regarding tricyclic antidepressants?

A. Tricyclic antidepressants increase the antihypertensive effect of guanethidine.
B. Tricyclic antidepressants have anticonvulsant activity.
C. Tricyclic antidepressants should not be used in patients with glaucoma. (Correct Answer)
D. Tricyclic antidepressants may increase oral absorption of levodopa.

Explanation: **Explanation:** Tricyclic Antidepressants (TCAs) like Amitriptyline and Imipramine are known for their complex pharmacological profile, involving the inhibition of Norepinephrine (NE) and Serotonin (5-HT) reuptake, as well as significant blockade of muscarinic, histaminergic, and alpha-adrenergic receptors [1]. **Why Option C is Correct:** TCAs possess potent **antimuscarinic (atropine-like) properties** [1]. Blockade of muscarinic receptors in the eye leads to mydriasis (dilation of the pupil). In patients with narrow-angle glaucoma, this can cause the iris to block the drainage angle of the eye, acutely increasing intraocular pressure and potentially precipitating an attack of **acute angle-closure glaucoma**. Therefore, they are contraindicated in such patients. **Analysis of Incorrect Options:** * **Option A:** TCAs **block the antihypertensive effect** of guanethidine. Guanethidine requires the neuronal uptake pump (NET) to reach its site of action; TCAs inhibit this pump, preventing the drug from entering the neuron. * **Option B:** TCAs actually **lower the seizure threshold**. They possess pro-convulsant activity rather than anticonvulsant activity, making them risky for patients with epilepsy. * **Option C:** TCAs **decrease the oral absorption** of levodopa. Due to their anticholinergic effect, they delay gastric emptying, leading to increased degradation of levodopa in the stomach before it reaches its absorption site in the small intestine. **High-Yield Clinical Pearls for NEET-PG:** * **Overdose Triad (The 3 C’s):** **C**onvulsions, **C**oma, and **C**ardiotoxicity (Arrhythmias due to Sodium channel blockade). * **Antidote for Cardiotoxicity:** Sodium Bicarbonate (to overcome sodium channel blockade). * **Most Sedating TCA:** Amitriptyline (due to high H1 receptor affinity). * **Least Sedating/Least Anticholinergic:** Desipramine or Nortriptyline [1].

Question 284: True about Imipramine is:

A. Antiepileptic
B. Antidepressant (Correct Answer)
C. Anxiolytic
D. Antipsychotic

Explanation: **Explanation:**1. Why Option B is Correct:Imipramine is a prototype drug belonging to the **Tricyclic Antidepressants (TCAs)** class [1, 2]. Its primary mechanism of action involves the non-selective inhibition of the reuptake of norepinephrine (NE) and serotonin (5-HT) from the synaptic cleft into the presynaptic nerve terminals [1, 2]. By increasing the concentration of these monoamines in the brain, it effectively alleviates the symptoms of clinical depression [2].2. Why Other Options are Incorrect:* **Option A (Antiepileptic):** Imipramine actually **lowers the seizure threshold**. It is contraindicated in patients with epilepsy as it can precipitate seizures.* **Option C (Anxiolytic):** While TCAs may be used for panic disorders, they are not classified as primary anxiolytics (like Benzodiazepines). In fact, initial doses can sometimes worsen agitation.* **Option D (Antipsychotic):** Antipsychotics (e.g., Haloperidol, Risperidone) primarily act by blocking Dopamine (D2) receptors. Imipramine does not possess significant antipsychotic properties.3. Clinical Pearls & High-Yield Facts for NEET-PG:* **Nocturnal Enuresis:** Imipramine is the drug of choice for bedwetting in children (above 5 years) due to its anticholinergic effect, which increases bladder capacity.* **Side Effect Profile:** TCAs are notorious for "3Cs": **C**oma, **C**onvulsions, and **C**ardiotoxicity (arrhythmias due to Na+ channel blockade).* **Anticholinergic Effects:** Common side effects include dry mouth, blurred vision, constipation, and urinary retention [1].* **Metabolism:** It is a tertiary amine that is metabolized into **Desipramine** (an active metabolite) [1, 2].

Question 285: Which of the following antidepressants is used for smoking cessation?

A. Fluoxetine
B. Bupropion (Correct Answer)
C. Reboxetine
D. Venlafaxine

Explanation: **Bupropion** is an atypical antidepressant that acts as a **Norepinephrine-Dopamine Reuptake Inhibitor (NDRI)** [2]. It is the only antidepressant FDA-approved for smoking cessation [1]. Its efficacy lies in its ability to increase dopamine levels in the nucleus accumbens (the brain's reward center), which mimics the effect of nicotine and reduces withdrawal symptoms and the urge to smoke [1].**Analysis of Options:** * **Fluoxetine (Option A):** An SSRI (Selective Serotonin Reuptake Inhibitor) primarily used for Depression, OCD, and Bulimia. It has no proven efficacy in smoking cessation.* **Reboxetine (Option C):** A Selective Norepinephrine Reuptake Inhibitor (SNRI) used for depression; it does not play a role in nicotine addiction management.* **Venlafaxine (Option D):** A Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) used for Major Depressive Disorder and Anxiety disorders, but not for smoking cessation.**High-Yield Clinical Pearls for NEET-PG:** * **Mechanism in Smoking:** Bupropion (Sustained Release) is typically started 1–2 weeks *before* the patient's "quit date."* **Contraindication (Must Know):** Bupropion lowers the seizure threshold. It is strictly contraindicated in patients with **Seizure disorders** or **Eating disorders** (Anorexia/Bulimia) due to increased risk of convulsions [1].* **Weight Neutrality:** Unlike many other antidepressants, Bupropion is associated with weight loss or is weight-neutral, making it a preferred choice in obese patients [1].* **Sexual Dysfunction:** It does not cause sexual dysfunction (unlike SSRIs), making it useful for patients experiencing SSRI-induced side effects [1].* **Other Smoking Cessation Drugs:** **Varenicline** (Partial agonist at α4β2 nicotinic receptors) is currently considered the most effective pharmacological agent for smoking cessation.

Question 286: Which of the following is a short-acting benzodiazepine?

A. Diazepam
B. Flurazepam
C. Lorazepam (Correct Answer)
D. Chlordiazepoxide

Explanation: **Explanation:** Benzodiazepines (BZDs) are classified based on their elimination half-life into short, intermediate, and long-acting agents. This classification is clinically significant for determining their use in insomnia, anxiety, or anesthesia. **Why Lorazepam is Correct:** **Lorazepam** is categorized as an **intermediate to short-acting** benzodiazepine (half-life approx. 10–20 hours). Unlike many other BZDs, it does not undergo phase I oxidative metabolism in the liver; instead, it is directly conjugated (Phase II) to inactive glucuronides. This lack of active metabolites prevents cumulative effects, making it relatively shorter-acting compared to the other options provided. **Analysis of Incorrect Options:** * **Diazepam (A):** A classic **long-acting** BZD (half-life >30 hours). It is converted into active metabolites like desmethyldiazepam, which has an extremely long half-life (up to 100 hours). * **Flurazepam (B):** A **long-acting** BZD primarily used for insomnia. Its active metabolite, desalkylflurazepam, remains in the system for a prolonged duration, often causing "daytime hangover." * **Chlordiazepoxide (D):** The first BZD synthesized, it is **long-acting** and frequently used in alcohol withdrawal due to its smooth tapering effect. **NEET-PG High-Yield Pearls:** * **Mnemonic for Short-Acting BZDs:** **ATOMS** (Alprazolam, Triazolam, Oxazepam, Midazolam, Temazepam). *Note: Lorazepam is often grouped here in exams due to its lack of active metabolites.* * **Safe in Liver Failure:** Use **LOT** (Lorazepam, Oxazepam, Temazepam) as they undergo direct glucuronidation and do not rely on hepatic microsomal enzymes. * **Ultra-short acting:** **Midazolam** (used for conscious sedation) and **Triazolam** (highest risk for rebound insomnia). * **Drug of Choice:** Lorazepam is the preferred BZD for **Status Epilepticus** (IV) due to its lower lipid solubility compared to Diazepam, allowing it to remain in the vascular compartment longer.

Question 287: Which of the following drugs is considered to have dual reuptake inhibition?

A. Clomipramine
B. Amitriptyline
C. Venlafaxine
D. All of the above (Correct Answer)

Explanation: ### Explanation The term **"Dual Reuptake Inhibition"** refers to the pharmacological action of inhibiting the reuptake of both **Serotonin (5-HT)** and **Norepinephrine (NE)** from the synaptic cleft. This increases the concentration of both neurotransmitters, providing a potent antidepressant effect. **Why "All of the above" is correct:** 1. **Clomipramine:** Although classified as a Tricyclic Antidepressant (TCA), it is unique because it is the most potent serotonin reuptake inhibitor among TCAs, while its active metabolite (desmethylclomipramine) strongly inhibits norepinephrine reuptake. 2. **Amitriptyline:** A classic Tertiary Amine TCA. It non-selectively inhibits the reuptake of both 5-HT and NE. 3. **Venlafaxine:** This drug belongs to the **SNRI (Serotonin-Norepinephrine Reuptake Inhibitor)** class. At lower doses, it primarily inhibits serotonin reuptake, but at medium to higher doses, it significantly inhibits norepinephrine reuptake as well. **Clinical Pearls for NEET-PG:** * **Clomipramine** is the drug of choice (DOC) for **Obsessive-Compulsive Disorder (OCD)**. * **Venlafaxine** is known for causing **dose-dependent hypertension** due to its noradrenergic activity. * **TCAs vs. SNRIs:** While both provide dual reuptake inhibition, SNRIs (like Venlafaxine and Duloxetine) are preferred in modern practice because they lack the "dirty" side-effect profile of TCAs (i.e., they do not significantly block alpha-1, H1-histamine, or muscarinic receptors). * **Duloxetine** (another SNRI) is frequently asked as the DOC for **Diabetic Neuropathy** and Fibromyalgia.

Question 288: Which antipsychotic drug has the longest elimination half-life?

A. Aripiprazole (Correct Answer)
B. Loxapine
C. Quetiapine
D. Ziprasidone

Explanation: **Explanation:** The correct answer is **Aripiprazole**. **1. Why Aripiprazole is correct:** Aripiprazole is a third-generation atypical antipsychotic characterized by a unique mechanism of action as a **D2 partial agonist**. Among the oral antipsychotics, it possesses an exceptionally long elimination half-life, averaging approximately **75 hours** (extending up to 94 hours in poor metabolizers of CYP2D6). This long half-life allows for once-daily dosing and provides a "buffer" against missed doses, as plasma levels decline slowly. **2. Why the other options are incorrect:** * **Loxapine:** A typical (first-generation) antipsychotic of the dibenzoxazepine class. It has a relatively short half-life of approximately **4 to 8 hours**. * **Quetiapine:** An atypical antipsychotic known for rapid dissociation from D2 receptors. It has one of the shortest half-lives among second-generation drugs, approximately **6 to 7 hours**, often requiring twice-daily dosing or extended-release formulations. * **Ziprasidone:** An atypical antipsychotic with a short half-life of approximately **7 hours**. It must be taken with food (at least 500 calories) to ensure adequate absorption. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Aripiprazole acts as a "Dopamine Stabilizer" (Partial agonist at D2 and 5-HT1A; antagonist at 5-HT2A). * **Side Effect Profile:** It has the lowest risk of weight gain, hyperprolactinemia, and sedation among atypical antipsychotics. However, it is frequently associated with **Akathisia**. * **Long-acting Injectable (LAI):** Aripiprazole is also available as a monthly depot (Aripiprazole Maintena), but even in its **oral form**, it has the longest half-life of the options provided. * **Metabolism:** It is primarily metabolized by **CYP2D6** and **CYP3A4**.

Question 289: Which of the following drugs is not associated with an increase in prolactin levels?

A. Haloperidol
B. Chlorpromazine
C. Hydroxysulpiride
D. Quetiapine (Correct Answer)

Explanation: **Explanation:** The regulation of prolactin secretion is primarily controlled by the **Tuberoinfundibular pathway** in the brain. In this pathway, dopamine acts as a "Prolactin Inhibiting Factor" by stimulating **D2 receptors** on lactotroph cells in the anterior pituitary. Antipsychotic drugs that block these D2 receptors remove this inhibition, leading to **hyperprolactinemia**. **Why Quetiapine is the correct answer:** Quetiapine is a **Second-Generation (Atypical) Antipsychotic**. It is characterized by "loose" binding and rapid dissociation from D2 receptors. Because it does not maintain prolonged blockade of D2 receptors in the pituitary, it is considered **prolactin-sparing**. Along with Aripiprazole and Clozapine, Quetiapine is least likely to cause prolactin elevation. **Analysis of incorrect options:** * **Haloperidol & Chlorpromazine:** These are **First-Generation (Typical) Antipsychotics**. They are potent D2 receptor antagonists with high affinity. They significantly block the tuberoinfundibular pathway, frequently causing side effects like galactorrhea, amenorrhea, and gynecomastia. * **Hydroxysulpiride (and Sulpiride/Amisulpiride):** These are substituted benzamides. Despite being classified as atypical in some contexts, they are notorious for causing the **highest** increases in prolactin levels because they do not cross the blood-brain barrier well and concentrate in the pituitary (which lies outside the BBB). **NEET-PG High-Yield Pearls:** 1. **Highest Prolactin Elevation:** Risperidone, Paliperidone, and Amisulpiride. 2. **Lowest Prolactin Elevation:** Aripiprazole (D2 partial agonist), Quetiapine, and Clozapine. 3. **Clinical Sign:** Hyperprolactinemia can lead to decreased bone mineral density (osteoporosis) due to suppressed GnRH/estrogen.

Question 290: All are true about Desvenlafaxine except?

A. It is a D2 receptor antagonist (Correct Answer)
B. Can cause priapism
C. Can cause glaucoma
D. Can cause hyperlipidemia

Explanation: **Explanation:** **1. Why Option A is the correct answer (The "Except"):** Desvenlafaxine is a **Selective Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)**. It is the active metabolite of Venlafaxine. Its mechanism of action involves inhibiting the reuptake of serotonin (5-HT) and norepinephrine (NE) in the synaptic cleft. It has **no significant affinity** for D2 (Dopamine), cholinergic, histaminergic, or alpha-adrenergic receptors. Therefore, stating it is a D2 receptor antagonist is pharmacologically incorrect. **2. Analysis of other options:** * **Option B (Priapism):** While rare compared to Trazodone, SNRIs and SSRIs have been associated with idiosyncratic cases of priapism due to complex downstream effects on neurotransmitters. * **Option C (Glaucoma):** SNRIs can cause pupillary dilation (mydriasis) due to increased norepinephrine levels. This can trigger an attack of **acute angle-closure glaucoma** in predisposed individuals. * **Option D (Hyperlipidemia):** Desvenlafaxine treatment is clinically associated with dose-related increases in fasting serum total cholesterol, LDL, and triglycerides. Regular lipid monitoring is recommended during therapy. **High-Yield Clinical Pearls for NEET-PG:** * **Active Metabolite:** Desvenlafaxine is the major active metabolite of Venlafaxine (formed via CYP2D6). * **Dose-Response:** Unlike Venlafaxine, which acts like an SSRI at low doses and an SNRI at high doses, Desvenlafaxine shows SNRI activity even at the starting dose (50mg). * **Side Effect Profile:** Common side effects include nausea, insomnia, sweating, and **dose-dependent hypertension** (due to increased NE). * **Discontinuation Syndrome:** SNRIs have a high risk of withdrawal symptoms; tapering is essential.

Question 291: All of the following are used for the treatment of morphine dependence except?

A. Methadone
B. Clonidine
C. Naltrexone
D. Disulfiram (Correct Answer)

Explanation: **Explanation:** The treatment of morphine (opioid) dependence involves managing acute withdrawal symptoms and long-term maintenance therapy to prevent relapse. **Why Disulfiram is the correct answer:** **Disulfiram** is an aldehyde dehydrogenase inhibitor used exclusively in the treatment of **Alcohol Dependence**. It creates an aversive reaction (Disulfiram-like reaction) by causing acetaldehyde accumulation if alcohol is consumed. It has no pharmacological role in the management of opioid withdrawal or dependence. **Analysis of Incorrect Options:** * **Methadone (Option A):** A long-acting μ-opioid agonist used for **opioid substitution therapy (OST)**. It prevents withdrawal symptoms and reduces "drug-seeking" behavior due to its long half-life and cross-tolerance with morphine. * **Clonidine (Option B):** An $\alpha_2$ agonist used to manage the **autonomic symptoms** of opioid withdrawal (e.g., hypertension, tachycardia, sweating, and tremors). It reduces the sympathetic overactivity caused by the locus coeruleus during detoxification. * **Naltrexone (Option C):** A long-acting **opioid antagonist** used for relapse prevention. It blocks the reinforcing effects (euphoria) of opioids. It is only started after the patient is completely detoxified to avoid precipitating acute withdrawal. **High-Yield Clinical Pearls for NEET-PG:** * **Buprenorphine:** A partial μ-agonist and κ-antagonist; it is the preferred drug for office-based opioid substitution due to its "ceiling effect" on respiratory depression. * **Naloxone:** The drug of choice for **acute opioid poisoning** (short-acting antagonist). * **Lofexidine:** An $\alpha_{2A}$ agonist recently approved specifically for managing opioid withdrawal symptoms, often preferred over clonidine due to less hypotension.

Question 292: Which of the following is a Selective Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)?

A. Venlafaxine (Correct Answer)
B. Reboxetine
C. Moclobemide
D. Bupropion

Explanation: ### Explanation **Correct Option: A. Venlafaxine** Venlafaxine is a prototype **Selective Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)**. It works by inhibiting the reuptake of both serotonin (5-HT) and norepinephrine (NE) into the presynaptic neuron, thereby increasing their concentration in the synaptic cleft. At lower doses, it primarily acts on serotonin, while at higher doses, its effect on norepinephrine becomes significant. It is commonly used for Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), and neuropathic pain. **Analysis of Incorrect Options:** * **B. Reboxetine:** This is a **Selective Norepinephrine Reuptake Inhibitor (NARI)**. It selectively increases norepinephrine levels without significantly affecting serotonin. * **C. Moclobemide:** This is a **Reversible Inhibitor of MAO-A (RIMA)**. It prevents the breakdown of monoamines (primarily serotonin and NE) but does not inhibit their reuptake. * **D. Bupropion:** This is an **Atypical Antidepressant** that acts as a **Norepinephrine-Dopamine Reuptake Inhibitor (NDRI)**. It is notable for having no serotonergic activity, making it a preferred choice to avoid sexual dysfunction. **High-Yield Clinical Pearls for NEET-PG:** * **SNRI Examples:** Venlafaxine, Desvenlafaxine, Duloxetine, and Milnacipran. * **Duloxetine** is the drug of choice for **diabetic neuropathy** and fibromyalgia. * **Venlafaxine Side Effect:** Can cause a dose-dependent **increase in blood pressure** (hypertension); monitoring is essential. * **Bupropion** is used for **smoking cessation** but is contraindicated in patients with seizure disorders (lowers seizure threshold).

Question 293: Agranulocytosis is a known side effect of which of the following medications?

A. Risperidone
B. Clonazepam
C. Olanzapine
D. Carbamazepine (Correct Answer)

Explanation: **Explanation:** **Correct Answer: D. Carbamazepine** **Mechanism and Rationale:** Carbamazepine is an iminostilbene derivative used as an antiepileptic and a mood stabilizer in Bipolar Disorder. One of its most serious, albeit rare, idiosyncratic adverse effects is **bone marrow suppression**, leading to **agranulocytosis**, aplastic anemia, and leucopenia. This occurs due to the direct toxic effect of its metabolites on the bone marrow or an immune-mediated reaction. Because of this risk, baseline and periodic Complete Blood Count (CBC) monitoring is recommended during treatment. **Analysis of Incorrect Options:** * **A. Risperidone:** An atypical antipsychotic primarily associated with extrapyramidal symptoms (at high doses), hyperprolactinemia, and weight gain. It does not typically cause agranulocytosis. * **B. Clonazepam:** A benzodiazepine used for anxiety and seizures. Its primary side effects are sedation, ataxia, and cognitive impairment; it is not associated with hematological toxicity. * **C. Olanzapine:** An atypical antipsychotic notorious for causing significant metabolic side effects (weight gain, dyslipidemia, and Type 2 Diabetes). While it is chemically related to Clozapine, it does **not** carry the same high risk of agranulocytosis. **High-Yield Clinical Pearls for NEET-PG:** * **Clozapine vs. Carbamazepine:** Both cause agranulocytosis. Clozapine is the *most common* psychiatric drug associated with this (requires mandatory WBC monitoring), but among the options provided, Carbamazepine is the correct answer. * **HLA-B*1502:** In patients of Asian descent, Carbamazepine is strongly linked to Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). * **Enzyme Induction:** Carbamazepine is a potent **cytochrome P450 inducer**, leading to numerous drug-drug interactions (e.g., decreasing the efficacy of oral contraceptives). * **Other Side Effects:** SIADH (hyponatremia) and teratogenicity (neural tube defects).

Question 294: What adverse effect can sodium valproate cause in a patient with bipolar mood disorder?

A. Peripheral neuropathy
B. Hepatotoxicity (Correct Answer)
C. Renal failure
D. Cystitis

Explanation: **Explanation:** **Sodium Valproate** is a broad-spectrum antiepileptic drug also used as a first-line mood stabilizer in Bipolar Mood Disorder. **Why Hepatotoxicity is the Correct Answer:** Valproate is metabolized in the liver. Its most serious and potentially fatal adverse effect is **idiosyncratic hepatotoxicity**. This typically occurs within the first six months of therapy. It is caused by the formation of toxic metabolites (like 4-pentenoic acid) that interfere with mitochondrial beta-oxidation. Risk is highest in children under two years old and those on polytherapy, but it remains a critical monitoring parameter for all psychiatric patients on long-term valproate. **Analysis of Incorrect Options:** * **A. Peripheral neuropathy:** This is more commonly associated with drugs like **Phenytoin** or **Isoniazid**, not Valproate. * **B. Renal failure:** Valproate is not nephrotoxic. In contrast, **Lithium** (another mood stabilizer) is known for causing nephrogenic diabetes insipidus and chronic interstitial nephritis. * **D. Cystitis:** Specifically **Hemorrhagic Cystitis** is a classic side effect of **Cyclophosphamide** (due to acrolein), not valproate. **High-Yield NEET-PG Pearls:** * **Teratogenicity:** Valproate is highly teratogenic, causing **Neural Tube Defects** (specifically Spina Bifida) due to interference with folate metabolism. * **Other Side Effects:** Remember the mnemonic **VALPROATE**: **V**omiting, **A**lopecia (transient), **L**iver toxicity, **P**ancreatitis (acute), **R**etention of weight (Weight gain), **O**edema, **A**ppetite increase, **T**hrombocytopenia, and **E**ncephalopathy (due to hyperammonemia). * **Monitoring:** Baseline and periodic **Liver Function Tests (LFTs)** are mandatory.

Question 295: Which antipsychotic drug has the maximum hypotensive side effect?

A. Fluphenazine
B. Trifluoperazine
C. Thioridazine (Correct Answer)
D. Haloperidol

Explanation: **Explanation:** The hypotensive effect of antipsychotic drugs is primarily mediated by the blockade of **alpha-1 (̑1) adrenergic receptors** in the peripheral vasculature [2]. **Why Thioridazine is correct:** Antipsychotics are broadly classified into high-potency and low-potency groups. **Thioridazine** is a **low-potency** typical antipsychotic [3]. Low-potency drugs generally have a lower affinity for D2 receptors but a much higher affinity for alpha-adrenergic, muscarinic, and histaminergic receptors. Among the options provided, Thioridazine has the most potent ̑1-blocking activity, leading to significant peripheral vasodilation and **orthostatic (postural) hypotension** [2]. **Why other options are incorrect:** * **Fluphenazine, Trifluoperazine, and Haloperidol** are all **high-potency** typical antipsychotics [3]. * High-potency drugs have a very high affinity for D2 receptors (leading to more Extrapyramidal Side Effects/EPS) but a **low affinity** for alpha-1 receptors [2]. * Consequently, these drugs are much less likely to cause hypotension compared to low-potency agents like Thioridazine or Chlorpromazine. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** "Low potency = Low BP, High Sedation, High Anticholinergic." * **Cardiotoxicity:** Thioridazine is also notorious for causing **QT interval prolongation** and *Torsades de Pointes*, often limiting its clinical use [3]. * **Ocular Side Effect:** Thioridazine is uniquely associated with **retinitis pigmentosa** (brownish discoloration of vision) at high doses. * **Potency vs. Efficacy:** All antipsychotics have similar efficacy for positive symptoms; they differ only in their potency and side-effect profiles [1].

Question 296: Which of the following antipsychotics is not available as a depot preparation for the treatment of psychosis?

A. Aripiprazole
B. Olanzapine
C. Clozapine (Correct Answer)
D. Haloperidol

Explanation: **Explanation:** The correct answer is **Clozapine**. Depot preparations (Long-Acting Injectables or LAIs) are designed to improve compliance in patients with chronic schizophrenia by providing sustained drug release over weeks or months. **Why Clozapine is not available as a depot:** Clozapine is reserved for **treatment-resistant schizophrenia**. Its use is strictly regulated due to the risk of **agranulocytosis** (severe leucopenia). Patients on Clozapine require mandatory, regular blood monitoring (ANC counts). If Clozapine were administered as a long-acting depot, it would be impossible to rapidly "withdraw" the drug from the system if a patient developed life-threatening bone marrow suppression. Therefore, it is only available in oral formulations to allow for immediate cessation if toxicity occurs. **Analysis of Incorrect Options:** * **Haloperidol:** A typical (first-generation) antipsychotic available as **Haloperidol Decanoate**, usually administered every 4 weeks. * **Aripiprazole:** An atypical (second-generation) antipsychotic available as **Aripiprazole Maintena** (monthly) and **Lauroxil**. * **Olanzapine:** Available as **Olanzapine Pamoate**. Note: It carries a risk of "Post-injection Delirium Sedation Syndrome," requiring 3 hours of clinical observation after administration. **High-Yield Clinical Pearls for NEET-PG:** * **Other Depot Drugs:** Fluphenazine decanoate, Risperidone microspheres, and Paliperidone palmitate. * **Clozapine Side Effects:** Agranulocytosis (most serious), seizures (dose-dependent), myocarditis, and significant weight gain/sialorrhea. * **Monitoring:** Clozapine is the only antipsychotic proven to reduce **suicidal behavior** in schizophrenia.

Question 297: Which of the following is a reversible monoamine oxidase inhibitor (MAOI)?

A. Nicorandil
B. Selegiline
C. Moclobemide (Correct Answer)
D. Fluphenazine

Explanation: **Explanation:** **Moclobemide** is the correct answer because it is a **Reversible Inhibitor of MAO-A (RIMA)**. Unlike older, irreversible MAOIs (like Phenelzine), Moclobemide binds non-covalently to the MAO-A enzyme. This reversibility is clinically significant because if dietary tyramine levels rise, the tyramine can displace Moclobemide from the enzyme, allowing for its metabolism. This significantly reduces the risk of the "Cheese Reaction" (hypertensive crisis). **Analysis of Incorrect Options:** * **A. Nicorandil:** This is a potassium channel opener with a nitrate-like action used in the management of angina pectoris, not a psychiatric medication. * **B. Selegiline:** While it is an MAOI, it is an **irreversible** inhibitor. At low doses, it is selective for MAO-B (used in Parkinson’s disease); at higher doses, it loses selectivity and inhibits both MAO-A and MAO-B. * **C. Fluphenazine:** This is a high-potency **typical antipsychotic** (Phenothiazine class) that acts primarily by blocking D2 receptors. **NEET-PG High-Yield Pearls:** * **MAO-A** primarily metabolizes Norepinephrine, Serotonin, and Tyramine. **MAO-B** primarily metabolizes Dopamine. * **RIMA (Moclobemide):** Preferred in atypical depression due to the lack of stringent dietary restrictions. * **Cheese Reaction:** Occurs when irreversible MAOIs prevent the breakdown of tyramine (found in aged cheese/wine), leading to massive NE release and hypertensive crisis. **Phentolamine** (alpha-blocker) is the drug of choice for treatment. * **Serotonin Syndrome:** A dangerous interaction when MAOIs are combined with SSRIs; a "washout period" of 2–5 weeks is required when switching between these classes.

Question 298: Which of the following is an antidepressant?

A. Amitriptyline
B. Trazodone
C. Nefazodone
D. Citalopram (Correct Answer)

Explanation: **Explanation:** The question asks to identify an antidepressant from the given list. While all options listed are technically used in the management of depression, this question likely focuses on the primary classification of **Selective Serotonin Reuptake Inhibitors (SSRIs)**, which are the first-line agents for depression in modern clinical practice. **1. Why Citalopram is the Correct Answer:** **Citalopram** is a prototypical SSRI. It works by specifically inhibiting the reuptake of serotonin (5-HT) at the presynaptic terminal, increasing its availability in the synaptic cleft. It is preferred due to its high selectivity, better side-effect profile, and lower toxicity in overdose compared to older classes. **2. Analysis of Other Options:** * **Amitriptyline:** This is a **Tricyclic Antidepressant (TCA)**. It inhibits the reuptake of both Norepinephrine and Serotonin but also blocks muscarinic, histaminic, and alpha-adrenergic receptors, leading to significant side effects (sedation, dry mouth, arrhythmias). * **Trazodone & Nefazodone:** These belong to the **SARI (Serotonin Antagonist and Reuptake Inhibitor)** class. They are "atypical" antidepressants. Trazodone is more commonly used today as a hypnotic for insomnia rather than a primary antidepressant due to its highly sedative nature. **Clinical Pearls for NEET-PG:** * **SSRIs (Drug of Choice):** Escitalopram is the most specific SSRI; Fluoxetine has the longest half-life (safe from withdrawal syndrome). * **Side Effects:** SSRIs commonly cause sexual dysfunction and GI upset. TCAs are notorious for the "3 Cs": Coma, Convulsions, and Cardiotoxicity (arrhythmias due to Na+ channel blockade). * **Nefazodone Warning:** It is rarely used now due to the risk of **hepatotoxicity**. * **Trazodone:** Associated with the rare but high-yield side effect of **priapism**.

Question 299: Which of the following is a tricyclic antidepressant?

A. Amitriptyline (Correct Answer)
B. Fluoxetine
C. Trazodone
D. Bupropion

Explanation: **Explanation:** **Amitriptyline** is the correct answer as it belongs to the **Tricyclic Antidepressant (TCA)** class. TCAs are characterized by a three-ring chemical structure and work primarily by inhibiting the reuptake of both Serotonin (5-HT) and Norepinephrine (NE) from the synaptic cleft. Amitriptyline is a tertiary amine, meaning it has a more pronounced effect on serotonin reuptake compared to secondary amines like Nortriptyline. **Analysis of Incorrect Options:** * **Fluoxetine (Option B):** This is a prototype **Selective Serotonin Reuptake Inhibitor (SSRI)**. It is the first-line treatment for depression due to its better safety profile and fewer side effects compared to TCAs. * **Trazodone (Option C):** This is a **Serotonin Antagonist and Reuptake Inhibitor (SARI)**. It is frequently used off-label as a hypnotic due to its significant sedative properties (H1 blockade). * **Bupropion (Option D):** This is an **Atypical Antidepressant** that acts as a Norepinephrine-Dopamine Reuptake Inhibitor (NDRI). It is notable for lacking sexual side effects and is also used for smoking cessation. **High-Yield Clinical Pearls for NEET-PG:** * **Side Effects of TCAs:** They cause "3 Cs"—**C**oma, **C**onvulsions, and **C**ardiotoxicity (due to sodium channel blockade leading to QRS prolongation). They also have strong anticholinergic (dry mouth, blurred vision) and antihistaminic (sedation) effects. * **Antidote:** Sodium bicarbonate is used to treat TCA-induced cardiotoxicity. * **Drug of Choice:** While SSRIs are first-line for depression, TCAs like Amitriptyline are often used for **neuropathic pain** and **migraine prophylaxis**. Imipramine (another TCA) is a classic drug for **nocturnal enuresis** in children.

Question 300: Thrombocytopenia is a known side effect of which of the following drugs?

A. Valproate (Correct Answer)
B. Clonazepam
C. Aripiprazole
D. Amisulpride

Explanation: **Explanation:** **Valproate (Sodium Valproate/Valproic Acid)** is the correct answer. It is a broad-spectrum anti-epileptic drug also used as a first-line mood stabilizer in Bipolar Disorder. **Why Valproate causes Thrombocytopenia:** Valproate-induced thrombocytopenia is a well-documented, dose-dependent side effect. The underlying mechanism involves both **bone marrow suppression** (inhibiting megakaryocytopoiesis) and the production of **anti-platelet antibodies** (peripheral destruction). Clinically, this necessitates regular monitoring of Complete Blood Counts (CBC), especially before surgery or when used at high serum concentrations (>100 μg/mL). **Analysis of Incorrect Options:** * **Clonazepam:** A benzodiazepine used for anxiety and seizures. Its primary side effects are sedation, ataxia, and cognitive impairment; it does not typically cause hematological toxicity. * **Aripiprazole:** An atypical antipsychotic (partial D2 agonist). Common side effects include akathisia and insomnia. It is generally "metabolically neutral" and rarely associated with blood dyscrasias. * **Amisulpride:** An atypical antipsychotic (D2/D3 antagonist). Its most significant side effect is **hyperprolactinemia**; it is not known for causing thrombocytopenia. **High-Yield Clinical Pearls for NEET-PG:** * **Valproate Side Effects (Mnemonic: VALPROATE):** **V**omiting, **A**lopecia (curly hair), **L**iver toxicity (Hepatotoxicity), **P**ancreatitis, **R**etention of weight (Obesity), **O**edema, **A**norexia, **T**hrombocytopenia, **E**ncephalopathy (due to hyperammonemia). * **Teratogenicity:** Valproate is highly teratogenic, causing **Neural Tube Defects** (Spina Bifida). * **Drug of Choice:** It is the drug of choice for Myoclonic seizures and Bipolar Affective Disorder (Manic episodes).

Question 301: What is the primary abnormality to screen for when a pregnant female is prescribed lithium?

A. Cardiac anomaly (Correct Answer)
B. Neural tube defect
C. Facial defect
D. Urogenital defect

Explanation: **Explanation:** **Lithium** is a gold-standard mood stabilizer used in Bipolar Disorder, but it is a known human teratogen. When administered during the first trimester of pregnancy, it is specifically associated with a rare but serious **cardiac anomaly** known as **Ebstein’s Anomaly**. 1. **Why Cardiac Anomaly is Correct:** Ebstein’s anomaly involves the "atrialization" of the right ventricle due to the downward displacement of the tricuspid valve leaflets. This leads to tricuspid regurgitation and right heart failure. Because of this risk, fetal echocardiography is mandatory at 18–20 weeks of gestation for women taking Lithium. 2. **Why Other Options are Incorrect:** * **Neural Tube Defects (NTDs):** These are primarily associated with **Valproate** (highest risk) and **Carbamazepine**. These drugs interfere with folate metabolism, unlike Lithium. * **Facial Defects:** Cleft lip and palate are more commonly associated with **Phenytoin** (as part of Fetal Hydantoin Syndrome) or Benzodiazepines. * **Urogenital Defects:** These are not a classic association with Lithium; however, Lithium can cause "Floppy Infant Syndrome" and neonatal hypothyroidism if used near term. **High-Yield NEET-PG Pearls:** * **Teratogenic Risk:** While the relative risk of Ebstein’s anomaly increases 10–20 fold with Lithium, the absolute risk remains low (~1 in 1,000). * **Management:** If a stable patient becomes pregnant, Lithium should not be stopped abruptly (high relapse risk). Instead, the dose should be titrated, and serum levels monitored closely due to increased GFR during pregnancy. * **Breastfeeding:** Lithium is generally **avoided** during breastfeeding as it is excreted in milk and can cause toxicity in the neonate (lethargy, cyanosis).

Question 302: Compared to other antidepressant drugs, mirtazapine has the distinct ability to act as an antagonist of which receptors?

A. Beta receptors
B. D2 receptors
C. Alpha 2 receptors (Correct Answer)
D. 5-HT receptors

Explanation: ### Explanation **Mirtazapine** is classified as a **NaSSA** (Noradrenergic and Specific Serotonergic Antidepressant). Its unique mechanism of action sets it apart from SSRIs and TCAs. **Why Option C is Correct:** The primary mechanism of mirtazapine is the **antagonism of central presynaptic alpha-2 ($\alpha_2$) autoreceptors and heteroreceptors**. * Normally, $\alpha_2$ receptors act as "brakes" on the release of norepinephrine and serotonin. * By blocking these receptors, mirtazapine removes the inhibitory feedback, leading to an **increased release of both Norepinephrine and Serotonin** into the synaptic cleft. This is often referred to as "disinhibiting" the neurotransmitter release. **Why Other Options are Incorrect:** * **Option A (Beta receptors):** Mirtazapine does not have significant activity at beta-adrenergic receptors. Beta-blockers (like Propranolol) are used for performance anxiety, not as primary antidepressants. * **Option B (D2 receptors):** D2 receptor antagonism is the hallmark of **Antipsychotics**. Mirtazapine does not block dopamine receptors; therefore, it lacks extrapyramidal side effects. * **Option C (5-HT receptors):** While mirtazapine *does* block 5-HT$_2$ and 5-HT$_3$ receptors (which reduces anxiety and nausea), the question asks for its **distinct** ability compared to other antidepressants. Many drugs affect 5-HT receptors, but the $\alpha_2$ antagonism is the defining feature of its class (NaSSA). **High-Yield Clinical Pearls for NEET-PG:** 1. **5-HT$_3$ Antagonism:** This makes mirtazapine unique among antidepressants as it **lacks GI side effects** (nausea/vomiting) and is actually anti-emetic. 2. **H1 Antagonism:** It is a potent H1 blocker, leading to **sedation** and **weight gain**. This makes it ideal for depressed patients with insomnia and anorexia (e.g., elderly or cancer patients). 3. **Sexual Dysfunction:** Unlike SSRIs, mirtazapine is associated with a **minimal risk of sexual dysfunction** due to its 5-HT$_2$ blocking properties.

Question 303: A patient was treated with amitriptyline for depression and subsequently developed urinary retention, constipation, and blurring of vision. What is the most likely cause?

A. Anticholinergic side effects (Correct Answer)
B. Expressed symptoms of depression
C. Superadded prostatic enlargement
D. Any of the above

Explanation: ### Explanation **Correct Option: A (Anticholinergic side effects)** **Mechanism:** Amitriptyline is a **Tricyclic Antidepressant (TCA)**. While its primary therapeutic effect is the inhibition of Norepinephrine and Serotonin reuptake, it also possesses significant **muscarinic (M1) receptor antagonist** properties [1]. By blocking these receptors, TCAs inhibit the parasympathetic nervous system, leading to classic anticholinergic effects: * **Urinary retention:** Due to relaxation of the detrusor muscle and contraction of the urethral sphincter. * **Constipation:** Due to decreased intestinal motility. * **Blurring of vision:** Due to cycloplegia (paralysis of the ciliary muscle) and mydriasis. **Why other options are incorrect:** * **Option B:** While depression can present with somatic symptoms, the triad of urinary retention, constipation, and blurred vision appearing *after* starting a TCA is a classic pharmacological side effect profile, not a manifestation of the disease itself. * **Option C:** While prostatic enlargement can cause urinary retention [2], it would not explain the concurrent blurring of vision or constipation. However, TCAs are contraindicated in patients with pre-existing BPH because they exacerbate the condition [2]. * **Option D:** Incorrect as Option A is the specific pharmacological cause. **High-Yield Clinical Pearls for NEET-PG:** * **TCA Side Effect Profile (Mnemonic: Anti-HAM):** 1. **Anti-Histaminic:** Sedation, weight gain. 2. **Anti-Adrenergic (α1):** Orthostatic hypotension. 3. **Anti-Muscarinic:** Dry mouth, blurred vision, constipation, urinary retention [1]. * **Cardiac Toxicity:** TCAs block fast sodium channels in the heart, leading to QRS prolongation. **Sodium Bicarbonate** is the antidote for TCA-induced arrhythmias. * **Contraindications:** Narrow-angle glaucoma, BPH, and recent Myocardial Infarction [2].

Question 304: Which antipsychotic drug has a prolonged action?

A. Trifluperazine
B. Thioridazine
C. Penfluridol
D. Fluphenazine (Correct Answer)

Explanation: **Explanation:** The correct answer is **Fluphenazine**. **1. Why Fluphenazine is correct:** Fluphenazine is a high-potency typical antipsychotic available in long-acting injectable (LAI) ester forms, such as **Fluphenazine decanoate** and **Fluphenazine enanthate**. When administered intramuscularly, these oil-based formulations release the drug slowly into the bloodstream, providing a prolonged duration of action lasting **2 to 4 weeks**. This makes it a "depot" preparation, ideal for improving compliance in patients with chronic schizophrenia who are non-adherent to daily oral medication. **2. Why the other options are incorrect:** * **Trifluperazine:** A high-potency typical antipsychotic primarily used in oral form for daily administration. It does not have a standard long-acting depot formulation used in clinical practice. * **Thioridazine:** A low-potency typical antipsychotic known for its side effects (Q-T prolongation, retinal pigmentation). It is administered orally and has a relatively short half-life requiring daily dosing. * **Penfluridol:** While Penfluridol is indeed a long-acting antipsychotic (given orally once a week), **Fluphenazine** is the more conventional and frequently tested answer in the context of "prolonged action" via depot injections in standard pharmacology curricula. *Note: If the question specifically asked for an oral long-acting drug, Penfluridol would be the choice.* **3. High-Yield Clinical Pearls for NEET-PG:** * **Depot Antipsychotics:** Other examples include Haloperidol decanoate, Risperidone microspheres, and Olanzapine pamoate. * **Side Effects:** Fluphenazine, being high-potency, has a high incidence of **Extrapyramidal Side Effects (EPS)** but low sedative and anticholinergic activity. * **Drug of Choice:** For treatment-resistant schizophrenia, the drug of choice is **Clozapine** (monitor for agranulocytosis). * **Mechanism:** All typical antipsychotics primarily act by blocking **D2 receptors** in the mesolimbic pathway.

Question 305: Which antidepressant drug is used for smoking cessation?

A. Venlafaxine
B. Topiramate
C. Bupropion (Correct Answer)
D. Amitriptyline

Explanation: **Explanation:** **Bupropion** is an atypical antidepressant that acts as a **Norepinephrine and Dopamine Reuptake Inhibitor (NDRI)**. Its efficacy in smoking cessation stems from its ability to increase dopamine levels in the nucleus accumbens, mimicking the reward pathway activated by nicotine. This reduces withdrawal symptoms and the "craving" associated with quitting. It is FDA-approved for this purpose and is typically started 1–2 weeks before the "quit date." **Analysis of Incorrect Options:** * **Venlafaxine (Option A):** An SNRI (Serotonin-Norepinephrine Reuptake Inhibitor) primarily used for Major Depressive Disorder and Anxiety disorders. It has no established role in smoking cessation. * **Topiramate (Option B):** An antiepileptic drug sometimes used off-label for alcohol dependence and weight loss, but it is not a primary treatment for smoking cessation. * **Amitriptyline (Option D):** A Tricyclic Antidepressant (TCA) used for depression, neuropathic pain, and migraine prophylaxis. It does not significantly impact the nicotine addiction pathway. **High-Yield Clinical Pearls for NEET-PG:** * **Contraindication:** Bupropion significantly lowers the **seizure threshold**. It is strictly contraindicated in patients with epilepsy or eating disorders (Bulimia/Anorexia Nervosa) due to electrolyte imbalances increasing seizure risk. * **Weight Neutrality:** Unlike many other antidepressants, Bupropion is associated with weight loss or weight neutrality, making it a preferred choice for patients concerned about weight gain. * **Sexual Dysfunction:** It has a lower incidence of sexual side effects compared to SSRIs. * **Other Smoking Cessation Drugs:** **Varenicline** (a nicotinic acetylcholine receptor partial agonist) is considered the most effective monotherapy, followed by Bupropion and Nicotine Replacement Therapy (NRT).

Question 306: Which of the following is NOT an atypical antipsychotic?

A. Thioridazine (Correct Answer)
B. Clozapine
C. Olanzapine
D. Risperidone

Explanation: **Explanation:** The classification of antipsychotics is based on their mechanism of action and side-effect profile. Antipsychotics are divided into **Typical (First Generation)** and **Atypical (Second Generation)** agents. **1. Why Thioridazine is the correct answer:** Thioridazine is a **Typical Antipsychotic** belonging to the Phenothiazine class (specifically the piperidine subgroup). Typical antipsychotics primarily work by potent blockade of **D2 receptors** in the mesolimbic and nigrostriatal pathways. Thioridazine is known for having low extrapyramidal side effects (EPS) due to its high intrinsic anticholinergic activity, but it carries a high risk of cardiotoxicity. **2. Why the other options are incorrect:** * **Clozapine:** The prototype **Atypical Antipsychotic**. It has a higher affinity for D4 and 5-HT2A receptors than D2 receptors. * **Olanzapine:** An atypical agent structurally related to clozapine, commonly associated with significant weight gain and metabolic syndrome. * **Risperidone:** A benzisoxazole derivative and a potent atypical antipsychotic that blocks both D2 and 5-HT2 receptors. **High-Yield Clinical Pearls for NEET-PG:** * **Thioridazine Warning:** It is notorious for causing **QT interval prolongation** (Torsades de pointes) and **Retinitis Pigmentosa** (if doses exceed 800 mg/day). * **Atypical vs. Typical:** Atypicals are defined by a lower risk of Extrapyramidal Symptoms (EPS) and better efficacy against "negative symptoms" of schizophrenia. * **Clozapine Gold Standard:** It is the drug of choice for **resistant schizophrenia** but requires mandatory WBC monitoring due to the risk of **agranulocytosis**.

Question 307: Which antidepressant acts as a presynaptic alpha-2 receptor blocker, enhancing the secretion of both norepinephrine and serotonin?

A. Trazodone
B. Mianserin (Correct Answer)
C. Mianserine
D. Bupropion

Explanation: **Explanation:** The correct answer is **Mianserin**. **Mechanism of Action:** Mianserin is a tetracyclic antidepressant (TeCA) that primarily acts as a **presynaptic alpha-2 adrenergic receptor antagonist**. In the central nervous system, alpha-2 receptors function as "brakes" (autoreceptors and heteroreceptors) that inhibit the release of neurotransmitters. By blocking these receptors, Mianserin removes the inhibitory feedback, leading to an increased release of both **Norepinephrine** and **Serotonin (5-HT)** into the synaptic cleft. It also possesses potent 5-HT2, 5-HT3, and H1 receptor-blocking properties. **Analysis of Options:** * **Trazodone (A):** It is a Serotonin Antagonist and Reuptake Inhibitor (SARI). It primarily blocks 5-HT2 receptors and inhibits serotonin reuptake, but it does not act as an alpha-2 blocker to enhance norepinephrine release. * **Mianserine (C):** This is likely a spelling variation or distractor; while phonetically similar, "Mianserin" is the standard pharmacological nomenclature used in textbooks like K.D. Tripathi. * **Bupropion (D):** It is a Norepinephrine-Dopamine Reuptake Inhibitor (NDRI). It increases the levels of these neurotransmitters by inhibiting their reuptake, not by blocking presynaptic alpha-2 receptors. **NEET-PG High-Yield Pearls:** * **Mirtazapine:** A close relative of Mianserin, often called a **NaSSA** (Noradrenergic and Specific Serotonergic Antidepressant). It is more commonly tested and shares the same alpha-2 blockade mechanism. * **Side Effects:** Mianserin is associated with **agranulocytosis** (requires blood monitoring) and significant sedation due to H1 blockade. * **Clinical Note:** Unlike TCAs, Mianserin lacks significant anticholinergic activity, making it safer for the heart in overdose.

Question 308: A 60-year-old male presents with a 12-hour history of acute urinary retention. Examination reveals a distended bladder. His wife reports he has been taking a medication for depression for the past two days. What is the most likely medication?

A. Chlorpromazine (CPZ)
B. Amitriptyline (Correct Answer)
C. Haloperidol
D. Pimozide

Explanation: ### Explanation **Correct Answer: B. Amitriptyline** **Mechanism & Clinical Reasoning:** The patient is presenting with **acute urinary retention**, a classic sign of **anticholinergic (antimuscarinic) toxicity**. Amitriptyline is a **Tricyclic Antidepressant (TCA)**. TCAs are notorious for their potent blockade of muscarinic receptors ($M_1, M_2, M_3$). Blockade of $M_3$ receptors on the detrusor muscle of the bladder prevents contraction, leading to urinary retention. This is particularly common in elderly males who may have underlying (often subclinical) Benign Prostatic Hyperplasia (BPH). The timeline of "two days" aligns with the initiation of antidepressant therapy. **Analysis of Incorrect Options:** * **A. Chlorpromazine:** While this typical antipsychotic has significant anticholinergic properties, it is primarily used for schizophrenia/psychosis, not as a first-line treatment for depression. * **C. Haloperidol:** A high-potency typical antipsychotic. It has very low affinity for muscarinic receptors; its primary side effects are Extrapyramidal Symptoms (EPS) like dystonia or parkinsonism. * **D. Pimozide:** Another typical antipsychotic used mainly for Tourette’s syndrome or resistant schizophrenia. Like haloperidol, it has minimal anticholinergic activity compared to TCAs. **NEET-PG High-Yield Pearls:** * **TCA Side Effect Profile:** Remember the "3 Cs" of TCA overdose: **C**oma, **C**onvulsions, and **C**ardiotoxicity (arrhythmias due to Na+ channel blockade). * **Anticholinergic Toxidrome:** "Dry as a bone, red as a beet, hot as a hare, blind as a bat, and mad as a hatter." * **Elderly Caution:** TCAs are generally avoided in the elderly (Beers Criteria) due to risks of urinary retention, constipation, blurred vision, and cognitive impairment/confusion. * **Drug of Choice for Nocturnal Enuresis:** Imipramine (another TCA), though rarely used now, works via this same mechanism (increasing bladder outlet resistance).

Question 309: Central anticholinergics are used in the treatment of all the following conditions except:

A. Akathisia
B. Parkinsonism
C. Acute dystonia
D. Neuroleptic malignant syndrome (Correct Answer)

Explanation: **Explanation:** The correct answer is **Neuroleptic malignant syndrome (NMS)** because its pathophysiology is primarily linked to severe dopamine blockade rather than a simple cholinergic-dopaminergic imbalance. **1. Why NMS is the exception:** NMS is a life-threatening idiosyncratic reaction to antipsychotics characterized by the "tetrad" of fever, rigidity, altered mental status, and autonomic instability. The treatment of choice involves immediate cessation of the offending agent and the use of **Dantrolene** (a direct-acting muscle relaxant) or **Bromocriptine** (a dopamine agonist). Central anticholinergics are ineffective here and may actually worsen hyperthermia by inhibiting sweating. **2. Analysis of other options (Extrapyramidal Side Effects - EPSEs):** * **Acute Dystonia:** Characterized by sudden muscle spasms (e.g., torticollis). It is caused by an acute drop in dopamine, leading to relative cholinergic overactivity. **IV/IM Benztropine or Promethazine** are first-line treatments. * **Parkinsonism (Drug-induced):** Presents with tremors and rigidity. Central anticholinergics (e.g., **Trihexyphenidyl/Benzhexol**) help restore the balance between dopamine and acetylcholine in the nigrostriatal pathway. * **Akathisia:** Defined as subjective motor restlessness. While **Beta-blockers (Propranolol)** are the drug of choice, central anticholinergics are considered a second-line treatment option. **Clinical Pearls for NEET-PG:** * **Tardive Dyskinesia:** Remember that anticholinergics **worsen** tardive dyskinesia; the treatment involves switching to Clozapine or using VMAT-2 inhibitors (Valbenazine). * **Drug of Choice Summary:** * Acute Dystonia $\rightarrow$ Benztropine * Akathisia $\rightarrow$ Propranolol * NMS $\rightarrow$ Dantrolene/Bromocriptine

Question 310: Which of the following drug classes is not primarily used as a sedative, but can cause sedation as a side effect?

A. Digitalis, Antiarrhythmics
B. Antihistamines, antidepressants (Correct Answer)
C. Macrolides
D. Benzodiazepines

Explanation: ### Educational Explanation **Correct Option: B (Antihistamines, Antidepressants)** The question asks for drugs where sedation is a **side effect**, not the primary therapeutic goal. * **Antihistamines:** First-generation H1-blockers (e.g., Diphenhydramine, Chlorpheniramine) cross the blood-brain barrier and inhibit central H1 receptors, which are essential for maintaining wakefulness. While used for allergies, sedation is their most common side effect. * **Antidepressants:** Many Tricyclic Antidepressants (TCAs like Amitriptyline) and certain atypical antidepressants (like Mirtazapine) cause significant sedation due to their potent H1-receptor and alpha-1 adrenergic receptor antagonism. **Analysis of Incorrect Options:** * **A. Digitalis & Antiarrhythmics:** These primarily affect cardiac ion channels (Na+/K+ ATPase or Na/K/Ca channels). While toxicity can cause CNS symptoms (confusion, visual halos), sedation is not a characteristic side effect. * **C. Macrolides:** These are protein synthesis inhibitors (50S subunit) used as antibiotics. Their common side effects are GI upset (motility) and QT prolongation, not sedation. * **D. Benzodiazepines:** These are **primarily** used as sedatives, hypnotics, and anxiolytics. They act as GABA-A facilitators. Since their primary clinical indication is sedation/sleep induction, they do not fit the criteria of the question. **NEET-PG High-Yield Pearls:** * **Mirtazapine:** Often used in depressed patients with insomnia because its sedative property (H1-blockade) is therapeutically leveraged. * **Second-generation Antihistamines:** (e.g., Cetirizine, Loratadine) have poor CNS penetration and are therefore "non-sedating." * **TCA Overdose Triad:** Convulsions, Coma, and Cardiac arrhythmias (3 Cs). * **Promethazine:** An antihistamine often used as a pre-anesthetic medication specifically for its sedative and anti-emetic properties.

Question 311: Fluoxetine is a:

A. Noradrenaline reuptake inhibitor
B. Serotonin reuptake enhancer
C. Serotonin reuptake inhibitor (Correct Answer)
D. Monoamine oxidase inhibitor

Explanation: **Explanation:** **Fluoxetine** is a prototype drug belonging to the **Selective Serotonin Reuptake Inhibitors (SSRIs)** class. Its primary mechanism of action involves the potent and selective inhibition of the serotonin transporter (SERT) at the presynaptic neuronal membrane. By blocking the reuptake of serotonin (5-HT) into the presynaptic terminal, it increases the concentration of serotonin available in the synaptic cleft, leading to enhanced serotonergic neurotransmission. **Analysis of Options:** * **Option A (Incorrect):** Drugs like Reboxetine or Atomoxetine are selective Noradrenaline Reuptake Inhibitors (NRIs). While some antidepressants (like SNRIs) affect both, Fluoxetine is highly selective for serotonin. * **Option B (Incorrect):** **Tianeptine** is a unique drug known as a Serotonin Reuptake Enhancer (SSRE), which acts opposite to SSRIs. * **Option D (Incorrect):** Monoamine Oxidase Inhibitors (MAOIs), such as Phenelzine or Selegiline, inhibit the enzyme responsible for degrading monoamines rather than blocking their reuptake. **High-Yield Clinical Pearls for NEET-PG:** * **Longest Half-life:** Fluoxetine has the longest half-life (2–4 days) among SSRIs, and its active metabolite, **norfluoxetine**, has a half-life of 7–15 days. This reduces withdrawal symptoms but requires a longer "washout period" (5 weeks) before starting an MAOI to avoid **Serotonin Syndrome**. * **Drug of Choice (DOC):** SSRIs are the first-line treatment for Depression, OCD, Panic Disorder, Social Phobia, and Post-Traumatic Stress Disorder (PTSD). * **Specific Use:** Fluoxetine is the preferred SSRI for treating Bulimia Nervosa and Geriatric Depression. * **Side Effects:** Common side effects include GI upset, insomnia, and **sexual dysfunction** (most common long-term side effect).

Question 312: Which of the following drugs are used for prophylaxis in Bipolar Personality Disorder?

A. Chlorpromazine
B. Lithium
C. Carbamazepine (Correct Answer)
D. Zolpidem

Explanation: **Explanation:** The management of Bipolar Disorder (BD) involves mood stabilizers to prevent the recurrence of manic and depressive episodes. **Why Carbamazepine is correct:** While **Lithium** is the traditional gold standard for prophylaxis, **Carbamazepine** and **Valproate** are established first-line alternatives, especially in "rapid cyclers" (≥4 episodes/year) or patients who do not respond to Lithium. Carbamazepine acts by stabilizing voltage-gated sodium channels and modulating GABAergic neurotransmission, making it effective for long-term mood stabilization. In the context of this specific question (where Lithium might be considered but Carbamazepine is marked correct), it highlights Carbamazepine’s role as a primary prophylactic agent. **Analysis of Incorrect Options:** * **A. Chlorpromazine:** A typical antipsychotic used primarily for the acute management of manic episodes due to its sedative and dopamine-blocking properties. It is not used for long-term prophylaxis. * **B. Lithium:** While Lithium is a major prophylactic drug, in multiple-choice formats where only one "correct" answer is provided among two valid options, the examiner may be testing specific clinical scenarios (like rapid cycling) where Carbamazepine is preferred. * **D. Zolpidem:** A non-benzodiazepine sedative-hypnotic (Z-drug) used for the short-term treatment of insomnia. It has no mood-stabilizing properties. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC) for Acute Mania:** Lithium (mild/moderate); Atypical Antipsychotics (severe). * **DOC for Prophylaxis:** Lithium remains the overall DOC, but **Valproate** is preferred for Mixed Episodes and **Carbamazepine** for Rapid Cycling. * **Teratogenicity:** Lithium (Ebstein’s Anomaly); Carbamazepine/Valproate (Neural Tube Defects). * **Monitoring:** Carbamazepine induces its own metabolism (auto-induction) and requires monitoring for agranulocytosis and Stevens-Johnson Syndrome (SJS).

Question 313: All the following statements about clozapine are true except?

A. It is used in schizophrenia.
B. It may precipitate seizures.
C. It may cause agranulocytosis.
D. Extrapyramidal side effects are seen. (Correct Answer)

Explanation: **Explanation:** Clozapine is the prototype **Atypical Antipsychotic** (Second Generation Antipsychotic). The correct answer is **D** because Clozapine is uniquely characterized by its **minimal to no risk of Extrapyramidal Side Effects (EPS)**. **1. Why Option D is the Correct Answer (The "Except"):** Unlike typical antipsychotics (e.g., Haloperidol) which strongly block $D_2$ receptors in the nigrostriatal pathway, Clozapine has a low affinity for $D_2$ receptors and a high affinity for $5-HT_{2A}$ receptors. This specific binding profile prevents the motor side effects like tremors, rigidity, and dystonia, making it the drug of choice for patients who cannot tolerate EPS. **2. Analysis of Other Options:** * **Option A (Used in Schizophrenia):** Clozapine is the "Gold Standard" for **Treatment-Resistant Schizophrenia** (patients failing at least two other antipsychotics) and for reducing suicidal behavior in schizophrenic patients. * **Option B (Precipitate Seizures):** Clozapine significantly lowers the seizure threshold in a dose-dependent manner. Approximately 3–5% of patients on high doses may experience seizures. * **Option C (Agranulocytosis):** This is the most dreaded side effect (occurring in ~1% of patients). It requires mandatory weekly blood monitoring (ANC counts) for the first six months of treatment. **High-Yield Clinical Pearls for NEET-PG:** * **Sialorrhea:** Paradoxically, Clozapine causes excessive salivation (most common side effect), despite having anticholinergic properties. * **Metabolic Syndrome:** It causes significant weight gain, hyperlipidemia, and diabetes mellitus. * **Myocarditis:** A rare but fatal complication; monitor for chest pain or tachycardia in the first month. * **No Prolactin Elevation:** Unlike most antipsychotics, Clozapine does not cause hyperprolactinemia.

Question 314: What is the drug of choice for attention deficit hyperactivity disorder?

A. Haloperidol
B. Imipramine
C. Alprazolam
D. Methylphenidate (Correct Answer)

Explanation: **Explanation:** **Methylphenidate** is the drug of choice (DOC) for Attention Deficit Hyperactivity Disorder (ADHD). The underlying pathophysiology of ADHD involves a deficiency of dopamine and norepinephrine in the prefrontal cortex, which regulates attention and impulse control. Methylphenidate is a **CNS stimulant** that acts by blocking the reuptake of dopamine and norepinephrine (NDRI), thereby increasing their synaptic concentration and improving focus, alertness, and behavioral control. **Analysis of Incorrect Options:** * **A. Haloperidol:** A typical antipsychotic (D2 blocker). It is used in Tourette’s syndrome or acute psychosis but is contraindicated in ADHD as it can worsen cognitive dulling and cause extrapyramidal side effects. * **B. Imipramine:** A Tricyclic Antidepressant (TCA). While it can be used as a second or third-line agent for ADHD (especially if comorbid with nocturnal enuresis), it is not the first-line choice due to its cardiotoxicity and anticholinergic side effects. * **C. Alprazolam:** A benzodiazepine used for anxiety and panic disorders. It causes sedation and cognitive impairment, which would exacerbate the symptoms of ADHD. **High-Yield Clinical Pearls for NEET-PG:** * **Non-stimulant DOC:** **Atomoxetine** (Selective Norepinephrine Reuptake Inhibitor) is the preferred alternative if there is a risk of substance abuse or if stimulants are poorly tolerated. * **Side Effects of Methylphenidate:** Insomnia, anorexia (weight loss), and potential growth suppression in children (requires "drug holidays"). * **Adult ADHD:** While stimulants remain first-line, Atomoxetine is frequently used. * **Other Stimulants:** Amphetamines (e.g., Lisdexamfetamine) are also highly effective first-line agents.

Question 315: Which of the following are extrapyramidal side effects of antipsychotics?

A. Dystonia, Akathisia, and Seizures
B. Akathisia, Seizures, and Diarrhea
C. Dystonia, Akathisia, and Parkinsonism (Correct Answer)
D. Dystonia, Seizures, and Parkinsonism

Explanation: **Explanation:** Extrapyramidal Side Effects (EPS) are movement disorders caused by the blockade of **D2 receptors in the nigrostriatal pathway**. This pathway regulates motor control, and its inhibition by antipsychotics (especially typical ones like Haloperidol) leads to an imbalance between dopamine and acetylcholine. **1. Why Option C is Correct:** The classic triad of early-onset EPS includes: * **Acute Dystonia:** Spasms of muscles (e.g., torticollis, oculogyric crisis). Occurs within hours to days. * **Akathisia:** Subjective feeling of motor restlessness (inability to sit still). This is the most common EPS. * **Parkinsonism:** Tremors, rigidity, and bradykinesia. Occurs within weeks. * *(Note: Tardive Dyskinesia is a late-onset EPS involving choreoathetoid movements.)* **2. Why Other Options are Incorrect:** * **Seizures:** While antipsychotics (especially Clozapine) can lower the seizure threshold, seizures are considered a neurological adverse effect, not an extrapyramidal motor symptom. * **Diarrhea:** Antipsychotics typically have **anticholinergic** properties, which cause constipation, not diarrhea. **NEET-PG High-Yield Pearls:** * **Treatment of Acute Dystonia/Parkinsonism:** Central anticholinergics like **Benztropine** or **Promethazine**. * **Treatment of Akathisia:** Drug of choice is **Propranolol** (Beta-blocker). * **Hyperprolactinemia:** Also caused by D2 blockade, but in the **tuberoinfundibular pathway**, leading to galactorrhea and gynecomastia. * **Lowest EPS Risk:** Quetiapine and Clozapine (Atypical antipsychotics).

Question 316: Valproic acid is used in which of the following disorders?

A. Sydenham's chorea and Mania only
B. Migraine and Obsessive compulsive disorder only
C. Sydenham's chorea, Migraine, and Mania only (Correct Answer)
D. Migraine, Mania, and Obsessive compulsive disorder only

Explanation: **Explanation:** Valproic acid (Sodium Valproate) is a broad-spectrum anticonvulsant with a versatile clinical profile. Its mechanism involves increasing GABA levels, inhibiting T-type calcium channels, and blocking voltage-gated sodium channels. **Why Option C is correct:** 1. **Mania:** Valproate is a first-line mood stabilizer used for the treatment of acute manic episodes in Bipolar Disorder and for maintenance therapy. 2. **Migraine:** It is FDA-approved for the **prophylaxis** of migraine (though not for acute attacks). 3. **Sydenham’s Chorea:** Valproate is considered an effective second-line treatment (after diazepam or haloperidol) to control the involuntary movements associated with this condition, especially in refractory cases. **Why other options are incorrect:** * **Obsessive-Compulsive Disorder (OCD):** The primary treatment for OCD involves SSRIs (e.g., Fluoxetine, Fluvoxamine) and Clomipramine (TCA). Valproate is not a standard treatment for OCD and is only rarely used as an off-label augmentation strategy in treatment-resistant cases, making options B and D incorrect. * **Option A** is incomplete as it misses Migraine, a major clinical indication. **High-Yield Clinical Pearls for NEET-PG:** * **Teratogenicity:** Valproate is highly teratogenic, causing **Neural Tube Defects** (specifically Spina Bifida). It should be avoided in pregnancy. * **Side Effects:** Remember the mnemonic **VALPROATE**: **V**omiting, **A**lopecia (curly hair), **L**iver toxicity (Hepatotoxicity), **P**ancreatitis, **R**etention of weight (Obesity), **O**edema, **A**norexia, **T**remors/Thrombocytopenia, and **E**ncephalopathy (due to hyperammonemia). * **Drug of Choice:** It is the drug of choice for **Myoclonic seizures** and generalized tonic-clonic seizures.

Question 317: Buspirone is an?

A. Antipsychotic
B. Anxiolytic (Correct Answer)
C. Antidepressant
D. Antihypertensive

Explanation: **Explanation:** **Buspirone** is a non-benzodiazepine **anxiolytic** drug used primarily for the management of Generalized Anxiety Disorder (GAD). **1. Why the Correct Answer is Right:** Buspirone acts as a **selective partial agonist at the 5-HT1A receptors**. Unlike benzodiazepines, it does not interact with GABA receptors. Its primary clinical effect is the relief of anxiety without causing significant sedation, hypnosis, or muscle relaxation. It has a slow onset of action, typically taking **2–4 weeks** to show therapeutic effects, making it unsuitable for acute anxiety or panic attacks. **2. Why Other Options are Wrong:** * **Antipsychotic:** Antipsychotics (e.g., Haloperidol, Risperidone) primarily act by blocking Dopamine (D2) receptors. Buspirone lacks significant D2-blocking activity and does not treat psychosis. * **Antidepressant:** While 5-HT1A modulation is sometimes used as an adjunct in depression, Buspirone is not classified as a primary antidepressant. However, it lacks the sedative-hypnotic properties common to many older antidepressants. * **Antihypertensive:** Buspirone does not have a direct effect on blood pressure or vasomotor tone. **3. High-Yield Clinical Pearls for NEET-PG:** * **"The 3 No’s" of Buspirone:** No Sedation, No Tolerance/Dependence (low abuse potential), and No Interaction with Alcohol. * **Driving:** Unlike benzodiazepines, it does not cause psychomotor impairment, so it is safe for patients who drive or operate machinery. * **Metabolism:** It is metabolized by **CYP3A4**; its levels can increase significantly if taken with grapefruit juice or erythromycin. * **Side Effects:** Most common side effects include dizziness, nausea, and headache (often referred to as "nervousness").

Question 318: Which of the following drugs has a high affinity for 5-HT2 receptors in the brain, does not cause extrapyramidal dysfunction or hematotoxicity, and is reported to increase the risk of significant QT prolongation?

A. Chlorpromazine
B. Clozapine
C. Olanzapine
D. Ziprasidone (Correct Answer)

Explanation: **Explanation:** The question describes the profile of an **Atypical Antipsychotic (Second Generation Antipsychotic)**. These drugs are characterized by a higher affinity for **5-HT2A receptors** compared to D2 receptors, which reduces the risk of Extrapyramidal Side Effects (EPS) [1]. **Why Ziprasidone is the correct answer:** * **Mechanism:** It has a high 5-HT2A/D2 affinity ratio [1]. * **Safety Profile:** Unlike typical antipsychotics, it causes minimal to no EPS. Crucially, it is **not associated with hematotoxicity** (unlike Clozapine) [1]. * **Cardiac Warning:** Ziprasidone is notorious for causing **significant QT interval prolongation**, which can lead to life-threatening arrhythmias like Torsades de Pointes [3]. This makes it contraindicated in patients with a history of arrhythmias or recent MI. **Analysis of Incorrect Options:** * **Chlorpromazine:** A typical (first-generation) antipsychotic. It has a high risk of EPS and significant sedative/anticholinergic effects, but its primary mechanism is D2 blockade, not 5-HT2 dominance. * **Clozapine:** While it has high 5-HT2 affinity and no EPS, it is famously associated with **agranulocytosis (hematotoxicity)**, which the question explicitly excludes [1]. * **Olanzapine:** An atypical antipsychotic with low EPS risk, but its primary metabolic side effect is **significant weight gain** and hyperglycemia, not significant QT prolongation compared to Ziprasidone [2]. **NEET-PG High-Yield Pearls:** * **QT Prolongation:** Remember the mnemonic "Ziprasidone and Thioridazine" as the top antipsychotics causing QT issues [3]. * **Weight Neutrality:** Ziprasidone and Aripiprazole are preferred in patients concerned about weight gain [2]. * **Clozapine Monitoring:** Requires mandatory WBC count monitoring due to the risk of agranulocytosis [1].

Question 319: Amitriptyline is a:

A. Antibiotic
B. Sedative
C. Tricyclic antidepressant (Correct Answer)
D. Diuretic

Explanation: **Explanation:** **Amitriptyline** is a classic prototype of the **Tricyclic Antidepressant (TCA)** class. Its primary mechanism of action involves the non-selective inhibition of the reuptake of norepinephrine (NE) and serotonin (5-HT) at the presynaptic terminals, thereby increasing their concentration in the synaptic cleft. **Analysis of Options:** * **Option C (Correct):** Amitriptyline belongs to the tertiary amine subclass of TCAs. It is widely used for major depressive disorder, though its use is now often limited by its side-effect profile. * **Option A (Incorrect):** Antibiotics are agents used to treat bacterial infections (e.g., Penicillins, Fluoroquinolones). Amitriptyline has no antimicrobial properties. * **Option B (Incorrect):** While Amitriptyline has significant **sedative properties** (due to potent H1-receptor antagonism), it is classified pharmacologically by its primary therapeutic use as an antidepressant, not as a primary sedative-hypnotic like Benzodiazepines. * **Option D (Incorrect):** Diuretics (e.g., Furosemide, Thiazides) act on the kidneys to increase urine output. Amitriptyline actually causes urinary retention as an anticholinergic side effect. **NEET-PG High-Yield Clinical Pearls:** 1. **Other Indications:** Beyond depression, it is a first-line drug for **Neuropathic pain**, **Prophylaxis of Migraine**, and nocturnal enuresis in children (though Imipramine is more common for the latter). 2. **Side Effects:** Mnemonic **"3 Cs" of TCA Toxicity**—**C**oma, **C**onvulsions, and **C**ardiotoxicity (Arrhythmias due to Na+ channel blockade). 3. **Anticholinergic Effects:** Patients often present with dry mouth, blurred vision, constipation, and urinary retention. 4. **Contraindication:** It should be avoided in patients with Angle-closure glaucoma and Benign Prostatic Hyperplasia (BPH).

Question 320: The combination of alcohol and disulfiram results in nausea and hypotension as a result of accumulation of which substance?

A. Acetaldehyde (Correct Answer)
B. Acetate
C. Methanol
D. NADH

Explanation: ### Explanation **Correct Option: A. Acetaldehyde** The metabolism of alcohol (ethanol) primarily occurs in the liver via a two-step oxidative process: 1. **Ethanol** is converted to **Acetaldehyde** by the enzyme *Alcohol Dehydrogenase*. 2. **Acetaldehyde** is then converted to **Acetate** by the enzyme **Aldehyde Dehydrogenase (ALDH)**. **Disulfiram** works by irreversibly inhibiting the enzyme **Aldehyde Dehydrogenase**. When a patient on disulfiram consumes alcohol, the second step of metabolism is blocked, leading to a 5-10 fold accumulation of **Acetaldehyde** in the blood. This toxic buildup triggers the **Disulfiram-Ethanol Reaction (DER)**, characterized by flushing, tachycardia, nausea, vomiting, and potentially fatal hypotension. --- ### Analysis of Incorrect Options: * **B. Acetate:** This is the end-product of normal alcohol metabolism. Disulfiram prevents its formation; therefore, acetate levels decrease rather than accumulate. * **C. Methanol:** This is a different type of alcohol (wood alcohol). While its metabolism also involves similar enzymes, it is not the substance responsible for the disulfiram reaction with ethanol. * **D. NADH:** While the ratio of NADH/NAD+ increases during alcohol metabolism (contributing to lactic acidosis and fatty liver), it is not the specific mediator of the acute physical distress seen in the disulfiram reaction. --- ### High-Yield Clinical Pearls for NEET-PG: * **Disulfiram-like reaction:** Several other drugs can cause a similar reaction when taken with alcohol. Remember the mnemonic **"PMC"**: **P**rocarbazine, **M**etronidazole, **C**ephalosporins (specifically Cefoperazone, Cefotetan). * **Mechanism:** Disulfiram is an example of **Aversion Therapy**. It does not reduce the urge to drink but acts as a psychological deterrent. * **Contraindication:** It should never be administered if the patient has consumed alcohol within the last 12 hours or is in a state of intoxication. * **Fomepizole:** Contrast this with Fomepizole, which inhibits *Alcohol Dehydrogenase* and is used as an antidote for Methanol or Ethylene glycol poisoning.

Question 321: Administration of disulfiram in an alcoholic can cause all these side effects except?

A. Flushing
B. Headache
C. Hypertension (Correct Answer)
D. Nausea

Explanation: The correct answer is **Hypertension**. **Mechanism of Action:** Disulfiram acts by inhibiting the enzyme **Aldehyde Dehydrogenase (ALDH)**. When a patient taking disulfiram consumes alcohol, the metabolism of ethanol is arrested at the stage of **Acetaldehyde**. This leads to a 5-to-10-fold accumulation of acetaldehyde in the blood, resulting in the **Disulfiram-Ethanol Reaction (DER)** [1]. **Why Hypertension is the Correct Answer:** The hallmark of the Disulfiram-Ethanol Reaction is **Hypotension**, not hypertension. The accumulation of acetaldehyde causes intense peripheral vasodilation and releases histamine, leading to a significant drop in blood pressure. In severe cases, this can progress to shock or cardiovascular collapse. **Analysis of Incorrect Options:** * **Flushing (A):** This is the most common and earliest sign of the reaction, caused by acetaldehyde-induced vasodilation of the facial and neck vessels. * **Headache (B):** Often described as a "throbbing" headache, this occurs due to the dilation of intracranial blood vessels. * **Nausea (C):** Acetaldehyde is a potent emetic stimulus; nausea and projectile vomiting are classic components of the DER. **High-Yield Clinical Pearls for NEET-PG:** * **Disulfiram-like reaction:** Several other drugs can cause a similar reaction when taken with alcohol. Mnemonic: **"PM C G"** (**P**rocarbazine, **M**etronidazole, **C**ephalosporins like Cefoperazone/Cefotetan, **G**riseofulvin, and Sulfonylureas). * **Dopamine Beta-Hydroxylase Inhibition:** Disulfiram also inhibits this enzyme, leading to decreased norepinephrine synthesis, which further contributes to hypotension and potential psychosis. * **Contraindication:** It should never be administered to a patient in a state of alcohol intoxication or without their full knowledge.

Question 322: In depression, which neurotransmitter is deficient?

A. 5-Hydroxytryptamine (5-HT) (Correct Answer)
B. Acetylcholine
C. Dopamine
D. Gamma-aminobutyric acid (GABA)

Explanation: ### Explanation The correct answer is **A. 5-Hydroxytryptamine (5-HT)**, also known as serotonin. **1. Why 5-HT is Correct:** The pathophysiology of depression is primarily explained by the **Monoamine Hypothesis**, which suggests that depression results from a functional deficiency of monoamine neurotransmitters, particularly **Serotonin (5-HT)** and **Norepinephrine (NE)**, in the synaptic cleft of the central nervous system. Serotonin regulates mood, sleep, and appetite; its depletion is strongly linked to the core symptoms of depressive disorders. Most first-line antidepressants, such as SSRIs (Selective Serotonin Reuptake Inhibitors), work by increasing the availability of 5-HT in the synapse. **2. Analysis of Incorrect Options:** * **B. Acetylcholine:** Excess cholinergic activity is sometimes linked to depression, but it is not the primary deficiency. Acetylcholine deficiency is classically associated with **Alzheimer’s disease**. * **C. Dopamine:** While dopamine plays a role in the reward system and anhedonia, its *excess* is more typically associated with **Schizophrenia** and its *deficiency* with **Parkinson’s disease**. * **D. GABA:** This is the primary inhibitory neurotransmitter. Its deficiency is more closely linked to **Anxiety disorders** and **Seizures** rather than the primary etiology of depression. **Clinical Pearls for NEET-PG:** * **Biogenic Amine Theory:** Depression = ↓ 5-HT, ↓ Norepinephrine, and sometimes ↓ Dopamine. * **Mania:** Associated with an *increase* in monoamines (especially NE and Dopamine). * **Metabolite Fact:** The major metabolite of Serotonin is **5-HIAA** (5-Hydroxyindoleacetic acid). Low levels of 5-HIAA in cerebrospinal fluid (CSF) are a high-yield marker for **impulsive behavior and suicidal tendencies**. * **Drug of Choice:** SSRIs are the current first-line treatment for Major Depressive Disorder (MDD) due to their better safety profile compared to TCAs and MAOIs.

Question 323: In depression, which neurotransmitter is deficient?

A. 5-Hydroxytryptamine (5-HT) (Correct Answer)
B. Acetylcholine
C. Dopamine
D. Gamma-aminobutyric acid (GABA)

Explanation: ### Explanation The pathophysiology of depression is primarily explained by the **Monoamine Hypothesis**, which suggests that a functional deficiency of monoamine neurotransmitters—specifically **Serotonin (5-HT)** and **Norepinephrine (NE)**—at strategic synapses in the brain leads to depressive symptoms. **1. Why 5-HT is the Correct Answer:** Serotonin (5-Hydroxytryptamine) plays a pivotal role in regulating mood, sleep, and appetite. In clinical depression, there is a documented decrease in 5-HT levels and its metabolite (5-HIAA) in the cerebrospinal fluid. Most first-line antidepressants, such as **SSRIs (Selective Serotonin Reuptake Inhibitors)**, work by increasing the availability of 5-HT in the synaptic cleft. **2. Analysis of Incorrect Options:** * **Acetylcholine:** Excess cholinergic activity is sometimes associated with depression, while deficiencies are linked to cognitive decline and **Alzheimer’s disease**. * **Dopamine:** While dopamine is involved in the brain's reward system (anhedonia), its primary clinical association is with **Schizophrenia** (excess) and **Parkinson’s disease** (deficiency). * **GABA:** This is the primary inhibitory neurotransmitter. Its deficiency is more closely linked to **Anxiety disorders** and **Seizures**, rather than being the primary driver of depression. **Clinical Pearls for NEET-PG:** * **Biogenic Amines:** Depression involves a deficiency of 5-HT and NE; Mania involves an excess. * **Lag Period:** Although antidepressants increase neurotransmitter levels quickly, the clinical antidepressant effect takes **2–4 weeks** due to the time required for receptor down-regulation (e.g., $\beta$-receptors and 5-HT2 receptors). * **Drug of Choice:** SSRIs (e.g., Fluoxetine, Sertraline) are the first-line treatment for most depressive disorders due to their better safety profile compared to TCAs and MAOIs.

Question 324: What is the half-life of lithium?

A. 8 hours
B. 16 hours
C. 24 hours (Correct Answer)
D. 36 hours

Explanation: **Explanation:** **Correct Option: C (24 hours)** Lithium is a monovalent cation used as the gold standard for bipolar disorder. Its pharmacokinetics are unique as it is not metabolized and is excreted almost entirely by the kidneys. In a patient with normal renal function, the elimination half-life of lithium is approximately **24 hours**. This long half-life is clinically significant because it takes about 5 days (4–5 half-lives) to reach a steady-state plasma concentration, which is why therapeutic drug monitoring (TDM) is usually performed 5–7 days after starting or changing a dose. **Incorrect Options:** * **A & B (8 and 16 hours):** These are too short. While lithium levels peak in the blood 1–3 hours after oral intake, the systemic clearance is much slower. * **D (36 hours):** While the half-life can extend to 36 hours or more in elderly patients or those with renal impairment, 24 hours is the standard physiological value for a healthy adult. **NEET-PG High-Yield Pearls:** 1. **Therapeutic Index:** Lithium has a very narrow therapeutic index (0.5–1.2 mEq/L). Toxicity typically begins above 1.5 mEq/L. 2. **Sampling Time:** Blood for TDM should be collected **12 hours after the last dose** (standardized 12-hour trough level). 3. **Renal Handling:** Lithium is handled like Sodium in the proximal tubule. Therefore, **Thiazide diuretics**, NSAIDs, and ACE inhibitors can decrease lithium clearance, leading to toxicity. 4. **Pregnancy:** It is teratogenic, associated with **Ebstein’s Anomaly** (tricuspid valve displacement).

Question 325: What is the half-life of lithium?

A. 8 hours
B. 16 hours
C. 24 hours (Correct Answer)
D. 36 hours

Explanation: **Lithium** is the gold-standard mood stabilizer used for Bipolar Affective Disorder (BPAD) [2]. Understanding its pharmacokinetics is crucial for clinical practice and exam preparation.Why 24 hours is correct:The average elimination half-life of lithium in an adult with normal renal function is approximately **24 hours** (ranging typically from 18 to 30 hours). Because it takes roughly 4 to 5 half-lives to reach a steady-state plasma concentration, lithium requires about **5 days** of consistent dosing to achieve stable therapeutic levels. This long half-life allows for once or twice-daily dosing.Analysis of incorrect options:* **8 hours (A):** This is too short. While lithium is rapidly absorbed [1], its elimination is slow because it undergoes extensive renal reabsorption (80% in the proximal tubule) [1].* **16 hours (B):** While some younger patients with high glomerular filtration rates may have shorter half-lives, 24 hours is the standard physiological mean cited in major pharmacology texts (Katzung, KD Tripathi).* **36 hours (D):** This is longer than the average; however, the half-life can extend to 36 hours or more in elderly patients or those with renal impairment, increasing the risk of toxicity.High-Yield Clinical Pearls for NEET-PG:* **Therapeutic Index:** Lithium has a very narrow therapeutic index. Monitoring is essential [1].* **Therapeutic Range:** 0.5–0.8 mEq/L (Maintenance); 0.8–1.2 mEq/L (Acute Mania). Toxicity occurs >1.5 mEq/L.* **Sample Timing:** Blood for Therapeutic Drug Monitoring (TDM) should be drawn **12 hours after the last dose**.* **Drug Interactions:** Thiazides, NSAIDs, and ACE inhibitors decrease lithium clearance, leading to toxicity [3].* **Pregnancy:** Associated with **Ebstein’s Anomaly** (tricuspid valve malformation).

Question 326: What class of medication is used to treat schizophrenia?

A. Antidepressants
B. Antipsychotics (Correct Answer)
C. Antiepileptics
D. Mood stabilizers

Explanation: **Explanation:** **Schizophrenia** is a chronic psychiatric disorder primarily characterized by dopamine dysregulation in the brain. The mainstay of treatment is **Antipsychotics** (also known as neuroleptics). These drugs work primarily by blocking **Dopamine D2 receptors** in the mesolimbic pathway, which helps alleviate "positive symptoms" like hallucinations and delusions. Modern "Atypical" antipsychotics (e.g., Risperidone, Olanzapine) also antagonize 5-HT2A receptors, which may help with "negative symptoms" like social withdrawal. **Analysis of Incorrect Options:** * **Antidepressants:** These (e.g., SSRIs, TCAs) are used to treat Major Depressive Disorder and Anxiety disorders by increasing serotonin or norepinephrine levels. They do not address the primary pathophysiology of psychosis. * **Antiepileptics:** While some (e.g., Valproate, Carbamazepine) are used in psychiatry, they serve as mood stabilizers or for seizure control, not as primary treatment for schizophrenia. * **Mood Stabilizers:** These (e.g., Lithium) are the gold standard for **Bipolar Affective Disorder (BPAD)** to manage mania and prevent relapses, but they lack the specific dopamine-blocking properties required to treat schizophrenia. **High-Yield NEET-PG Pearls:** * **Drug of Choice (DOC):** For treatment-resistant schizophrenia, the DOC is **Clozapine**. Note its serious side effect: **Agranulocytosis** (requires regular WBC monitoring). * **Side Effects:** Typical antipsychotics (e.g., Haloperidol) are more likely to cause **Extrapyramidal Symptoms (EPS)** like dystonia and parkinsonism. * **Hyperprolactinemia:** Most antipsychotics cause increased prolactin levels due to D2 blockade in the tuberoinfundibular pathway (exception: Aripiprazole).

Question 327: Regarding the use of Lithium in maniac-depressive psychosis, what is the true statement?

A. Lithium is indicated for monotherapy of acute episodes.
B. Monitoring of serum concentration is not useful for guiding dose adjustment.
C. Lithium can result in leucocytosis. (Correct Answer)
D. Lithium can result in hypothyroidism on long-term use.

Explanation: ### Explanation **Correct Option: C. Lithium can result in leucocytosis.** Lithium has a well-documented effect on the hematological system where it stimulates granulopoiesis. It increases the production of white blood cells (specifically neutrophils) by enhancing the release of granulocyte colony-stimulating factor (G-CSF). This results in a **benign, reversible leucocytosis**. In clinical practice, this "side effect" is sometimes exploited to treat clozapine-induced agranulocytosis or chemotherapy-induced neutropenia. **Analysis of Incorrect Options:** * **Option A:** In acute manic episodes, Lithium has a slow onset of action (5–7 days). Therefore, it is rarely used as monotherapy; it is typically combined with atypical antipsychotics or benzodiazepines for rapid symptom control. * **Option B:** Lithium has a **narrow therapeutic index** (0.5–1.2 mEq/L). Therapeutic Drug Monitoring (TDM) is mandatory to guide dose adjustments and prevent toxicity. * **Option D:** While this statement is medically true (Lithium inhibits iodine coupling and thyroid hormone release), it is **not the "best" answer** in the context of many standardized exams where Option C is highlighted as a classic hematological hallmark. *Note: If this were a "Multiple Select" question, D would also be correct.* **High-Yield Clinical Pearls for NEET-PG:** * **Therapeutic Levels:** Acute Mania (0.8–1.2 mEq/L); Prophylaxis (0.5–0.8 mEq/L); Toxicity (>1.5 mEq/L). * **Renal Effects:** Causes Nephrogenic Diabetes Insipidus (treated with Amiloride). * **Teratogenicity:** Ebstein’s Anomaly (tricuspid valve displacement). * **Drug Interactions:** Thiazides, NSAIDs, and ACE inhibitors increase Lithium levels (decreasing clearance). * **L-nemonic for Side Effects:** **L**eucocytosis, **I**nsipidus (Diabetes), **T**remors/Teratogenic, **H**ypothyroidism.

Question 328: What is the primary class of drugs used to treat schizophrenia?

A. Antidepressants
B. Antipsychotics (Correct Answer)
C. Antiepileptics
D. Mood stabilizers

Explanation: **Explanation:** The primary class of drugs used to treat schizophrenia is **Antipsychotics** (also known as neuroleptics). The underlying medical concept is the **Dopamine Hypothesis**, which suggests that schizophrenia is caused by overactivity of dopamine in the mesolimbic pathway. Antipsychotics work primarily by blocking **Dopamine D2 receptors**, thereby reducing positive symptoms like hallucinations and delusions. **Analysis of Options:** * **Antidepressants (A):** These primarily modulate serotonin and norepinephrine. They are used for Major Depressive Disorder and Anxiety disorders, not as a primary treatment for the core symptoms of schizophrenia. * **Antiepileptics (C):** These drugs (e.g., Valproate) stabilize neuronal membranes. While some are used as adjuncts in psychiatry, they are not the primary treatment for schizophrenia. * **Mood Stabilizers (D):** Drugs like Lithium or Carbamazepine are the mainstay for Bipolar Affective Disorder (BPAD) to manage mania and prevent relapses. **NEET-PG High-Yield Pearls:** 1. **Classification:** Antipsychotics are divided into **Typical** (First Generation, e.g., Haloperidol) which cause more Extrapyramidal Side Effects (EPS), and **Atypical** (Second Generation, e.g., Risperidone, Olanzapine) which have a higher affinity for 5-HT2A receptors and lower risk of EPS. 2. **Drug of Choice:** **Clozapine** is the gold standard for **treatment-resistant schizophrenia** but requires monitoring for agranulocytosis. 3. **Side Effects:** Hyperprolactinemia is common with typical antipsychotics and Risperidone due to D2 blockade in the tuberoinfundibular pathway. 4. **Emergency:** Neuroleptic Malignant Syndrome (NMS) is a life-threatening reaction characterized by "lead-pipe" rigidity and hyperthermia.

Question 329: What class of medication is used to treat schizophrenia?

A. Antidepressants
B. Antipsychotics (Correct Answer)
C. Antiepileptics
D. Mood stabilizers

Explanation: **Explanation:** **Antipsychotics** (also known as neuroleptics) are the primary pharmacological treatment for schizophrenia. The underlying medical concept is the **Dopamine Hypothesis**, which suggests that schizophrenia is caused by overactivity of dopamine in the brain. Antipsychotics work primarily by blocking **Dopamine D2 receptors** in the mesolimbic pathway to alleviate positive symptoms like hallucinations and delusions. They are divided into First-Generation (Typical) and Second-Generation (Atypical) antipsychotics, with the latter also targeting serotonin (5-HT2A) receptors to improve negative symptoms. **Why other options are incorrect:** * **Antidepressants:** Primarily used for Major Depressive Disorder and Anxiety disorders. They increase synaptic levels of serotonin and norepinephrine, which does not address the core pathophysiology of schizophrenia. * **Antiepileptics:** Used to control seizures by stabilizing neuronal membranes. While some (like Valproate) are used in psychiatry, they are not primary treatments for schizophrenia. * **Mood Stabilizers:** These (e.g., Lithium) are the gold standard for Bipolar Affective Disorder (BPAD) to manage mania and prevent relapse, rather than treating primary psychosis. **High-Yield NEET-PG Pearls:** * **Drug of Choice (DOC) for Resistant Schizophrenia:** Clozapine (requires monitoring for agranulocytosis). * **Common Side Effect:** Typical antipsychotics (e.g., Haloperidol) frequently cause **Extrapyramidal Symptoms (EPS)** due to nigrostriatal D2 blockade. * **Hyperprolactinemia:** A common side effect of Risperidone due to D2 blockade in the tuberoinfundibular pathway. * **Metabolic Syndrome:** A major concern with Atypical antipsychotics, especially Olanzapine and Clozapine.

Question 330: Regarding the use of Lithium in maniac-depressive psychosis, what is the true statement?

A. Lithium is indicated for monotherapy of acute episodes.
B. Monitoring of serum concentration is not useful for guiding dose adjustment.
C. Lithium can result in leucocytosis. (Correct Answer)
D. Lithium can result in hypothyroidism on long-term use.

Explanation: ### Explanation **Correct Option: C. Lithium can result in leucocytosis.** Lithium has a well-documented effect on the hematological system where it stimulates granulopoiesis. It increases the production of white blood cells (specifically neutrophils) by enhancing the release of granulocyte colony-stimulating factor (G-CSF). This results in a benign, reversible **leucocytosis** (specifically neutrophilia). In clinical practice, this "side effect" is sometimes used therapeutically to treat Felty’s syndrome or chemotherapy-induced neutropenia. **Analysis of Incorrect Options:** * **Option A:** In acute manic episodes, Lithium has a slow onset of action (5–7 days). Therefore, it is rarely used as monotherapy; it is typically combined with atypical antipsychotics or benzodiazepines for immediate symptom control. * **Option B:** Lithium has a **narrow therapeutic index** (0.5–1.2 mEq/L). Serum concentration monitoring is mandatory to ensure efficacy and prevent toxicity. * **Option D:** While this statement is medically true (Lithium inhibits iodine coupling and thyroid hormone release), in the context of multiple-choice questions where one must pick the *most* definitive characteristic or when the question structure implies a single best answer, Option C is often highlighted in pharmacological texts as a classic "signature" hematological effect. *Note: In many exams, both C and D are technically correct side effects, but C is the specific physiological hallmark often tested in this question format.* **High-Yield Clinical Pearls for NEET-PG:** * **Therapeutic Range:** 0.5–0.8 mEq/L (Maintenance); 0.8–1.2 mEq/L (Acute Mania). * **Toxicity:** Occurs >1.5 mEq/L. Features include coarse tremors, ataxia, and seizures. * **Renal Effects:** Causes Nephrogenic Diabetes Insipidus (treated with Amiloride). * **Teratogenicity:** Ebstein’s Anomaly (tricuspid valve displacement). * **Drug Interactions:** Thiazides, NSAIDs, and ACE inhibitors increase Lithium levels (decreased clearance).

Question 331: What class of medication is used to treat schizophrenia?

A. Antidepressants
B. Antipsychotics (Correct Answer)
C. Antiepileptics
D. Mood stabilizers

Explanation: ### Explanation **Correct Answer: B. Antipsychotics** **Mechanism and Rationale:** Schizophrenia is primarily associated with the **Dopamine Hypothesis**, which suggests that overactivity of dopamine in the mesolimbic pathway leads to "positive symptoms" (hallucinations, delusions). **Antipsychotics** (also known as neuroleptics) work by blocking postsynaptic **Dopamine D2 receptors**. * **Typical Antipsychotics** (e.g., Haloperidol) primarily block D2 receptors. * **Atypical Antipsychotics** (e.g., Risperidone, Clozapine) block both D2 and Serotonin (5-HT2A) receptors, making them more effective for "negative symptoms" (apathy, social withdrawal) and reducing the risk of Extrapyramidal Side Effects (EPS). **Why other options are incorrect:** * **A. Antidepressants:** These (e.g., SSRIs, TCAs) increase synaptic levels of Serotonin or Norepinephrine. They are used for Major Depressive Disorder and Anxiety disorders, not as primary treatment for psychosis. * **C. Antiepileptics:** These stabilize neuronal membranes to prevent seizures. While some (like Valproate) are used in psychiatry, they are not the primary treatment for schizophrenia. * **D. Mood Stabilizers:** Drugs like Lithium or Carbamazepine are used to manage Bipolar Affective Disorder (BPAD) to prevent manic and depressive swings. **High-Yield Clinical Pearls for NEET-PG:** * **Clozapine:** The "Gold Standard" for **treatment-resistant schizophrenia**. It is the only drug proven to reduce suicidal behavior in schizophrenia but requires monitoring for **agranulocytosis**. * **Hyperprolactinemia:** A common side effect of typical antipsychotics and Risperidone due to D2 blockade in the tuberoinfundibular pathway. * **Drug of Choice for Acute Dystonia:** Intravenous/Intramuscular **Promethazine** or Benztropine (anticholinergics).

Question 332: Regarding the use of Lithium in maniac-depressive psychosis, what is the true statement?

A. Lithium is indicated for monotherapy of acute episodes.
B. Monitoring of serum concentration is not useful for guiding dose adjustment.
C. Lithium can result in leucocytosis. (Correct Answer)
D. Lithium can result in hypothyroidism on long-term use.

Explanation: ### Explanation **Correct Option: C. Lithium can result in leucocytosis.** Lithium has a well-documented effect on the hematological system where it stimulates granulopoiesis. It increases the production of white blood cells (specifically neutrophils) by enhancing the release of granulocyte colony-stimulating factor (G-CSF). This results in a **benign, reversible leucocytosis**. In clinical practice, this "side effect" is sometimes exploited to treat clozapine-induced agranulocytosis or chemotherapy-induced neutropenia. **Analysis of Incorrect Options:** * **A. Lithium is indicated for monotherapy of acute episodes:** While Lithium is a first-line agent for maintenance, it has a **slow onset of action** (5–10 days). Therefore, in acute manic episodes, it is rarely used as monotherapy and is typically combined with fast-acting atypical antipsychotics or benzodiazepines to achieve immediate control. * **B. Monitoring of serum concentration is not useful:** This is false. Lithium has a **narrow therapeutic index** (0.5–1.2 mEq/L). Therapeutic Drug Monitoring (TDM) is mandatory to prevent toxicity and ensure efficacy. * **D. Lithium can result in hypothyroidism on long-term use:** While this statement is medically **true**, it is not the "best" answer in the context of many standardized exams where Option C is the classic "textbook" physiological effect highlighted. However, in many clinical scenarios, both C and D are correct. In the context of this specific question format, leucocytosis is the primary intended learning point regarding Lithium's unique systemic effects. **High-Yield Clinical Pearls for NEET-PG:** * **Therapeutic Levels:** Acute Mania (0.8–1.2 mEq/L); Prophylaxis (0.5–0.8 mEq/L); Toxicity (>1.5 mEq/L). * **Renal Effects:** Causes Nephrogenic Diabetes Insipidus (treated with Amiloride). * **Teratogenicity:** Ebstein’s Anomaly (tricuspid valve displacement). * **Drug Interactions:** Thiazides, NSAIDs, and ACE inhibitors increase Lithium levels (decreased clearance). * **Thyroid:** Inhibits iodine coupling and thyroid hormone release (Goiter/Hypothyroidism).

Question 333: Which of the following is an atypical antipsychotic with the least metabolic side effects?

A. Risperidone
B. Ziprasidone (Correct Answer)
C. Haloperidol
D. Quetiapine

Explanation: ***Ziprasidone*** - Among the atypical (second-generation) antipsychotics, **Ziprasidone** has the lowest risk regarding adverse **metabolic side effects**, including **weight gain**, dyslipidemia, and insulin resistance. - Due to its minimal impact on metabolic parameters, it is a preferred choice for patients with pre-existing **cardiovascular risk factors** or obesity. *Haloperidol* - Haloperidol is a **first-generation (typical)** antipsychotic, which primarily risks **extrapyramidal symptoms (EPS)** and elevated prolactin, rather than being an atypical agent. - While its metabolic risk is generally lower than high-risk atypicals (e.g., Olanzapine), it is not the correct classification for answering a question focusing on *atypical* drugs. *Risperidone* - Risperidone is an atypical antipsychotic but carries a **moderate to high risk** of causing significant **weight gain** and **hyperprolactinemia**. - Its metabolic profile is considerably worse than that of Ziprasidone or Aripiprazole. *Quetiapine* - Quetiapine carries a substantial risk profile regarding metabolic adverse effects, specifically high rates of **sedation** and clinically significant **weight gain**. - It is frequently linked to the development of **dyslipidemia** and **Type 2 diabetes mellitus**.

Question 334: A patient was given an antipsychotic drug, haloperidol, and the patient developed acute dystonia. Which is the next best step?

A. Give Fluphenazine
B. Give Benztropine (Correct Answer)
C. Increase dose of haloperidol
D. Change to clozapine

Explanation: ***Give Benztropine***- **Acute dystonia** is a severe extrapyramidal symptom (EPS) requiring rapid intervention, often treated intramuscularly or intravenously.- **Benztropine** (an anticholinergic agent) is the drug of choice for the immediate management of acute dystonia, working to restore the balance between dopamine and acetylcholine.*Change to clozapine*- While **clozapine** has a significantly lower risk of causing acute dystonia, it is not the initial treatment for an acute episode due to its slow titration requirements and side-effect profile.- Switching to clozapine is a long-term strategy for patients intolerant to other antipsychotics, not an acute rescue medication.*Give Fluphenazine*- **Fluphenazine** is a high-potency first-generation antipsychotic, similar to haloperidol, which also carries a high risk of EPS.- Administering another high-potency antipsychotic would perpetuate the excessive **dopaminergic blockade** responsible for the acute dystonia.*Increase dose of haloperidol*- **Acute dystonia** is a direct dose-related side effect of D2 receptor blockade by haloperidol in the nigrostriatal pathway.- Increasing the dose of **haloperidol** would worsen the underlying neurochemical imbalance, thereby intensifying the dystonic symptoms.

Question 335: A 12-year-old child presents with palpitations, tremors, dry mouth, heart rate 130 bpm, respiratory rate 34/min. Which of the following substances is most likely responsible?

A. TCA (tricyclic antidepressant) (Correct Answer)
B. Opioid
C. Propranolol
D. Lithium

Explanation: ***TCA (tricyclic antidepressant)***- The constellation of tachycardia (palpitations, HR 130 bpm), tremors, and dry mouth suggests a severe mixed toxidrome, highly characteristic of a TCA overdose.- TCAs exhibit potent **anticholinergic effects** (dry mouth, tachycardia) combined with severe **sodium channel blockade** (contributing to CNS symptoms like tremors and cardiovascular instability) resulting in this critical presentation [1].*Lithium*- Lithium toxicity primarily presents with progressive **neurological symptoms** like ataxia, coarse tremors, lethargy, and seizures.- While tremor is present, the severe **tachycardia** and pronounced **dry mouth** are not typical primary features of the lithium toxidrome.*Opioid*- Opioid toxicity is defined by the classic triad of **miosis** (pinpoint pupils), **respiratory depression** (bradypnea), and altered consciousness.- The patient is profoundly **tachycardic** (130 bpm) and **tachypneic** (34/min), which directly contradicts the expected findings of an opioid overdose.*Propranolol*- Propranolol is a **beta-blocker**, and its overdose typically causes **bradycardia**, hypotension, and potential non-cardiogenic pulmonary edema.- The patient's presentation of significant **tachycardia** (130 bpm) rules out poisoning by a beta-blocking agent.

Question 336: A patient with schizophrenia, developed muscular dystonia and was treated for it. The patient now presents with complaints of dry mouth, dizziness, and hypotension. What is the most likely drug causing these side effects?

A. Benzotropine (Correct Answer)
B. Propranolol
C. Risperidone
D. Haloperidol

Explanation: ***Benzotropine***- This drug is an **anticholinergic agent** administered specifically to treat **extrapyramidal symptoms (EPS)** like acute muscular dystonia caused by antipsychotics.- **Dry mouth** is a characteristic manifestation of its peripheral **anticholinergic side effects**, while **dizziness and hypotension** can occur due to central effects or potentiation of adrenergic blockade, particularly when co-administered with antipsychotics.*Risperidone*- Although Risperidone (an atypical antipsychotic) commonly causes EPS and strong **orthostatic hypotension** due to **alpha-1 adrenergic blockade** (dizziness/hypotension), it has moderate anticholinergic activity, making it less likely to be the sole cause of prominent dry mouth.- The patient's presentation suggests a new medication was introduced *after* the dystonia developed; Risperidone was likely the cause of the *initial* dystonia.*Haloperidol*- Haloperidol, a high-potency typical antipsychotic, is a common cause of **muscular dystonia** (EPS).- It has relatively **low anticholinergic activity** and is therefore an improbable cause of severe **dry mouth** compared to agents like Benzotropine.*Propranolol*- Propranolol is a **beta-blocker** typically used to treat antipsychotic-induced **akathisia** or tremor, not acute dystonia.- Its most prominent side effects are related to beta-blockade, such as **bradycardia** and fatigue; it is not routinely associated with significant **dry mouth**.

Question 337: A 38-year-old professor with depression requests you to prescribe an antidepressant that would be least likely to cause sexual dysfunction. Which of the following drugs would you prescribe?

A. Bupropion (Correct Answer)
B. Venlafaxine
C. Fluoxetine
D. Escitalopram

Explanation: ***Bupropion***- Bupropion is a **norepinephrine-dopamine reuptake inhibitor (NDRI)** that differs structurally and mechanically from SSRIs and SNRIs. - It is known for its relatively neutral effect on sexual function, often having the **lowest incidence** of sexual side effects among commonly prescribed antidepressants, and is sometimes used to treat SSRI-induced sexual dysfunction.*Escitalopram*- As a **selective serotonin reuptake inhibitor (SSRI)**, escitalopram frequently causes sexual side effects such as decreased libido, delayed orgasm, and anorgasmia.- This class of drugs elevates **serotonin levels**, which is strongly implicated in causing sexual dysfunction.*Venlafaxine*- Venlafaxine is a **serotonin-norepinephrine reuptake inhibitor (SNRI)**, and its serotonergic component carries a medium-to-high risk of causing sexual dysfunction.- The common sexual side effects include **erectile dysfunction** in men and reduced arousal in women.*Fluoxetine*- Fluoxetine is a commonly prescribed **SSRI** with a significant association with sexual side effects, including inhibited orgasm and reduced libido.- Its long half-life means that these adverse effects, if they occur, can persist following **discontinuation**.

Question 338: A psychiatrist prescribes lithium for a patient who is diagnosed with bipolar disorder. Which of the following statements is incorrect regarding lithium?

A. Lithium is teratogenic if given to pregnant females
B. Lithium toxicity is exacerbated with thiazide
C. Hemodialysis is not useful in lithium overdose (Correct Answer)
D. Lithium can decrease thyroid hormone levels

Explanation: ***Correct Answer: Hemodialysis is not useful in lithium overdose*** - This statement is **INCORRECT** (making it the right answer to this negation question) - **Hemodialysis IS actually very useful** in severe lithium toxicity - Lithium has low molecular weight (~7 Da), minimal protein binding, and small volume of distribution, making it effectively removed by hemodialysis - **Indications for hemodialysis in lithium toxicity:** Lithium levels >4 mEq/L, severe clinical toxicity (seizures, altered consciousness), or renal failure *Incorrect Option: Lithium is teratogenic if given to pregnant females* - This statement is TRUE, so it's not the answer - Lithium causes **Ebstein's anomaly** (downward displacement of tricuspid valve) when given in first trimester - Risk is 1-2% (20x higher than general population) - FDA pregnancy category D *Incorrect Option: Lithium toxicity is exacerbated with thiazide* - This statement is TRUE, so it's not the answer - Thiazide diuretics decrease renal lithium clearance by promoting sodium depletion - This leads to **compensatory increase in proximal tubular reabsorption** of both sodium and lithium - NSAIDs and ACE inhibitors also increase lithium levels similarly *Incorrect Option: Lithium can decrease thyroid hormone levels* - This statement is TRUE, so it's not the answer - Lithium inhibits thyroid hormone synthesis and release, causing **hypothyroidism in 5-35%** of patients - Mechanism: Inhibits iodine uptake and blocks thyroid hormone release - Requires regular thyroid function monitoring (TSH, T3, T4) during lithium therapy

Question 339: Which of the following psychoactive substances is a new, rapidly acting antidepressant?

A. Ketamine (Correct Answer)
B. Bupropion
C. Haloperidol
D. Cannabinoids

Explanation: ***Ketamine*** - It is an **NMDA receptor antagonist** that produces a rapid and often sustained antidepressant effect, typically within hours, making it a new class of rapidly acting antidepressants. - **Esketamine** (a derivative) is specifically approved for **treatment-resistant depression** and acute suicidal ideation. *Bupropion* - This is a traditional antidepressant classified as a **Norepinephrine and Dopamine Reuptake Inhibitor (NDRI)**. - Like most conventional antidepressants (SSRIs, SNRIs), Bupropion has a **delayed onset of action**, usually requiring weeks for clinical efficacy. *Haloperidol* - This substance is a typical or first-generation **antipsychotic** used primarily to treat conditions involving psychosis, such as schizophrenia and acute mania. - Its primary function involves potent blockade of **Dopamine D2 receptors**, and it is not used in the management of primary depression. *Cannabinoids* - These agents primarily modulate the **endocannabinoid system (CB1 and CB2 receptors)**, and while they have CNS effects, they are generally not used as primary, rapid-acting antidepressants. - Research into cannabinoids for mood is complex, and they may sometimes lead to dysphoria or **anxiety/psychosis exacerbation**.

Question 340: Which drug has propensity to cause such involuntary movements?

A. Flupenthixol (Correct Answer)
B. Clozapine
C. Risperidone
D. Tetrabenazine

Explanation: ***Flupenthixol*** - The image displays various **involuntary movements** of the face, characteristic of **tardive dyskinesia**. - **Flupenthixol** is a **typical (first-generation) antipsychotic** with **high D2 receptor blockade**, giving it the **highest propensity** among the options to cause **extrapyramidal symptoms** including tardive dyskinesia. - Typical antipsychotics are the **most common cause** of drug-induced tardive dyskinesia due to chronic dopamine receptor blockade. *Risperidone* - **Risperidone** is an atypical antipsychotic with **moderate risk** of extrapyramidal symptoms and tardive dyskinesia, particularly at higher doses. - While it can cause TD, its risk is **lower than typical antipsychotics** like flupenthixol but **higher than other atypical antipsychotics** like clozapine or quetiapine. *Tetrabenazine* - **Tetrabenazine** is a **monoamine depletor** (VMAT2 inhibitor) used to **treat tardive dyskinesia and chorea** in Huntington's disease. - It can cause **drug-induced parkinsonism and akathisia**, but does **not typically cause tardive dyskinesia** itself. - It works by depleting presynaptic dopamine rather than blocking postsynaptic receptors. *Clozapine* - **Clozapine** is an atypical antipsychotic with the **lowest risk of extrapyramidal symptoms** and tardive dyskinesia among all antipsychotics. - It has **weak D2 receptor affinity** and strong 5-HT2A antagonism, making it protective against TD. - Often chosen specifically for patients at high risk of or with existing movement disorders.

Question 341: Which of the following medications may be used in a child diagnosed with Attention Deficit Hyperactivity Disorder? I. Carbamazepine II. Methylphenidate III. Atomoxetine IV. Clonazepam Select the correct answer using the code given below :

A. I and III
B. I and IV
C. II and III (Correct Answer)
D. II and IV

Explanation: ***II and III*** - **Methylphenidate** is a first-line **CNS stimulant** that increases dopamine and norepinephrine in the prefrontal cortex, improving attention and reducing hyperactivity/impulsivity - **Atomoxetine** is a **selective norepinephrine reuptake inhibitor (SNRI)**, FDA-approved as a non-stimulant alternative for ADHD management - Both medications are **evidence-based treatments** for ADHD in children with proven efficacy in controlled trials *I and III* - **Carbamazepine** is an anticonvulsant used for epilepsy and bipolar disorder, **not indicated for ADHD** - While Atomoxetine is correct, pairing it with Carbamazepine makes this option incorrect *I and IV* - **Carbamazepine** has no role in ADHD management - **Clonazepam** is a benzodiazepine used for anxiety and seizures, **contraindicated in ADHD** as it causes sedation and may worsen attention deficits *II and IV* - While Methylphenidate is a core ADHD medication, **Clonazepam is inappropriate** for ADHD treatment - Benzodiazepines can impair cognitive function and exacerbate attention problems in ADHD patients

Question 342: A 35-year-old male patient presents to surgery emergency with painful erection for past 7 hours. He has a history of mood disorder and was recently prescribed a medication by treating psychiatrist. Which is the likely offending drug?

A. Venlafaxine
B. Tianeptine
C. Trazodone (Correct Answer)
D. Mirtazapine

Explanation: ***Trazodone*** - **Trazodone** is a commonly known antidepressant that can cause **priapism** as a side effect, especially at higher doses, due to its alpha-adrenergic blocking activity. [1] - The patient's presentation of a **painful erection lasting 7 hours** after starting a new psychiatric medication strongly points towards a drug-induced cause, for which trazodone is a well-established culprit. [1] *Venlafaxine* - **Venlafaxine** is an SNRI antidepressant that generally does not cause priapism as a recognized side effect. - Its adverse effect profile primarily includes nausea, insomnia, and sexual dysfunction (e.g., erectile dysfunction, anorgasmia), rather than prolonged erections. *Tianeptine* - **Tianeptine** is an atypical antidepressant that is not known to cause priapism. - It works by enhancing serotonin reuptake and is more commonly associated with side effects such as nausea, constipation, and dizziness. *Mirtazapine* - **Mirtazapine** is a tetracyclic antidepressant that works by blocking alpha-2 adrenergic receptors and certain serotonin receptors. - While it can cause sedation and weight gain, priapism is not a typical or recognized side effect of mirtazapine.

Question 343: Choose the correctly matched pairs regarding the drugs used in schizophrenia: 1. D2 antagonism: Reduces positive symptoms 2. 5HT2A antagonism: Reduces negative symptoms 3. 5HT1A agonism: Weight loss 4. Muscarinic antagonism: Reduces extrapyramidal symptoms

A. 1,4
B. 1,2,4
C. 1,2,3,4
D. 1,2 (Correct Answer)

Explanation: ***1,2*** - **D2 antagonism** is the primary mechanism by which antipsychotics reduce **positive symptoms** of schizophrenia, such as hallucinations and delusions. - **5HT2A antagonism** is a key mechanism of atypical antipsychotics contributing to the reduction of **negative symptoms** (e.g., apathy, anhedonia, flat affect) and cognitive deficits, while also reducing the risk of extrapyramidal symptoms. *1,2,3,4* - This option is incorrect because **5HT1A agonism** is not associated with **weight loss**. While 5HT1A partial agonism (as seen with aripiprazole and brexpiprazole) may improve negative symptoms, anxiety, and cognitive function, it does not directly cause weight loss. - Additionally, **muscarinic antagonism** does not reduce extrapyramidal symptoms as a primary mechanism. Rather, anticholinergic (muscarinic antagonist) drugs like benztropine are used to **treat** EPS after it occurs. The reduction of EPS in atypical antipsychotics primarily comes from 5HT2A antagonism and lower D2 binding affinity. *1,2,4* - This option is incorrect because **muscarinic antagonism** is not a mechanism that reduces EPS. Anticholinergic agents are used therapeutically to counteract EPS caused by dopamine blockade, but anticholinergic effects themselves do not prevent or reduce EPS. - The reduction of EPS with atypical antipsychotics is mainly due to **5HT2A antagonism** balancing dopaminergic blockade, selective limbic over striatal binding, and fast D2 dissociation kinetics. *1,4* - This option is incorrect because it omits **5HT2A antagonism**, which is crucial for reducing **negative symptoms** in schizophrenia. - It also incorrectly includes muscarinic antagonism as a mechanism that reduces EPS, when in reality anticholinergics are used to treat EPS rather than prevent it.

Question 344: A patient of schizophrenia is being treated with clozapine. For which rare but serious side effects should he be monitored?

A. Seizures
B. Agranulocytosis (Correct Answer)
C. Hepatomegaly
D. Renal bleed

Explanation: ***Agranulocytosis*** - **Agranulocytosis** is a severe and potentially fatal reduction in white blood cells (specifically neutrophils) that can occur with clozapine use [2, 3]. - This is the **rare but serious side effect** that requires mandatory monitoring, occurring in **0.8-2%** of patients. - Patients on clozapine require routine **complete blood count (CBC)** monitoring: **weekly for the first 6 months**, then biweekly for months 6-12, then monthly thereafter . - This is the primary reason clozapine has restricted use despite being the most effective antipsychotic for treatment-resistant schizophrenia. *Seizures* - While clozapine can lower the **seizure threshold** (especially at higher doses), seizures occur in **1-2%** of patients and are **dose-dependent** . - Seizures are a known side effect that warrants dosage adjustment, but they are **not as rare** as agranulocytosis and do not require the same intensive blood monitoring protocol. - Management involves dose reduction or adding anticonvulsants. *Hepatomegaly* - **Hepatic dysfunction** can occur with clozapine, but **hepatomegaly** (enlarged liver) itself is not one of its rare, life-threatening side effects requiring specific monitoring above other, more severe issues. - Liver enzyme elevation may be monitored, but this is not the primary "rare but serious" concern. *Renal bleed* - **Renal complications** or **renal bleeding** are not recognized as significant or specifically monitored rare side effects of clozapine. - Clozapine's major concerns primarily involve hematologic (agranulocytosis), cardiovascular (myocarditis), and metabolic systems.

Question 345: Which of the following is true about lithium?

A. It is also used for treatment of absence seizures
B. It is not teratogenic
C. It can cause fine postural tremors at therapeutic dosage (Correct Answer)
D. It is not absorbed from the gut

Explanation: ***It can cause fine postural tremors at therapeutic dosage*** - **Fine postural tremors** are a common and well-known side effect of lithium, even within its therapeutic range. - This side effect can be dose-dependent and may worsen with higher lithium concentrations. *It is also used for treatment of absence seizures* - Lithium is primarily used as a **mood stabilizer** for bipolar disorder and is not indicated for the treatment of **absence seizures**. - **Absence seizures** are typically treated with drugs like ethosuximide or valproate. *It is not teratogenic* - Lithium is known to be **teratogenic**, especially during the first trimester of pregnancy. - It is associated with an increased risk of **Ebstein's anomaly**, a congenital heart defect. *It is not absorbed from the gut* - Lithium is **rapidly and completely absorbed** from the gastrointestinal tract after oral administration. - Its absorption is not significantly affected by food, and peak plasma concentrations are usually reached within 1-3 hours.

Question 346: Venlafaxine comes under which class of drugs?

A. Monoamine oxidase inhibitors
B. Serotonin receptor antagonist
C. Selective serotonin reuptake inhibitor
D. Serotonin-norepinephrine reuptake inhibitor (SNRI) (Correct Answer)

Explanation: ***Serotonergic noradrenergic reuptake inhibitor*** - **Venlafaxine** is an antidepressant that works by inhibiting the reuptake of both **serotonin** and **norepinephrine**, making it a **Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)**. - This dual mechanism contributes to its efficacy in treating **major depressive disorder**, **anxiety disorders**, and **neuropathic pain**. *Monoamine oxidase inhibitors* - **MAOIs** inhibit the enzyme **monoamine oxidase**, which metabolizes neurotransmitters like **serotonin**, **norepinephrine**, and **dopamine**. - They are associated with significant **food and drug interactions**, unlike venlafaxine. *Serotonin receptor antagonist* - These drugs *block* **serotonin receptors**, often used as **antiemetics** (e.g., ondansetron) or in some **antipsychotics**. - They do not primarily increase serotonin or norepinephrine levels via reuptake inhibition. *Selective serotonin reuptake inhibitor* - **SSRIs** (e.g., fluoxetine, sertraline) primarily inhibit the reuptake of **serotonin**, with minimal effect on other neurotransmitters. - While venlafaxine affects serotonin, it also significantly impacts norepinephrine, distinguishing it from SSRIs.

Question 347: Disulfiram is a type of:-

A. Anticraving therapy
B. Detoxification
C. Opioid management therapy
D. Aversion therapy (Correct Answer)

Explanation: **Aversion therapy** - **Disulfiram** works by inhibiting aldehyde dehydrogenase, leading to the accumulation of acetaldehyde when alcohol is consumed, which causes unpleasant symptoms like flushing, nausea, and vomiting. - This creates an **aversive reaction** to alcohol, which discourages further drinking, making it a form of aversion therapy. *Anticraving therapy* - While disulfiram can indirectly reduce cravings by making alcohol consumption unpleasant, its primary mechanism is not to directly modulate craving pathways in the brain. - Drugs like **naltrexone** or **acamprosate** are more commonly categorized as specific anticraving agents for alcohol dependence. *Detoxification* - **Detoxification** refers to the supervised withdrawal from a substance to manage acute withdrawal symptoms and stabilize the patient. - Disulfiram is used after detoxification to help maintain abstinence, not during the acute withdrawal phase. *Opioid management therapy* - **Opioid management therapy** involves medications like **methadone** or **buprenorphine** used to treat opioid dependence. - Disulfiram is specifically used for **alcohol use disorder** and has no role in managing opioid dependence.

Question 348: Which of the following drugs is specifically approved for the treatment of premature ejaculation?

A. Dapoxetine (Correct Answer)
B. Escitalopram
C. Citalopram
D. Chlorpromazine

Explanation: ***Dapoxetine*** - **Dapoxetine** is a **short-acting selective serotonin reuptake inhibitor (SSRI)** specifically approved for the on-demand treatment of **premature ejaculation (PE)**. - It works by delaying the ejaculatory reflex through its effect on serotonin transporters in the brain, thereby increasing the **intravaginal ejaculatory latency time (IELT)**. *Escitalopram* - **Escitalopram** is a **long-acting SSRI** primarily used for the treatment of **depression and anxiety disorders**. - While other SSRIs can be used off-label for PE, escitalopram's long half-life makes it less suitable for on-demand use, and it is not specifically approved for this indication. *Citalopram* - **Citalopram** is another **long-acting SSRI** used mainly for **depression and anxiety**, similar to escitalopram. - Its pharmacokinetic profile is not ideal for on-demand treatment of PE, and it carries a risk of QT prolongation, which further limits its use in this context. *Chlorpromazine* - **Chlorpromazine** is a **first-generation antipsychotic** used to treat **psychotic disorders** like schizophrenia, as well as severe nausea and vomiting. - It has no role in the direct treatment of premature ejaculation and its side effect profile, including sedation and extrapyramidal symptoms, makes it inappropriate for this condition.

Question 349: All are used in attention deficit hyperactivity disorder (ADHD) except:

A. Dextro-amphetamine
B. Methylphenidate
C. Phenobarbitone (Correct Answer)
D. Atomoxetine

Explanation: ***Phenobarbitone*** - **Phenobarbitone** (phenobarbital) is a **barbiturate** primarily used as an **anticonvulsant** and for sedation. - It works as a **CNS depressant** and would worsen, not improve, symptoms of ADHD, which include inattention, hyperactivity, and impulsivity. - **Not indicated** for ADHD management and may cause sedation, cognitive impairment, and paradoxical hyperactivity in children. *Dextro-amphetamine* - **Dextro-amphetamine** is a **stimulant medication** commonly used in ADHD. - It works by increasing levels of **dopamine** and **norepinephrine** in the brain, improving focus and reducing hyperactivity. - Approved for ADHD treatment in both children and adults. *Methylphenidate* - **Methylphenidate** is a **stimulant** widely prescribed for ADHD and considered a first-line treatment. - It acts as a **norepinephrine-dopamine reuptake inhibitor**, thereby increasing the availability of these neurotransmitters. - Available in immediate-release and extended-release formulations. *Atomoxetine* - **Atomoxetine** is a **non-stimulant** selective norepinephrine reuptake inhibitor (SNRI) used for ADHD. - It is particularly useful in patients who cannot tolerate stimulants or have comorbid anxiety disorders. - Preferred when there is concern about substance abuse or tic disorders.

Question 350: Which of the following drugs are used in the treatment of Attention-Deficit Hyperactivity Disorder (ADHD)?

A. Atomoxetine
B. Dexmethylphenidate
C. Methylphenidate
D. All of the options (Correct Answer)

Explanation: ***All of the options*** - **Atomoxetine**, **dexmethylphenidate**, and **methylphenidate** are all approved and commonly used medications for managing Attention-Deficit Hyperactivity Disorder (ADHD) [1]. - They represent different classes or formulations of drugs targeting neurotransmitter systems involved in ADHD. *Atomoxetine* - This is a **selective norepinephrine reuptake inhibitor** used for ADHD. - It is a **non-stimulant** option, often preferred for patients who do not tolerate stimulants or have co-existing anxiety disorders. *Dexmethylphenidate* - This is the **dextro-isomer** of methylphenidate, and it is a **central nervous system (CNS) stimulant** [1]. - It is known for its **potency** and faster onset of action due to only containing the active isomer. *Methylphenidate* - This is a **CNS stimulant** medication that works by blocking the reuptake of norepinephrine and dopamine [1]. - It is available in various formulations (short-acting, intermediate-acting, long-acting) to suit individual patient needs [1].

Question 351: Second line drug in Enuresis is

A. Haloperidol
B. Chlorpromazine
C. Diazepam
D. Imipramine (Correct Answer)

Explanation: ***Imipramine*** - **Imipramine** is a tricyclic antidepressant (TCA) and is the established **second-line pharmacological treatment** for **nocturnal enuresis** when first-line therapies (like desmopressin or behavioral interventions) are ineffective. - TCAs like imipramine work by increasing bladder capacity, reducing sleep arousal threshold (making it easier to wake up), and having anticholinergic effects that relax the detrusor muscle. - Imipramine is specifically approved for enuresis and has the most evidence among TCAs for this indication. *Haloperidol* - **Haloperidol** is a typical antipsychotic primarily used to treat psychotic disorders such as schizophrenia and Tourette's syndrome. - It is not indicated for the treatment of **enuresis** and has significant extrapyramidal side effects. *Chlorpromazine* - **Chlorpromazine** is another typical antipsychotic, known for its sedative and antiemetic properties, and is used in conditions like schizophrenia and bipolar disorder. - It is not used for **enuresis** and carries risks of sedation and various neurological side effects. *Diazepam* - **Diazepam** is a benzodiazepine primarily used for anxiety, muscle spasms, and seizures due to its anxiolytic, sedative, muscle relaxant, and anticonvulsant properties. - It is not an appropriate treatment for **enuresis** and could worsen it due to its sedative effects, which might reduce arousal in sleep.

Question 352: A patient with nocturnal enuresis and depressive symptoms was started on an antidepressant. What is the drug?

A. clomipramine
B. sertraline
C. amitriptyline
D. imipramine (Correct Answer)

Explanation: ***Imipramine*** - **Imipramine (Tofranil)** is a **tricyclic antidepressant (TCA)** [1] historically used for **nocturnal enuresis** due to its anticholinergic and alpha-adrenergic effects, which increase bladder capacity and sphincter tone. While it treats **depressive symptoms** [2], its use in enuresis has declined due to newer therapies with fewer side effects. *Clomipramine* - **Clomipramine (Anafranil)** is primarily used for **obsessive-compulsive disorder (OCD)** but also has antidepressant effects. While it shares some properties with imipramine as a TCA, it is **not the primary choice for nocturnal enuresis** and is more known for its serotonin reuptake inhibition. *Sertraline* - **Sertraline (Zoloft)** is a **selective serotonin reuptake inhibitor (SSRI)** commonly used for depression, anxiety disorders, and OCD. It **does not have a recognized role in treating nocturnal enuresis** and can sometimes even worsen urinary symptoms or cause nocturnal polyuria. *Amitriptyline* - **Amitriptyline (Elavil)** is a TCA effective for **depression**, **neuropathic pain**, and **migraine prophylaxis**. While it has strong anticholinergic properties that could theoretically affect bladder function, it is **not the preferred TCA for nocturnal enuresis**; imipramine has a more established history for this indication.

Question 353: Nocturnal enuresis is commonly treated with:

A. Haloperidol
B. Chlordiazepoxide
C. Chlorpromazine
D. Imipramine (Correct Answer)

Explanation: **Imipramine** - **Imipramine**, a tricyclic antidepressant, is known to reduce the depth of sleep, decrease the volume of urine produced at night, and increase bladder capacity, making it an effective treatment for **nocturnal enuresis**. - Its mechanism involves both anticholinergic effects on the bladder and direct effects on the central nervous system to reduce arousal threshold. *Haloperidol* - **Haloperidol** is a typical antipsychotic primarily used to treat psychotic disorders like schizophrenia and acute delirium. - It is not indicated for the management of nocturnal enuresis and could potentially have severe neurological side effects. *Chlordiazepoxide* - **Chlordiazepoxide** is a benzodiazepine used for anxiety, alcohol withdrawal, and muscle spasms. - It acts as a central nervous system depressant and would likely worsen enuresis by further relaxing bladder control and increasing sleep depth. *Chlorpromazine* - **Chlorpromazine** is another typical antipsychotic, also used as an antiemetic and for severe behavioral problems. - It has no role in the treatment of nocturnal enuresis and can cause significant side effects such as sedation and extrapyramidal symptoms.

Question 354: Which of the following drugs used for obsessive-compulsive disorder has maximum anticholinergic effect?

A. Fluvoxamine
B. Buspirone
C. Sertraline
D. Clomipramine (Correct Answer)

Explanation: ***Clomipramine*** - **Clomipramine** is a **tricyclic antidepressant (TCA)** with potent efficacy in OCD treatment. - It has **strong anticholinergic effects** including dry mouth, blurred vision, constipation, urinary retention, and cognitive impairment. - Among all medications used for OCD, clomipramine has the **maximum anticholinergic burden** due to its action on muscarinic receptors. - While effective for OCD, its significant side effect profile often limits its use to refractory cases. *Fluvoxamine* - **Fluvoxamine** is a **selective serotonin reuptake inhibitor (SSRI)** with FDA approval for OCD. - SSRIs have **minimal anticholinergic effects** compared to TCAs. - It selectively targets serotonin reuptake with little affinity for muscarinic cholinergic receptors. *Buspirone* - **Buspirone** is a **5-HT1A partial agonist** used primarily for **generalized anxiety disorder**. - It is **not a standard or approved treatment for OCD** - this makes it an inappropriate choice regardless of side effect profile. - It has negligible anticholinergic effects but lacks efficacy in OCD. *Sertraline* - **Sertraline** is an **SSRI** with FDA approval for OCD treatment. - Like other SSRIs, it has **very low affinity for muscarinic receptors** and minimal anticholinergic effects. - It is a first-line agent for OCD with a favorable side effect profile.

Question 355: Atomoxetine is used in the management of which of the following conditions?

A. Bipolar disorder
B. Schizophrenia
C. Depression
D. ADHD (Correct Answer)

Explanation: ***Correct: ADHD*** * **Atomoxetine** is a **selective norepinephrine reuptake inhibitor (SNRI)** primarily used in the management of **Attention-Deficit/Hyperactivity Disorder (ADHD)**. * It is a **non-stimulant** medication, making it a suitable alternative for patients who do not respond to or cannot tolerate traditional stimulant medications for ADHD. * FDA-approved in 2002, atomoxetine remains an important treatment option, particularly for patients with concerns about stimulant abuse potential or those with comorbid anxiety disorders. *Incorrect: Bipolar disorder* * **Bipolar disorder** is typically treated with mood stabilizers (e.g., lithium, valproate), antipsychotics, and sometimes antidepressants, but atomoxetine is not a first-line or common treatment option. * While some ADHD symptoms can overlap with bipolar disorder, atomoxetine is specifically designed for ADHD and lacks the broad mood-stabilizing effects needed for bipolar disorder. *Incorrect: Schizophrenia* * **Schizophrenia** is a severe mental disorder treated primarily with **antipsychotic medications** that target dopamine and serotonin systems. * Atomoxetine does not have efficacy in treating the positive or negative symptoms of schizophrenia and is not indicated for this condition. *Incorrect: Depression* * While atomoxetine affects **norepinephrine**, some SNRIs (e.g., venlafaxine, duloxetine) are used for depression. However, atomoxetine's primary indication and efficacy profile are not for treating **major depressive disorder**. * Its mechanism of action is more specifically tailored to the neurochemical imbalances seen in ADHD rather than the broader neurotransmitter dysregulation in depression.

Question 356: Fingernail hypoplasia is a complication of which of the following drugs?

A. risperidone
B. lithium
C. olanzapine
D. carbamazepine (Correct Answer)

Explanation: ***Carbamazepine*** - **Fingernail hypoplasia** (underdevelopment of nails) is a known teratogenic effect associated with first-trimester exposure to **carbamazepine**, part of the **fetal anticonvulsant syndrome**. - Other features of this syndrome include characteristic facial dysmorphism, microcephaly, developmental delay, and skeletal abnormalities. *Risperidone* - Risperidone is an **atypical antipsychotic** and its primary teratogenic risks are related to neonatal adaptation syndrome, such as withdrawal symptoms, rather than structural defects like fingernail hypoplasia. - While all antipsychotics should be used with caution during pregnancy, specific associations with structural malformations are less common and less severe than with some antiepileptic drugs. *Lithium* - Lithium is associated with a specific cardiac malformation, **Ebstein's anomaly**, when taken during the first trimester of pregnancy. - It is not typically linked to limb or nail hypoplasia. *Olanzapine* - Olanzapine is another **atypical antipsychotic** whose use in pregnancy is primarily linked to risks like **gestational diabetes** and **neonatal withdrawal symptoms**. - There is no strong evidence linking olanzapine to structural malformations like fingernail hypoplasia.

Question 357: Donepezil is used in treatment of:

A. Alzheimer's dementia (Correct Answer)
B. Anxiety disorder
C. Schizophrenia
D. Parkinson's disease

Explanation: ***Alzheimer's dementia*** - **Donepezil** is a **cholinesterase inhibitor** that increases the availability of **acetylcholine** in the brain, improving **cognitive function** in patients with Alzheimer's. - It is one of the primary medications approved for the symptomatic treatment of **mild to moderate** Alzheimer's disease. *Anxiety disorder* - **Anxiety disorders** are typically treated with **selective serotonin reuptake inhibitors (SSRIs)**, **benzodiazepines**, or psychotherapy. - Donepezil has no established role or efficacy in the treatment of anxiety disorders. *Schizophrenia* - **Schizophrenia** is managed with **antipsychotic medications** that primarily target **dopamine** and **serotonin** systems in the brain. - Donepezil's mechanism of action, increasing acetylcholine, is not relevant to the pathology or treatment of schizophrenia. *Parkinson's disease* - **Parkinson's disease** is primarily characterized by the degeneration of **dopaminergic neurons** and motor symptoms are treated with medications like **levodopa**. - While **rivastigmine** (another cholinesterase inhibitor) is approved for Parkinson's disease dementia, **donepezil** is specifically indicated for **Alzheimer's disease**, not Parkinson's disease.

Question 358: Which antipsychotic has highest risk of QTc prolongation?

A. Ziprasidone (Correct Answer)
B. Risperidone
C. Olanzapine
D. Aripiprazole

Explanation: ***Ziprasidone*** - **Ziprasidone** is known to have the highest risk of **QTc prolongation** among the commonly used atypical antipsychotics. - This effect is dose-dependent and necessitates careful monitoring, especially in patients with pre-existing cardiac conditions or those on other QTc-prolonging medications. *Risperidone* - While **risperidone** can cause **QTc prolongation**, its risk is generally considered to be lower than that of ziprasidone. - It also carries a significant risk of **hyperprolactinemia** and **extrapyramidal symptoms (EPS)**, which are important distinguishing features. *Olanzapine* - **Olanzapine** has a relatively low risk of **QTc prolongation** compared to ziprasidone. - Its primary concerns include substantial **weight gain** and **metabolic syndrome**, which are less prominent with ziprasidone. *Aripiprazole* - **Aripiprazole** is generally associated with a very low risk of **QTc prolongation** and is often considered a safer choice in this regard. - It is known for its unique partial agonist activity at dopamine D2 and serotonin 5-HT1A receptors, and antagonist activity at 5-HT2A receptors, leading to a different side effect profile.

Question 359: Which of the following is not an adverse effect of Escitalopram?

A. Sialorrhoea (Correct Answer)
B. Anorgasmia
C. Vivid dreams
D. Nausea

Explanation: ***Sialorrhoea*** - **Sialorrhoea** (excessive salivation) is generally *not* an adverse effect associated with **escitalopram** or other SSRIs; in fact, **dry mouth** is a more common side effect due to cholinergic blockade [2]. - SSRIs primarily act by increasing **serotonin** levels in the synaptic cleft, and this mechanism does not typically lead to overproduction of saliva. *Anorgasmia* - **Anorgasmia** (inability to achieve orgasm) is a well-known and common sexual adverse effect of **escitalopram** and other **SSRIs** [1, 2]. - This occurs due to increased serotonin activity in the brain, impacting neural pathways involved in sexual response. *Vivid dreams* - **Vivid dreams** or nightmares are a recognized neuropsychiatric side effect of **escitalopram** and other **SSRIs** [1, 3]. - This effect is thought to be related to changes in **REM sleep architecture** caused by serotonin modulation. *Nausea* - **Nausea** is a very common gastrointestinal adverse effect of **escitalopram**, especially during the initial phase of treatment [1]. - It results from increased serotonin activity in the **gastrointestinal tract**, where many serotonin receptors are located.

Question 360: How does fluoxetine help in treating depression?

A. Increases serotonin reuptake
B. Increases GABA levels
C. Inhibits serotonin reuptake (Correct Answer)
D. Blocks dopamine receptors

Explanation: ***Inhibits serotonin reuptake*** - Fluoxetine is a **selective serotonin reuptake inhibitor (SSRI)**, meaning it blocks the reabsorption of serotonin into presynaptic neurons. - This action leads to increased concentrations of serotonin in the **synaptic cleft**, enhancing serotonergic neurotransmission and alleviating depressive symptoms. *Increases serotonin reuptake* - This statement is incorrect as increasing serotonin reuptake would **reduce serotonin availability** in the synapse, worsening depressive symptoms rather than improving them. - Antidepressants like fluoxetine aim to **increase serotonin levels**, not decrease them through increased reuptake. *Increases GABA levels* - Medications that increase **GABA (gamma-aminobutyric acid)** levels are typically anxiolytics or anticonvulsants (e.g., benzodiazepines), not primary antidepressants. - While GABAergic pathways can influence mood, fluoxetine's primary mechanism is specifically on **serotonin**. *Blocks dopamine receptors* - Blocking dopamine receptors is the mechanism of action for many **antipsychotic medications**, which are used to treat conditions like schizophrenia or bipolar disorder. - This action is generally **not the primary mechanism** by which antidepressants like fluoxetine exert their effects; in fact, blocking dopamine can sometimes worsen depression.

Question 361: Which antipsychotic is most likely to cause metabolic syndrome?

A. Olanzapine
B. Haloperidol
C. Clozapine (Correct Answer)
D. Risperidone

Explanation: ***Clozapine*** - **Clozapine** has the **highest risk** of causing **metabolic syndrome** among all antipsychotics, characterized by significant **weight gain**, **dyslipidemia**, **insulin resistance**, and **new-onset diabetes mellitus**. - Multiple meta-analyses consistently show clozapine causes the **most severe metabolic disturbances**, with weight gain often exceeding 5-10 kg in the first year of treatment. - The mechanism involves potent antagonism of **5-HT2C receptors**, **histamine H1 receptors**, and effects on **leptin signaling** and **glucose metabolism**. - Its use requires careful **metabolic monitoring** including baseline and periodic measurement of weight, BMI, waist circumference, fasting glucose, and lipid profile. - Despite these risks, clozapine remains the gold standard for **treatment-resistant schizophrenia**, but its metabolic effects necessitate risk-benefit consideration. *Olanzapine* - **Olanzapine** has the **second-highest risk** for metabolic syndrome after clozapine, also causing significant weight gain and metabolic disturbances. - Like clozapine, it has potent **5-HT2C** and **H1 antagonism**, leading to increased appetite and altered glucose-lipid metabolism. - The metabolic risk is substantial but generally slightly less severe than clozapine in head-to-head comparisons. *Haloperidol* - **Haloperidol** is a first-generation (typical) antipsychotic with a **significantly lower risk** of metabolic syndrome compared to clozapine or olanzapine. - Its primary adverse effects are **extrapyramidal symptoms** (akathisia, dystonia, parkinsonism) and **hyperprolactinemia** rather than metabolic disturbances. - It causes minimal weight gain and has low risk for diabetes or dyslipidemia. *Risperidone* - **Risperidone** has an **intermediate metabolic risk** among atypical antipsychotics, lower than clozapine or olanzapine but higher than some others like aripiprazole or ziprasidone. - While it can cause weight gain and metabolic changes, the magnitude is generally more modest. - Its more prominent side effect is **hyperprolactinemia** due to potent D2 antagonism.

Question 362: How do SSRIs alleviate symptoms of depression?

A. By increasing synaptic serotonin levels (Correct Answer)
B. By inhibiting GABA receptors
C. By increasing norepinephrine degradation
D. By decreasing dopamine release

Explanation: ***By increasing synaptic serotonin levels*** - **Selective Serotonin Reuptake Inhibitors (SSRIs)** block the reabsorption (reuptake) of **serotonin** by neurons, leading to higher concentrations of serotonin in the synaptic cleft. - Increased **synaptic serotonin** availability is believed to enhance neuronal communication and mood regulation, thus alleviating symptoms of depression. *By inhibiting GABA receptors* - Inhibiting **GABA receptors** would typically lead to increased neuronal excitability, potentially worsening anxiety or causing seizures, rather than alleviating depression. - Medications that act on GABA receptors, such as **benzodiazepines**, are primarily used for anxiety and sedation, not as first-line antidepressants. *By increasing norepinephrine degradation* - Increasing **norepinephrine degradation** would reduce the levels of norepinephrine, a neurotransmitter associated with alertness and mood, which would likely worsen depressive symptoms. - Many antidepressants, such as **SNRIs**, aim to *increase* norepinephrine levels, not degrade them. *By decreasing dopamine release* - Decreasing **dopamine release** would likely lead to symptoms of anhedonia, lack of motivation, and other features of depression, or even extrapyramidal symptoms if significantly reduced. - **Dopamine** is often associated with reward and pleasure pathways, and increasing its availability can be beneficial in some forms of depression.

Question 363: Which of the following antipsychotic drugs is known for its high risk of agranulocytosis?

A. Haloperidol
B. Clozapine (Correct Answer)
C. Olanzapine
D. Aripiprazole

Explanation: ***Clozapine*** - **Clozapine** is an atypical antipsychotic with a unique efficacy for **treatment-resistant schizophrenia**, but its use is restricted due to a significant risk of **agranulocytosis**. - Due to this risk, patients on clozapine require **regular blood monitoring** (weekly to biweekly, then monthly) to check their **white blood cell count (WBC)** and **absolute neutrophil count (ANC)**. *Haloperidol* - **Haloperidol** is a typical (first-generation) antipsychotic primarily known for its risk of **extrapyramidal symptoms (EPS)** and **tardive dyskinesia**, but not agranulocytosis. - While it can cause leukocytosis or mild neutropenia, it does not carry the same high risk of **severe agranulocytosis** as clozapine. *Olanzapine* - **Olanzapine** is an atypical antipsychotic associated with a higher risk of **metabolic side effects** such as weight gain, hyperglycemia, and dyslipidemia. - Although it can cause neutropenia in rare cases, its risk of **agranulocytosis** is very low and not considered a defining adverse effect on par with clozapine. *Aripiprazole* - **Aripiprazole** is an atypical antipsychotic known for its unique mechanism as a **partial dopamine agonist** and a lower incidence of metabolic side effects compared to other atypicals. - While it can cause some hematological changes, the risk of **agranulocytosis** is exceedingly rare and not a significant concern with its use.

Question 364: A patient on antipsychotic therapy develops tardive dyskinesia. What is the underlying cause?

A. Serotonin receptor dysfunction and imbalance
B. Histamine receptor hypersensitivity
C. Chronic blockade of dopamine receptors leading to upregulation of dopamine receptors (Correct Answer)
D. GABA receptor downregulation

Explanation: ***Chronic blockade of dopamine receptors leading to upregulation of dopamine receptors*** - **Tardive dyskinesia** is primarily attributed to a chronic blockade of **dopamine D2 receptors** by antipsychotic medications, leading to a compensatory **upregulation and hypersensitivity** of these receptors. - When dopamine is released, these hypersensitive receptors over-respond, causing involuntary and repetitive movements, particularly in the face and limbs. *Serotonin receptor dysfunction and imbalance* - While some antipsychotics affect **serotonin receptors**, dysfunction in these receptors is not considered the primary underlying cause of tardive dyskinesia. - Serotonin modulation is more commonly associated with the efficacy of **atypical antipsychotics** in reducing psychotic symptoms and their potentially lower risk of extrapyramidal side effects compared to older drugs. *Histamine receptor hypersensitivity* - Hypersensitivity of **histamine receptors** is not directly linked to the pathophysiology of tardive dyskinesia. - Histamine blockade can contribute to side effects such as **sedation and weight gain** with some antipsychotics, but not the specific motor symptoms of tardive dyskinesia. *GABA receptor downregulation* - Downregulation of **GABA receptors** is not considered the main etiological factor for tardive dyskinesia. - GABAergic system involvement is linked more to conditions like **anxiety and epilepsy**, and while it can indirectly influence motor control, it's not the central mechanism.

Question 365: Which antipsychotic drug has the lowest risk of causing extrapyramidal side effects (EPS)?

A. Haloperidol
B. Chlorpromazine
C. Fluphenazine
D. Clozapine (Correct Answer)

Explanation: ***Clozapine*** - Clozapine is an **atypical antipsychotic** known for its unique pharmacological profile, including very low D2 receptor affinity at the striatum, which is why it has the **lowest risk of EPS**. - Its efficacy in **treatment-resistant schizophrenia** and low EPS risk are balanced by a higher risk of **agranulocytosis** and myocarditis, requiring careful monitoring. *Haloperidol* - Haloperidol is a **high-potency typical antipsychotic** with strong D2 receptor blockade, leading to a **high risk of EPS**. - It is frequently associated with **dystonia**, **akathisia**, and **parkinsonism**. *Chlorpromazine* - Chlorpromazine is a **typical antipsychotic** that, while having anticholinergic properties that can mitigate some EPS, still carries a **significant risk of EPS** due to its D2 receptor blockade. - It is also known for a high incidence of **sedation** and **orthostatic hypotension**. *Fluphenazine* - Fluphenazine is another **high-potency typical antipsychotic** with a very strong D2 receptor blockade, consequently having a **high risk of EPS**. - It is often available in a **depot injection** form, which can be useful for adherence but does not reduce its inherent EPS risk.

Question 366: A patient with a history of opioid addiction is given a drug for long-term relapse prevention in opioid use disorder. Which drug is most suitable for this purpose?

A. Naloxone
B. Methadone
C. Buprenorphine
D. Naltrexone (Correct Answer)

Explanation: ***Naltrexone*** - **Naltrexone** is an **opioid antagonist** that blocks opioid receptors, preventing both the euphoric and respiratory depressant effects of opioids. - It is used for **relapse prevention** in opioid use disorder by reducing cravings and blocking the effects of any opioids consumed. *Naloxone* - **Naloxone** is a short-acting **opioid antagonist**, primarily used to **reverse acute opioid overdose** by rapidly displacing opioids from receptors. - It is not typically used for long-term **relapse prevention** due to its short half-life and route of administration (injectable for overdose reversal). *Methadone* - **Methadone** is a **long-acting opioid agonist** used in opioid maintenance therapy to reduce cravings and withdrawal symptoms. - While it helps prevent relapse by stabilizing the patient, it is an **opioid itself** and can cause dependence, unlike naltrexone which is an antagonist. *Buprenorphine* - **Buprenorphine** is a **partial opioid agonist** used in opioid replacement therapy; it reduces cravings and withdrawal symptoms without producing the same high as full agonists. - It is similar to methadone in its use for maintenance therapy but is not a pure antagonist like naltrexone for blocking effects.

Question 367: A patient with schizophrenia is prescribed an atypical antipsychotic that has potent blockade of both serotonin 5-HT2A and dopamine D2 receptors and is commonly used as a first-line agent. Which drug is appropriate?

A. Haloperidol
B. Clozapine
C. Aripiprazole
D. Olanzapine (Correct Answer)

Explanation: ***Olanzapine*** - **Olanzapine** is an **atypical antipsychotic** with **potent blockade** of both **dopamine D2** and **serotonin 5-HT2A** receptors [4]. - This balanced dual receptor antagonism contributes to its efficacy in treating positive and negative symptoms of schizophrenia with a lower risk of **extrapyramidal side effects** compared to typical antipsychotics [4]. - It is widely used as a **first-line atypical antipsychotic** with a well-established safety profile [2]. *Haloperidol* - **Haloperidol** is a **first-generation (typical) antipsychotic** that primarily acts as a potent **dopamine D2 receptor antagonist** [3]. - It has minimal affinity for **serotonin 5-HT2A receptors** and is associated with a higher incidence of **extrapyramidal symptoms (EPS)** [3]. *Clozapine* - **Clozapine** is an **atypical antipsychotic** with antagonism at **5-HT2A** receptors, but its **D2 receptor binding** is characterized by **rapid dissociation** (loose binding) [4]. - It is reserved for **treatment-resistant schizophrenia** due to serious side effects including **agranulocytosis**, **myocarditis**, and **metabolic syndrome** [1]. - Not used as a first-line agent due to mandatory blood monitoring requirements [1]. *Aripiprazole* - **Aripiprazole** is an **atypical antipsychotic** that acts as a **dopamine D2 partial agonist** (not a pure antagonist) and **serotonin 5-HT1A partial agonist**, along with **5-HT2A antagonism**. - Its **partial agonist** mechanism at D2 receptors distinguishes it from agents that have pure antagonist blockade of both D2 and 5-HT2A receptors.

Question 368: Which drug, used to treat alcohol dependence, works by inhibiting aldehyde dehydrogenase and leads to an unpleasant reaction when alcohol is consumed?

A. Naltrexone
B. Acamprosate
C. Disulfiram (Correct Answer)
D. Baclofen

Explanation: ***Disulfiram*** - **Disulfiram** inhibits **aldehyde dehydrogenase**, leading to an accumulation of **acetaldehyde** when alcohol is consumed. - The accumulation of acetaldehyde causes an unpleasant reaction, including flushing, nausea, vomiting, dizziness, and headache, which serves as a deterrent to drinking. *Naltrexone* - **Naltrexone** is an **opioid antagonist** that blocks the **euphoric and reinforcing effects** of alcohol. - It works by reducing cravings and the pleasure associated with alcohol consumption, rather than inducing adverse physical reactions. *Acamprosate* - **Acamprosate** is believed to restore the balance of **GABA and glutamate neurotransmission** in the brain, which is disrupted by chronic alcohol use. - It helps reduce cravings for alcohol and maintain abstinence, but it does not cause an acute physiological reaction to alcohol. *Baclofen* - **Baclofen** is a **GABA-B receptor agonist** primarily used as a muscle relaxant. - While it has shown some promise in reducing alcohol cravings in certain populations, its mechanism is distinct from inhibiting aldehyde dehydrogenase and it does not cause an unpleasant reaction to alcohol consumption.

Question 369: A patient with bipolar disorder is on valproate and presents with symptoms of lethargy, confusion, and elevated ammonia levels. What condition is most likely associated with these symptoms?

A. Hyperammonemia due to valproate use (Correct Answer)
B. Toxicity from lithium
C. Toxicity from carbamazepine
D. Rash induced by lamotrigine

Explanation: ***Hyperammonemia due to valproate use*** - Valproate can inhibit the urea cycle, leading to impaired ammonia detoxification and subsequent hyperammonemia - Symptoms like lethargy and confusion are common manifestations of elevated ammonia levels, particularly in the absence of liver failure - This is a well-recognized adverse effect that can occur even with therapeutic valproate levels *Toxicity from lithium* - Lithium toxicity typically presents with symptoms such as tremor, polyuria, polydipsia, and potentially seizures or arrhythmias, which are not described here - While it can cause neurological symptoms, it is not directly associated with elevated ammonia levels *Toxicity from carbamazepine* - Carbamazepine toxicity often involves ataxia, nystagmus, and diplopia, and in severe cases, coma - It does not primarily lead to hyperammonemia; instead, it can cause hyponatremia or blood dyscrasias *Rash induced by lamotrigine* - Lamotrigine-induced rash is a dermatological manifestation, ranging from benign maculopapular rash to severe conditions like Stevens-Johnson syndrome - It does not cause lethargy, confusion, or elevated ammonia levels

Question 370: Which neuroleptic is most commonly associated with causing tardive dyskinesia?

A. Olanzapine
B. Haloperidol (Correct Answer)
C. Clozapine
D. Risperidone

Explanation: ***Haloperidol*** - **Haloperidol** is a **first-generation (typical) antipsychotic** that acts as a strong **dopamine D2 receptor antagonist**. This potent blockade increases the risk of **extrapyramidal symptoms (EPS)**, including tardive dyskinesia, especially with long-term use. - **Tardive dyskinesia (TD)** is characterized by involuntary, repetitive movements, particularly of the face, mouth, and tongue. Its development is strongly linked to the duration and dosage of typical antipsychotics like haloperidol. *Clozapine* - **Clozapine** is a **second-generation (atypical) antipsychotic** known for its very low risk of causing **tardive dyskinesia** and other **extrapyramidal symptoms**. - Its mechanism involves both dopamine and serotonin receptor antagonism, with a weaker, more transient D2 blockade. *Olanzapine* - **Olanzapine** is also a **second-generation (atypical) antipsychotic** with a relatively low risk of causing **tardive dyskinesia** compared to first-generation agents. - While it can cause EPS, its incidence is significantly lower than that of typical antipsychotics. *Risperidone* - **Risperidone** is an **atypical antipsychotic** that, at higher doses, can have a **stronger D2 receptor blockade** compared to other atypicals, making its risk of **extrapyramidal symptoms** (including tardive dyskinesia) somewhat higher than other second-generation agents, though still lower than typical antipsychotics. - Its D2 antagonism is more pronounced than drugs like clozapine or quetiapine.

Question 371: A 45-year-old female with schizophrenia is prescribed an antipsychotic drug. Which of the following drugs is most commonly associated with extrapyramidal side effects?

A. Clozapine
B. Olanzapine
C. Haloperidol (Correct Answer)
D. Risperidone

Explanation: ***Haloperidol*** - **Haloperidol** is a **first-generation antipsychotic** (FGA) that primarily blocks D2 dopamine receptors in the **mesolimbic pathway**, but also significantly in the **nigrostriatal pathway**, leading to a high incidence of extrapyramidal side effects (EPS). - EPS include **dystonia, akathisia, parkinsonism, and tardive dyskinesia**, due to the strong antagonism of dopamine in the basal ganglia. *Clozapine* - **Clozapine** is a **second-generation antipsychotic** (SGA) known for its very low risk of EPS. - Its unique pharmacological profile includes weak D2 receptor blockade and strong serotonergic (5-HT2A) receptor antagonism, along with other receptor interactions, which contribute to its efficacy and minimal EPS. *Olanzapine* - **Olanzapine** is an **SGA** with a relatively low risk of EPS compared to FGAs like haloperidol, but it is not entirely free of this risk. - Its primary side effects are metabolic, including **weight gain, hyperglycemia, and dyslipidemia**, due to its broad receptor affinity. *Risperidone* - **Risperidone** is an **SGA** that has a dose-dependent risk of EPS; at higher doses, its D2 receptor blockade becomes more pronounced, increasing the likelihood of EPS. - While generally having a lower EPS risk than FGAs, it is considered to have a higher EPS risk among SGAs, often presenting with **akathisia** at therapeutic doses.

Question 372: A 45-year-old man with a long history of smoking presents with irritability, anxiety, and cravings for cigarettes after attempting to quit. What is the most appropriate treatment?

A. Bupropion (Correct Answer)
B. Amitriptyline
C. Haloperidol
D. Alprazolam

Explanation: ***Bupropion*** - **Bupropion** is an antidepressant that acts as a **norepinephrine-dopamine reuptake inhibitor** and a non-competitive antagonist of neuronal nicotinic acetylcholine receptors, making it effective for reducing **nicotine cravings** and withdrawal symptoms. - Its use is indicated for **smoking cessation** and can also treat **depression**, which can be comorbid with smoking. **Amitriptyline** - **Amitriptyline** is a **tricyclic antidepressant** primarily used for treating depression, neuropathic pain, and migraines. - It is not a first-line treatment for **nicotine withdrawal** or **smoking cessation**. **Haloperidol** - **Haloperidol** is a **first-generation antipsychotic** used to treat psychosis, schizophrenia, and acute agitation. - It has a significant side effect profile, including **extrapyramidal symptoms**, and is not indicated for smoking cessation. **Alprazolam** - **Alprazolam** is a **benzodiazepine** primarily used to treat anxiety disorders and panic attacks. - While it can reduce anxiety, it is associated with **dependence** and **sedation** and is not recommended as a primary treatment for smoking cessation.

Question 373: A patient with severe anxiety requires long-term management. Which class of antidepressants, known for its efficacy in treating anxiety disorders, should be considered?

A. Tricyclic antidepressants
B. Monoamine oxidase inhibitors
C. Atypical antipsychotics
D. Selective serotonin reuptake inhibitors (SSRIs) (Correct Answer)

Explanation: ***Selective serotonin reuptake inhibitors (SSRIs)*** - SSRIs are considered **first-line agents** for the long-term management of most anxiety disorders due to their efficacy and generally favorable side-effect profile. - They work by increasing the concentration of **serotonin** in the synaptic cleft, helping to regulate mood and anxiety. - Evidence supports their use in generalized anxiety disorder, panic disorder, social anxiety disorder, and other anxiety conditions. *Tricyclic antidepressants* - While effective for some anxiety disorders, **TCAs** have a less favorable side-effect profile, including anticholinergic effects, sedation, and cardiac toxicity. - They are generally reserved for cases where SSRIs are ineffective or contraindicated. *Monoamine oxidase inhibitors* - **MAOIs** are highly effective but carry a significant risk of **hypertensive crisis** when consumed with tyramine-rich foods or certain medications. - Their strict dietary restrictions and drug interactions limit their use to **refractory cases** of anxiety. *Atypical antipsychotics* - **Atypical antipsychotics** are primarily used for psychotic disorders and severe mood disorders, sometimes as an augmentation strategy for anxiety. - They are not considered a first-line or long-term monotherapy for general anxiety due to potential side effects like metabolic syndrome and extrapyramidal symptoms.

Question 374: Which antipsychotic drug blocks serotonin 5-HT2A receptors and dopamine D2 receptors to treat schizophrenia while presenting a lower risk of extrapyramidal side effects?

A. Haloperidol
B. Clozapine
C. Quetiapine
D. Olanzapine (Correct Answer)

Explanation: ***Olanzapine*** - **Olanzapine** is a **second-generation (atypical) antipsychotic** that potently blocks both dopamine D2 and serotonin 5-HT2A receptors, which contributes to its efficacy in treating both positive and negative symptoms of schizophrenia. - Its **higher affinity for 5-HT2A receptors compared to D2 receptors** is believed to be the reason for a **significantly lower risk of extrapyramidal side effects (EPS)** compared to first-generation antipsychotics. - **Olanzapine is a first-line atypical antipsychotic** with a favorable balance of efficacy and tolerability, making it a standard choice for schizophrenia treatment. *Haloperidol* - **Haloperidol** is a **first-generation (typical) antipsychotic** that primarily acts as a potent D2 antagonist. - It is associated with a **high risk of extrapyramidal side effects (EPS)** including acute dystonia, parkinsonism, and akathisia due to its selective blockade of D2 receptors. - It has **minimal affinity for serotonin 5-HT2A receptors**, which distinguishes it from second-generation agents and contributes to its higher EPS risk. *Clozapine* - **Clozapine** is an atypical antipsychotic that blocks both D2 and 5-HT2A receptors and actually has the **lowest EPS risk** of all antipsychotics. - However, it is **reserved for treatment-resistant schizophrenia** due to its serious adverse effects, including **agranulocytosis** (requires regular blood monitoring), **seizures**, **myocarditis**, and significant metabolic effects. - It is **not a first-line agent** due to its adverse effect profile and monitoring requirements. *Quetiapine* - **Quetiapine** also blocks D2 and 5-HT2A receptors and has a **low risk of EPS**, similar to olanzapine. - However, it is characterized by **rapid dissociation from D2 receptors**, which contributes to its lower EPS but may also result in less robust antipsychotic efficacy for positive symptoms compared to olanzapine. - It is more commonly associated with **sedation, orthostatic hypotension**, and **somnolence**, which can limit its use as a first-line agent.

Question 375: Which class of drugs is commonly used to treat anxiety by enhancing the effects of GABA?

A. Benzodiazepines (Correct Answer)
B. Selective serotonin reuptake inhibitors
C. Tricyclic antidepressants
D. Monoamine oxidase inhibitors

Explanation: ***Benzodiazepines*** - **Benzodiazepines** act as positive **allosteric modulators** of the **GABA-A receptor**, increasing the frequency of **chloride channel opening**. - This enhanced **GABAergic transmission** leads to a **hyperpolarization** of neurons, resulting in reduced neuronal excitability, which exerts **anxiolytic**, sedative, and muscle relaxant effects. *Selective serotonin reuptake inhibitors* - **SSRIs** primarily increase the concentration of **serotonin** in the **synaptic cleft** by inhibiting its reuptake, rather than directly acting on GABA. - While effective for anxiety, their mechanism of action is distinct from GABA potentiation, and their therapeutic effects typically have a **delayed onset**. *Tricyclic antidepressants* - **TCAs** primarily inhibit the **reuptake of norepinephrine** and **serotonin**, and also block various receptors like **histaminic**, **cholinergic**, and **adrenergic receptors**. - They do not directly enhance **GABAergic activity**, and their use can be limited by a wide range of side effects due to their broad receptor blockade. *Monoamine oxidase inhibitors* - **MAOIs** prevent the enzymatic degradation of **norepinephrine**, **serotonin**, and **dopamine** by inhibiting the enzyme **monoamine oxidase**, thereby increasing their synaptic concentrations. - Their mechanism is focused on **monoamine neurotransmitters**, and they do not directly modulate **GABAergic transmission**.

Question 376: A patient being treated with an antipsychotic drug develops tardive dyskinesia. Which class of antipsychotic drugs is most commonly associated with this condition?

A. Dopamine partial agonists
B. Anticholinergic drugs
C. Atypical antipsychotics
D. Typical antipsychotics (Correct Answer)

Explanation: ***Typical antipsychotics*** - **First-generation antipsychotics**, also known as typical antipsychotics, are commonly associated with **tardive dyskinesia** due to their strong **D2 dopamine receptor blockade**. - Prolonged use leads to postsynaptic dopamine receptor hypersensitivity, resulting in involuntary movements. *Atypical antipsychotics* - **Second-generation antipsychotics** (atypical) have a **lower risk** of tardive dyskinesia due to their weaker D2 blockade and strong 5-HT2A serotonin receptor antagonism. - While the risk is present, it is significantly less compared to typical antipsychotics. *Dopamine partial agonists* - Drugs like **aripiprazole** (a dopamine partial agonist) have an even **lower risk of dyskinesia** because they modulate dopamine activity rather than completely blocking it. - They act as functional antagonists in areas with high dopamine and functional agonists in areas with low dopamine. *Anticholinergic drugs* - **Anticholinergic drugs** are sometimes used to treat **acute extrapyramidal symptoms** (like parkinsonism) caused by antipsychotics, but they do not cause or prevent tardive dyskinesia. - In some cases, discontinuing anticholinergics can unmask or worsen tardive dyskinesia.

Question 377: A 30-year-old man presents with symptoms of depression. He is prescribed a selective serotonin reuptake inhibitor (SSRI). Which of the following drugs is he most likely taking?

A. Fluoxetine (Correct Answer)
B. Amitriptyline
C. Venlafaxine
D. Mirtazapine

Explanation: ***Fluoxetine*** - **Fluoxetine** is a prototypical **selective serotonin reuptake inhibitor (SSRI)**, commonly prescribed for depression. - SSRIs function by **blocking the reuptake of serotonin** in the presynaptic neuron, increasing its concentration in the synaptic cleft. *Amitriptyline* - **Amitriptyline** is a **tricyclic antidepressant (TCA)**, not an SSRI. - TCAs have a broader spectrum of action, blocking the reuptake of both **serotonin and norepinephrine**, and also affecting other receptors (e.g., muscarinic acetylcholine, histamine H1), leading to more side effects. *Venlafaxine* - **Venlafaxine** is a **serotonin-norepinephrine reuptake inhibitor (SNRI)**, not an SSRI. - SNRIs block the reuptake of both **serotonin and norepinephrine**, providing a dual mechanism of action that can be effective for some forms of depression or anxiety. *Mirtazapine* - **Mirtazapine** is an **atypical antidepressant** that primarily acts as an **alpha-2 adrenergic receptor antagonist**, which enhances noradrenergic and serotonergic transmission. - It also blocks 5-HT2 and 5-HT3 serotonin receptors and H1 histamine receptors, which contributes to its unique side effect profile (e.g., sedation, increased appetite).

Question 378: What is the most common electrolyte imbalance associated with lithium treatment?

A. Hyperkalemia (high potassium levels)
B. Hypercalcemia (high calcium levels) (Correct Answer)
C. Hypokalemia (low potassium levels)
D. Hypernatremia (high sodium levels)

Explanation: ***Hypercalcemia (high calcium levels)*** - **Hypercalcemia** is the most commonly reported electrolyte abnormality with chronic lithium therapy, occurring in **10-15% of patients**. - Lithium can cause **hyperparathyroidism** by affecting parathyroid gland function, leading to increased PTH secretion and subsequent elevation of serum calcium levels [2]. - This effect can develop after **months to years** of lithium treatment and may persist even after lithium discontinuation. - Regular monitoring of serum calcium and PTH levels is recommended during long-term lithium therapy. *Hypernatremia (high sodium levels)* - **Hypernatremia** is not a direct or common electrolyte imbalance from lithium itself. - While lithium can cause **nephrogenic diabetes insipidus (NDI)** leading to polyuria and polydipsia, patients typically maintain normal sodium levels if they have adequate water access [1], [3]. - Hypernatremia may occur as a **secondary complication** if patients with lithium-induced NDI become dehydrated, but this is not the primary electrolyte abnormality. *Hyperkalemia (high potassium levels)* - **Hyperkalemia** is not typically associated with lithium treatment. - Lithium's effects on renal function do not consistently lead to significant alterations in potassium homeostasis. *Hypokalemia (low potassium levels)* - **Hypokalemia** is not a characteristic electrolyte imbalance with lithium therapy. - Lithium primarily affects water handling and calcium metabolism rather than potassium balance.

Question 379: What is the drug of choice (DOC) for a schizophrenic patient with poor oral absorption?

A. Fluphenazine (Correct Answer)
B. Clozapine
C. Sulpride
D. Penfluridol

Explanation: ***Fluphenazine*** - **Fluphenazine** is available as a **long-acting injectable** (LAI) formulation, specifically **fluphenazine decanoate**, making it an ideal choice for patients with **poor oral absorption** or adherence issues. - Its **depot injection** bypasses the need for oral intake, ensuring therapeutic drug levels are maintained over several weeks. *Clozapine* - **Clozapine** is an **oral antipsychotic** and requires consistent oral intake for efficacy. - It is often reserved for **treatment-resistant schizophrenia** and is not available in a long-acting injectable form suitable for poor oral absorption. *Sulpride* - **Sulpride** is primarily an **oral antipsychotic** and its administration relies on adequate oral absorption. - It is not available in a formulation that would circumvent issues of poor oral absorption. *Penfluridol* - **Penfluridol** is an **oral long-acting antipsychotic**, but it still requires oral administration. - While long-acting, its efficacy depends on the patient's ability to absorb the drug orally, which is compromised in this scenario.

Question 380: Which of the following is a side effect of quetiapine?

A. Sudden cardiac death
B. Dyspepsia
C. Dry mouth (Correct Answer)
D. Hair loss

Explanation: ***Dry mouth*** - **Quetiapine** is an atypical antipsychotic that commonly causes **anticholinergic side effects**, including **dry mouth (xerostomia)**. - This symptom results from the drug's antagonistic activity at **muscarinic acetylcholine receptors**. - Dry mouth is a **frequent and well-recognized side effect** occurring in a significant proportion of patients, making it the best answer among the options provided. *Sudden cardiac death* - Quetiapine can cause **QT interval prolongation**, particularly at higher doses or in susceptible individuals, which may increase the risk of **fatal cardiac arrhythmias**. - However, sudden cardiac death is a **rare but serious adverse event**, not a common side effect seen in routine clinical practice. - While this is a documented risk requiring monitoring, **dry mouth is far more frequently encountered** in patients taking quetiapine. *Dyspepsia* - **Dyspepsia (indigestion)** can occur with various medications, but it is not a particularly prominent or characteristic side effect of **quetiapine**. - The more notable side effects of quetiapine include **sedation, weight gain, metabolic effects, and anticholinergic symptoms** rather than gastrointestinal upset. *Hair loss* - **Hair loss (alopecia)** is not a recognized or documented side effect of **quetiapine**. - This is not typically associated with atypical antipsychotics and would not be expected with quetiapine therapy.

Question 381: Which of the following conditions is NOT a contraindication for the use of Tricyclic Antidepressants (TCAs)?

A. Narrow angle glaucoma
B. Prostate hypertrophy
C. Impaired renal function (Correct Answer)
D. A patient on MAO inhibitors

Explanation: ***Impaired renal function*** - While **Tricyclic Antidepressants (TCAs)** are metabolized in the liver and excreted by the kidneys, **impaired renal function** alone is generally not considered an absolute contraindication but necessitates **dose adjustments** and careful monitoring. - The primary concern with renal impairment is the **accumulation of active metabolites**, which can increase the risk of side effects, but it doesn't preclude their use entirely. *Narrow angle glaucoma* - TCAs have **anticholinergic properties** that can cause mydriasis (pupil dilation), which can precipitate an acute attack in individuals with **narrow-angle glaucoma**. - This is an important contraindication due to the risk of **irreversible vision loss**. *Prostate hypertrophy* - The **anticholinergic effects** of TCAs can worsen urinary retention in patients with **prostate hypertrophy** by relaxing the detrusor muscle and contracting the bladder sphincter. - This can lead to increased discomfort and potentially acute urinary retention. *A patient on MAO inhibitors* - Concomitant use of TCAs with **MAO inhibitors** is an absolute contraindication due to the risk of **hypertensive crisis** and **hyperpyrexia** from potentiation of noradrenergic effects. - This dangerous interaction can lead to severe and potentially fatal symptoms such as hyperthermia, severe hypertension, seizures, and cardiovascular collapse. A washout period of at least 2 weeks is required when switching between these medications.

Question 382: What is the primary use of Acamprosate in medical treatment?

A. Alcohol abstinence (Correct Answer)
B. Nicotine abstinence
C. Opioid abstinence
D. Cocaine abstinence

Explanation: ***Alcohol abstinence*** - **Acamprosate** is primarily used to maintain **abstinence from alcohol** in patients recovering from alcohol dependence. - It works by restoring the balance of **neurotransmitters** in the brain, particularly **GABA** and **glutamate**, which are often disrupted by chronic alcohol use. *Nicotine abstinence* - Medications for **nicotine abstinence** typically include **varenicline**, bupropion, or nicotine replacement therapies. - **Acamprosate** does not have a primary indication or established efficacy for smoking cessation. *Opioid abstinence* - **Opioid dependence** is commonly treated with medications such as **methadone**, **buprenorphine**, or naltrexone for maintenance and relapse prevention. - **Acamprosate** is not indicated for the management of opioid withdrawal or opioid use disorder. *Cocaine abstinence* - There are currently no FDA-approved medications specifically for treating **cocaine dependence**. - Treatment typically involves behavioral therapies, and **acamprosate** has not shown efficacy in this context.

Question 383: Which FDA approved drug is used for refractory schizophrenia?

A. Amoxapine
B. Haloperidol
C. Clozapine (Correct Answer)
D. Penfluridol

Explanation: ***Clozapine*** - **Clozapine** is an **atypical antipsychotic** uniquely approved for the treatment of **refractory schizophrenia**, where other antipsychotics have failed. - Its efficacy in treatment-resistant cases is attributed to its complex pharmacological profile, including antagonism of multiple **dopamine** and **serotonin receptors**. *Amoxapine* - **Amoxapine** is a **tetracyclic antidepressant** with some antipsychotic properties due to **dopamine receptor blockade**, but it is not a first-line or approved treatment for refractory schizophrenia. - It's primarily used for **major depressive disorder** and carries a risk of inducing **extrapyramidal symptoms**. *Haloperidol* - **Haloperidol** is a **first-generation (typical) antipsychotic** effective in treating acute psychotic symptoms but generally not used as the agent of choice for **refractory schizophrenia**. - Its primary mechanism involves potent **D2 dopamine receptor blockade**, which often leads to significant **extrapyramidal side effects**. *Penfluridol* - **Penfluridol** is a **long-acting, first-generation antipsychotic** that is used for maintenance treatment of schizophrenia, but it is not specifically indicated or uniquely effective for **refractory cases**. - It has a prolonged duration of action, making it suitable for patients requiring less frequent dosing to improve **medication adherence**.

Question 384: What is the mechanism of action of tianeptine?

A. NMDA receptor antagonism
B. Serotonin reuptake enhancement
C. Mu-opioid receptor agonism
D. AMPA receptor potentiation (Correct Answer)

Explanation: ***AMPA receptor potentiation*** - Tianeptine has been shown to modulate **glutamatergic activity** by potentiating **AMPA receptor function**, promoting neuroplasticity [1]. - This effect is thought to contribute to its **antidepressant and anxiolytic properties**, particularly in stress-related neuronal changes [1]. *Mu-opioid receptor agonism* - While tianeptine does exhibit some weak **mu-opioid receptor agonist activity** at higher doses, it is not considered its primary therapeutic mechanism for antidepressant effects. - The opioid effects are usually associated with its **abuse potential** and are distinct from its primary antidepressant action. *Serotonin reuptake enhancement* - Tianeptine is unique among antidepressants for its property of **enhancing serotonin reuptake**, rather than inhibiting it. - Although it increases serotonin reuptake, this effect alone does not fully explain its antidepressant action, and its **glutamatergic modulation** is considered more critical. *NMDA receptor antagonism* - **NMDA receptor antagonism** is associated with drugs like ketamine, which have rapid antidepressant effects by blocking the receptor [2]. - Tianeptine does not directly act as an NMDA receptor antagonist; instead, it influences synaptic plasticity through **AMPA receptor modulation**.

Question 385: Which of the following is true about ziprasidone?

A. Has anti-depressant properties
B. Not safe in cardiac patients due to QT prolongation risk
C. Lower risk of extrapyramidal symptoms compared to typical antipsychotics (Correct Answer)
D. Commonly causes significant weight gain

Explanation: ***Lower risk of extrapyramidal symptoms compared to typical antipsychotics*** - **Ziprasidone** is an **atypical antipsychotic**, which generally carries a **lower risk of extrapyramidal symptoms (EPS)** compared to older, first-generation (typical) antipsychotics. - This is primarily due to its different receptor binding profile, including weaker **D2 dopamine receptor antagonism** and significant **5-HT2A serotonin receptor antagonism**. *Commonly causes significant weight gain* - **Incorrect**: Ziprasidone is considered one of the most **weight-neutral antipsychotics**, causing minimal weight gain. - Unlike **olanzapine** and **clozapine**, which are associated with significant weight gain and metabolic side effects, ziprasidone has a favorable metabolic profile. - This makes it a preferred option when weight gain is a concern. *Has anti-depressant properties* - While ziprasidone can be used as adjunctive therapy in **bipolar depression**, it is not classified as a primary antidepressant. - Its efficacy in mood symptoms is attributed to **serotonin** and **dopamine** modulation, but it lacks the direct mechanism of action of true antidepressants. - It is primarily indicated for **schizophrenia** and **bipolar disorder**, not major depressive disorder. *Not safe in cardiac patients due to QT prolongation risk* - **Partially true but too absolute**: Ziprasidone does carry a dose-dependent risk of **QT interval prolongation**. - However, it is not completely contraindicated in cardiac patients; rather, it requires **careful cardiac monitoring**, **baseline ECG**, and avoidance in patients with known QT prolongation. - With appropriate precautions and patient selection, it can be used safely under medical supervision.

Question 386: Which of the following was the PRIMARY indication for which venlafaxine was first FDA approved?

A. Bipolar disorder
B. Attention deficit hyperactivity disorder (ADHD)
C. Schizophrenia
D. Major depressive disorder (Correct Answer)

Explanation: ***Major depressive disorder***- Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) [1], and its primary FDA approval was for the treatment of major depressive disorder [1]- Its mechanism of action, increasing the availability of serotonin and norepinephrine in the brain, is highly effective for managing symptoms of depression [2]- It was first approved by the FDA in 1993 specifically for this indication*Attention deficit hyperactivity disorder (ADHD)*- While some antidepressants are used off-label for ADHD, particularly norepinephrine-reuptake inhibitors like atomoxetine, venlafaxine was not primarily approved for this condition- The mainstays for ADHD treatment are typically stimulants (e.g., methylphenidate, amphetamine) or non-stimulants like atomoxetine*Bipolar disorder*- Venlafaxine can be used as an adjunct in treating the depressive phase of bipolar disorder, but it is not indicated as a monotherapy due to the risk of inducing mania or hypomania- The primary medications for bipolar disorder are mood stabilizers (e.g., lithium, valproate) and atypical antipsychotics*Schizophrenia*- Venlafaxine has no role in the primary treatment of schizophrenia, which is a psychotic disorder- The first-line treatment for schizophrenia involves antipsychotic medications that primarily target dopamine and serotonin receptors

Question 387: All the following drugs are used to prevent relapse and maintain abstinence in cases of alcohol use disorder except?

A. Acamprosate
B. Naltrexone
C. Propranolol (Correct Answer)
D. Disulfiram

Explanation: ***Propranolol*** - **Propranolol** is a **beta-blocker** primarily used to treat conditions like hypertension, angina, and anxiety. - While it can help manage some **symptoms associated with alcohol withdrawal**, such as tremors and tachycardia, it is **not indicated or effective for preventing relapse or maintaining abstinence** from alcohol use disorder. *Disulfiram* - **Disulfiram** works by inhibiting **acetaldehyde dehydrogenase**, leading to an unpleasant accumulation of acetaldehyde if alcohol is consumed. - This adverse reaction serves as a **deterrent** to drinking alcohol, helping to prevent relapse [1], [2]. *Acamprosate* - **Acamprosate** is believed to restore the balance between **excitatory (glutamate)** and **inhibitory (GABA)** neurotransmission in the brain, which is often disrupted in alcohol dependence. - It helps reduce cravings and the **negative reinforcement** associated with protracted withdrawal, aiding in the maintenance of abstinence [1]. *Naltrexone* - **Naltrexone** is an **opioid receptor antagonist** that works by blocking the euphoric and pleasurable effects of alcohol [1]. - By reducing the **rewarding effects of alcohol**, it helps decrease cravings and subsequently the risk of relapse [1].

Question 388: The clinical effects of antidepressant drugs are mainly based on?

A. Reduction in neurotransmitter levels
B. Change in neurotransmitter receptor sensitivity (Correct Answer)
C. Modification of neurotransmitter signaling pathways
D. Inhibition of neurotransmitter reuptake

Explanation: ***B. Change in neurotransmitter receptor sensitivity*** - While many antidepressants initially alter neurotransmitter levels by blocking reuptake, their delayed therapeutic effects (weeks) are thought to be mediated by **adaptive changes** in postsynaptic receptor sensitivity and gene expression, leading to **downregulation of hypersensitive receptors**. - This **receptor plasticity** is crucial for long-term clinical improvement, as the brain adapts to sustained changes in neurotransmitter availability. *A. Reduction in neurotransmitter levels* - This option is incorrect as antidepressants generally aim to **increase** the functional availability of **neurotransmitters** like serotonin and norepinephrine within the synaptic cleft. - A reduction in neurotransmitter levels would typically exacerbate depressive symptoms, not alleviate them. *C. Modification of neurotransmitter signaling pathways* - While antidepressants do ultimately affect intracellular signaling pathways, this is often a **downstream consequence** of changes in receptor sensitivity and neurotransmitter binding, rather than the primary *main* basis of their clinical effects. - This option is broader and less precise than the change in receptor sensitivity, missing the direct impact on how neurons respond to available neurotransmitters. *D. Inhibition of neurotransmitter reuptake* - This describes the **initial and acute mechanism of action** for many antidepressant classes (e.g., SSRIs, SNRIs) by increasing the concentration of neurotransmitters in the synaptic cleft. - However, the **clinical antidepressant effects** often take several weeks to manifest, suggesting that this acute increase in neurotransmitter availability is not the sole or primary basis for long-term symptom relief, but rather initiates the adaptive changes in receptor sensitivity.

Question 389: In which condition is Atomoxetine primarily indicated?

A. ADHD (Correct Answer)
B. Treatment of nocturnal enuresis
C. Management of temper tantrums
D. Treatment of patent ductus arteriosus

Explanation: ***ADHD*** - **Atomoxetine** is a **norepinephrine reuptake inhibitor** primarily used for the treatment of **Attention-Deficit/Hyperactivity Disorder (ADHD)** in children, adolescents, and adults [1]. - It helps improve symptoms such as **inattention**, **hyperactivity**, and **impulsivity** by increasing the concentration of norepinephrine in the brain [1], [2]. *Treatment of nocturnal enuresis* - While some medications for **ADHD** (like **imipramine**) can be used off-label for **nocturnal enuresis**, atomoxetine is **not a primary indication** for this condition [3]. - Management of **nocturnal enuresis** typically involves behavioral interventions, desmopressin, or tricyclic antidepressants [3]. *Management of temper tantrums* - **Temper tantrums** are primarily behavioral issues and are generally managed through **behavioral therapy** and parenting strategies. - **Atomoxetine** is not indicated as a primary treatment for temper tantrums; if tantrums are a symptom of an underlying disorder like ADHD, addressing the ADHD might indirectly help. *Treatment of patent ductus arteriosus* - **Patent ductus arteriosus (PDA)** is a cardiovascular condition typically seen in newborns, involving a persistent opening between the aorta and pulmonary artery. - Treatment for PDA usually involves **NSAIDs (like indomethacin or ibuprofen)** or surgical ligation, not atomoxetine.

Question 390: Which of the following statements about aripiprazole is true?

A. It has low sedating potential
B. It has 5HT1A partial agonist action
C. Only antipsychotic with D2 partial agonist activity
D. It is used in the treatment of acute mania (Correct Answer)

Explanation: ***It is used in the treatment of acute mania*** - Aripiprazole is a **second-generation antipsychotic** approved for the treatment of **acute manic and mixed episodes** associated with bipolar I disorder. - This is a **major FDA-approved indication** and represents one of its most clinically significant uses, making it the best answer among the true statements. - Its efficacy in stabilizing mood through its unique partial agonism at dopamine D2 and serotonin 5-HT1A receptors, along with antagonism at 5-HT2A receptors, makes it suitable for this indication. *It has 5HT1A partial agonist action* - This statement is **factually TRUE** - aripiprazole does have **5-HT1A partial agonist action** as part of its pharmacological profile. - However, this mechanistic detail alone does not represent its primary clinical significance or most distinguishing therapeutic feature. - Its unique mechanism also involves **D2 partial agonism** and 5-HT2A antagonism. *It has low sedating potential* - This statement is also **TRUE** - aripiprazole is well-established as having **low sedating potential** compared to most other antipsychotics. - This is actually one of its **distinguishing advantages** and a key feature that differentiates it from highly sedating antipsychotics like quetiapine or olanzapine. - While sedation can occur in some patients, it is relatively uncommon, and the low sedation profile is a recognized clinical benefit. *Only antipsychotic with D2 partial agonist activity* - This statement is **FALSE** - aripiprazole was one of the first antipsychotics with significant **D2 partial agonist activity**, but it is **not the *only* one**. - Other antipsychotics, such as **brexpiprazole** and **cariprazine**, also exhibit D2 partial agonist activity, distinguishing them from traditional D2 antagonists.

Question 391: Which receptor is most commonly targeted by typical antipsychotics?

A. D1
B. D2 (Correct Answer)
C. D3
D. D4

Explanation: ***Correct: D2*** - **Typical antipsychotics** (first-generation antipsychotics) primarily exert their therapeutic effects by blocking **dopamine D2 receptors** in the mesolimbic pathway, thereby reducing positive symptoms of psychosis such as hallucinations and delusions. - The degree of **D2 receptor blockade** correlates directly with **clinical efficacy** for typical antipsychotics. - High-potency typical antipsychotics like haloperidol have strong D2 receptor affinity, while low-potency agents like chlorpromazine also work primarily through D2 blockade. - D2 blockade in the nigrostriatal pathway is responsible for extrapyramidal side effects (EPS), a hallmark of typical antipsychotics. *Incorrect: D1* - **D1 receptors** are dopaminergic receptors involved in cognitive and motor functions, but their blockade is not the primary mechanism of action of typical antipsychotics. - While some antipsychotics may have D1 affinity, this is not what defines typical antipsychotics or drives their therapeutic efficacy. *Incorrect: D3* - **Dopamine D3 receptors** are involved in the limbic system and may play a role in some antipsychotic effects, but they are not the primary target for **typical antipsychotics**. - Some newer atypical antipsychotics have higher affinity for D3 receptors, but this is not characteristic of first-generation typical agents. *Incorrect: D4* - **D4 receptors** have high affinity for certain atypical antipsychotics like **clozapine**, but this is not the main receptor target for **typical antipsychotics**. - D4 receptor selectivity is more associated with atypical rather than typical antipsychotic profiles.

Question 392: What electrolyte imbalance is commonly associated with lithium use?

A. Hypercalcemia (Correct Answer)
B. Hyponatremia
C. Hyperkalemia
D. Hypokalemia

Explanation: ***Hypercalcemia*** - Long-term lithium therapy can lead to an increased risk of developing **primary hyperparathyroidism** (occurs in approximately 10% of chronic users), which subsequently causes hypercalcemia. - Lithium can affect the **set point of the calcium-sensing receptor** in the parathyroid glands, leading to inappropriate secretion of parathyroid hormone (PTH). - This is a **well-recognized complication** of chronic lithium therapy requiring monitoring of calcium and PTH levels. *Hyponatremia* - **Hyponatremia** is actually a frequently encountered electrolyte disturbance with lithium use, occurring through multiple mechanisms: - Lithium-induced **nephrogenic diabetes insipidus** leading to polyuria, polydipsia, and potential dehydration - Interaction with **thiazide diuretics** (which are sometimes used to treat lithium-induced polyuria, paradoxically) - SIADH-like effects in some patients - However, in the context of this examination question, **hypercalcemia due to hyperparathyroidism** is considered the characteristic chronic complication specifically linked to lithium's unique mechanism of action. *Hyperkalemia* - **Hyperkalemia** is not a commonly reported electrolyte imbalance specifically associated with lithium use. - While lithium can affect renal function and cause **renal tubular dysfunction**, this does not typically manifest as hyperkalemia. *Hypokalemia* - **Hypokalemia** is not typically associated with lithium use. - It is more commonly caused by diuretic use, vomiting, or diarrhea rather than lithium therapy directly.

Question 393: A patient was recently started on Fluphenazine. A few weeks later, he developed tremors, rigidity, bradykinesia, and excessive salivation. The first line of management for this patient is

A. Trihexyphenidyl (Correct Answer)
B. Amantadine
C. Selegiline (MAO-B inhibitor)
D. Pramipexole (Dopamine agonist)

Explanation: ***Trihexyphenidyl*** - The patient is exhibiting symptoms consistent with drug-induced **parkinsonism** caused by fluphenazine, an antipsychotic. - **Anticholinergics** like trihexyphenidyl are the **first-line treatment** for drug-induced parkinsonism by blocking muscarinic receptors in the striatum, restoring the dopamine-acetylcholine balance. *Selegiline (MAO-B inhibitor)* - Selegiline is used in Parkinson's disease to **increase dopamine levels** by inhibiting its breakdown, but it is not the first-line treatment for drug-induced parkinsonism where the issue is receptor blockade. - Its primary role is in **idiopathic Parkinson's disease** as an adjunctive therapy or for early symptom control, not for antipsychotic-induced extrapyramidal symptoms. *Amantadine* - Amantadine is an **NMDA receptor antagonist** and dopamine reuptake inhibitor used in Parkinson's disease. - While it has some efficacy in drug-induced parkinsonism, it is generally considered **second-line** after anticholinergics and is more effective for dyskinesia in idiopathic Parkinson's disease. *Pramipexole (Dopamine agonist)* - Dopamine agonists work by **directly stimulating dopamine receptors**, which would exacerbate the effects of D2 receptor blockade by fluphenazine. - They are used for **idiopathic Parkinson's disease** and restless legs syndrome, but are typically avoided in drug-induced parkinsonism.

Question 394: Which of the following typical antipsychotic drugs is least commonly used in depot form?

A. Haloperidol
B. Fluphenazine
C. Chlorpromazine (Correct Answer)
D. Trifluoperazine

Explanation: ***Chlorpromazine*** - Chlorpromazine is a **typical antipsychotic** that is **NOT available in depot form** for clinical use. - It is available only in **oral** and **short-acting injectable** formulations, making it the **least commonly used in depot form** among the options listed. - Its high sedative properties, orthostatic hypotension risk, and pharmacokinetic profile make it unsuitable for long-acting depot formulation. *Haloperidol* - **Haloperidol decanoate** is one of the **most widely used depot formulations** of typical antipsychotics. - Administered intramuscularly every **3-4 weeks**, it is highly effective for **long-term maintenance treatment** in schizophrenia. - Its favorable pharmacokinetic profile makes it ideal for depot preparation. *Fluphenazine* - **Fluphenazine decanoate** and **fluphenazine enanthate** are **well-established depot preparations** with decades of clinical use. - These formulations allow for dosing every **2-4 weeks**, significantly improving **medication adherence** in chronic psychotic disorders. - Fluphenazine depot is a first-line option for long-acting injectable antipsychotic therapy. *Trifluoperazine* - Trifluoperazine is primarily available and used as an **oral medication** for maintenance therapy. - While some limited depot formulations have been reported in older literature, they are **not commonly used in clinical practice**. - However, it is still more available in depot form than chlorpromazine, which has essentially **no depot use**.

Question 395: Which of the following actions is NOT associated with tricyclic antidepressants?

A. Block 5-HT or NE reuptake
B. Anticholinergic action
C. MAO inhibition (Correct Answer)
D. Causes sedation

Explanation: ***MAO inhibition*** - Tricyclic antidepressants (TCAs) primarily exert their effects by inhibiting the reuptake of **norepinephrine** and **serotonin**, not by inhibiting monoamine oxidase (MAO). - **MAO inhibitors** are a distinct class of antidepressants with a different mechanism of action and side effect profile. *Anticholinergic action* - Many TCAs have significant **anticholinergic effects**, blocking muscarinic receptors and leading to side effects like dry mouth, constipation, and blurred vision. - These effects contribute to the **adverse event profile** of TCAs, especially in elderly patients. *Block 5-HT or NE reuptake* - The primary mechanism of action of TCAs involves the **inhibition of serotonin (5-HT)** and **norepinephrine (NE) reuptake** into presynaptic neurons. - This action increases the concentration of these neurotransmitters in the **synaptic cleft**, thereby potentiating their effects. *Causes sedation* - TCAs frequently cause **sedation**, particularly the more histaminergic ones (e.g., amitriptyline, doxepin), due to their **histamine H1 receptor antagonism**. - This side effect can be beneficial for patients with insomnia but can be problematic for daytime functioning.

Question 396: Which drug is not considered a mood stabilizer?

A. Lithium
B. Lamotrigine
C. Imipramine (Correct Answer)
D. Carbamazepine

Explanation: ***Imipramine*** - Imipramine is a **tricyclic antidepressant (TCA)**, primarily used to treat depression, not to stabilize mood in bipolar disorder. - TCAs can sometimes induce **mania** or hypomania in individuals with bipolar disorder, thus they are generally not used as monotherapy for mood stabilization. *Lithium* - **Lithium** is considered the gold standard and one of the oldest and most effective **mood stabilizers** for bipolar disorder. - It works by modulating **neurotransmitter systems** and second messenger pathways in the brain. *Lamotrigine* - **Lamotrigine** is an **anticonvulsant** medication that is also recognized as an effective **mood stabilizer**, particularly for preventing depressive episodes in bipolar disorder. - Its mechanism involves stabilizing neuronal membranes by blocking **voltage-gated sodium channels**. *Carbamazepine* - **Carbamazepine** is an **anticonvulsant** medication often used as a **mood stabilizer** for the treatment of acute manic and mixed episodes in bipolar disorder. - It works by reducing the excitability of nerve impulses through blocking **voltage-sensitive sodium channels**.

Question 397: What is the mechanism of action of duloxetine?

A. Selective serotonin reuptake inhibition
B. Selective norepinephrine reuptake inhibition
C. Inhibition of both serotonin and norepinephrine reuptake (Correct Answer)
D. No effect on neurotransmitter reuptake

Explanation: ***Inhibition of both serotonin and norepinephrine reuptake*** - **Duloxetine** is a **serotonin-norepinephrine reuptake inhibitor (SNRI)**, meaning it blocks the reuptake of both neurotransmitters, increasing their concentrations in the synaptic cleft [2]. - This dual action contributes to its efficacy in treating **depression**, **anxiety disorders**, and **neuropathic pain** [2], [3]. *Selective serotonin reuptake inhibition* - This describes the mechanism of **SSRIs (Selective Serotonin Reuptake Inhibitors)**, such as fluoxetine or sertraline, which primarily target serotonin [1]. - Duloxetine's mechanism is broader, affecting both serotonin and norepinephrine [2]. *Selective norepinephrine reuptake inhibition* - This mechanism is characteristic of medications like **atomoxetine**, used for ADHD, which primarily targets norepinephrine. - Duloxetine has a dual action, not selective to norepinephrine alone. *No effect on neurotransmitter reuptake* - Medications with no effect on neurotransmitter reuptake would not typically be effective as antidepressants or treatments for neuropathic pain. - Duloxetine's therapeutic effects are directly linked to its inhibition of reuptake for both serotonin and norepinephrine [2], [4].

Question 398: What is the mechanism of action of buspirone?

A. Antagonism at the 5-HT1B receptor.
B. Antagonism at the 5-HT2C receptor.
C. Partial agonism at the 5-HT1B receptor.
D. Partial agonism at the 5-HT1A receptor. (Correct Answer)

Explanation: ***Partial agonism at the 5-HT1A receptor.*** - Buspirone is known to act primarily as a **partial agonist** at the **serotonin 5-HT1A receptor**, which is responsible for its anxiolytic effects. - This action helps to modulate serotonin neurotransmission, leading to a reduction in anxiety symptoms without significant sedative or addictive properties. *Antagonism at the 5-HT1B receptor.* - While 5-HT1B receptors are involved in serotonin regulation, buspirone's primary anxiolytic effect is not mediated through **antagonism** at these receptors. - Antagonism at 5-HT1B receptors is not a prominent mechanism for typical anxiolytic medications like buspirone. *Antagonism at the 5-HT2C receptor.* - **Antagonism at the 5-HT2C receptor** is sometimes associated with **atypical antipsychotics** and their metabolic side effects, but it is not the primary mechanism of action for buspirone. - Buspirone is not generally considered an antipsychotic and its effects are distinct from those driven by 5-HT2C antagonism. *Partial agonism at the 5-HT1B receptor.* - Buspirone's main anxiolytic action is distinctly linked to the **5-HT1A receptor**, not the 5-HT1B receptor. - Although serotonin receptors are numerous and complex, buspirone's specific therapeutic profile arises from its interaction with 5-HT1A.

Question 399: Which of the following is the most characteristic sexual side effect of SSRIs?

A. Retrograde ejaculation
B. Erectile dysfunction
C. Delayed ejaculation (Correct Answer)
D. Anxiety

Explanation: ***Delayed ejaculation*** - **Delayed ejaculation** is a common and characteristic sexual side effect of SSRIs due to their impact on serotonin pathways involved in sexual response. - This effect can lead to significant distress and non-adherence to treatment, and often requires dose adjustment or switching to an alternative antidepressant. *Erectile dysfunction* - While **erectile dysfunction** can occur with SSRIs, it is a less specific and less consistently reported sexual side effect compared to ejaculatory dysfunction. - Many factors, including underlying mood disorder and comorbidities, can contribute to erectile dysfunction, making it less characteristic of SSRI use alone. *Retrograde ejaculation* - **Retrograde ejaculation** is a condition where semen enters the bladder during orgasm, and while it can be a side effect of some medications (e.g., alpha-blockers), it is not a hallmark sexual side effect of SSRIs. - SSRIs primarily affect the process of emission and expulsion, leading more commonly to delayed or absent ejaculation rather than retrograde flow. *Anxiety* - **Anxiety** is generally a *primary symptom* of the conditions SSRIs are prescribed to treat, such as depression or anxiety disorders, not a sexual side effect of the medication itself. - Although SSRIs can initially cause or worsen anxiety in some patients before therapeutic effects are seen, this is a systemic side effect, not a sexual one.

Question 400: At which receptor is the primary action of antipsychotic medications required?

A. M, muscarinic
B. 5HT4 serotonergic
C. D1 dopaminergic
D. D2 dopaminergic (Correct Answer)

Explanation: ***D2 dopaminergic*** - The **antipsychotic effects** of typical (first-generation) antipsychotics are primarily mediated through **D2 receptor blockade** [1]. - Blocking D2 receptors in the **mesolimbic pathway** helps reduce positive symptoms of psychosis like hallucinations and delusions [2]. *M, muscarinic* - **Muscarinic receptor blockade** is a common adverse effect of some antipsychotics, leading to anticholinergic side effects such as **dry mouth** and **blurred vision**, rather than their primary therapeutic action. - This action does not directly contribute to the antipsychotic effect. *D1 dopaminergic* - While D1 receptors are involved in dopamine signaling, they are **not the primary target** for the antipsychotic action of most drugs [1]. - Some atypical antipsychotics may affect D1 receptors, but it's secondary to their D2 antagonism and serotonin modulation. *5HT4 serotonergic* - **Serotonin receptors (5HT)**, particularly 5HT2A, are important targets for atypical (second-generation) antipsychotics. - However, 5HT4 receptors are **not a primary target** for the antipsychotic effects, and 5HT2A blockade modulates dopamine release, which is still connected to the D2 hypothesis.

Question 401: Most common renal sequela of lithium toxicity is?

A. Renal tubular acidosis
B. Glycosuria
C. MPGN
D. Nephrogenic Diabetes Insipidus (Correct Answer)

Explanation: ***Nephrogenic Diabetes Insipidus*** - **Lithium** interferes with the action of **ADH** on the renal tubules, specifically at the **collecting ducts**, leading to an inability to concentrate urine. - This results in **polyuria** (excessive urination) and **polydipsia** (excessive thirst), characteristic symptoms of **nephrogenic diabetes insipidus**. *Renal tubular acidosis* - While lithium can affect tubular function, **renal tubular acidosis** is less common than nephrogenic diabetes insipidus. - RTA involves impaired acid excretion or bicarbonate reabsorption, leading to **metabolic acidosis**. *Glycosuria* - **Glycosuria** (glucose in urine) is primarily associated with **diabetes mellitus** or other conditions affecting glucose reabsorption in the proximal tubule. - Lithium toxicity does not typically cause glycosuria. *MPGN* - **Membranoproliferative glomerulonephritis (MPGN)** is a type of glomerular injury characterized by specific changes in the glomerulus. - MPGN is not directly caused by **lithium toxicity**; lithium primarily affects tubular function rather than glomerular structure.

Question 402: Lithium directly affects which ion ?

A. Sodium (Correct Answer)
B. Potassium
C. Magnesium
D. Calcium

Explanation: ***Sodium*** - Lithium directly interferes with **sodium ion transport** across cell membranes, particularly by inhibiting the **Na+/K+-ATPase** pump. - This interference alters intracellular sodium concentrations and affects neural excitability, contributing to its **mood-stabilizing** effects. *Potassium* - While potassium transport is linked to the **Na+/K+-ATPase pump**, lithium primarily acts through its effect on **sodium transport**, rather than directly mimicking or significantly altering potassium. - Changes in potassium levels due to lithium are largely secondary to its primary impact on sodium. *Magnesium* - Lithium has a more direct impact on **sodium channels** and transporters, contrasting with its less direct or significant interaction with magnesium metabolism. - Though magnesium is crucial for numerous cellular processes, it is not the primary ion directly affected by lithium's therapeutic actions. *Calcium* - Lithium does not directly affect **calcium channels** or calcium signaling pathways in the same way it impacts sodium. - While lithium may indirectly influence calcium-dependent processes, its primary direct target for therapeutic effects is not calcium.

Question 403: Which of the following is a classic tricyclic antidepressant (TCA) commonly used as the prototype for the class?

A. Amitriptyline (Correct Answer)
B. Citalopram
C. Venlafaxine
D. Nortriptyline

Explanation: ***Amitriptyline*** - **Amitriptyline** is a classic tricyclic antidepressant (TCA) and is widely recognized for its use in treating depression, neuropathic pain, and migraine prophylaxis. Its characteristic side effect profile, including **anticholinergic effects** and **sedation**, is well-known. - It is one of the **oldest and most frequently prescribed TCAs**, making it a common reference point in pharmacology and clinical practice. *Citalopram* - **Citalopram** is an **SSRI** (selective serotonin reuptake inhibitor), not a TCA. It works by selectively inhibiting the reuptake of serotonin. - It has a different side effect profile compared to TCAs, generally with fewer anticholinergic and cardiovascular effects. *Venlafaxine* - **Venlafaxine** is an **SNRI** (serotonin-norepinephrine reuptake inhibitor), not a TCA. It inhibits the reuptake of both serotonin and norepinephrine. - It has efficacy in treating depression and anxiety disorders, but its mechanism of action is distinct from TCAs. *Nortriptyline* - **Nortriptyline** is indeed a TCA, specifically a **secondary amine TCA**, which is an active metabolite of amitriptyline. - While it is a TCA, amitriptyline is generally more broadly recognized and used as the prototype for the class, with nortriptyline often being highlighted for its slightly better tolerability profile (e.g., less sedation, less orthostatic hypotension) compared to tertiary amine TCAs like amitriptyline.

Question 404: Which of the following is a tricyclic antidepressant?

A. Fluoxetine
B. Citalopram
C. Doxepin (Correct Answer)
D. Venlafaxine

Explanation: ***Doxepin*** - **Doxepin** is a **tricyclic antidepressant (TCA)** that inhibits the reuptake of **serotonin** and **norepinephrine**, and also has significant **histaminergic** and **cholinergic** blocking effects. - TCAs, including doxepin, are commonly used for treating **depression**, **anxiety**, and certain pain conditions. *Venlafaxine* - **Venlafaxine** is a **serotonin-norepinephrine reuptake inhibitor (SNRI)**, not a tricyclic antidepressant. - SNRIs selectively block the reuptake of both **serotonin** and **norepinephrine**, but lack the broad receptor affinity of TCAs. *Fluoxetine* - **Fluoxetine** is a **selective serotonin reuptake inhibitor (SSRI)**, which specifically targets serotonin reuptake. - SSRIs are generally considered a first-line treatment for depression due to a more favorable side effect profile compared to TCAs. *Citalopram* - **Citalopram** is also a **selective serotonin reuptake inhibitor (SSRI)**, much like fluoxetine. - It works by increasing the levels of **serotonin** in the brain by blocking its reuptake, differentiating it from tricyclic antidepressants.

Question 405: Which amino acid-derived neurotransmitter is primarily targeted in the pharmacological treatment of depression?

A. Histamine
B. None of the options
C. Serotonin (Correct Answer)
D. Acetylcholine

Explanation: ***Serotonin*** - **Serotonin** is an amino acid-derived neurotransmitter (from **tryptophan**) known to play a crucial role in mood regulation, sleep, appetite, and other functions, making it a primary target for **antidepressant medications**. - Medications like **Selective Serotonin Reuptake Inhibitors (SSRIs)** increase serotonin levels in the brain to alleviate symptoms of depression. *Histamine* - **Histamine** is an amino acid-derived neurotransmitter (from **histidine**) primarily involved in allergic reactions, inflammation, and regulating wakefulness. - While it has some central nervous system effects, its primary role is not directly in the treatment of **depression**. *Acetylcholine* - **Acetylcholine** is a neurotransmitter involved in muscle contraction, learning, memory, and attention, and is not derived from amino acids; it is synthesized from **choline** and acetyl-CoA. - It is not directly used for treating **depression**, although imbalances can play a role in cognitive aspects of some psychiatric disorders. *None of the options* - This option is incorrect because **Serotonin** is indeed an amino acid-derived neurotransmitter (from tryptophan) targeted for treating **depression**. - Many antidepressant drugs work by modulating **serotonergic pathways**.

Question 406: Which of the following is not a selective serotonin reuptake inhibitor?

A. Buspirone (Correct Answer)
B. Citalopram
C. Fluoxetine
D. Fluvoxamine

Explanation: ***Buspirone*** - **Buspirone** is an anxiolytic that primarily acts as a **serotonin 5-HT1A receptor partial agonist**, not an SSRI. - It does not significantly affect the reuptake of serotonin, distinguishing it from SSRIs. *Fluoxetine* - **Fluoxetine** is a well-known and widely used **SSRI**. - It works by selectively inhibiting the reuptake of serotonin, thereby increasing its concentration in the synaptic cleft. *Fluvoxamine* - **Fluvoxamine** is another antidepressant classified as an **SSRI**. - It is often used for the treatment of **obsessive-compulsive disorder (OCD)** due to its strong serotonin reuptake inhibition. *Citalopram* - **Citalopram** is an **SSRI** frequently prescribed for depression and anxiety disorders. - Its mechanism involves potent and selective inhibition of **serotonin reuptake**.

Question 407: Which of the following is a selective serotonin and norepinephrine reuptake inhibitor?

A. Fluoxetine
B. Venlafaxine (Correct Answer)
C. Sertraline
D. Aripiprazole

Explanation: ***Venlafaxine*** - **Venlafaxine** is a commonly used antidepressant that inhibits the reuptake of both **serotonin** and **norepinephrine**, making it an SNRI. - Its dual mechanism of action can be effective for a broad range of depressive and anxiety disorders. *Fluoxetine* - **Fluoxetine** is a **selective serotonin reuptake inhibitor (SSRI)**, primarily affecting serotonin levels in the brain. - It does not significantly inhibit norepinephrine reuptake and, thus, is not classified as an SNRI. *Sertraline* - **Sertraline** is another widely prescribed antidepressant that is also a **selective serotonin reuptake inhibitor (SSRI)**. - It works mainly by increasing serotonin availability in the synaptic cleft. *Aripiprazole* - **Aripiprazole** is an **atypical antipsychotic** medication, often used as an adjunct therapy for depression, but its primary mechanism is partial agonism at dopamine D2 and serotonin 5-HT1A receptors, and antagonism at serotonin 5-HT2A receptors. - It is not classified as a selective serotonin and norepinephrine reuptake inhibitor.

Question 408: An SSRI antidepressant, such as fluoxetine, will be prescribed for an adult patient. You should advise him or her that two of the most likely side effects or adverse responses that may eventually occur at therapeutic blood levels are which of the following?

A. Sexual dysfunction and sleep disturbances (Correct Answer)
B. Sexual dysfunction and nausea
C. Headache and diarrhea
D. Tremor and weight gain

Explanation: ***Sexual dysfunction and sleep disturbances*** - **Sexual dysfunction** is one of the most common and persistent adverse effects of SSRIs, affecting 40-65% of patients and continuing throughout treatment at therapeutic levels [2], [3]. - **Sleep disturbances** (insomnia or altered sleep architecture) can persist during long-term SSRI therapy and are among the eventual side effects patients experience [1], [2], [3]. - Both effects are characteristic of chronic SSRI use and significantly impact patient compliance and quality of life. *Sexual dysfunction and nausea* - While **sexual dysfunction** is indeed very common and persistent, **nausea** is typically a transient side effect that occurs during the first 1-2 weeks of treatment and usually resolves with continued use [2]. - The question specifically asks about *eventual* occurrence at therapeutic levels over time, making nausea less appropriate as it is not a chronic issue. *Tremor and weight gain* - **Tremor** is not among the most common side effects of SSRIs and occurs less frequently than sexual dysfunction or sleep disturbances. - **Weight gain** can occur with some SSRIs (particularly paroxetine), but fluoxetine is actually considered weight-neutral or may even cause weight loss in some patients, making this combination less likely for fluoxetine specifically [1]. *Headache and diarrhea* - Both **headache** and **diarrhea** are common initial side effects when starting SSRIs but typically improve or resolve within the first few weeks of treatment [1]. - These are transient effects rather than eventual persistent side effects that characterize long-term therapeutic use.

Question 409: Which of the following is NOT a common effect of tricyclic antidepressants?

A. Prolongation of QRS complexes
B. Myoclonic jerks
C. Metabolic alkalosis (Correct Answer)
D. Coma

Explanation: ***Metabolic alkalosis*** - **Tricyclic antidepressants (TCAs)** do not typically cause metabolic alkalosis. Their overdose or therapeutic use is not associated with this acid-base imbalance. - While TCAs can disrupt various physiological processes, **metabolic alkalosis** is not a characteristic adverse effect or sign of overdose. *Prolongation of QRS complexes* - **TCAs block sodium channels** in the myocardium, which can lead to widening of the **QRS complex**, indicating delayed ventricular depolarization. - This is a significant cardiac toxicity of TCA overdose, increasing the risk of **ventricular arrhythmias**. *Myoclonic jerks* - **TCA overdose** can manifest with **neurological symptoms**, including involuntary muscle contractions like **myoclonic jerks**. - These are often part of the **seizure activity** that can occur with severe TCA toxicity. *Coma* - **Central nervous system depression** is a common and serious effect of TCA overdose, often leading to **coma**. - This is due to the broad **anticholinergic** and **sedative effects** of these drugs at high doses.

Question 410: Which of the following is not classified as a traditional anxiolytic?

A. Fluoxetine (Correct Answer)
B. Buspirone
C. Diazepam
D. Nitrazepam

Explanation: ***Fluoxetine*** - **Fluoxetine** is a **selective serotonin reuptake inhibitor (SSRI)** primarily used as an antidepressant, not a traditional anxiolytic. - While SSRIs are now used to treat anxiety disorders, they are not classified as traditional anxiolytics, which historically refer to benzodiazepines and related compounds. - Traditional anxiolytics work primarily through GABAergic mechanisms, whereas fluoxetine works through serotonin reuptake inhibition. *Buspirone* - **Buspirone** is a non-benzodiazepine anxiolytic that acts as a partial agonist at 5-HT1A serotonin receptors. - It is specifically indicated and FDA-approved for the treatment of generalized anxiety disorder. - Though it has a different mechanism from benzodiazepines, it is classified as an anxiolytic agent. *Diazepam* - **Diazepam** is a **benzodiazepine** that enhances the effect of the neurotransmitter **GABA** at the **GABA-A receptor**, leading to sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties. - It is a classic and widely recognized traditional anxiolytic, representing the prototypical benzodiazepine anxiolytic. *Nitrazepam* - **Nitrazepam** is a **benzodiazepine**, primarily indicated as a **hypnotic** for the treatment of severe insomnia. - As a benzodiazepine, it belongs to the traditional anxiolytic drug class and possesses anxiolytic properties through GABAergic mechanisms. - Despite being primarily used as a hypnotic, it is still considered part of the traditional anxiolytic class (benzodiazepines).

Question 411: Which of the following antidepressant drugs is used in the treatment of nocturnal enuresis?

A. Imipramine (Correct Answer)
B. Fluoxetine
C. Trazodone
D. Sertraline

Explanation: ***Imipramine*** - **Imipramine**, a **tricyclic antidepressant (TCA)**, is effective in treating nocturnal enuresis, particularly in children. - Its mechanism of action in this context is thought to involve anticholinergic effects, leading to **increased bladder capacity**, and alpha-adrenergic effects, causing **contraction of the internal urethral sphincter**. *Fluoxetine* - **Fluoxetine** is a **selective serotonin reuptake inhibitor (SSRI)** primarily used to treat depression, anxiety disorders, and obsessive-compulsive disorder. - It does not have a primary indication or established efficacy for the treatment of nocturnal enuresis. *Trazodone* - **Trazodone** is an **antidepressant** with sedative properties, often used for insomnia and depression. - While it modulates serotonin, it is not a first-line or established treatment for nocturnal enuresis. *Sertraline* - **Sertraline** is another **selective serotonin reuptake inhibitor (SSRI)** commonly prescribed for depression, anxiety, and panic disorder. - Like other SSRIs, it is not indicated for and has no significant role in the management of nocturnal enuresis.

Question 412: What is the drug of choice for treating delirium tremens?

A. Phenytoin
B. Morphine
C. Lorazepam (Correct Answer)
D. Diazepam

Explanation: ***Lorazepam*** - **Benzodiazepines** are the first-line treatment for **delirium tremens** due to their effectiveness in reducing central nervous system hyperexcitability through GABA-A receptor agonism. - **Lorazepam** is often preferred, especially in patients with liver impairment (common in chronic alcoholics), because it is metabolized by **glucuronidation** rather than hepatic oxidation, making it safer in hepatic dysfunction. - It has an **intermediate half-life (10-20 hours)** with **no active metabolites**, providing predictable pharmacokinetics and easier dose titration. - Can be administered via multiple routes (IV, IM, oral), making it versatile in acute settings. *Diazepam* - Also a **first-line benzodiazepine** for alcohol withdrawal and delirium tremens, particularly effective in patients with normal liver function. - Has a **long half-life (20-100 hours)** with **active metabolites** (desmethyldiazepam), which can accumulate in patients with hepatic impairment, leading to prolonged sedation. - Metabolized by hepatic **oxidation** (CYP450), making it less ideal in liver disease. - The longer duration of action can be advantageous for tapering protocols but may cause excessive sedation in vulnerable patients. *Phenytoin* - **Phenytoin** is an **anticonvulsant** that is **not effective** for treating delirium tremens or alcohol withdrawal seizures as monotherapy. - It does not address the primary pathophysiology of alcohol withdrawal, which involves GABAergic and glutamatergic system imbalance. - May be used as **adjunctive therapy** in patients with concurrent seizure disorders, but benzodiazepines remain the mainstay. *Morphine* - **Morphine** is an **opioid analgesic** with **no role** in the treatment of delirium tremens. - Use of opioids could **worsen respiratory depression**, particularly dangerous in agitated patients with potential for aspiration. - Does not address the neurochemical basis of alcohol withdrawal and may complicate management.

Question 413: Which drug is most commonly used worldwide in maintenance treatment for opioid dependence?

A. Disulfiram
B. Methadone (Correct Answer)
C. Naltrexone
D. Imipramine

Explanation: ***Methadone (Correct Answer)***- It is a **long-acting opioid agonist** that helps reduce cravings and withdrawal symptoms associated with opioid dependence, making it highly effective for maintenance treatment [2].- Its widespread availability and established efficacy in reducing illicit opioid use, crime, and disease transmission contribute to its global prevalence [1].- Methadone acts on **μ-opioid receptors** [2] and has a long half-life (24-36 hours), allowing once-daily dosing in maintenance therapy.*Disulfiram (Incorrect)*- This drug is primarily used in the management of **alcohol dependence** by causing unpleasant reactions when alcohol is consumed (inhibits aldehyde dehydrogenase) [3].- It has no role in the treatment of opioid dependence, as its mechanism of action is unrelated to opioid receptors.*Naltrexone (Incorrect)*- While used for opioid dependence, **naltrexone** is an **opioid antagonist** that blocks the effects of opioids [4].- Its use requires complete detoxification from opioids before initiation to avoid precipitated withdrawal, which can be a barrier to its common use in maintenance compared to methadone [1].- Less commonly used globally compared to methadone for maintenance treatment.*Imipramine (Incorrect)*- **Imipramine** is a **tricyclic antidepressant** primarily used to treat depression and some anxiety disorders.- It does not have any direct pharmacological action on opioid receptors and is not used in the treatment of opioid dependence.

Question 414: Which of the following antipsychotic medications is most commonly used in depot preparation?

A. Haloperidol (Correct Answer)
B. Olanzapine
C. Fluphenazine
D. Risperidone

Explanation: ***Haloperidol*** - **Haloperidol decanoate** is the **most commonly used** depot antipsychotic preparation worldwide - It has been available since the **1970s** and remains the **gold standard** for long-acting injectable antipsychotics - Advantages include **long history of use**, **well-established efficacy**, **wide availability**, and **low cost** - Administered as **intramuscular injection** typically every **2-4 weeks** - Main limitation is higher risk of **extrapyramidal symptoms (EPS)** compared to second-generation depot antipsychotics *Risperidone* - **Risperidone** is available in depot formulations (**Risperdal Consta** - microspheres, **Risperdal Sustenna** - extended-release) - While widely used, it is **not the most common** depot preparation globally - Advantages include being a **second-generation antipsychotic** with lower EPS risk than haloperidol - More expensive than haloperidol decanoate, limiting its use in resource-constrained settings *Olanzapine* - **Olanzapine pamoate** is available as a **long-acting injectable** formulation - Requires mandatory **3-hour post-injection observation** due to risk of **post-injection delirium/sedation syndrome (PDSS)** - This monitoring requirement limits its practical use compared to other depot preparations - Less commonly used than haloperidol or risperidone depot formulations *Fluphenazine* - **Fluphenazine decanoate** is another first-generation antipsychotic available in depot form - Has been used since the 1960s-70s for maintenance therapy in schizophrenia - Similar to haloperidol in terms of EPS risk but less commonly used in current practice

Question 415: Myocarditis is a side effect of which drug(s)?

A. clozapine (Correct Answer)
B. aripiprazole
C. olanzapine
D. chlorpromazine

Explanation: ***Clozapine*** - **Clozapine** is an atypical antipsychotic known to cause several serious side effects, including **myocarditis**, particularly during the initial weeks of treatment. - Patients on clozapine must be monitored for symptoms of myocarditis, such as **tachycardia**, **fever**, chest pain, and fatigue. *Aripiprazole* - **Aripiprazole** is generally considered to have a favorable cardiovascular safety profile compared to other antipsychotics. - While it can cause some cardiovascular side effects like **orthostatic hypotension**, **myocarditis** is not a commonly associated side effect. *Olanzapine* - **Olanzapine** is associated with metabolic side effects such as weight gain, dyslipidemia, and hyperglycemia. - Although it can rarely cause other cardiovascular issues like **QT prolongation**, **myocarditis** is not a characteristic adverse effect. *Chlorpromazine* - **Chlorpromazine** is a first-generation antipsychotic often linked to **QT prolongation** and **orthostatic hypotension**. - While it can have cardiovascular effects, **myocarditis** is not typically listed as one of its prominent or common adverse reactions.

Question 416: Which of the following is an atypical antipsychotic?

A. Clozapine (Correct Answer)
B. Chlorpromazine
C. Thiothixene
D. Haloperidol

Explanation: ***Clozapine*** - **Clozapine** is an **atypical antipsychotic** characterized by its efficacy in treating **refractory schizophrenia** and a lower risk of **extrapyramidal symptoms (EPS)** compared to typical antipsychotics. - Its mechanism involves antagonism of **dopamine D2** and **serotonin 5-HT2A** receptors, as well as several other receptor types. *Chlorpromazine* - **Chlorpromazine** is a **typical (first-generation) antipsychotic**, known for its strong **D2 blockade** and higher incidence of **extrapyramidal side effects**. - It was one of the first antipsychotics developed and is also used for its **antiemetic** properties. *Thiothixene* - **Thiothixene** is a **typical (first-generation) antipsychotic** that primarily acts by blocking **dopamine D2 receptors**. - It is associated with a higher risk of **extrapyramidal symptoms** and other side effects characteristic of typical antipsychotics. *Haloperidol* - **Haloperidol** is a **high-potency typical (first-generation) antipsychotic** with potent **D2 receptor antagonism**. - It is often used for acute psychosis and delirium but carries a significant risk of **extrapyramidal side effects** and **tardive dyskinesia**.

Question 417: Which of the following drugs is not useful in the rehabilitation of alcoholic patients?

A. Acamprosate
B. Rimonabant (Correct Answer)
C. Naltrexone
D. Varenicline

Explanation: Rimonabant - Rimonabant is an inverse agonist of the cannabinoid CB1 receptor that was used as an anti-obesity drug. [1] - It was withdrawn from the market due to significant psychiatric side effects, including depression and suicidal ideation. [1] - Rimonabant has absolutely no role in alcohol rehabilitation and is no longer available for clinical use. Acamprosate - Acamprosate is commonly used in alcohol rehabilitation to reduce alcohol cravings and promote abstinence in detoxified alcohol-dependent individuals. [2] - It is thought to act by restoring the balance between excitation and inhibition in the brain, particularly by modulating glutamate and GABA neurotransmission. - It is FDA-approved for maintenance of alcohol abstinence. Naltrexone - Naltrexone is an opioid receptor antagonist used to reduce alcohol craving and relapse by blocking the pleasurable effects of alcohol. [2], [3] - It is available in both oral and intramuscular long-acting injectable forms and is FDA-approved for alcohol use disorder. [3] - It can also be used for opioid use disorder. [3] Varenicline - Varenicline is a partial agonist of the nicotinic acetylcholine receptor and is primarily FDA-approved for smoking cessation. - Some research has explored its potential for reducing alcohol consumption due to its effects on reward pathways, though it is not FDA-approved for alcohol dependence. - Unlike rimonabant (which is withdrawn and has no role), varenicline has some supporting evidence in alcohol treatment, though it remains off-label use.

Question 418: Which of the following antipsychotics is a partial D2 agonist?

A. Clozapine
B. Quetiapine
C. Ziprasidone
D. Aripiprazole (Correct Answer)

Explanation: Aripiprazole - Aripiprazole is a D2 partial agonist [1][3], meaning it acts as an agonist in areas with low dopamine and an antagonist in areas with high dopamine [3]. - This unique mechanism helps to stabilize dopamine activity, leading to fewer extrapyramidal symptoms and hyperprolactinemia compared to typical antipsychotics. Clozapine - Clozapine is a D2 antagonist with a high affinity for D4 receptors and potent antagonism of 5-HT2A receptors; it is known for its efficacy in treatment-resistant schizophrenia [2]. - It carries a risk of severe side effects such as agranulocytosis [2] and myocarditis, requiring regular blood monitoring. Quetiapine - Quetiapine is primarily a D2 antagonist with significant antagonism at histamine H1 and alpha-1 adrenergic receptors, contributing to its sedative and orthostatic hypotensive effects. - It is known for its relatively low risk of extrapyramidal symptoms due to its rapid dissociation from D2 receptors. Ziprasidone - Ziprasidone is a D2 antagonist and a serotonin 5-HT1A agonist and 5-HT2C antagonist, contributing to its antidepressant and anti-anxiety effects. - It is associated with a risk of QTc prolongation, which necessitates cardiac monitoring in susceptible patients.

Question 419: Which is the mood stabilizer with a narrow therapeutic index?

A. lithium (Correct Answer)
B. valproate
C. lamotrigine
D. carbamazepine

Explanation: Correct Option: Lithium - Lithium has a narrow therapeutic index, meaning there is a small difference between therapeutic and toxic doses (therapeutic range: 0.6-1.2 mEq/L; toxic level: >1.5 mEq/L) [1] - This narrow therapeutic window necessitates frequent monitoring of serum lithium levels and careful dosage adjustments to prevent toxicity while maintaining efficacy in mood stabilization [2] - Common signs of lithium toxicity include tremor, confusion, ataxia, and in severe cases, seizures and renal failure Incorrect Option: Valproate - While valproate is an effective mood stabilizer, its therapeutic index is wider compared to lithium, making it generally safer with less stringent monitoring requirements for toxicity [4] - It's associated with adverse effects like hepatotoxicity and pancreatitis, but acute toxicity from minor dose variations is less common than with lithium Incorrect Option: Carbamazepine - Carbamazepine is an anticonvulsant and mood stabilizer with a wider therapeutic index than lithium, though it requires monitoring for drug interactions and hematologic effects (agranulocytosis, aplastic anemia) [3] - Common side effects include dizziness, ataxia, and hyponatremia, but the risk of severe toxicity from minor dose changes is significantly lower than with lithium [3] Incorrect Option: Lamotrigine - Lamotrigine is a mood stabilizer used for bipolar disorder with a relatively wide therapeutic index, especially when compared to lithium - The most concerning side effect is Stevens-Johnson syndrome, a rare but serious skin rash, which risk is increased by rapid dose escalation; requires slow titration

Question 420: What is the primary use of Naltrexone in the context of opioid dependence?

A. Prevent relapse (Correct Answer)
B. Prevent respiratory depression
C. Treatment of opioid overdose
D. Treat withdrawal symptoms

Explanation: ***Prevent relapse*** - **Naltrexone** is an **opioid antagonist** that blocks opioid receptors, thereby preventing the euphoric and other intoxicating effects of opioids. - This action helps to reduce cravings and deter opioid use, making it a primary medication for **relapse prevention** in individuals with opioid dependence. *Prevent respiratory depression* - Preventing respiratory depression is not the primary use of naltrexone; opioid antagonists like **naloxone** are used to reverse **opioid-induced respiratory depression** in overdose situations. - Naltrexone is used for longer-term management and does not have a direct role in acute respiratory support. *Treatment of opioid overdose* - While both are opioid antagonists, **naloxone** is the drug of choice for immediate **opioid overdose reversal** due to its rapid onset and shorter duration of action. - Naltrexone has a slower onset and longer duration, making it unsuitable for acute overdose treatment. *Treat withdrawal symptoms* - **Naltrexone** is generally *not* used to treat acute opioid withdrawal symptoms because it can precipitate or worsen withdrawal by blocking opioid receptors. - Withdrawal symptoms are typically managed with opioid agonists like **buprenorphine** or other symptomatic treatments.

Question 421: Which of the following is not an antidepressant?

A. Fluoxetine
B. Trazodone
C. Pimozide (Correct Answer)
D. Amitriptyline

Explanation: ***Pimozide*** - **Pimozide** is a **first-generation antipsychotic** medication primarily used to treat **Tourette's syndrome** and chronic severe tics, not depression [1], [2]. - Its mechanism involves blocking **dopamine D2 receptors**, differentiating it from typical antidepressant actions. *Amitriptyline* - **Amitriptyline** is a **tricyclic antidepressant (TCA)** commonly used to treat depression, anxiety, and neuropathic pain [2]. - Its antidepressant effect is due to the **inhibition of serotonin and norepinephrine reuptake** [2]. *Fluoxetine* - **Fluoxetine** is a widely prescribed **selective serotonin reuptake inhibitor (SSRI)**, making it a common antidepressant [2]. - It specifically **blocks the reuptake of serotonin**, leading to increased serotonin levels in the synaptic cleft [2]. *Trazodone* - **Trazodone** is an **antidepressant** with significant sedative properties, often used for depression associated with insomnia. - It acts as a **serotonin antagonist and reuptake inhibitor (SARI)**, with effects on 5-HT2A receptors and serotonin reuptake.

Question 422: Which of the following medications is most commonly associated with causing Neuroleptic Malignant Syndrome (NMS)?

A. Metoclopramide
B. Phenothiazines
C. Haloperidol (Correct Answer)
D. Clozapine

Explanation: ***Haloperidol*** - **Haloperidol** is a potent **first-generation (typical) antipsychotic** (butyrophenone class) that strongly blocks **dopamine D2 receptors**. - This potent D2 antagonism is the primary mechanism underlying the development of **Neuroleptic Malignant Syndrome (NMS)**. - The risk of NMS is **highest** with high-potency typical antipsychotics like haloperidol, especially when initiated at **high doses** or with **rapid dose escalation**. - Haloperidol is the **most commonly cited** individual agent associated with NMS in medical literature. *Phenothiazines* - **Phenothiazines** (e.g., chlorpromazine, fluphenazine) are a class of **first-generation antipsychotics** that also cause NMS due to **dopamine D2 receptor blockade**. - While phenothiazines as a class are associated with NMS, **haloperidol** (a butyrophenone) is considered the **prototypical** and most commonly cited individual drug for NMS. - High-potency phenothiazines (like fluphenazine) carry higher NMS risk than low-potency ones (like chlorpromazine). *Metoclopramide* - Metoclopramide is primarily an **antiemetic** and **prokinetic agent** that has **dopamine-blocking** properties (D2 antagonist). - It has been **rarely** associated with NMS or NMS-like reactions, but this is far less common compared to potent antipsychotics. - Its primary use is for gastrointestinal disorders, not psychiatric conditions. *Clozapine* - **Clozapine** is an **atypical (second-generation) antipsychotic** with relatively **weak D2 receptor affinity** and stronger effects on serotonin receptors. - It has the **lowest risk** of causing NMS among all antipsychotics due to its unique receptor binding profile. - Clozapine is actually sometimes used as an alternative in patients who have experienced NMS with typical antipsychotics.

Question 423: Which drug is the most useful in treating an episode of antipsychotic-induced acute dystonia?

A. Procyclidine
B. Benztropine (Correct Answer)
C. Biperiden
D. Trihexyphenidyl

Explanation: ***Benztropine*** - **Benztropine** is an anticholinergic medication that is the **conventional first-line treatment** for acute dystonic reactions caused by antipsychotics. - It works by blocking muscarinic acetylcholine receptors, thereby restoring the balance between **dopamine** and **acetylcholine** in the basal ganglia. - Can be administered **IV or IM**, providing rapid relief within 15-30 minutes. - Most commonly recommended in standard pharmacology references for Indian medical examinations. *Biperiden* - **Biperiden** is also an effective anticholinergic used for acute dystonia and can be given **IV or IM**. - Has a very rapid onset when given IV (2-5 minutes), making it equally effective for acute episodes. - While both biperiden and benztropine are acceptable first-line agents, **benztropine** is more conventionally cited in standard teaching. *Procyclidine* - **Procyclidine** is another anticholinergic drug used to treat extrapyramidal side effects, including dystonia. - Primarily available as **oral formulation**, making it less suitable for acute emergencies requiring immediate intervention. - More appropriate for maintenance therapy or less severe extrapyramidal symptoms. *Trihexyphenidyl* - **Trihexyphenidyl** is an anticholinergic medication used for drug-induced parkinsonism and dystonia. - Available only in **oral form**, making it unsuitable for acute dystonic crises requiring rapid reversal. - Better suited for chronic management rather than acute emergency treatment.

Question 424: Antipsychotic drug with the least extrapyramidal symptoms?

A. Pimozide
B. Clozapine (Correct Answer)
C. Fluphenazine
D. Thioridazine

Explanation: ***Clozapine***- **Atypical antipsychotics** like clozapine have a **lower affinity for D2 dopamine receptors** and a higher affinity for serotonin 5-HT2A receptors, which contributes to their reduced risk of EPS.- It is known for its effectiveness in **treatment-resistant schizophrenia** and its **low propensity for causing movement disorders** [1, 2].*Pimozide*- **Pimozide** is a **typical antipsychotic** (first-generation) that has a high affinity for D2 dopamine receptors.- This strong D2 antagonism leads to a **higher risk of extrapyramidal symptoms**.*Thioridazine*- **Thioridazine** is a **low-potency typical antipsychotic** that, while having a lower incidence of EPS compared to high-potency typicals, still carries a significant risk [1].- It is associated with other side effects such as **cardiac conduction abnormalities** (e.g., QT prolongation) at higher doses.*Fluphenazine*- **Fluphenazine** is a **high-potency typical antipsychotic** with strong D2 receptor antagonism.- High-potency typical antipsychotics like **Fluphenazine** are known for their **high risk of extrapyramidal symptoms** [1].

Question 425: Which drug is used for long-term maintenance in opioid addiction?

A. Naloxone
B. Nalorphine
C. Methadone (Correct Answer)
D. Butorphanol

Explanation: ***Methadone*** - **Methadone** is a long-acting opioid agonist used daily for **maintenance therapy** in opioid addiction, preventing withdrawal symptoms and reducing cravings. - Its long half-life allows for once-daily dosing, which helps in stabilizing patients and reducing illicit opioid use. - Along with **buprenorphine** (a partial agonist), methadone is one of the two primary medications used for opioid maintenance therapy. *Naloxone* - **Naloxone** is an **opioid antagonist** used to rapidly reverse opioid overdose by competitively binding to opioid receptors. - It is not used for long-term maintenance but rather as an emergency intervention to counteract life-threatening respiratory depression. *Nalorphine* - **Nalorphine** is an older, mixed opioid agonist-antagonist that was once used for opioid overdose but has largely been replaced by naloxone due to its own opioid agonistic effects. - It does not have a role in current long-term maintenance treatment for opioid addiction. *Butorphanol* - **Butorphanol** is a mixed opioid agonist-antagonist primarily used as an analgesic, particularly for pain management. - It can precipitate withdrawal in opioid-dependent individuals and is not indicated for the treatment or maintenance of opioid addiction.

Question 426: Which of the following is a typical antipsychotic drug?

A. Risperidone
B. Olanzapine
C. Clozapine
D. Haloperidol (Correct Answer)

Explanation: ***Haloperidol*** - **Haloperidol** is a **first-generation (typical)** antipsychotic that primarily blocks **D2 dopamine receptors** in the brain. - It is often used for acute psychotic episodes and has a higher risk of **extrapyramidal symptoms (EPS)** compared to atypical antipsychotics. *Clozapine* - **Clozapine** is an **atypical (second-generation)** antipsychotic, known for its effectiveness in **treatment-resistant schizophrenia**. - Its mechanism involves broader receptor binding, including **dopamine** and **serotonin** receptors, and it carries risks like **agranulocytosis** and **myocarditis**. *Risperidone* - **Risperidone** is an **atypical (second-generation)** antipsychotic, known for its mixed **D2 dopamine** and **5-HT2A serotonin** receptor antagonism. - It has a lower risk of EPS than typical antipsychotics but can cause dose-dependent **hyperprolactinemia**. *Olanzapine* - **Olanzapine** is an **atypical (second-generation)** antipsychotic with broad receptor binding, including **dopamine, serotonin, histamine, and muscarinic receptors**. - It is associated with a significant risk of **metabolic side effects**, such as weight gain, hyperglycemia, and dyslipidemia.

Question 427: Which of the following drugs is given for detoxification of alcohol in chronic alcoholics?

A. Haloperidol
B. Naltrexone
C. Chlordiazepoxide (Correct Answer)
D. Buprenorphine

Explanation: ***Correct Option: Chlordiazepoxide*** - **Chlordiazepoxide** is a **benzodiazepine** commonly used for acute alcohol withdrawal syndrome due to its long half-life and efficacy in reducing withdrawal symptoms. - It helps prevent **seizures** and **delirium tremens** by acting on GABA receptors, reducing neuronal hyperexcitability. *Incorrect Option: Haloperidol* - **Haloperidol** is an **antipsychotic** medication primarily used to manage acute psychosis, agitation, or delirium. - It does not directly address alcohol withdrawal symptoms and can potentially lower the **seizure threshold**, which is risky in alcohol withdrawal. *Incorrect Option: Naltrexone* - **Naltrexone** is an **opioid antagonist** used to reduce alcohol cravings and prevent relapse in individuals who have achieved abstinence. - It is not used for acute detoxification or withdrawal management, as it does not alleviate acute symptoms. *Incorrect Option: Buprenorphine* - **Buprenorphine** is a **partial opioid agonist** used primarily in the treatment of opioid use disorder. - It has no role in the detoxification or management of alcohol withdrawal syndrome.

Question 428: Sedation as an adverse effect is most commonly associated with which of the following atypical antipsychotics?

A. Risperidone
B. Olanzapine
C. Quetiapine (Correct Answer)
D. Aripiprazole

Explanation: ***Quetiapine*** - **Quetiapine** is known for its strong **H1 histamine receptor blockade**, which directly contributes to its prominent sedating effects. - This sedation is often dose-dependent and can be beneficial for patients with insomnia or agitation, but it is also a common complaint and reason for discontinuation. - Among the options listed, quetiapine is classically taught as the **most sedating** atypical antipsychotic. *Risperidone* - While risperidone can cause some sedation [1], it is generally less sedating than quetiapine or olanzapine and is more commonly associated with **extrapyramidal symptoms (EPS)**, especially at higher doses [1]. - Its mechanism of action primarily involves **D2 dopamine receptor blockade** and **5-HT2A serotonin receptor blockade** [1]. *Olanzapine* - **Olanzapine** also causes significant sedation [1] due to its strong antagonism of **H1 histamine receptors** and **alpha-1 adrenergic receptors**. - Clinically, olanzapine's sedative effects are comparable to quetiapine, though quetiapine is traditionally emphasized in exam contexts as the most sedating among these options. - Olanzapine is additionally notable for significant **metabolic side effects** like weight gain and dyslipidemia. *Aripiprazole* - **Aripiprazole** acts as a **partial agonist** at D2 dopamine receptors and 5-HT1A serotonin receptors, and an antagonist at 5-HT2A serotonin receptors, which results in minimal sedation. - It is often considered to be more **activating** or have a **neutral** effect on sedation compared to other atypical antipsychotics.

Question 429: Which of the antidepressants is used in low doses as a hypnotic?

A. fluoxetine
B. fluvoxamine
C. bupropion
D. trazodone (Correct Answer)

Explanation: ***trazodone*** - **Trazodone** is an antidepressant that is frequently prescribed off-label at low doses as a **hypnotic** due to its potent **histamine H1 receptor antagonism** and **alpha-1 adrenergic blocking effects**, inducing sedation. - Its sedative properties differentiate it from other antidepressants that are primarily stimulating. *fluoxetine* - **Fluoxetine** is a **selective serotonin reuptake inhibitor (SSRI)** known for its **activating** effects, making it a poor choice for a hypnotic. - It is more likely to cause **insomnia** and agitation rather than sedation. *fluvoxamine* - **Fluvoxamine** is another **SSRI** primarily used for **obsessive-compulsive disorder (OCD)**. - Like other SSRIs, its primary action is not sedation, and it can sometimes lead to **sleep disturbances**. *bupropion* - **Bupropion** is a **norepinephrine-dopamine reuptake inhibitor (NDRI)** known for its **stimulating effects** and lack of sexual side effects. - It is often avoided in patients with **insomnia** due to its activating properties and is not used as a hypnotic.

Question 430: Antipsychotic drug causing retinal pigment disorder is which?

A. Clozapine
B. Chlorpromazine
C. None of the options
D. Thioridazine (Correct Answer)

Explanation: ***Thioridazine*** - **Thioridazine** is a **first-generation antipsychotic** known to cause **retinal pigmentary changes** (pigmentary retinopathy) at high doses, particularly above 800 mg/day. - This condition can lead to **vision loss** due to the deposition of melanin-like pigment in the retina and progressive retinal degeneration. - This is a dose-related toxic effect and is one of the reasons thioridazine is less commonly used today. *Clozapine* - **Clozapine** is primarily associated with severe side effects like **agranulocytosis** and **myocarditis**. - It is not typically known to cause **retinal pigment disorder** as a common or significant side effect. *Chlorpromazine* - **Chlorpromazine**, another first-generation antipsychotic, is more commonly linked to **corneal and lenticular opacities** (blue-gray discoloration of the eye) than retinal pigment changes. - While it can affect the eye, its primary ocular toxicity differs from the **retinal pigment disorder** caused by thioridazine. *None of the options* - This option is incorrect because **Thioridazine** is a well-established cause of **retinal pigment disorder**. - There is a specific antipsychotic drug listed that causes this condition.

Question 431: What is a common side effect of a selective serotonin reuptake inhibitor (SSRI) medication prescribed to a 50-year-old woman with depression?

A. Hepatotoxicity
B. Weight gain
C. Hypertension
D. Decreased libido and difficulty achieving orgasm (Correct Answer)

Explanation: ***Decreased libido and difficulty achieving orgasm*** - **Sexual dysfunction**, including decreased libido, anorgasmia, and ejaculatory delay, is a very common and often dose-dependent side effect of SSRIs. - This is attributed to increased serotonin levels affecting **dopamine** and **norepinephrine** pathways involved in sexual response. *Hepatotoxicity* - While possible with many medications, **severe hepatotoxicity** is rare with SSRIs and not considered a common side effect in routine clinical practice. - Liver enzyme elevations can occur, but significant liver damage requiring discontinuation is infrequent. *Weight gain* - **Weight gain** is a known side effect of some antidepressants, particularly **tricyclic antidepressants (TCAs)** and some **atypical antipsychotics**, but it is less consistently associated with SSRIs. - Although some SSRIs can cause weight gain, it is not as universally common or as prominent as sexual dysfunction. *Hypertension* - **Hypertension** is not a common side effect of SSRIs; in fact, some studies suggest a potential for SSRIs to slightly lower **blood pressure**. - **Serotonin-norepinephrine reuptake inhibitors (SNRIs)**, like venlafaxine, are more likely to cause dose-dependent increases in blood pressure.

Practice by Chapter

Antipsychotics: Typical and Atypical

Practice Questions

Antidepressants: SSRIs and SNRIs

Practice Questions

Tricyclic Antidepressants

Practice Questions

MAO Inhibitors

Practice Questions

Mood Stabilizers

Practice Questions

Anxiolytics

Practice Questions

Drugs for ADHD

Practice Questions

Drugs for Sleep Disorders

Practice Questions

Drugs for Dementia

Practice Questions

Drug-Induced Psychiatric Symptoms

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free

Drugs in Psychiatric Disorders — MCQs

Drugs in Psychiatric Disorders — MCQs

On this page